data_2cpf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cpf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.895 0.378 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.7 p -103.14 150.0 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.53 7.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.4 mt -148.88 123.85 10.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -93.65 130.54 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.22 142.76 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -128.71 165.85 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 60.93 47.85 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 38.4 mt -90.83 113.53 25.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -52.22 121.49 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -44.86 -32.11 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.2 t -68.2 -41.33 81.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 85.8 m -46.28 146.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 38.3 p -121.17 174.71 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.04 -38.06 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -54.01 -59.79 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 59.2 m -54.16 -46.08 72.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.465 HD12 ' CE1' ' A' ' 380' ' ' PHE . 22.2 tp -54.0 -46.01 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 381' ' ' SER . 24.4 mtpp -60.56 -41.12 93.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.65 -51.86 54.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.469 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 68.5 t -59.8 -39.34 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.465 ' CE1' HD12 ' A' ' 376' ' ' LEU . 11.0 m-85 -82.16 -21.21 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 377' ' ' LYS . 2.0 t -68.92 -14.84 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -66.85 -41.27 87.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 420' ' ' ALA . 3.9 t -67.49 -48.91 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.155 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.09 38.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.96 123.09 23.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.138 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.401 HD12 ' CB ' ' A' ' 380' ' ' PHE . 19.1 mt -81.17 130.35 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -76.29 -51.21 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 27.1 t -159.26 134.01 8.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 15.2 p -123.1 126.82 47.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 16.2 m -143.5 122.36 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 392' ' ' SER . 34.1 mt -101.01 142.75 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.441 ' N ' HG21 ' A' ' 391' ' ' ILE . 73.8 m -60.78 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -121.86 135.35 54.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.63 167.41 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.67 106.83 15.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.5 p30 -84.98 179.27 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -39.35 -48.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.89 74.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.51 22.4 26.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 401' ' ' LEU . 44.7 t -101.32 143.0 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.461 ' N ' HG13 ' A' ' 400' ' ' VAL . 1.9 mm? -72.24 99.71 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.55 140.64 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 31.6 m -58.05 162.91 3.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 21.4 mtm -117.04 16.26 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.23 3.79 63.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -158.29 157.06 31.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -153.9 -172.96 22.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -137.39 119.26 15.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 36.5 t -107.47 138.48 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -118.56 150.66 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . 0.56 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.5 m-85 -122.6 163.08 20.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -70.68 -30.87 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -139.63 143.7 36.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.64 -42.03 23.95 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 418' ' ' GLN . 7.4 tt0 -51.71 -66.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -37.82 -48.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -63.23 -40.13 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 415' ' ' GLU . 45.7 mm-40 -60.86 -33.98 73.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -79.03 -60.14 2.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 383' ' ' VAL . . . -50.32 -24.51 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 14.0 tp -50.08 -66.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.404 ' C ' ' HD2' ' A' ' 422' ' ' LYS . 0.6 OUTLIER -90.99 -35.18 14.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -49.64 -43.14 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 95.0 mt -85.81 -18.28 33.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 8.0 tp60 -62.22 142.38 57.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 88.29 -18.68 39.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -57.83 121.86 11.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.6 m -71.15 96.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.61 123.05 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 59.08 28.81 18.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.64 -4.19 52.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.444 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -124.05 149.33 46.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -91.01 140.14 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.489 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 14.0 mt -97.89 154.61 17.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -104.45 103.38 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.24 132.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -139.98 152.17 46.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 8.7 mm -71.37 96.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.88 0.372 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.0 p -112.95 136.98 52.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.72 137.99 3.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.3 119.02 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.372 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -99.19 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.45 ' CD1' ' N ' ' A' ' 364' ' ' ILE . 1.2 mm -98.72 142.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -129.66 163.23 26.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 6.3 t30 72.49 32.53 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 32.5 mt -81.5 131.79 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.432 HD22 ' CD2' ' A' ' 432' ' ' HIS . 5.0 m120 -71.7 125.82 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -45.88 -31.22 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 85.3 p -68.54 -38.25 80.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 45.9 m -57.79 137.37 56.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 69.0 p -114.87 176.35 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -65.59 -46.81 77.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.89 -55.0 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 56.9 m -59.93 -51.8 68.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.509 HD11 ' CE1' ' A' ' 380' ' ' PHE . 8.9 tp -51.16 -42.54 60.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -57.62 -47.66 81.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.25 -43.88 97.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.06 -45.86 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 0.0 111.141 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.509 ' CE1' HD11 ' A' ' 376' ' ' LEU . 10.1 m-85 -80.22 -26.41 39.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.0 t -61.95 -16.36 50.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -67.22 -20.97 65.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 73.8 t -84.51 -48.66 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -171.95 -166.77 31.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.93 26.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.2 mt -92.55 139.16 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.168 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -53.86 3.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.0 t -151.36 126.97 10.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 49.7 t -127.36 118.72 24.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 167.05 20.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 392' ' ' SER . 74.6 mt -126.65 143.7 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.46 ' N ' HG21 ' A' ' 391' ' ' ILE . 32.1 m -72.69 103.76 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.87 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -114.34 137.95 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' A' ' 395' ' ' LYS . 4.7 ttpt -127.2 149.43 49.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.939 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.468 ' N ' ' HG3' ' A' ' 394' ' ' LYS . 49.8 mttm -69.49 105.24 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 399' ' ' GLY . 2.0 p30 -81.69 179.09 7.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -41.39 -41.53 2.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -71.22 -32.52 68.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.58 15.65 49.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 401' ' ' LEU . 41.3 t -96.67 143.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.459 ' N ' HG13 ' A' ' 400' ' ' VAL . 1.5 mm? -74.27 99.64 3.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.85 156.33 36.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 21.3 m -57.78 158.72 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.481 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 23.1 mtm -117.06 15.79 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.84 69.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 404' ' ' MET . 5.5 p90 -155.5 155.36 33.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.361 . . . . 0.0 110.895 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.42 25.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.449 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -121.66 121.82 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 76.9 t -116.45 130.47 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -112.55 147.7 36.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.44 153.35 34.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -62.71 -33.42 75.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -125.28 159.8 58.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.566 0.698 . . . . 0.0 110.9 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -18.61 21.23 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -78.21 -49.71 13.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -48.86 -37.43 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.66 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -58.18 -29.51 65.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -78.03 -59.58 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -56.14 -17.98 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 13.7 tp -52.79 -59.15 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 425' ' ' GLN . 12.9 tptp -99.72 -45.14 5.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -39.94 -39.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.442 ' CD1' ' CD2' ' A' ' 380' ' ' PHE . 95.8 mt -88.11 -26.42 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 10.3 tp60 -57.6 134.63 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.32 31.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -55.03 125.21 19.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.9 m -69.66 97.37 1.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.44 113.91 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.78 29.38 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.859 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.85 39.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . 0.432 ' CD2' HD22 ' A' ' 368' ' ' ASN . 25.5 m-70 -125.42 125.4 43.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -73.89 124.94 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.481 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 7.4 mt -89.39 164.11 15.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -116.43 103.23 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.28 126.02 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -130.93 162.9 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 20.0 mm -86.92 98.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.843 0.354 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 80.7 p -85.48 125.73 33.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.439 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 145.44 139.08 3.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.519 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.4 mt -141.43 122.17 14.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.452 ' CB ' ' HB2' ' A' ' 439' ' ' SER . 0.5 OUTLIER -90.66 124.75 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.1 mm -113.35 146.59 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.89 167.02 20.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 12.2 t30 68.86 32.61 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 46.4 mt -82.64 113.87 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.49 123.73 17.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -46.06 -21.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -78.37 -39.66 38.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 98.0 m -49.94 131.9 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.134 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 22.0 p -105.77 161.13 14.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 374' ' ' GLU . 2.0 mp0 -61.85 -54.52 40.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 373' ' ' GLU . 36.5 mt-10 -36.65 -49.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 86.3 m -64.56 -50.88 65.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.457 HD12 ' CD1' ' A' ' 380' ' ' PHE . 13.6 tp -54.66 -35.13 63.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 381' ' ' SER . 12.5 mmmt -61.25 -50.2 74.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.48 -42.92 95.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.52 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.85 -56.29 11.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.457 ' CD1' HD12 ' A' ' 376' ' ' LEU . 8.4 m-85 -72.13 -39.96 68.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.842 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 14.4 t -48.52 -22.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -55.75 -46.82 77.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 420' ' ' ALA . 24.6 t -55.51 -61.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -161.13 -152.05 6.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -83.74 127.24 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.327 . . . . 0.0 111.098 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.7 mt -96.34 130.61 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.425 ' NZ ' ' HA ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -78.07 -51.32 10.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.924 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 45.7 t -157.31 131.71 8.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 21.4 t -127.0 110.83 13.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -130.48 138.4 50.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 40.3 mt -99.49 149.04 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 40.7 m -70.28 102.14 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -123.94 147.15 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -69.66 102.89 1.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 399' ' ' GLY . 9.2 p30 -81.28 177.02 9.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -38.52 -49.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.39 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.92 30.51 8.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 401' ' ' LEU . 35.9 t -113.36 143.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.112 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.452 ' N ' HG11 ' A' ' 400' ' ' VAL . 2.0 mm? -72.75 100.29 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 29.4 mt -126.33 152.4 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 37.6 m -57.93 161.1 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 42.5 mtm -117.09 17.09 14.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.846 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.35 0.77 64.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 4.7 p90 -153.69 155.27 35.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.868 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -143.02 -178.86 19.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . 0.559 ' CZ ' ' HG3' ' A' ' 410' ' ' GLU . 20.0 t80 -133.28 122.39 23.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 73.9 t -120.42 119.59 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.559 ' HG3' ' CZ ' ' A' ' 408' ' ' PHE . 15.2 mt-10 -109.55 141.65 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.0 161.13 15.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -62.58 -34.45 77.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -120.11 157.08 53.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 -10.01 21.28 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.47 -53.68 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -45.98 -38.05 7.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.16 90.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -62.13 -29.6 70.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -72.69 -64.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.435 ' HB2' ' CG2' ' A' ' 383' ' ' VAL . . . -50.45 -34.01 23.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 420' ' ' ALA . 12.8 tp -37.88 -63.35 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -93.41 -41.02 10.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -47.39 -42.33 21.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' A' ' 380' ' ' PHE . 90.3 mt -86.51 -23.13 26.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -56.85 146.98 24.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.78 -16.25 32.59 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -62.42 117.53 6.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 29.1 m -69.89 112.33 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.3 117.6 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 62.31 26.7 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 81.47 -9.33 55.6 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.517 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -116.61 142.67 46.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.428 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 24.0 mttt -88.12 138.04 31.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.63 156.26 16.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -109.48 109.33 20.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.06 136.04 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -141.69 161.26 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.99 96.5 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' SER . . . . . 0.452 ' HB2' ' CB ' ' A' ' 363' ' ' PHE . 5.4 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.838 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.6 p -104.05 144.6 31.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.78 147.59 7.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 5.3 mt -146.57 120.44 9.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.52 132.39 34.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.4 mm -118.95 144.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -131.96 160.18 36.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 51.3 t30 69.5 33.8 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 57.7 mt -78.46 107.11 10.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 371' ' ' THR . 2.5 m120 -50.12 118.16 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -40.32 -31.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 p -65.7 -43.01 90.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 368' ' ' ASN . 82.4 m -49.49 147.35 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.089 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 53.0 p -127.46 165.25 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.4 -36.04 79.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -50.34 -59.71 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 55.9 m -61.97 -44.95 95.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.492 HD12 ' CD1' ' A' ' 380' ' ' PHE . 21.0 tp -57.22 -33.19 67.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 381' ' ' SER . 4.0 mtpm? -73.09 -28.16 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -82.14 -50.7 4.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.441 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.24 -37.88 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.814 0.34 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.492 ' CD1' HD12 ' A' ' 376' ' ' LEU . 16.6 m-85 -86.27 -22.74 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.9 t -69.51 -9.61 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.86 -28.14 44.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 420' ' ' ALA . 94.3 t -75.71 -38.17 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 178.51 -167.17 37.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.77 121.24 24.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.081 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.44 ' O ' ' NZ ' ' A' ' 412' ' ' LYS . 20.3 mt -83.52 131.37 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -79.49 -53.3 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 t -157.26 135.07 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.5 p -117.89 128.75 55.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.7 m -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 392' ' ' SER . 79.9 mt -100.69 153.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 391' ' ' ILE . 65.6 m -75.35 94.72 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . 0.411 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 33.7 mttm -119.44 154.72 33.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -146.03 162.5 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.04 101.53 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 399' ' ' GLY . 6.6 p30 -77.14 178.62 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.58 -28.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -84.89 -32.98 22.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.069 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.77 18.86 33.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.453 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 401' ' ' LEU . 47.0 t -102.25 143.66 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.89 0.376 . . . . 0.0 111.151 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.454 ' N ' HG13 ' A' ' 400' ' ' VAL . 1.5 mm? -72.89 102.13 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.411 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 24.3 mt -122.5 149.01 44.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -60.65 159.33 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.519 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 49.4 mtm -116.97 16.68 15.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 92.68 3.32 66.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.519 ' CE1' ' O ' ' A' ' 404' ' ' MET . 1.9 p90 -158.29 159.65 36.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -156.92 -175.8 28.26 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -131.13 121.39 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.07 120.77 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -103.89 154.03 20.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.73 174.66 7.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.44 ' NZ ' ' O ' ' A' ' 386' ' ' ILE . 23.3 mmtm -77.02 -37.14 55.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -137.38 151.46 71.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 415' ' ' GLU . 72.1 Cg_exo -46.72 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.25 . . . . 0.0 112.334 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 414' ' ' PRO . 17.7 tt0 -38.07 -48.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -48.54 -54.01 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.4 87.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -59.74 -29.69 68.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -80.41 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.423 ' N ' HG11 ' A' ' 383' ' ' VAL . . . -53.56 -18.2 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 13.4 tp -53.76 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -92.04 -34.35 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . 0.428 ' CD ' ' O ' ' A' ' 423' ' ' GLN . 0.5 OUTLIER -47.35 -40.77 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.461 HD13 ' CE2' ' A' ' 380' ' ' PHE . 50.2 mt -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -56.12 147.82 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.14 -12.97 34.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -64.72 115.8 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 75.6 m -70.74 101.95 2.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.37 121.39 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 62.05 34.0 16.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.35 -6.98 49.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -122.86 138.25 54.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 7.2 mtpm? -79.34 146.19 33.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 7.3 mt -105.76 159.13 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.464 ' OE1' ' CG ' ' A' ' 437' ' ' ARG . 3.4 tm-20 -110.49 127.76 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.11 135.86 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.464 ' CG ' ' OE1' ' A' ' 435' ' ' GLU . 14.3 mmt180 -140.54 152.49 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 12.9 mm -76.12 98.49 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 12.0 p -111.55 153.65 25.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.08 135.83 5.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.2 mt -137.27 136.43 38.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.89 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.34 124.56 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.1 mm -111.33 142.17 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -132.35 161.7 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 72.73 37.03 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 25.5 mt -86.28 126.95 34.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 371' ' ' THR . 5.4 m-20 -69.5 122.23 18.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -39.23 -40.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.9 m -62.44 -39.95 95.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 368' ' ' ASN . 53.4 m -50.88 126.49 16.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 82.6 p -106.82 157.42 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 374' ' ' GLU . 33.9 mt-10 -54.06 -50.04 67.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 373' ' ' GLU . 16.4 tt0 -34.89 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 83.4 m -55.91 -53.16 60.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.528 HD11 ' CE1' ' A' ' 380' ' ' PHE . 21.6 tp -49.98 -43.48 50.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -50.79 -54.9 19.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.3 -50.98 61.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 92.8 t -47.41 -55.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.182 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.528 ' CE1' HD11 ' A' ' 376' ' ' LEU . 6.7 m-85 -71.46 -34.65 70.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.0 t -53.76 -23.07 10.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -61.14 -35.89 78.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.83 -42.79 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 176.58 -166.01 36.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.78 118.48 16.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 0.0 111.128 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.8 mt -82.24 131.38 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.45 -42.84 28.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 m -169.54 126.42 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 2.3 t -119.61 117.25 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 98.9 m -139.77 136.45 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.114 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 80.5 mt -100.81 152.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.9 m -70.97 101.7 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -126.41 152.03 46.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -144.0 158.65 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 395' ' ' LYS . 2.3 mppt? -74.12 101.9 4.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 400' ' ' VAL . 4.8 p30 -74.68 179.27 4.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -20.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -91.52 -30.47 16.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 94.59 20.15 30.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.476 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 56.8 t -106.12 143.35 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 0.0 111.135 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.442 ' N ' HG12 ' A' ' 400' ' ' VAL . 1.9 mm? -72.38 98.56 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 97.2 mt -111.46 141.81 44.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 14.2 t -58.07 159.96 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 16.0 mmm -115.71 24.82 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 78.62 -3.89 62.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 1.2 p90 -150.3 147.05 27.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -136.51 177.9 19.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.475 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -130.48 118.72 21.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.842 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.06 146.13 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -129.92 146.38 51.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -120.57 164.5 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -66.42 -48.57 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.32 156.65 35.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.513 0.673 . . . . 0.0 110.917 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.39 -8.29 21.59 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.347 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.35 -46.65 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -49.2 -33.87 13.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -67.86 -43.85 78.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.94 -31.45 72.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -70.42 -63.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -49.93 -36.98 29.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 420' ' ' ALA . 16.2 tp -34.84 -64.49 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -96.39 -39.77 9.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -45.09 -45.81 11.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.413 HD12 ' CD1' ' A' ' 380' ' ' PHE . 75.3 mt -83.76 -26.24 29.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.8 tp60 -52.15 152.02 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.3 -21.53 7.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.46 118.96 7.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 41.7 m -72.46 114.14 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.46 ' CG2' HD12 ' A' ' 434' ' ' LEU . 99.6 t -114.22 118.64 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 58.54 25.64 13.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 86.09 -8.62 72.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -118.43 138.94 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -82.34 144.02 30.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.499 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 6.4 mt -101.86 158.69 15.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.74 102.57 10.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.5 t -94.06 125.91 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -130.85 164.21 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 15.3 mm -82.32 96.05 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 83.2 p -107.39 134.89 49.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.476 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 137.93 139.27 3.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.48 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.58 125.17 14.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 363' ' ' PHE . 0.6 OUTLIER -93.64 118.63 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.5 mm -105.78 148.97 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -136.5 167.49 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 64.83 43.41 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 35.3 mt -94.39 100.66 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -40.74 118.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.419 ' C ' ' O ' ' A' ' 368' ' ' ASN . 6.4 m-85 -36.85 -45.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 65.3 m -58.21 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.4 m -48.59 143.86 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 54.2 p -124.39 157.03 36.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.1 mm-40 -48.07 -47.63 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 373' ' ' GLU . 3.0 tm-20 -34.64 -65.98 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 37.8 m -51.67 -60.38 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.537 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 12.5 tp -44.71 -37.41 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 381' ' ' SER . 7.9 mtpm? -71.53 -39.94 70.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.23 -19.99 70.82 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.75 -47.65 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.537 ' CD1' ' CD1' ' A' ' 376' ' ' LEU . 12.3 m-85 -74.94 -25.44 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 15.1 t -64.94 -16.42 63.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -67.82 -37.55 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.41 -42.35 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.078 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -179.2 -158.65 21.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.527 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -85.14 124.11 31.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 26.5 mt -82.53 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -54.15 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 98.3 p -149.26 123.16 9.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.447 ' C ' ' OE2' ' A' ' 373' ' ' GLU . 6.2 p -127.39 112.93 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -144.43 138.67 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.151 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 392' ' ' SER . 76.2 mt -97.73 143.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.411 ' N ' HG23 ' A' ' 391' ' ' ILE . 8.9 m -65.6 108.13 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -124.44 134.75 52.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.82 156.98 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 4.7 ptpt -78.9 106.37 10.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 399' ' ' GLY . 50.6 p30 -67.85 177.86 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 397' ' ' LYS . 0.4 OUTLIER -43.5 -35.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.6 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.95 38.0 3.98 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 401' ' ' LEU . 84.0 t -119.95 143.64 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.464 ' N ' HG13 ' A' ' 400' ' ' VAL . 1.2 mm? -74.27 107.75 6.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.3 mt -128.91 139.11 52.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.1 m -57.85 164.0 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 36.2 mtm -117.27 23.69 11.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.857 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.55 5.5 89.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 12.3 p90 -152.6 154.11 34.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.905 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.08 -162.03 9.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.472 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . 0.476 ' CE1' ' CA ' ' A' ' 361' ' ' GLY . 29.6 t80 -137.77 126.53 23.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.877 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 70.0 t -119.57 120.4 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -113.07 151.31 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.51 158.91 26.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -63.12 -36.16 82.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -117.37 160.19 38.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 0.0 110.931 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.66 -20.07 15.93 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.12 -49.35 14.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -46.39 -43.1 15.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.01 -51.52 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.11 -29.32 57.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -77.67 -67.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -50.45 -20.21 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 12.8 tp -51.52 -70.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -92.29 -31.68 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.924 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -50.52 -39.47 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.18 -36.97 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 12.7 tp60 -40.63 149.13 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.68 -19.26 9.51 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -59.95 133.84 56.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 30.2 m -72.88 123.56 23.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.0 t -132.35 118.62 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.09 26.98 10.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 84.56 -17.62 29.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -113.24 139.06 49.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -78.06 135.94 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.428 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 9.2 mt -92.81 161.71 14.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.52 113.39 21.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.939 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.63 130.66 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -131.57 163.91 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 20.1 mm -85.51 96.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.7 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 57.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 5.8 p -102.9 140.08 37.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.6 142.4 4.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 12.1 mt -146.95 117.19 7.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -91.3 115.46 28.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.467 ' CD1' HG11 ' A' ' 436' ' ' VAL . 3.2 mm -106.05 143.73 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . 0.465 ' CG ' ' HB3' ' A' ' 435' ' ' GLU . 12.4 ptmt -138.84 178.25 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 47.9 t-20 65.62 27.84 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.1 mt -76.86 149.79 36.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -88.95 125.78 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -47.13 -20.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.5 m -80.13 -37.86 32.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 43.2 m -61.52 129.95 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 58.8 p -109.99 159.67 17.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -45.51 -42.91 11.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -41.62 -69.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 376' ' ' LEU . 42.3 m -47.18 -67.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.173 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.508 HD11 ' CE1' ' A' ' 380' ' ' PHE . 10.3 tp -35.53 -53.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -55.91 -52.15 65.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.36 -14.08 39.59 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 71.4 t -90.18 -53.52 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.142 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 376' ' ' LEU . 7.4 m-85 -66.8 -37.68 85.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 11.4 p -52.19 -16.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -63.89 -39.51 94.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 420' ' ' ALA . 37.1 t -68.62 -54.85 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.418 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -163.71 -170.33 28.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.7 120.78 18.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.3 mt -79.31 138.36 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.98 -55.1 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 8.7 t -142.19 121.73 13.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.99 116.35 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -148.41 137.17 21.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 392' ' ' SER . 33.8 mt -101.39 143.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.468 ' N ' HG21 ' A' ' 391' ' ' ILE . 14.2 m -58.3 107.62 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 32.0 mttp -127.15 153.36 46.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -149.76 163.66 37.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -73.26 101.81 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.3 p30 -79.51 178.71 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -41.65 -45.44 3.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.57 -32.64 71.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.88 33.84 6.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.467 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 401' ' ' LEU . 84.9 t -119.58 143.69 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.367 . . . . 0.0 111.106 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.464 ' N ' HG12 ' A' ' 400' ' ' VAL . 2.2 mm? -71.01 98.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.414 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 62.8 mt -118.44 153.6 33.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 50.4 m -57.88 159.7 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 49.7 mtp -117.1 13.05 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 96.41 -3.33 63.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.525 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 6.8 p90 -153.21 157.42 40.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.383 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.04 -179.86 22.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -130.33 124.25 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.41 132.87 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.72 143.06 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.4 153.83 32.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -59.65 -34.15 72.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -122.82 160.72 47.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.58 0.705 . . . . 0.0 110.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.99 -18.98 16.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.311 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -77.15 -52.28 9.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . 0.418 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 21.1 mm-40 -47.39 -31.78 4.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.73 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.07 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -61.92 -30.61 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -71.15 -60.24 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 383' ' ' VAL . . . -58.21 -33.82 69.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 420' ' ' ALA . 13.5 tp -36.63 -55.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 425' ' ' GLN . 11.7 pttm -100.93 -50.44 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 -38.59 -39.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 380' ' ' PHE . 55.9 mt -88.59 -30.87 18.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 422' ' ' LYS . 7.9 tp60 -56.79 126.18 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . 0.427 ' O ' ' NZ ' ' A' ' 433' ' ' LYS . . . 109.02 -17.81 31.79 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . 0.498 ' CD2' HG23 ' A' ' 429' ' ' VAL . 16.4 t60 -60.93 114.48 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 34.1 m -70.95 98.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' A' ' 427' ' ' HIS . 84.9 t -104.44 122.64 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 58.26 27.97 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.12 77.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -123.67 128.66 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 37.0 mttm -80.42 119.53 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.9 mt -78.87 161.95 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.465 ' HB3' ' CG ' ' A' ' 365' ' ' LYS . 5.7 tt0 -121.51 109.16 14.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.467 HG11 ' CD1' ' A' ' 364' ' ' ILE . 61.5 t -98.16 135.44 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.15 160.03 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.48 95.48 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.058 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.897 0.38 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p -107.34 129.12 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.17 143.89 4.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 12.4 mt -144.48 123.3 12.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 363' ' ' PHE . 0.7 OUTLIER -94.78 112.39 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 1.4 mm -97.81 144.15 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 366' ' ' ASN . 0.3 OUTLIER -133.52 154.96 50.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.455 ' N ' ' HD2' ' A' ' 365' ' ' LYS . 32.6 t-20 74.72 44.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.32 123.51 36.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.93 125.63 25.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -45.89 -25.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.1 t -76.58 -38.3 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 62.9 m -54.57 125.47 19.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.175 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 62.5 p -107.49 152.84 23.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 47.1 mt-10 -47.36 -50.92 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 55.4 mt-10 -34.85 -58.35 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 88.7 m -58.2 -62.47 1.8 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 380' ' ' PHE . 24.5 tp -40.19 -48.29 2.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 381' ' ' SER . 45.0 mtpt -54.85 -43.16 72.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -66.99 -26.73 73.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.502 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.85 -41.33 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 111.142 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.465 ' CD1' HD11 ' A' ' 376' ' ' LEU . 5.9 m-85 -83.21 -22.48 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 12.5 t -67.73 -15.77 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -68.79 -33.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 18.6 t -72.61 -44.21 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -176.23 -170.67 39.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -77.23 128.65 34.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 111.084 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 35.0 mt -90.63 135.77 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -89.07 -50.65 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 25.9 t -147.83 121.43 9.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.8 117.12 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 8.4 m -143.3 141.62 31.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 392' ' ' SER . 88.0 mt -106.68 154.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.429 ' N ' HG22 ' A' ' 391' ' ' ILE . 56.2 m -71.7 87.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -109.74 131.0 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.2 157.72 43.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.51 ' O ' ' CG ' ' A' ' 395' ' ' LYS . 3.1 ptpp? -75.71 102.08 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 399' ' ' GLY . 0.4 OUTLIER -62.15 175.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 398' ' ' ALA . 0.0 OUTLIER -42.32 -37.92 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.455 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -71.89 -32.89 67.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.75 38.02 3.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 401' ' ' LEU . 58.3 t -120.45 143.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.85 0.357 . . . . 0.0 111.156 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.468 ' N ' HG11 ' A' ' 400' ' ' VAL . 1.7 mm? -74.16 101.01 3.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 86.9 mt -127.08 148.76 50.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.94 163.05 2.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 38.2 mtp -117.09 14.3 14.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.25 70.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.414 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 2.5 p90 -156.05 158.27 37.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.951 0.405 . . . . 0.0 110.846 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.11 -176.85 22.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.79 115.03 16.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.84 130.4 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.162 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -111.42 149.53 31.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.08 153.02 43.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -64.37 -38.46 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -116.22 154.22 48.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.24 -14.72 28.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -82.75 -50.96 8.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.87 -41.61 16.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.0 82.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -57.73 -30.38 65.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -72.87 -68.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -48.44 -25.16 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.083 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 41.5 tp -46.65 -66.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -98.92 -40.8 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -41.64 -34.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.6 -37.96 11.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 5.7 tp60 -38.61 142.28 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 90.14 -23.53 20.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -56.3 130.0 42.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.7 m -74.16 110.09 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.3 28.06 17.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.65 1.12 60.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.507 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -126.38 142.24 51.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -83.75 136.66 34.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.48 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 18.7 mt -96.36 157.46 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -111.1 102.04 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.32 121.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -128.26 161.52 29.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.09 95.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 16.9 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 84.2 p -108.48 148.36 30.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 117.26 144.11 7.71 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.3 mt -147.54 141.58 25.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.4 OUTLIER -109.23 134.4 51.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.4 mm -119.01 147.69 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -134.85 159.84 40.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 405' ' ' GLY . 46.5 t-20 70.33 34.46 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 53.4 mt -80.73 103.16 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.7 m120 -48.66 119.31 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 368' ' ' ASN . 8.2 m-85 -38.17 -42.73 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 52.3 p -58.19 -42.62 86.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 368' ' ' ASN . 35.5 m -44.53 141.61 1.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.173 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' THR . . . . . 0.448 ' N ' HG23 ' A' ' 371' ' ' THR . 49.2 p -121.1 143.65 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 39.2 mt-10 -43.32 -52.98 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 21.8 mp0 -34.59 -61.13 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 89.5 m -55.73 -47.01 77.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.564 HD13 ' CD1' ' A' ' 380' ' ' PHE . 16.0 tp -54.44 -54.84 35.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -55.87 -36.35 67.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.93 61.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.5 -41.52 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.564 ' CD1' HD13 ' A' ' 376' ' ' LEU . 8.5 m-85 -77.67 -12.96 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 6.9 t -77.31 -21.41 53.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -61.56 -27.58 68.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.85 -48.95 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -172.05 -154.63 10.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -90.1 114.69 26.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 36.0 mt -74.81 138.06 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -93.53 -53.81 3.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.1 t -147.77 112.19 5.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 36.1 t -119.13 113.06 20.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' THR . . . . . 0.434 HG21 ' N ' ' A' ' 391' ' ' ILE . 3.5 m -144.59 136.85 26.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.465 HG21 ' N ' ' A' ' 392' ' ' SER . 51.2 mt -93.67 156.62 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.119 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.465 ' N ' HG21 ' A' ' 391' ' ' ILE . 71.8 m -77.47 109.51 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -126.01 172.33 10.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -152.53 154.27 35.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 101.76 6.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 399' ' ' GLY . 48.4 p30 -72.49 176.82 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -47.83 -23.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -89.36 -26.95 20.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 87.76 35.51 9.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 401' ' ' LEU . 93.5 t -116.83 143.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.159 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.464 ' N ' HG11 ' A' ' 400' ' ' VAL . 0.5 OUTLIER -73.23 122.43 21.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 70.4 mt -141.01 140.24 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -58.44 156.61 10.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.2 mtm -114.95 20.7 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 88.66 0.92 81.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.487 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 14.2 p90 -156.45 155.0 31.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.01 -179.9 22.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -130.4 118.31 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.48 144.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -124.66 156.42 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . 0.405 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 30.1 m-85 -131.81 156.9 45.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -65.44 -35.48 81.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -128.3 143.49 48.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.87 -52.35 7.79 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.695 2.263 . . . . 0.0 112.359 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 416' ' ' GLN . 34.1 mt-10 -44.56 -62.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mm100 -35.85 -42.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -59.33 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.29 -27.11 68.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -69.14 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -51.91 -35.52 45.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 420' ' ' ALA . 24.0 tp -36.14 -61.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -100.49 -32.15 10.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -58.26 -16.86 15.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 380' ' ' PHE . 79.1 mt -115.77 -23.72 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -54.64 147.15 15.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 78.96 -10.82 31.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.501 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -58.88 132.93 55.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.1 m -72.52 109.82 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.193 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 77.4 t -126.92 113.47 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 61.39 28.79 18.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.48 39.22 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -115.66 143.16 45.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.358 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -84.87 121.04 27.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 8.8 mt -84.07 155.36 22.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.57 127.88 56.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 28.1 t -112.78 139.3 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 -139.96 166.35 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.1 mm -86.61 95.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.901 0.382 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 6.4 p -109.65 126.47 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.66 135.34 2.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.2 mt -138.57 137.26 36.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -111.49 112.96 25.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.9 mm -97.42 143.71 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -131.8 160.31 35.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 5.5 t30 71.18 40.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -87.28 121.37 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 371' ' ' THR . 12.9 m120 -58.81 122.34 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -43.7 -24.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 -37.88 46.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.3 m -51.31 131.73 28.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 41.4 p -113.89 154.33 27.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 374' ' ' GLU . 85.3 mt-10 -45.85 -54.42 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 373' ' ' GLU . 54.4 mm-40 -35.05 -66.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 378' ' ' GLY . 32.7 m -51.73 -64.03 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 375' ' ' THR . 15.3 tp -36.66 -52.59 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.419 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 4.4 mtpm? -55.78 -42.19 75.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -68.82 -25.26 75.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.524 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 94.8 t -78.83 -45.29 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.573 ' CD2' ' CD1' ' A' ' 424' ' ' LEU . 12.6 m-85 -79.26 -46.02 18.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 47.7 t -42.81 -28.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -48.15 -47.73 34.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.79 -57.56 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.59 -167.42 24.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.466 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.9 121.26 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.45 HG21 ' N ' ' A' ' 387' ' ' LYS . 46.2 mt -85.25 139.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.45 ' N ' HG21 ' A' ' 386' ' ' ILE . 11.0 tptm -82.9 -52.88 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -155.82 122.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 15.4 t -119.99 124.04 44.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -146.42 166.68 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 392' ' ' SER . 73.5 mt -127.35 142.22 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.46 ' N ' HG23 ' A' ' 391' ' ' ILE . 1.2 t -68.14 115.04 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -128.51 149.92 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -149.5 151.8 34.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 395' ' ' LYS . 2.4 ptpt -69.58 102.57 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 399' ' ' GLY . 52.5 p30 -64.41 179.12 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -42.88 -40.17 2.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.31 -32.16 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.6 31.94 5.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 401' ' ' LEU . 93.4 t -118.47 143.51 29.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.464 ' N ' HG11 ' A' ' 400' ' ' VAL . 1.6 mm? -74.14 116.74 15.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 39.6 mt -137.32 156.53 48.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.3 t -57.9 158.53 6.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 16.8 mtm -117.07 19.28 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.89 88.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 404' ' ' MET . 16.8 p90 -158.33 158.93 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.3 -172.6 20.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -125.32 123.69 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 89.9 t -118.53 119.28 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -106.54 153.68 21.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . 0.521 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 14.5 m-85 -122.53 153.14 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -59.54 -40.55 87.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -125.43 143.72 45.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.31 -41.61 28.13 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.743 2.295 . . . . 0.0 112.342 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 418' ' ' GLN . 1.2 tp10 -57.83 -62.63 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -37.91 -38.14 0.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.521 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -71.98 -41.19 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.086 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 415' ' ' GLU . 34.8 mm-40 -66.53 -22.19 66.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -83.28 -63.2 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -49.26 -40.39 34.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 420' ' ' ALA . 8.4 tp -35.42 -62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -92.77 -51.41 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -38.62 -36.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.573 ' CD1' ' CD2' ' A' ' 380' ' ' PHE . 90.4 mt -92.25 -35.27 13.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -43.6 150.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.01 -8.48 15.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -66.44 118.42 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 10.4 m -69.23 116.82 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 79.9 t -125.12 122.74 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.157 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 58.82 31.76 21.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.97 -8.12 24.67 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -119.58 133.01 55.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -76.57 151.53 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 5.4 mt -116.54 159.9 21.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -116.11 129.38 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 36.0 t -116.95 142.35 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -137.11 159.47 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 24.9 mm -83.89 95.69 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.899 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.892 0.377 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.08 155.08 17.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.84 148.77 9.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.544 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mt -147.24 131.88 17.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 365' ' ' LYS . 0.3 OUTLIER -98.38 131.0 45.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.0 mm -117.1 142.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . 0.451 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 12.2 tptp -132.29 162.36 31.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.3 t30 64.93 31.52 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 33.7 mt -72.23 128.84 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.441 HD22 ' CD2' ' A' ' 432' ' ' HIS . 16.3 m120 -70.9 128.92 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -54.52 -15.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 69.4 m -81.8 -29.03 32.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 81.8 m -65.98 138.93 58.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.6 p -120.13 162.22 19.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.18 -36.51 75.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -50.48 -60.46 2.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 42.9 m -62.29 -55.66 26.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.492 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.6 tp -43.16 -38.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -69.38 -43.73 72.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.79 -20.45 72.34 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.478 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.16 -40.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.492 ' CD1' HD12 ' A' ' 376' ' ' LEU . 11.6 m-85 -82.6 -14.66 54.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 75.8 p -74.87 -15.28 60.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -65.03 -27.52 68.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.39 -64.18 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -153.33 -162.44 11.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -84.28 118.46 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.755 0.312 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.92 132.34 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -84.07 -55.04 4.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.7 p -154.46 116.62 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 28.5 p -108.54 120.36 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 95.2 m -137.79 127.54 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.77 140.79 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 70.1 m -57.55 99.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.85 157.82 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -153.96 156.34 37.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -74.67 104.58 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.4 p30 -78.5 178.12 8.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -45.08 -33.62 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -78.73 -29.26 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 88.57 36.91 7.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.491 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 401' ' ' LEU . 67.5 t -121.9 143.41 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 400' ' ' VAL . 1.4 mm? -69.12 107.5 3.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 56.0 mt -126.88 143.92 51.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.0 p -59.3 162.39 4.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.537 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 37.6 mtp -117.08 13.78 14.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.12 1.48 64.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.557 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 404' ' ' MET . 1.7 p90 -158.31 158.82 35.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.03 -175.03 22.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -140.7 113.6 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 63.4 t -103.49 121.0 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.18 145.31 28.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -120.82 151.38 39.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -64.64 -14.04 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -141.47 159.07 61.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.635 0.731 . . . . 0.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.67 -44.93 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.4 -49.41 72.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -47.24 -47.9 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -54.37 -60.01 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -48.88 -31.13 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -75.55 -56.76 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.426 ' CB ' HD12 ' A' ' 424' ' ' LEU . . . -57.88 -15.03 7.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 14.2 tp -63.61 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.7 -34.63 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -55.18 -14.69 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.426 HD12 ' CB ' ' A' ' 420' ' ' ALA . 46.7 mt -117.82 -37.22 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.7 tp60 -42.13 145.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.9 -10.75 59.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -67.79 122.48 18.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.0 m -69.24 116.33 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.147 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.5 123.21 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.26 26.66 15.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.29 40.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.541 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . 0.441 ' CD2' HD22 ' A' ' 368' ' ' ASN . 89.9 m-70 -121.61 137.34 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -77.73 143.25 38.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.487 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 8.0 mt -102.73 159.18 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -113.81 105.99 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.92 133.95 38.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -139.33 166.08 25.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 3.2 mm -87.11 101.53 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.914 0.388 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.6 p -109.82 125.36 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.86 138.07 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.91 129.58 19.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.899 0.38 . . . . 0.0 110.902 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -105.17 116.61 32.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.9 mm -103.57 141.2 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -127.56 165.11 20.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 9.2 t30 71.79 28.12 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.409 HD11 ' C ' ' A' ' 406' ' ' PHE . 36.4 mt -74.59 126.51 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.7 m120 -73.66 121.94 21.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -39.27 -38.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.4 t -61.66 -42.71 99.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 368' ' ' ASN . 90.3 m -50.13 121.72 5.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.3 p -99.66 154.12 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.25 -55.37 15.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -43.35 -44.53 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 85.3 m -64.66 -54.35 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.543 HD13 ' CD1' ' A' ' 380' ' ' PHE . 11.7 tp -53.2 -43.72 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -59.45 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -54.55 -57.76 16.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 88.1 t -41.17 -49.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.543 ' CD1' HD13 ' A' ' 376' ' ' LEU . 9.9 m-85 -78.46 -25.51 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.1 t -63.2 -12.94 32.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.3 -24.12 64.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 78.4 t -81.39 -59.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.12 -172.65 30.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -68.99 117.03 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.739 0.304 . . . . 0.0 111.055 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.58 133.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.17 -52.13 7.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.4 m -162.48 117.66 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 17.6 t -120.13 132.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.836 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -144.44 162.65 35.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 392' ' ' SER . 87.8 mt -123.82 138.77 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 406' ' ' PHE . 4.9 p -58.35 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -115.93 140.73 48.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -136.25 170.01 16.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.404 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 3.8 mtmp? -86.63 108.81 18.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.25 178.67 8.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -46.03 -35.8 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.412 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -76.02 -31.83 59.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 96.25 35.3 5.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.449 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 401' ' ' LEU . 18.9 t -118.85 145.24 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.378 . . . . 0.0 111.13 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.452 ' N ' HG13 ' A' ' 400' ' ' VAL . 2.3 mm? -73.0 96.4 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 63.0 mt -110.95 137.67 48.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.4 p -57.67 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 80.0 mtp -116.44 14.49 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.53 74.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.607 ' CZ ' ' CB ' ' A' ' 392' ' ' SER . 16.8 p90 -148.97 174.33 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.64 39.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.545 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -126.55 117.47 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 63.0 t -111.8 136.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -123.33 146.7 47.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.02 153.81 33.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -59.39 -42.03 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -113.32 159.52 34.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 110.875 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -16.34 18.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.346 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.66 -48.82 12.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.52 -35.94 14.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.82 65.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -58.56 -27.93 65.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -78.89 -63.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -55.67 -15.86 3.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 25.2 tp -57.81 -62.16 2.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -95.78 -27.63 15.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . 0.439 ' CD ' ' O ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -58.48 -45.14 89.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.529 ' CD1' ' CD2' ' A' ' 380' ' ' PHE . 94.4 mt -83.98 -17.08 41.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 15.8 tp60 -64.85 134.7 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.03 45.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -55.25 131.79 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.3 m -73.44 96.23 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.7 t -111.31 113.2 43.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.58 31.3 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 65.33 6.28 26.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -126.4 126.46 43.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -73.03 126.8 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.488 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 6.7 mt -90.75 159.34 16.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -110.56 103.18 11.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.51 131.83 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -136.47 164.94 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 30.9 mm -88.21 97.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 81.8 p -112.32 139.11 48.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.14 144.01 5.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.8 mt -149.94 112.95 4.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.36 113.61 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 364' ' ' ILE . 1.9 mm -98.8 145.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -131.87 161.59 32.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.6 t30 71.19 30.26 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 76.5 mt -74.77 112.93 11.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -57.85 117.06 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 368' ' ' ASN . 5.6 m-85 -34.26 -54.59 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 m -46.7 -45.17 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 368' ' ' ASN . 85.9 m -48.3 138.48 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 14.6 t -123.22 163.31 20.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -56.57 -15.13 3.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -68.47 -60.33 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 379' ' ' VAL . 51.6 m -61.58 -38.05 86.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.561 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 7.4 tp -62.9 -57.5 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -53.1 -31.87 44.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -80.75 -23.96 59.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 375' ' ' THR . 94.5 t -80.62 -45.25 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.561 ' CD1' ' CD1' ' A' ' 376' ' ' LEU . 8.2 m-85 -76.0 -24.44 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.3 p -61.71 -24.28 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.877 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -58.56 -39.82 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 420' ' ' ALA . 12.0 t -66.96 -48.29 79.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.416 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -179.02 -168.57 38.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.01 130.58 43.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 28.0 mt -92.9 137.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -86.05 -50.19 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -160.06 126.27 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 50.9 t -123.84 98.98 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 87.5 m -117.84 125.32 50.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 392' ' ' SER . 29.0 mt -101.44 155.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 406' ' ' PHE . 50.6 p -69.86 92.93 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -121.29 141.02 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -138.08 167.55 21.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.446 ' HE3' ' N ' ' A' ' 395' ' ' LYS . 0.1 OUTLIER -82.44 102.89 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 399' ' ' GLY . 3.7 p30 -76.28 178.35 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -39.35 -52.62 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.72 73.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 95.03 30.98 7.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.459 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 13.8 t -109.18 151.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.459 ' N ' HG12 ' A' ' 400' ' ' VAL . 0.8 OUTLIER -76.28 112.72 13.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.1 mt -136.54 136.34 39.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.7 m -57.86 164.12 2.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 6.1 mtm -112.29 15.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 98.09 0.72 58.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 392' ' ' SER . 53.5 p90 -156.57 172.33 18.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -167.97 -177.02 38.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -132.38 133.54 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 410' ' ' GLU . 54.5 t -125.55 141.68 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.158 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.404 ' N ' HG13 ' A' ' 409' ' ' VAL . 7.9 tt0 -124.42 142.77 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 23.8 m-85 -113.87 156.51 23.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -61.42 -41.41 97.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -126.93 142.69 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.583 0.706 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.27 -41.58 27.83 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.93 -55.99 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . 0.416 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 42.5 mm-40 -45.45 -36.69 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -69.2 -45.93 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -60.71 -25.28 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -80.73 -63.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' A' ' 383' ' ' VAL . . . -55.52 -18.32 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 17.4 tp -55.84 -66.43 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -93.81 -41.68 9.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -42.27 -46.26 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 57.9 mt -82.24 -29.49 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.3 tp60 -50.17 142.08 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.7 -18.3 30.88 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -56.62 128.04 34.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.463 ' HA ' ' CE ' ' A' ' 433' ' ' LYS . 1.4 m -71.29 99.27 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.15 124.55 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.49 28.52 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.05 -1.53 47.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -124.65 151.53 44.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.463 ' CE ' ' HA ' ' A' ' 428' ' ' THR . 6.0 mmpt? -88.86 133.4 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.496 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 13.4 mt -94.21 154.71 17.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.915 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.79 106.31 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.7 t -97.65 126.76 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -133.95 163.63 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.815 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 10.7 mm -86.36 99.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.909 0.385 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.1 p -107.57 131.77 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.871 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.9 142.78 5.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.85 124.41 13.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.4 OUTLIER -90.71 127.75 36.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.3 mm -116.29 142.32 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -131.56 161.18 33.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 72.35 35.91 1.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 406' ' ' PHE . 50.9 mt -85.35 109.55 18.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -52.57 130.96 33.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.839 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -52.33 -16.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.8 t -82.23 -37.26 26.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 97.0 m -55.21 131.99 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 23.2 p -110.66 156.27 21.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -50.48 -43.71 55.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -43.18 -63.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 378' ' ' GLY . 19.5 m -55.95 -65.8 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.557 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 11.8 tp -37.12 -44.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -62.87 -44.13 96.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -61.48 -52.91 48.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.09 -34.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.159 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.557 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 13.5 m-85 -87.19 -11.84 48.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 t -78.07 -14.16 59.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.51 -38.07 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.431 HG13 ' NE2' ' A' ' 416' ' ' GLN . 60.2 t -64.42 -55.93 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -169.04 -163.2 22.68 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.77 126.17 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 19.7 mt -88.84 136.94 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -86.09 -53.21 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 14.2 t -165.67 130.56 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 45.1 t -123.09 122.63 38.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.3 m -130.9 127.42 38.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 392' ' ' SER . 57.9 mt -95.8 140.68 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.692 ' CB ' ' CE2' ' A' ' 406' ' ' PHE . 2.8 p -60.01 91.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . 0.404 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 48.4 mttm -119.8 140.67 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.884 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -139.76 160.79 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -70.72 107.93 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 399' ' ' GLY . 8.6 p30 -88.61 179.25 6.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -38.92 -47.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.63 68.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 91.86 29.83 11.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.454 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 401' ' ' LEU . 57.0 t -110.78 142.6 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.462 ' N ' HG12 ' A' ' 400' ' ' VAL . 2.2 mm? -72.29 96.63 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.404 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 28.9 mt -119.22 149.35 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 p -57.87 160.7 4.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.1 mtm -116.81 10.89 14.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.52 56.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.692 ' CE2' ' CB ' ' A' ' 392' ' ' SER . 9.4 p90 -152.78 176.09 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -166.73 -172.99 34.64 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -137.8 121.65 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 84.7 t -110.65 132.87 57.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -115.91 153.14 32.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -131.89 152.16 51.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -67.15 -25.3 66.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -117.97 151.58 49.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.407 ' O ' ' NE2' ' A' ' 418' ' ' GLN . 58.7 Cg_endo -71.96 -27.72 17.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 416' ' ' GLN . 14.4 tp10 -75.95 -57.19 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 415' ' ' GLU . 30.9 mm100 -34.83 -43.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -56.0 -51.01 69.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mp0 -63.73 -28.49 69.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -65.49 -59.15 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.89 75.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 15.8 tp -38.64 -55.18 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.84 -43.07 6.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -47.49 -43.76 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.25 -24.15 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -56.99 147.22 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.47 11.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -61.06 118.86 7.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 20.7 m -69.23 116.38 9.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.37 117.68 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 61.28 31.2 19.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.12 -4.47 47.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -122.63 131.44 53.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -74.7 143.83 44.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.0 mt -105.57 161.51 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.52 120.26 39.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.406 ' C ' ' HG2' ' A' ' 437' ' ' ARG . 11.7 t -109.41 134.72 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.406 ' HG2' ' C ' ' A' ' 436' ' ' VAL . 5.5 mmm-85 -140.93 159.6 41.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 22.4 mm -76.93 97.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.4 p -114.32 137.34 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.844 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 130.24 141.86 5.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.51 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.11 117.63 7.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -95.78 112.4 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.1 mm -98.97 149.99 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -133.86 158.24 43.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 405' ' ' GLY . 37.4 t30 74.72 36.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 406' ' ' PHE . 45.9 mt -84.21 118.82 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.6 m-20 -56.38 119.87 6.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -41.0 -30.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 53.7 p -73.39 -39.22 65.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 368' ' ' ASN . 55.2 m -46.18 121.11 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 39.4 p -96.23 157.48 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 374' ' ' GLU . 45.1 mt-10 -56.34 -55.9 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.2 tt0 -36.84 -57.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 33.0 m -52.2 -50.5 61.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 380' ' ' PHE . 15.1 tp -55.49 -49.76 71.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -53.08 -36.46 60.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -75.04 -43.65 26.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.455 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.79 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.479 ' CD2' HG12 ' A' ' 409' ' ' VAL . 5.8 m-85 -81.29 -24.48 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.3 t -65.81 -19.98 66.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -63.29 -35.49 80.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.4 -62.7 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -158.07 -150.3 5.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -88.88 122.33 32.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.424 HG21 ' N ' ' A' ' 387' ' ' LYS . 23.1 mt -87.32 142.53 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 386' ' ' ILE . 16.4 tptm -90.26 -49.19 6.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 33.8 t -164.7 118.26 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 7.7 t -113.31 130.34 56.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.5 t -146.05 154.12 41.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 392' ' ' SER . 77.8 mt -115.27 141.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.441 ' N ' HG23 ' A' ' 391' ' ' ILE . 74.6 m -64.87 91.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 53.6 mttt -115.17 147.61 40.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -134.48 156.5 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 395' ' ' LYS . 0.6 OUTLIER -76.9 110.74 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.1 p-10 -82.58 178.48 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 398' ' ' ALA . 0.0 OUTLIER -41.72 -30.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.439 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -87.79 -32.25 19.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.097 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.54 31.02 8.12 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.529 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 401' ' ' LEU . 89.1 t -105.92 143.2 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.105 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 400' ' ' VAL . 0.9 OUTLIER -73.12 112.16 8.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.413 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 32.2 mt -134.5 136.1 42.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.1 m -57.84 159.19 5.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.507 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 47.0 mtm -116.9 21.13 13.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 90.05 4.96 71.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.453 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 404' ' ' MET . 5.7 p90 -155.08 154.31 32.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.388 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.6 168.37 30.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.28 122.23 45.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.479 HG12 ' CD2' ' A' ' 380' ' ' PHE . 86.5 t -115.27 125.21 72.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.55 155.38 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -126.54 165.75 18.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.906 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -71.93 -34.5 69.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.21 161.75 41.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.18 -16.31 19.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.22 -41.54 14.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -51.04 -44.5 61.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.47 88.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -57.13 -35.95 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -67.47 -61.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -52.24 -34.65 46.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.095 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 420' ' ' ALA . 63.7 tp -34.86 -61.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.25 -44.83 5.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -39.87 -35.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 84.0 mt -93.3 -33.4 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.4 tp60 -47.03 139.88 5.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.2 56.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -59.69 129.88 44.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 18.2 m -69.83 114.12 7.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.169 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.1 116.73 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 54.59 31.16 14.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 73.05 -2.79 32.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -123.45 133.13 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -77.95 145.28 36.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.487 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 9.8 mt -106.12 163.28 12.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.46 108.57 17.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.485 ' O ' ' CZ ' ' A' ' 437' ' ' ARG . 42.0 t -92.47 124.74 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.485 ' CZ ' ' O ' ' A' ' 436' ' ' VAL . 11.3 mmp_? -127.17 165.96 18.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 5.2 mm -90.63 97.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.867 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.879 0.371 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.1 p -105.57 159.4 15.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 103.26 139.43 10.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.502 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 409' ' ' VAL . 9.6 mt -141.86 131.3 23.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.64 125.85 40.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.2 mm -116.3 142.06 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.077 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 13.1 tptm -128.89 162.5 27.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 405' ' ' GLY . 35.2 t-20 65.08 45.56 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 43.6 mt -89.52 107.36 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -50.49 124.51 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -47.1 -28.5 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 t -69.22 -35.55 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 13.1 m -56.67 130.44 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.088 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 43.8 p -108.16 156.52 19.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -49.75 -49.42 48.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -43.35 -68.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 91.3 m -44.98 -64.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 18.5 tp -39.77 -51.76 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -54.39 -43.43 71.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -62.13 -48.85 80.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 66.6 t -58.23 -40.77 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -82.51 -20.91 35.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 24.3 t -70.27 -14.01 62.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.809 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -71.49 -37.71 71.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.88 -39.82 85.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.41 44.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.15 123.08 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.08 133.13 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -52.56 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.4 p -157.77 120.87 3.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 36.1 t -119.16 120.43 37.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -143.92 145.44 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 59.0 mt -106.1 148.66 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.4 m -72.65 101.22 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -124.51 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -126.65 165.34 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -77.11 103.42 7.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.445 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 5.6 p30 -79.06 178.14 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -41.08 -46.93 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 96.28 26.66 10.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 401' ' ' LEU . 65.1 t -108.0 142.45 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.136 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.468 ' N ' HG12 ' A' ' 400' ' ' VAL . 2.0 mm? -71.6 102.09 2.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.12 147.66 43.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.5 t -57.99 155.79 10.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.582 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 52.6 mtm -116.06 19.47 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 87.86 1.4 82.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -156.27 153.28 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.12 167.81 30.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.04 128.07 55.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 362' ' ' LEU . 82.3 t -120.49 122.3 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -110.75 144.74 39.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -114.23 169.0 9.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -73.29 -36.9 66.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -131.92 143.88 50.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.37 -39.16 21.56 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 418' ' ' GLN . 25.1 mm-40 -56.95 -63.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.2 mm100 -36.51 -45.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.08 -44.99 90.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 415' ' ' GLU . 16.1 mm-40 -59.14 -30.85 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -75.5 -66.7 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -47.2 -33.0 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 12.7 tp -40.7 -66.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -94.37 -36.56 11.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -48.63 -46.36 39.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 82.3 mt -82.07 -35.57 28.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 9.6 tp60 -42.65 152.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.39 -25.54 4.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -59.57 118.78 6.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 80.8 m -70.88 122.61 20.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.04 119.91 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 60.89 26.73 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.826 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 88.63 -15.89 55.71 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.474 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -116.86 145.45 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -85.11 146.19 27.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.445 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 10.0 mt -100.14 161.58 13.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -115.04 105.2 12.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -97.18 134.94 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -141.79 160.63 39.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.49 95.99 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.895 0.379 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 9.1 p -108.54 128.41 54.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 150.93 143.37 3.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 mt -145.89 127.58 15.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -102.8 122.93 45.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.464 ' CD1' HG13 ' A' ' 436' ' ' VAL . 3.5 mm -108.66 144.82 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -135.16 159.64 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.7 t30 73.93 27.33 1.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.98 117.79 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.5 m120 -56.73 120.27 7.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -42.04 -35.34 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.5 m -64.9 -40.12 94.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 368' ' ' ASN . 84.8 m -55.31 146.24 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.163 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.8 p -123.19 168.61 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.6 mp0 -57.98 -54.38 47.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.3 mp0 -36.78 -70.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 16.1 m -43.77 -51.43 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.517 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 12.8 tp -54.44 -42.75 70.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 381' ' ' SER . 13.3 mtpt -61.07 -45.11 96.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.0 57.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.517 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.19 -52.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.117 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.517 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 10.8 m-85 -72.23 -20.27 61.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.6 t -69.26 -12.38 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -67.66 -39.56 84.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.413 ' CG2' ' HB1' ' A' ' 420' ' ' ALA . 46.2 t -64.64 -35.18 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.417 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . 169.17 -166.85 40.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.17 125.46 27.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 50.0 mt -85.83 130.5 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -74.36 -52.27 12.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.2 t -160.36 122.97 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 4.5 t -119.39 121.16 38.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 46.5 m -145.76 133.28 20.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 392' ' ' SER . 80.0 mt -99.52 154.89 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 391' ' ' ILE . 38.0 m -73.03 100.15 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . 0.44 ' HG2' ' N ' ' A' ' 403' ' ' SER . 4.1 mtmp? -124.75 134.66 52.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.11 171.58 8.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -81.38 102.38 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.504 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.7 p30 -76.07 177.23 7.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -40.06 -54.36 2.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.19 -28.06 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.43 30.75 8.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.504 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 17.9 t -110.48 144.39 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.435 ' N ' HG11 ' A' ' 400' ' ' VAL . 2.1 mm? -71.68 97.56 1.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.411 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.0 mt -114.85 142.76 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.44 ' N ' ' HG2' ' A' ' 393' ' ' LYS . 58.3 m -58.0 160.5 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.543 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 28.7 mtm -116.86 22.71 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 83.66 1.43 90.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 404' ' ' MET . 4.8 p90 -152.8 154.67 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.917 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.55 -170.24 17.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.479 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -140.26 121.58 14.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 87.5 t -108.7 141.9 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -127.89 145.59 50.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.98 166.3 12.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -68.03 -36.61 80.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -123.28 162.17 41.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.582 0.706 . . . . 0.0 110.889 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.87 -18.86 16.59 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.647 2.231 . . . . 0.0 112.322 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.91 -55.82 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . 0.417 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 42.3 mt-30 -50.33 -31.44 14.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.55 -48.12 65.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -60.78 -29.71 69.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -70.86 -63.93 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.413 ' HB1' ' CG2' ' A' ' 383' ' ' VAL . . . -49.09 -36.62 19.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 420' ' ' ALA . 7.8 tp -37.58 -69.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 -34.46 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -51.8 -34.76 41.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 85.1 mt -96.41 -29.57 13.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -48.33 144.93 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.4 12.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.462 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -55.26 115.9 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 42.0 m -71.11 114.24 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 73.6 t -121.42 125.78 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.82 27.14 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.811 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.51 -3.96 61.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -122.79 142.8 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -88.01 141.65 28.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.24 157.31 17.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.46 119.76 39.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.464 HG13 ' CD1' ' A' ' 364' ' ' ILE . 42.5 t -110.39 138.3 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -133.43 163.71 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.39 95.34 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.862 0.363 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 7.2 p -121.46 158.04 29.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.55 12.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.7 mt -142.05 126.32 17.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -90.81 128.7 36.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 4.1 mm -117.63 144.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -133.14 160.31 37.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 22.6 t30 72.61 40.5 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 25.1 mt -85.61 148.94 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.464 HD22 ' CD2' ' A' ' 432' ' ' HIS . 3.0 m-20 -88.99 124.79 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -46.01 -39.8 9.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -63.28 -32.51 73.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 99.3 m -59.9 131.11 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.0 p -114.19 143.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -40.58 -43.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -38.78 -57.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 76.8 m -62.96 -60.22 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.547 HD12 ' CE1' ' A' ' 380' ' ' PHE . 11.0 tp -39.13 -44.85 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -52.28 -56.17 16.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -59.87 -25.55 61.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 382' ' ' LYS . 57.5 t -73.21 -34.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 409' ' ' VAL . 9.1 m-85 -94.14 -16.36 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 48.7 p -73.6 -17.08 61.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 379' ' ' VAL . 0.2 OUTLIER -75.43 -18.52 59.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 420' ' ' ALA . 53.8 t -95.3 -41.17 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.423 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -167.44 -178.64 39.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.509 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.57 120.08 22.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.775 0.321 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 387' ' ' LYS . 36.8 mt -81.8 143.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.454 ' N ' HG22 ' A' ' 386' ' ' ILE . 13.1 tptp -105.21 -38.87 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.4 t -160.52 118.09 2.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 21.5 t -121.52 116.89 25.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.1 m -142.7 151.15 41.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 392' ' ' SER . 63.4 mt -107.99 148.86 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 391' ' ' ILE . 10.5 m -64.71 85.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -110.71 137.49 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -122.1 156.55 33.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.934 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -73.8 101.5 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.537 ' ND2' ' CD1' ' A' ' 402' ' ' LEU . 21.7 p30 -77.76 179.24 6.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.914 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -40.33 -54.11 2.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.27 69.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.63 31.34 8.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.541 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 401' ' ' LEU . 58.0 t -113.98 143.3 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.089 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.463 ' N ' HG11 ' A' ' 400' ' ' VAL . 2.3 mm? -73.11 96.65 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.537 ' CD1' ' ND2' ' A' ' 396' ' ' ASN . 97.1 mt -105.99 139.29 40.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.1 p -57.9 156.12 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 9.4 mtm -116.42 21.94 13.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.2 89.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 7.8 p90 -149.14 150.4 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -139.51 -172.7 12.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -139.44 116.44 10.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 380' ' ' PHE . 91.5 t -104.5 124.74 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -107.06 137.1 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.55 162.81 14.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -78.1 -22.92 48.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm -133.44 158.78 74.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -30.28 14.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.625 2.217 . . . . 0.0 112.347 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.6 -39.14 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . 0.423 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 2.8 mm-40 -51.42 -49.38 61.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.41 75.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -64.88 -29.72 70.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -78.56 -54.63 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.461 ' N ' HG12 ' A' ' 383' ' ' VAL . . . -61.94 -24.9 67.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 14.2 tp -44.8 -56.24 4.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.21 -44.58 5.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -43.28 -46.71 6.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.463 ' CD2' ' HE2' ' A' ' 382' ' ' LYS . 30.6 mt -80.94 -43.53 19.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 4.2 tp60 -47.25 121.03 3.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.75 -20.11 37.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -60.23 130.06 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.7 m -70.49 96.32 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.115 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.11 112.95 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 62.1 26.02 15.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 70.0 6.58 57.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . 0.464 ' CD2' HD22 ' A' ' 368' ' ' ASN . 21.8 m-70 -121.38 120.59 35.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 110.836 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -71.72 107.39 4.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.411 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 11.2 mt -67.74 161.56 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -119.6 99.26 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.15 134.72 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.068 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -143.46 145.99 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.39 98.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.922 0.391 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.96 150.68 21.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.845 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.22 143.69 7.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.2 mt -146.55 132.49 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.359 . . . . 0.0 110.921 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.77 126.48 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 3.7 mm -112.15 144.78 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -133.87 162.33 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 68.47 43.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.28 106.5 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.3 m120 -46.92 122.23 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -43.59 -24.46 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 70.2 m -77.05 -38.96 51.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 368' ' ' ASN . 25.5 m -48.8 131.83 18.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 76.5 p -108.48 148.44 30.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 374' ' ' GLU . 2.8 mp0 -45.57 -50.76 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 373' ' ' GLU . 5.8 mm-40 -36.09 -67.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 378' ' ' GLY . 71.1 m -48.71 -67.79 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.154 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.545 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 7.2 tp -35.82 -46.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -64.84 -44.53 89.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -60.43 -21.38 57.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.98 -48.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 10.0 m-85 -70.23 -29.33 66.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 53.5 p -58.74 -19.59 41.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.892 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -64.26 -36.58 84.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.94 -47.66 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.45 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -175.82 -154.43 11.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.523 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 412' ' ' LYS . . . -82.77 125.83 31.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.759 0.314 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 45.2 mt -93.02 130.13 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.123 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -77.5 -49.03 15.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.1 t -169.73 117.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 51.2 t -108.94 128.6 55.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.3 t -140.06 163.15 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 392' ' ' SER . 73.8 mt -126.35 137.23 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 391' ' ' ILE . 27.8 m -56.04 102.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 35.6 mtmt -125.66 136.9 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -128.37 156.26 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -71.71 104.24 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 399' ' ' GLY . 0.5 OUTLIER -79.33 178.82 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -38.61 -53.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.98 74.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.77 22.21 14.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 401' ' ' LEU . 45.8 t -101.34 143.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.376 . . . . 0.0 111.105 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 401' ' ' LEU . 2.4 mm? -73.67 96.03 2.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.412 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.6 mt -109.41 143.82 38.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.4 p -57.91 161.56 3.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 35.9 mtp -117.03 16.7 15.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.02 86.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.51 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -153.02 155.07 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -148.76 -176.01 21.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -127.29 123.26 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 77.8 t -105.62 106.1 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.117 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -85.36 152.72 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -132.7 152.22 51.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 385' ' ' ALA . 4.6 mtmp? -65.22 -32.62 74.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -135.14 141.73 39.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.91 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 415' ' ' GLU . 74.2 Cg_exo -47.64 -58.66 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.689 2.259 . . . . 0.0 112.378 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 414' ' ' PRO . 32.1 mt-10 -37.59 -57.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . 0.45 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 26.8 mm-40 -43.52 -46.09 6.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.4 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -56.6 -27.26 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -77.81 -63.98 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -52.73 -19.44 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 45.5 tp -51.28 -64.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -92.67 -47.64 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . 0.467 ' N ' ' HD3' ' A' ' 422' ' ' LYS . 2.7 tm0? -38.27 -34.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.411 HD13 ' CD1' ' A' ' 380' ' ' PHE . 94.3 mt -96.84 -31.8 12.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -49.63 135.04 19.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.86 -24.94 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.457 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -56.18 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 99.7 m -70.44 106.95 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.155 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.51 118.89 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 62.27 31.06 17.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.29 51.41 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -122.03 129.54 52.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.41 145.92 50.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 7.6 mt -103.57 158.81 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -108.98 119.93 41.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.419 ' C ' ' HG2' ' A' ' 437' ' ' ARG . 14.5 t -109.99 133.87 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 436' ' ' VAL . 8.3 mmm180 -142.0 149.29 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.8 mm -70.14 96.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.871 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 64.8 p -95.96 128.01 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 408' ' ' PHE . . . 140.63 141.92 4.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 409' ' ' VAL . 8.4 mt -140.21 127.64 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.98 135.63 33.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 1.8 mm -126.05 142.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 363' ' ' PHE . 7.4 tptp -133.52 159.12 41.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 70.13 45.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 37.4 mt -93.53 108.27 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -51.02 124.31 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -46.48 -28.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -36.94 70.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.83 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 60.2 m -54.95 127.91 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.5 p -99.19 178.44 4.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.89 -47.49 21.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -42.34 -61.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 26.5 m -49.22 -62.36 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.155 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 380' ' ' PHE . 23.0 tp -45.11 -48.56 12.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.427 ' CD ' ' HB3' ' A' ' 389' ' ' CYS . 14.7 mmmt -49.34 -50.07 41.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.41 -34.63 89.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.494 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.49 -44.81 98.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' A' ' 409' ' ' VAL . 5.9 m-85 -80.59 -35.31 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -29.02 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -55.62 -41.61 73.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.497 ' O ' ' NE2' ' A' ' 416' ' ' GLN . 57.5 t -61.79 -39.83 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 169.23 -160.42 33.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.447 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.49 131.72 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 55.1 mt -98.01 134.84 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -81.26 -49.21 11.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.3 t -165.66 116.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.427 ' HB3' ' CD ' ' A' ' 377' ' ' LYS . 4.8 t -111.77 123.11 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -138.08 151.66 48.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 392' ' ' SER . 66.7 mt -118.9 139.33 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.141 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 391' ' ' ILE . 58.0 m -58.43 94.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -121.69 148.25 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -139.1 171.17 14.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -83.55 103.17 12.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 400' ' ' VAL . 9.0 p30 -79.94 177.8 8.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 398' ' ' ALA . 13.2 ptmt -43.77 -35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 397' ' ' LYS . . . -78.8 -32.92 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 97.25 18.93 27.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.496 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 401' ' ' LEU . 59.4 t -102.43 143.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.142 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 400' ' ' VAL . 2.2 mm? -72.88 96.9 2.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.438 HD13 ' ND2' ' A' ' 396' ' ' ASN . 73.7 mt -111.12 148.4 32.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 25.4 m -57.95 159.79 5.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' MET . . . . . 0.47 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 46.6 mtp -116.98 13.82 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 93.8 -4.87 72.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.491 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 1.7 p90 -153.61 158.8 41.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.18 -178.3 24.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . 0.412 ' CZ ' ' HA3' ' A' ' 361' ' ' GLY . 37.8 t80 -131.96 109.75 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.37 . . . . 0.0 110.898 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 380' ' ' PHE . 71.3 t -100.35 124.97 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -110.73 142.35 42.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.6 m-85 -114.83 154.12 29.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -61.83 -34.42 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -122.0 156.97 59.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.578 0.704 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.2 -8.48 19.87 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.341 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.11 -49.51 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 383' ' ' VAL . 30.7 mm100 -52.25 -39.94 61.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.541 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -66.01 -40.02 90.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -63.05 -32.48 73.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -72.7 -66.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -44.99 -36.61 3.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 420' ' ' ALA . 12.6 tp -34.66 -64.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -96.76 -41.51 8.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -39.56 -41.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 91.1 mt -92.21 -28.54 16.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.2 tp60 -48.78 138.32 11.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.82 -26.04 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -60.11 118.26 6.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 28.7 m -69.88 132.08 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.1 t -135.29 123.01 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 59.13 29.82 19.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 82.97 -13.56 43.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -116.93 145.19 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -88.59 144.02 26.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.49 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 8.3 mt -97.2 149.83 21.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -108.19 112.78 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.78 139.58 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -147.45 149.46 32.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 19.0 mm -68.68 95.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.913 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 77.5 p -165.22 112.24 0.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 110.846 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 61.5 m -113.85 126.17 54.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 127.25 97.68 0.98 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m -149.74 151.48 33.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.378 . . . . 0.0 110.814 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.7 p -103.14 150.0 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.53 7.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.4 mt -148.88 123.85 10.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -93.65 130.54 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.22 142.76 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -128.71 165.85 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 60.93 47.85 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 38.4 mt -90.83 113.53 25.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -52.22 121.49 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -44.86 -32.11 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.2 t -68.2 -41.33 81.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 85.8 m -46.28 146.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 38.3 p -121.17 174.71 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.04 -38.06 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -54.01 -59.79 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 59.2 m -54.16 -46.08 72.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.465 HD12 ' CE1' ' A' ' 380' ' ' PHE . 22.2 tp -54.0 -46.01 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 381' ' ' SER . 24.4 mtpp -60.56 -41.12 93.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.65 -51.86 54.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.469 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 68.5 t -59.8 -39.34 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.465 ' CE1' HD12 ' A' ' 376' ' ' LEU . 11.0 m-85 -82.16 -21.21 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 377' ' ' LYS . 2.0 t -68.92 -14.84 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -66.85 -41.27 87.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 420' ' ' ALA . 3.9 t -67.49 -48.91 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.155 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.09 38.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.96 123.09 23.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.138 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.401 HD12 ' CB ' ' A' ' 380' ' ' PHE . 19.1 mt -81.17 130.35 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -76.29 -51.21 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 27.1 t -159.26 134.01 8.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 15.2 p -123.1 126.82 47.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 16.2 m -143.5 122.36 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 392' ' ' SER . 34.1 mt -101.01 142.75 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.441 ' N ' HG21 ' A' ' 391' ' ' ILE . 73.8 m -60.78 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -121.86 135.35 54.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.63 167.41 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.67 106.83 15.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.5 p30 -84.98 179.27 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -39.35 -48.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.89 74.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.51 22.4 26.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 401' ' ' LEU . 44.7 t -101.32 143.0 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.461 ' N ' HG13 ' A' ' 400' ' ' VAL . 1.9 mm? -72.24 99.71 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.55 140.64 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 31.6 m -58.05 162.91 3.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 21.4 mtm -117.04 16.26 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.23 3.79 63.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -158.29 157.06 31.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -153.9 -172.96 22.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -137.39 119.26 15.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 36.5 t -107.47 138.48 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -118.56 150.66 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . 0.56 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.5 m-85 -122.6 163.08 20.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -70.68 -30.87 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -139.63 143.7 36.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.64 -42.03 23.95 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 418' ' ' GLN . 7.4 tt0 -51.71 -66.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -37.82 -48.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -63.23 -40.13 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 415' ' ' GLU . 45.7 mm-40 -60.86 -33.98 73.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -79.03 -60.14 2.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 383' ' ' VAL . . . -50.32 -24.51 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 14.0 tp -50.08 -66.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.404 ' C ' ' HD2' ' A' ' 422' ' ' LYS . 0.6 OUTLIER -90.99 -35.18 14.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -49.64 -43.14 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 95.0 mt -85.81 -18.28 33.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 8.0 tp60 -62.22 142.38 57.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 88.29 -18.68 39.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -57.83 121.86 11.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.6 m -71.15 96.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.61 123.05 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 59.08 28.81 18.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.64 -4.19 52.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.444 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -124.05 149.33 46.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -91.01 140.14 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.489 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 14.0 mt -97.89 154.61 17.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -104.45 103.38 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.24 132.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -139.98 152.17 46.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 8.7 mm -71.37 96.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p -41.23 154.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 71.04 30.28 2.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -89.85 132.03 35.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -46.07 -53.23 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 58.1 p -60.43 125.52 24.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -87.91 144.58 35.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 130.59 19.6 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.667 2.245 . . . . 0.0 112.356 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -97.19 95.92 8.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.124 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 67.0 m -89.25 110.25 21.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -82.18 167.73 47.73 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.446 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 179.34 3.78 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.671 2.248 . . . . 0.0 112.332 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 7.8 t -128.53 -53.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 17.4 m -80.13 166.74 21.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 58.2 m -47.07 -57.72 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.368 . . . . 0.0 110.847 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 3.2 m -44.68 -55.36 5.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.83 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.63 109.62 2.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.475 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 15.9 m -152.12 169.33 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.372 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.0 p -112.95 136.98 52.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.72 137.99 3.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.3 119.02 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.372 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -99.19 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.45 ' CD1' ' N ' ' A' ' 364' ' ' ILE . 1.2 mm -98.72 142.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -129.66 163.23 26.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 6.3 t30 72.49 32.53 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 32.5 mt -81.5 131.79 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.432 HD22 ' CD2' ' A' ' 432' ' ' HIS . 5.0 m120 -71.7 125.82 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -45.88 -31.22 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 85.3 p -68.54 -38.25 80.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 45.9 m -57.79 137.37 56.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 69.0 p -114.87 176.35 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -65.59 -46.81 77.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.89 -55.0 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 56.9 m -59.93 -51.8 68.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.509 HD11 ' CE1' ' A' ' 380' ' ' PHE . 8.9 tp -51.16 -42.54 60.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -57.62 -47.66 81.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.25 -43.88 97.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.06 -45.86 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 0.0 111.141 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.509 ' CE1' HD11 ' A' ' 376' ' ' LEU . 10.1 m-85 -80.22 -26.41 39.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.0 t -61.95 -16.36 50.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -67.22 -20.97 65.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 73.8 t -84.51 -48.66 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -171.95 -166.77 31.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.93 26.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.2 mt -92.55 139.16 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.168 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -53.86 3.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.0 t -151.36 126.97 10.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 49.7 t -127.36 118.72 24.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 167.05 20.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 392' ' ' SER . 74.6 mt -126.65 143.7 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.46 ' N ' HG21 ' A' ' 391' ' ' ILE . 32.1 m -72.69 103.76 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.87 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -114.34 137.95 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' A' ' 395' ' ' LYS . 4.7 ttpt -127.2 149.43 49.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.939 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.468 ' N ' ' HG3' ' A' ' 394' ' ' LYS . 49.8 mttm -69.49 105.24 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 399' ' ' GLY . 2.0 p30 -81.69 179.09 7.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -41.39 -41.53 2.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -71.22 -32.52 68.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.58 15.65 49.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 401' ' ' LEU . 41.3 t -96.67 143.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.459 ' N ' HG13 ' A' ' 400' ' ' VAL . 1.5 mm? -74.27 99.64 3.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.85 156.33 36.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 21.3 m -57.78 158.72 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.481 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 23.1 mtm -117.06 15.79 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.84 69.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 404' ' ' MET . 5.5 p90 -155.5 155.36 33.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.361 . . . . 0.0 110.895 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.42 25.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.449 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -121.66 121.82 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 76.9 t -116.45 130.47 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -112.55 147.7 36.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.44 153.35 34.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -62.71 -33.42 75.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -125.28 159.8 58.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.566 0.698 . . . . 0.0 110.9 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -18.61 21.23 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -78.21 -49.71 13.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -48.86 -37.43 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.66 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -58.18 -29.51 65.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -78.03 -59.58 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -56.14 -17.98 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 13.7 tp -52.79 -59.15 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 425' ' ' GLN . 12.9 tptp -99.72 -45.14 5.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -39.94 -39.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.442 ' CD1' ' CD2' ' A' ' 380' ' ' PHE . 95.8 mt -88.11 -26.42 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 10.3 tp60 -57.6 134.63 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.32 31.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -55.03 125.21 19.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.9 m -69.66 97.37 1.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.44 113.91 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.78 29.38 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.859 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.85 39.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . 0.432 ' CD2' HD22 ' A' ' 368' ' ' ASN . 25.5 m-70 -125.42 125.4 43.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -73.89 124.94 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.481 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 7.4 mt -89.39 164.11 15.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -116.43 103.23 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.28 126.02 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -130.93 162.9 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 20.0 mm -86.92 98.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 48.1 t -81.34 127.88 33.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -98.65 154.33 18.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -75.52 114.53 14.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -59.83 170.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.1 m -68.99 99.98 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -75.81 149.77 83.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.564 0.697 . . . . 0.0 110.888 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 137.77 36.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.256 . . . . 0.0 112.331 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . 37.48 52.91 1.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.13 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 34.3 m -147.05 113.85 6.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -118.05 162.13 13.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.532 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 0.69 5.28 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.674 2.249 . . . . 0.0 112.344 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 4.6 t -127.8 151.1 49.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 4.8 t -94.57 116.56 28.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.539 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 5.7 m -38.74 -50.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.828 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.2 m -80.07 165.68 22.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 179.71 156.83 18.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.5 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t -117.76 86.39 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 80.7 p -85.48 125.73 33.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.439 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 145.44 139.08 3.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.519 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.4 mt -141.43 122.17 14.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.452 ' CB ' ' HB2' ' A' ' 439' ' ' SER . 0.5 OUTLIER -90.66 124.75 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.1 mm -113.35 146.59 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.89 167.02 20.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 12.2 t30 68.86 32.61 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 46.4 mt -82.64 113.87 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.49 123.73 17.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -46.06 -21.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -78.37 -39.66 38.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 98.0 m -49.94 131.9 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.134 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 22.0 p -105.77 161.13 14.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 374' ' ' GLU . 2.0 mp0 -61.85 -54.52 40.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 373' ' ' GLU . 36.5 mt-10 -36.65 -49.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 86.3 m -64.56 -50.88 65.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.457 HD12 ' CD1' ' A' ' 380' ' ' PHE . 13.6 tp -54.66 -35.13 63.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 381' ' ' SER . 12.5 mmmt -61.25 -50.2 74.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.48 -42.92 95.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.52 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.85 -56.29 11.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.457 ' CD1' HD12 ' A' ' 376' ' ' LEU . 8.4 m-85 -72.13 -39.96 68.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.842 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 14.4 t -48.52 -22.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -55.75 -46.82 77.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 420' ' ' ALA . 24.6 t -55.51 -61.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -161.13 -152.05 6.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -83.74 127.24 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.327 . . . . 0.0 111.098 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.7 mt -96.34 130.61 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.425 ' NZ ' ' HA ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -78.07 -51.32 10.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.924 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 45.7 t -157.31 131.71 8.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 21.4 t -127.0 110.83 13.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -130.48 138.4 50.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 40.3 mt -99.49 149.04 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 40.7 m -70.28 102.14 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -123.94 147.15 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -69.66 102.89 1.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 399' ' ' GLY . 9.2 p30 -81.28 177.02 9.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -38.52 -49.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.39 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.92 30.51 8.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 401' ' ' LEU . 35.9 t -113.36 143.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.112 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.452 ' N ' HG11 ' A' ' 400' ' ' VAL . 2.0 mm? -72.75 100.29 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 29.4 mt -126.33 152.4 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 37.6 m -57.93 161.1 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 42.5 mtm -117.09 17.09 14.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.846 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.35 0.77 64.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 4.7 p90 -153.69 155.27 35.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.868 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -143.02 -178.86 19.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . 0.559 ' CZ ' ' HG3' ' A' ' 410' ' ' GLU . 20.0 t80 -133.28 122.39 23.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 73.9 t -120.42 119.59 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.559 ' HG3' ' CZ ' ' A' ' 408' ' ' PHE . 15.2 mt-10 -109.55 141.65 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.0 161.13 15.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -62.58 -34.45 77.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -120.11 157.08 53.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 -10.01 21.28 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.47 -53.68 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -45.98 -38.05 7.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.16 90.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -62.13 -29.6 70.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -72.69 -64.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.435 ' HB2' ' CG2' ' A' ' 383' ' ' VAL . . . -50.45 -34.01 23.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 420' ' ' ALA . 12.8 tp -37.88 -63.35 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -93.41 -41.02 10.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -47.39 -42.33 21.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' A' ' 380' ' ' PHE . 90.3 mt -86.51 -23.13 26.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -56.85 146.98 24.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.78 -16.25 32.59 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -62.42 117.53 6.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 29.1 m -69.89 112.33 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.3 117.6 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 62.31 26.7 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 81.47 -9.33 55.6 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.517 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -116.61 142.67 46.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.428 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 24.0 mttt -88.12 138.04 31.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.63 156.26 16.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -109.48 109.33 20.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.06 136.04 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -141.69 161.26 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.99 96.5 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' SER . . . . . 0.452 ' HB2' ' CB ' ' A' ' 363' ' ' PHE . 5.4 t -91.2 158.65 16.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.838 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -140.49 160.74 39.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -69.28 151.76 45.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -106.86 -43.88 4.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.091 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 10.8 t -126.99 147.48 50.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -77.24 146.73 75.08 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.538 0.685 . . . . 0.0 110.861 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -46.46 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.65 2.233 . . . . 0.0 112.367 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -88.65 89.98 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.13 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 20.3 m -79.94 132.25 36.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 155.67 -170.35 33.56 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 129.61 17.93 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.658 2.239 . . . . 0.0 112.362 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 2.0 t -51.16 155.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 72.4 p -142.19 169.56 17.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.543 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 9.2 m -64.82 -59.22 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.88 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 1.1 t 54.23 37.68 27.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -89.93 112.44 4.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.44 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 66.1 m -144.46 118.46 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.851 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.6 p -104.05 144.6 31.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.78 147.59 7.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 5.3 mt -146.57 120.44 9.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.52 132.39 34.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.4 mm -118.95 144.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -131.96 160.18 36.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 51.3 t30 69.5 33.8 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 57.7 mt -78.46 107.11 10.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 371' ' ' THR . 2.5 m120 -50.12 118.16 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -40.32 -31.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 p -65.7 -43.01 90.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 368' ' ' ASN . 82.4 m -49.49 147.35 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.089 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 53.0 p -127.46 165.25 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.4 -36.04 79.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -50.34 -59.71 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 55.9 m -61.97 -44.95 95.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.492 HD12 ' CD1' ' A' ' 380' ' ' PHE . 21.0 tp -57.22 -33.19 67.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 381' ' ' SER . 4.0 mtpm? -73.09 -28.16 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -82.14 -50.7 4.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.441 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.24 -37.88 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.814 0.34 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.492 ' CD1' HD12 ' A' ' 376' ' ' LEU . 16.6 m-85 -86.27 -22.74 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.9 t -69.51 -9.61 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.86 -28.14 44.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 420' ' ' ALA . 94.3 t -75.71 -38.17 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 178.51 -167.17 37.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.77 121.24 24.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.081 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.44 ' O ' ' NZ ' ' A' ' 412' ' ' LYS . 20.3 mt -83.52 131.37 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -79.49 -53.3 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 t -157.26 135.07 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.5 p -117.89 128.75 55.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.7 m -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 392' ' ' SER . 79.9 mt -100.69 153.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 391' ' ' ILE . 65.6 m -75.35 94.72 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . 0.411 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 33.7 mttm -119.44 154.72 33.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -146.03 162.5 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.04 101.53 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 399' ' ' GLY . 6.6 p30 -77.14 178.62 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.58 -28.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -84.89 -32.98 22.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.069 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.77 18.86 33.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.453 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 401' ' ' LEU . 47.0 t -102.25 143.66 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.89 0.376 . . . . 0.0 111.151 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.454 ' N ' HG13 ' A' ' 400' ' ' VAL . 1.5 mm? -72.89 102.13 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.411 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 24.3 mt -122.5 149.01 44.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -60.65 159.33 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.519 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 49.4 mtm -116.97 16.68 15.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 92.68 3.32 66.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.519 ' CE1' ' O ' ' A' ' 404' ' ' MET . 1.9 p90 -158.29 159.65 36.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -156.92 -175.8 28.26 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -131.13 121.39 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.07 120.77 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -103.89 154.03 20.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.73 174.66 7.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.44 ' NZ ' ' O ' ' A' ' 386' ' ' ILE . 23.3 mmtm -77.02 -37.14 55.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -137.38 151.46 71.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 415' ' ' GLU . 72.1 Cg_exo -46.72 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.25 . . . . 0.0 112.334 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 414' ' ' PRO . 17.7 tt0 -38.07 -48.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -48.54 -54.01 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.4 87.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -59.74 -29.69 68.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -80.41 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.423 ' N ' HG11 ' A' ' 383' ' ' VAL . . . -53.56 -18.2 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 13.4 tp -53.76 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -92.04 -34.35 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . 0.428 ' CD ' ' O ' ' A' ' 423' ' ' GLN . 0.5 OUTLIER -47.35 -40.77 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.461 HD13 ' CE2' ' A' ' 380' ' ' PHE . 50.2 mt -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -56.12 147.82 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.14 -12.97 34.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -64.72 115.8 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 75.6 m -70.74 101.95 2.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.37 121.39 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 62.05 34.0 16.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.35 -6.98 49.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -122.86 138.25 54.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 7.2 mtpm? -79.34 146.19 33.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 7.3 mt -105.76 159.13 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.464 ' OE1' ' CG ' ' A' ' 437' ' ' ARG . 3.4 tm-20 -110.49 127.76 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.11 135.86 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.464 ' CG ' ' OE1' ' A' ' 435' ' ' GLU . 14.3 mmt180 -140.54 152.49 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 12.9 mm -76.12 98.49 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p -50.08 142.31 9.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.72 121.78 45.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -69.21 159.19 33.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -97.98 149.81 22.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.97 137.71 18.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -90.71 138.71 26.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.551 0.691 . . . . 0.0 110.914 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 447' ' ' SER . 54.4 Cg_endo -69.79 -39.77 6.05 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 0.0 112.36 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -54.29 83.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 445' ' ' PRO . 38.3 t -125.75 91.58 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -80.7 146.24 26.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.499 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 450' ' ' SER . 53.4 Cg_endo -69.81 123.72 10.36 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.681 2.254 . . . . 0.0 112.301 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 449' ' ' PRO . 60.1 p 34.39 46.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 63.5 p -77.1 -48.56 17.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.493 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 13.9 m -76.71 119.35 20.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 58.2 m -59.21 155.16 14.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -142.73 89.1 0.17 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.4 m -160.72 147.81 15.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 12.0 p -111.55 153.65 25.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.08 135.83 5.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.2 mt -137.27 136.43 38.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.89 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.34 124.56 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.1 mm -111.33 142.17 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -132.35 161.7 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 72.73 37.03 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 25.5 mt -86.28 126.95 34.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 371' ' ' THR . 5.4 m-20 -69.5 122.23 18.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -39.23 -40.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.9 m -62.44 -39.95 95.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 368' ' ' ASN . 53.4 m -50.88 126.49 16.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 82.6 p -106.82 157.42 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 374' ' ' GLU . 33.9 mt-10 -54.06 -50.04 67.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 373' ' ' GLU . 16.4 tt0 -34.89 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 83.4 m -55.91 -53.16 60.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.528 HD11 ' CE1' ' A' ' 380' ' ' PHE . 21.6 tp -49.98 -43.48 50.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -50.79 -54.9 19.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.3 -50.98 61.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 92.8 t -47.41 -55.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.182 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.528 ' CE1' HD11 ' A' ' 376' ' ' LEU . 6.7 m-85 -71.46 -34.65 70.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.0 t -53.76 -23.07 10.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -61.14 -35.89 78.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.83 -42.79 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 176.58 -166.01 36.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.78 118.48 16.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 0.0 111.128 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.8 mt -82.24 131.38 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.45 -42.84 28.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 m -169.54 126.42 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 2.3 t -119.61 117.25 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 98.9 m -139.77 136.45 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.114 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 80.5 mt -100.81 152.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.9 m -70.97 101.7 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -126.41 152.03 46.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -144.0 158.65 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 395' ' ' LYS . 2.3 mppt? -74.12 101.9 4.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 400' ' ' VAL . 4.8 p30 -74.68 179.27 4.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -20.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -91.52 -30.47 16.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 94.59 20.15 30.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.476 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 56.8 t -106.12 143.35 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 0.0 111.135 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.442 ' N ' HG12 ' A' ' 400' ' ' VAL . 1.9 mm? -72.38 98.56 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 97.2 mt -111.46 141.81 44.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 14.2 t -58.07 159.96 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 16.0 mmm -115.71 24.82 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 78.62 -3.89 62.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 1.2 p90 -150.3 147.05 27.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -136.51 177.9 19.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.475 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -130.48 118.72 21.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.842 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.06 146.13 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -129.92 146.38 51.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -120.57 164.5 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -66.42 -48.57 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.32 156.65 35.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.513 0.673 . . . . 0.0 110.917 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.39 -8.29 21.59 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.347 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.35 -46.65 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -49.2 -33.87 13.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -67.86 -43.85 78.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.94 -31.45 72.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -70.42 -63.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -49.93 -36.98 29.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 420' ' ' ALA . 16.2 tp -34.84 -64.49 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -96.39 -39.77 9.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -45.09 -45.81 11.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.413 HD12 ' CD1' ' A' ' 380' ' ' PHE . 75.3 mt -83.76 -26.24 29.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.8 tp60 -52.15 152.02 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.3 -21.53 7.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.46 118.96 7.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 41.7 m -72.46 114.14 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.46 ' CG2' HD12 ' A' ' 434' ' ' LEU . 99.6 t -114.22 118.64 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 58.54 25.64 13.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 86.09 -8.62 72.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -118.43 138.94 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -82.34 144.02 30.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.499 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 6.4 mt -101.86 158.69 15.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.74 102.57 10.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.5 t -94.06 125.91 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -130.85 164.21 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 15.3 mm -82.32 96.05 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 8.1 t -88.01 90.45 8.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.73 173.38 6.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -100.98 130.93 47.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -82.39 -60.01 2.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 81.8 p -114.22 154.86 27.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -108.19 148.61 37.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 0.96 4.92 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.716 2.277 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -46.83 141.55 3.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.8 m -46.7 170.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -97.01 -158.1 31.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 0.98 4.82 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.746 2.298 . . . . 0.0 112.349 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 69.5 p -128.36 170.67 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 2.7 m -96.87 109.88 22.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.471 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 2.1 m -59.02 101.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.866 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 19.6 m -57.72 146.59 30.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 174.78 131.37 1.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.0 m -132.42 109.55 9.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 83.2 p -107.39 134.89 49.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.476 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 137.93 139.27 3.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.48 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.58 125.17 14.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 363' ' ' PHE . 0.6 OUTLIER -93.64 118.63 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.5 mm -105.78 148.97 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -136.5 167.49 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 64.83 43.41 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 35.3 mt -94.39 100.66 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -40.74 118.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.419 ' C ' ' O ' ' A' ' 368' ' ' ASN . 6.4 m-85 -36.85 -45.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 65.3 m -58.21 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.4 m -48.59 143.86 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 54.2 p -124.39 157.03 36.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.1 mm-40 -48.07 -47.63 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 373' ' ' GLU . 3.0 tm-20 -34.64 -65.98 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 37.8 m -51.67 -60.38 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.537 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 12.5 tp -44.71 -37.41 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 381' ' ' SER . 7.9 mtpm? -71.53 -39.94 70.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.23 -19.99 70.82 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.75 -47.65 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.537 ' CD1' ' CD1' ' A' ' 376' ' ' LEU . 12.3 m-85 -74.94 -25.44 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 15.1 t -64.94 -16.42 63.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -67.82 -37.55 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.41 -42.35 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.078 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -179.2 -158.65 21.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.527 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -85.14 124.11 31.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 26.5 mt -82.53 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -54.15 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 98.3 p -149.26 123.16 9.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.447 ' C ' ' OE2' ' A' ' 373' ' ' GLU . 6.2 p -127.39 112.93 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -144.43 138.67 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.151 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 392' ' ' SER . 76.2 mt -97.73 143.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.411 ' N ' HG23 ' A' ' 391' ' ' ILE . 8.9 m -65.6 108.13 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -124.44 134.75 52.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.82 156.98 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 4.7 ptpt -78.9 106.37 10.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 399' ' ' GLY . 50.6 p30 -67.85 177.86 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 397' ' ' LYS . 0.4 OUTLIER -43.5 -35.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.6 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.95 38.0 3.98 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 401' ' ' LEU . 84.0 t -119.95 143.64 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.464 ' N ' HG13 ' A' ' 400' ' ' VAL . 1.2 mm? -74.27 107.75 6.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.3 mt -128.91 139.11 52.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.1 m -57.85 164.0 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 36.2 mtm -117.27 23.69 11.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.857 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.55 5.5 89.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 12.3 p90 -152.6 154.11 34.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.905 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.08 -162.03 9.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.472 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . 0.476 ' CE1' ' CA ' ' A' ' 361' ' ' GLY . 29.6 t80 -137.77 126.53 23.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.877 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 70.0 t -119.57 120.4 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -113.07 151.31 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.51 158.91 26.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -63.12 -36.16 82.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -117.37 160.19 38.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 0.0 110.931 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.66 -20.07 15.93 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.12 -49.35 14.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -46.39 -43.1 15.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.01 -51.52 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.11 -29.32 57.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -77.67 -67.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -50.45 -20.21 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 12.8 tp -51.52 -70.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -92.29 -31.68 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.924 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -50.52 -39.47 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.18 -36.97 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 12.7 tp60 -40.63 149.13 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.68 -19.26 9.51 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -59.95 133.84 56.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 30.2 m -72.88 123.56 23.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.0 t -132.35 118.62 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.09 26.98 10.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 84.56 -17.62 29.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -113.24 139.06 49.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -78.06 135.94 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.428 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 9.2 mt -92.81 161.71 14.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.52 113.39 21.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.939 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.63 130.66 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -131.57 163.91 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 20.1 mm -85.51 96.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.7 t -82.13 94.25 7.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . 0.42 ' CD ' ' O ' ' A' ' 440' ' ' GLU . 2.5 pp20? -98.8 37.59 1.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 3.4 tpp85 -104.05 124.31 48.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -92.19 119.55 31.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.14 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 23.9 m -82.16 -63.8 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -103.44 144.35 28.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.58 0.705 . . . . 0.0 110.919 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 111.89 2.94 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.23 . . . . 0.0 112.325 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -39.41 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 32.2 t -174.98 115.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 174.01 148.01 6.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 113.34 3.35 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.65 2.233 . . . . 0.0 112.33 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 34.8 p -48.18 100.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 80.8 p -133.8 119.22 18.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 4.1 m -65.77 107.9 1.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.371 . . . . 0.0 110.86 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 44.5 m -76.41 140.18 41.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.797 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -139.98 87.79 0.2 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 57.4 m -136.73 117.02 13.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 5.8 p -102.9 140.08 37.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.6 142.4 4.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 12.1 mt -146.95 117.19 7.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -91.3 115.46 28.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.467 ' CD1' HG11 ' A' ' 436' ' ' VAL . 3.2 mm -106.05 143.73 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . 0.465 ' CG ' ' HB3' ' A' ' 435' ' ' GLU . 12.4 ptmt -138.84 178.25 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 47.9 t-20 65.62 27.84 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.1 mt -76.86 149.79 36.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -88.95 125.78 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -47.13 -20.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.5 m -80.13 -37.86 32.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 43.2 m -61.52 129.95 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 58.8 p -109.99 159.67 17.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -45.51 -42.91 11.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -41.62 -69.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 376' ' ' LEU . 42.3 m -47.18 -67.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.173 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.508 HD11 ' CE1' ' A' ' 380' ' ' PHE . 10.3 tp -35.53 -53.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -55.91 -52.15 65.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.36 -14.08 39.59 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 71.4 t -90.18 -53.52 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.142 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 376' ' ' LEU . 7.4 m-85 -66.8 -37.68 85.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 11.4 p -52.19 -16.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -63.89 -39.51 94.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 420' ' ' ALA . 37.1 t -68.62 -54.85 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.418 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -163.71 -170.33 28.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.7 120.78 18.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.3 mt -79.31 138.36 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.98 -55.1 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 8.7 t -142.19 121.73 13.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.99 116.35 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -148.41 137.17 21.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 392' ' ' SER . 33.8 mt -101.39 143.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.468 ' N ' HG21 ' A' ' 391' ' ' ILE . 14.2 m -58.3 107.62 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 32.0 mttp -127.15 153.36 46.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -149.76 163.66 37.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -73.26 101.81 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.3 p30 -79.51 178.71 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -41.65 -45.44 3.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.57 -32.64 71.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.88 33.84 6.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.467 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 401' ' ' LEU . 84.9 t -119.58 143.69 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.367 . . . . 0.0 111.106 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.464 ' N ' HG12 ' A' ' 400' ' ' VAL . 2.2 mm? -71.01 98.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.414 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 62.8 mt -118.44 153.6 33.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 50.4 m -57.88 159.7 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 49.7 mtp -117.1 13.05 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 96.41 -3.33 63.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.525 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 6.8 p90 -153.21 157.42 40.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.383 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.04 -179.86 22.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -130.33 124.25 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.41 132.87 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.72 143.06 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.4 153.83 32.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -59.65 -34.15 72.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -122.82 160.72 47.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.58 0.705 . . . . 0.0 110.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.99 -18.98 16.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.311 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -77.15 -52.28 9.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . 0.418 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 21.1 mm-40 -47.39 -31.78 4.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.73 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.07 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -61.92 -30.61 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -71.15 -60.24 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 383' ' ' VAL . . . -58.21 -33.82 69.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 420' ' ' ALA . 13.5 tp -36.63 -55.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 425' ' ' GLN . 11.7 pttm -100.93 -50.44 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 -38.59 -39.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 380' ' ' PHE . 55.9 mt -88.59 -30.87 18.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 422' ' ' LYS . 7.9 tp60 -56.79 126.18 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . 0.427 ' O ' ' NZ ' ' A' ' 433' ' ' LYS . . . 109.02 -17.81 31.79 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . 0.498 ' CD2' HG23 ' A' ' 429' ' ' VAL . 16.4 t60 -60.93 114.48 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 34.1 m -70.95 98.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' A' ' 427' ' ' HIS . 84.9 t -104.44 122.64 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 58.26 27.97 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.12 77.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -123.67 128.66 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 37.0 mttm -80.42 119.53 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.9 mt -78.87 161.95 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.465 ' HB3' ' CG ' ' A' ' 365' ' ' LYS . 5.7 tt0 -121.51 109.16 14.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.467 HG11 ' CD1' ' A' ' 364' ' ' ILE . 61.5 t -98.16 135.44 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.15 160.03 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.48 95.48 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.058 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 6.0 t -92.65 127.97 38.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -118.35 149.82 40.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -109.67 138.93 45.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -84.73 -46.74 11.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 64.5 p -79.43 163.08 25.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.89 147.1 59.92 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.614 0.721 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 143.78 52.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.387 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -86.04 -57.51 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 59.7 m -43.99 128.13 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 160.77 -76.15 0.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.51 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -4.71 14.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.628 2.219 . . . . 0.0 112.376 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 37.4 m -43.75 115.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 44.1 p -102.4 167.02 10.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.856 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.435 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 4.7 t -88.25 -63.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 110.839 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 21.1 t -75.17 -52.84 9.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -178.62 156.69 19.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.3 t -117.67 109.15 16.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.38 . . . . 0.0 110.806 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p -107.34 129.12 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.17 143.89 4.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 12.4 mt -144.48 123.3 12.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 363' ' ' PHE . 0.7 OUTLIER -94.78 112.39 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 1.4 mm -97.81 144.15 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 366' ' ' ASN . 0.3 OUTLIER -133.52 154.96 50.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.455 ' N ' ' HD2' ' A' ' 365' ' ' LYS . 32.6 t-20 74.72 44.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.32 123.51 36.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.93 125.63 25.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -45.89 -25.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.1 t -76.58 -38.3 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 62.9 m -54.57 125.47 19.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.175 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 62.5 p -107.49 152.84 23.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 47.1 mt-10 -47.36 -50.92 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 55.4 mt-10 -34.85 -58.35 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 88.7 m -58.2 -62.47 1.8 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 380' ' ' PHE . 24.5 tp -40.19 -48.29 2.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 381' ' ' SER . 45.0 mtpt -54.85 -43.16 72.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -66.99 -26.73 73.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.502 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.85 -41.33 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 111.142 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.465 ' CD1' HD11 ' A' ' 376' ' ' LEU . 5.9 m-85 -83.21 -22.48 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 12.5 t -67.73 -15.77 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -68.79 -33.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 18.6 t -72.61 -44.21 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -176.23 -170.67 39.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -77.23 128.65 34.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 111.084 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 35.0 mt -90.63 135.77 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -89.07 -50.65 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 25.9 t -147.83 121.43 9.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.8 117.12 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 8.4 m -143.3 141.62 31.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 392' ' ' SER . 88.0 mt -106.68 154.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.429 ' N ' HG22 ' A' ' 391' ' ' ILE . 56.2 m -71.7 87.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -109.74 131.0 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.2 157.72 43.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.51 ' O ' ' CG ' ' A' ' 395' ' ' LYS . 3.1 ptpp? -75.71 102.08 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 399' ' ' GLY . 0.4 OUTLIER -62.15 175.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 398' ' ' ALA . 0.0 OUTLIER -42.32 -37.92 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.455 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -71.89 -32.89 67.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.75 38.02 3.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 401' ' ' LEU . 58.3 t -120.45 143.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.85 0.357 . . . . 0.0 111.156 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.468 ' N ' HG11 ' A' ' 400' ' ' VAL . 1.7 mm? -74.16 101.01 3.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 86.9 mt -127.08 148.76 50.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.94 163.05 2.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 38.2 mtp -117.09 14.3 14.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.25 70.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.414 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 2.5 p90 -156.05 158.27 37.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.951 0.405 . . . . 0.0 110.846 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.11 -176.85 22.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.79 115.03 16.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.84 130.4 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.162 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -111.42 149.53 31.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.08 153.02 43.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -64.37 -38.46 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -116.22 154.22 48.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.24 -14.72 28.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -82.75 -50.96 8.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.87 -41.61 16.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.0 82.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -57.73 -30.38 65.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -72.87 -68.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -48.44 -25.16 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.083 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 41.5 tp -46.65 -66.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -98.92 -40.8 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -41.64 -34.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.6 -37.96 11.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 5.7 tp60 -38.61 142.28 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 90.14 -23.53 20.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -56.3 130.0 42.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.7 m -74.16 110.09 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.3 28.06 17.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.65 1.12 60.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.507 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -126.38 142.24 51.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -83.75 136.66 34.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.48 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 18.7 mt -96.36 157.46 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -111.1 102.04 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.32 121.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -128.26 161.52 29.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.09 95.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 16.9 t -82.96 87.43 6.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -62.89 -38.51 91.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -90.73 131.73 36.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -91.23 159.17 16.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.114 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 8.4 t -46.38 131.37 10.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.143 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -117.21 142.29 29.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -3.0 11.12 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . 73.78 38.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.6 m -65.24 -42.93 92.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.95 83.16 1.03 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 85.83 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 88.4 p -115.24 131.75 56.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 77.9 p -144.37 141.12 29.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.827 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.504 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 51.4 m -74.75 138.91 43.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 39.1 t -74.25 -65.59 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -167.93 110.01 0.37 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.3 m -136.57 160.77 37.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 84.2 p -108.48 148.36 30.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 117.26 144.11 7.71 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.3 mt -147.54 141.58 25.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.4 OUTLIER -109.23 134.4 51.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.4 mm -119.01 147.69 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -134.85 159.84 40.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 405' ' ' GLY . 46.5 t-20 70.33 34.46 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 53.4 mt -80.73 103.16 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.7 m120 -48.66 119.31 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 368' ' ' ASN . 8.2 m-85 -38.17 -42.73 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 52.3 p -58.19 -42.62 86.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 368' ' ' ASN . 35.5 m -44.53 141.61 1.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.173 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' THR . . . . . 0.448 ' N ' HG23 ' A' ' 371' ' ' THR . 49.2 p -121.1 143.65 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 39.2 mt-10 -43.32 -52.98 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 21.8 mp0 -34.59 -61.13 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 89.5 m -55.73 -47.01 77.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.564 HD13 ' CD1' ' A' ' 380' ' ' PHE . 16.0 tp -54.44 -54.84 35.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -55.87 -36.35 67.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.93 61.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.5 -41.52 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.564 ' CD1' HD13 ' A' ' 376' ' ' LEU . 8.5 m-85 -77.67 -12.96 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 6.9 t -77.31 -21.41 53.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -61.56 -27.58 68.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.85 -48.95 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -172.05 -154.63 10.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -90.1 114.69 26.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 36.0 mt -74.81 138.06 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -93.53 -53.81 3.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.1 t -147.77 112.19 5.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 36.1 t -119.13 113.06 20.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' THR . . . . . 0.434 HG21 ' N ' ' A' ' 391' ' ' ILE . 3.5 m -144.59 136.85 26.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.465 HG21 ' N ' ' A' ' 392' ' ' SER . 51.2 mt -93.67 156.62 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.119 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.465 ' N ' HG21 ' A' ' 391' ' ' ILE . 71.8 m -77.47 109.51 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -126.01 172.33 10.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -152.53 154.27 35.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 101.76 6.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 399' ' ' GLY . 48.4 p30 -72.49 176.82 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -47.83 -23.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -89.36 -26.95 20.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 87.76 35.51 9.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 401' ' ' LEU . 93.5 t -116.83 143.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.159 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.464 ' N ' HG11 ' A' ' 400' ' ' VAL . 0.5 OUTLIER -73.23 122.43 21.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 70.4 mt -141.01 140.24 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -58.44 156.61 10.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.2 mtm -114.95 20.7 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 88.66 0.92 81.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.487 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 14.2 p90 -156.45 155.0 31.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.01 -179.9 22.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -130.4 118.31 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.48 144.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -124.66 156.42 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . 0.405 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 30.1 m-85 -131.81 156.9 45.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -65.44 -35.48 81.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -128.3 143.49 48.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.87 -52.35 7.79 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.695 2.263 . . . . 0.0 112.359 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 416' ' ' GLN . 34.1 mt-10 -44.56 -62.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mm100 -35.85 -42.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -59.33 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.29 -27.11 68.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -69.14 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -51.91 -35.52 45.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 420' ' ' ALA . 24.0 tp -36.14 -61.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -100.49 -32.15 10.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -58.26 -16.86 15.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 380' ' ' PHE . 79.1 mt -115.77 -23.72 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -54.64 147.15 15.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 78.96 -10.82 31.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.501 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -58.88 132.93 55.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.1 m -72.52 109.82 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.193 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 77.4 t -126.92 113.47 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 61.39 28.79 18.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.48 39.22 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -115.66 143.16 45.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.358 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -84.87 121.04 27.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 8.8 mt -84.07 155.36 22.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.57 127.88 56.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 28.1 t -112.78 139.3 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 -139.96 166.35 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.1 mm -86.61 95.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.9 t -86.55 108.11 18.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -105.34 173.85 6.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -78.71 134.55 37.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.03 78.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.095 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 10.1 t -129.2 139.27 51.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 143.76 88.67 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.892 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 95.6 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -122.31 154.69 37.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.8 m -42.99 164.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -122.25 83.46 0.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.436 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 101.56 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.732 2.288 . . . . 0.0 112.314 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 8.0 t -165.42 170.84 14.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 12.7 m -109.93 141.1 43.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 356' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 355' ' ' GLY . 2.5 t 36.86 37.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.341 . . . . 0.0 110.802 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 36.1 m -115.81 95.01 4.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -158.5 133.98 3.65 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.7 t -148.82 145.54 27.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.848 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 6.4 p -109.65 126.47 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.66 135.34 2.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.2 mt -138.57 137.26 36.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -111.49 112.96 25.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.9 mm -97.42 143.71 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -131.8 160.31 35.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 5.5 t30 71.18 40.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -87.28 121.37 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 371' ' ' THR . 12.9 m120 -58.81 122.34 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -43.7 -24.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 -37.88 46.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.3 m -51.31 131.73 28.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 41.4 p -113.89 154.33 27.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 374' ' ' GLU . 85.3 mt-10 -45.85 -54.42 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 373' ' ' GLU . 54.4 mm-40 -35.05 -66.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 378' ' ' GLY . 32.7 m -51.73 -64.03 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 375' ' ' THR . 15.3 tp -36.66 -52.59 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.419 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 4.4 mtpm? -55.78 -42.19 75.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -68.82 -25.26 75.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.524 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 94.8 t -78.83 -45.29 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.573 ' CD2' ' CD1' ' A' ' 424' ' ' LEU . 12.6 m-85 -79.26 -46.02 18.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 47.7 t -42.81 -28.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -48.15 -47.73 34.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.79 -57.56 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.59 -167.42 24.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.466 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.9 121.26 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.45 HG21 ' N ' ' A' ' 387' ' ' LYS . 46.2 mt -85.25 139.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.45 ' N ' HG21 ' A' ' 386' ' ' ILE . 11.0 tptm -82.9 -52.88 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -155.82 122.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 15.4 t -119.99 124.04 44.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -146.42 166.68 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 392' ' ' SER . 73.5 mt -127.35 142.22 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.46 ' N ' HG23 ' A' ' 391' ' ' ILE . 1.2 t -68.14 115.04 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -128.51 149.92 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -149.5 151.8 34.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 395' ' ' LYS . 2.4 ptpt -69.58 102.57 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 399' ' ' GLY . 52.5 p30 -64.41 179.12 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -42.88 -40.17 2.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.31 -32.16 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.6 31.94 5.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 401' ' ' LEU . 93.4 t -118.47 143.51 29.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.464 ' N ' HG11 ' A' ' 400' ' ' VAL . 1.6 mm? -74.14 116.74 15.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 39.6 mt -137.32 156.53 48.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.3 t -57.9 158.53 6.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 16.8 mtm -117.07 19.28 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.89 88.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 404' ' ' MET . 16.8 p90 -158.33 158.93 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.3 -172.6 20.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -125.32 123.69 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 89.9 t -118.53 119.28 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -106.54 153.68 21.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . 0.521 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 14.5 m-85 -122.53 153.14 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -59.54 -40.55 87.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -125.43 143.72 45.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.31 -41.61 28.13 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.743 2.295 . . . . 0.0 112.342 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 418' ' ' GLN . 1.2 tp10 -57.83 -62.63 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -37.91 -38.14 0.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.521 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -71.98 -41.19 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.086 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 415' ' ' GLU . 34.8 mm-40 -66.53 -22.19 66.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -83.28 -63.2 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -49.26 -40.39 34.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 420' ' ' ALA . 8.4 tp -35.42 -62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -92.77 -51.41 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -38.62 -36.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.573 ' CD1' ' CD2' ' A' ' 380' ' ' PHE . 90.4 mt -92.25 -35.27 13.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -43.6 150.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.01 -8.48 15.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -66.44 118.42 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 10.4 m -69.23 116.82 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 79.9 t -125.12 122.74 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.157 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 58.82 31.76 21.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.97 -8.12 24.67 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -119.58 133.01 55.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -76.57 151.53 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 5.4 mt -116.54 159.9 21.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -116.11 129.38 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 36.0 t -116.95 142.35 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -137.11 159.47 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 24.9 mm -83.89 95.69 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 23.3 t -79.61 97.83 6.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -72.64 -47.08 50.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -76.69 131.81 39.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -128.61 113.0 14.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.6 p -45.53 164.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -75.78 145.02 77.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.562 0.696 . . . . 0.0 110.919 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -32.8 17.97 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.668 2.246 . . . . 0.0 112.361 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -62.37 116.11 4.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.2 m -73.56 103.2 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 94.16 85.89 1.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.46 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 2.8 3.2 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.335 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 15.8 m 59.07 45.42 14.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.3 t -73.59 135.75 43.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.531 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 7.9 t -63.07 151.57 39.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 110.886 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 3.6 m -118.33 -43.27 2.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.906 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 97.07 115.41 3.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 6.2 m -170.44 154.85 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.86 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.08 155.08 17.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.84 148.77 9.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.544 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mt -147.24 131.88 17.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 365' ' ' LYS . 0.3 OUTLIER -98.38 131.0 45.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.0 mm -117.1 142.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . 0.451 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 12.2 tptp -132.29 162.36 31.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.3 t30 64.93 31.52 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 33.7 mt -72.23 128.84 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.441 HD22 ' CD2' ' A' ' 432' ' ' HIS . 16.3 m120 -70.9 128.92 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -54.52 -15.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 69.4 m -81.8 -29.03 32.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 81.8 m -65.98 138.93 58.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.6 p -120.13 162.22 19.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.18 -36.51 75.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -50.48 -60.46 2.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 42.9 m -62.29 -55.66 26.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.492 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.6 tp -43.16 -38.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -69.38 -43.73 72.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.79 -20.45 72.34 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.478 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.16 -40.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.492 ' CD1' HD12 ' A' ' 376' ' ' LEU . 11.6 m-85 -82.6 -14.66 54.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 75.8 p -74.87 -15.28 60.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -65.03 -27.52 68.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.39 -64.18 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -153.33 -162.44 11.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -84.28 118.46 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.755 0.312 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.92 132.34 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -84.07 -55.04 4.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.7 p -154.46 116.62 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 28.5 p -108.54 120.36 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 95.2 m -137.79 127.54 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.77 140.79 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 70.1 m -57.55 99.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.85 157.82 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -153.96 156.34 37.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -74.67 104.58 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.4 p30 -78.5 178.12 8.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -45.08 -33.62 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -78.73 -29.26 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 88.57 36.91 7.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.491 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 401' ' ' LEU . 67.5 t -121.9 143.41 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 400' ' ' VAL . 1.4 mm? -69.12 107.5 3.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 56.0 mt -126.88 143.92 51.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.0 p -59.3 162.39 4.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.537 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 37.6 mtp -117.08 13.78 14.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.12 1.48 64.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.557 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 404' ' ' MET . 1.7 p90 -158.31 158.82 35.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.03 -175.03 22.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -140.7 113.6 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 63.4 t -103.49 121.0 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.18 145.31 28.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -120.82 151.38 39.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -64.64 -14.04 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -141.47 159.07 61.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.635 0.731 . . . . 0.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.67 -44.93 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.4 -49.41 72.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -47.24 -47.9 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -54.37 -60.01 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -48.88 -31.13 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -75.55 -56.76 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.426 ' CB ' HD12 ' A' ' 424' ' ' LEU . . . -57.88 -15.03 7.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 14.2 tp -63.61 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.7 -34.63 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -55.18 -14.69 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.426 HD12 ' CB ' ' A' ' 420' ' ' ALA . 46.7 mt -117.82 -37.22 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.7 tp60 -42.13 145.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.9 -10.75 59.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -67.79 122.48 18.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.0 m -69.24 116.33 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.147 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.5 123.21 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.26 26.66 15.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.29 40.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.541 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . 0.441 ' CD2' HD22 ' A' ' 368' ' ' ASN . 89.9 m-70 -121.61 137.34 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -77.73 143.25 38.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.487 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 8.0 mt -102.73 159.18 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -113.81 105.99 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.92 133.95 38.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -139.33 166.08 25.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 3.2 mm -87.11 101.53 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 30.9 t -84.68 131.44 34.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -132.29 118.98 20.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.925 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.417 ' NH1' ' HB2' ' A' ' 441' ' ' ARG . 0.0 OUTLIER -100.41 136.38 40.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -42.39 161.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 72.8 p 47.61 41.93 14.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.111 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 148.56 87.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.567 0.699 . . . . 0.0 110.905 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 137.8 36.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.719 2.28 . . . . 0.0 112.331 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -142.58 156.83 45.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.6 p -96.9 163.23 13.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 161.99 169.23 25.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.518 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -0.24 6.64 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.728 2.286 . . . . 0.0 112.312 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 9.9 t -48.49 167.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.831 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 16.5 t -155.3 144.36 20.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 95.8 p -40.47 125.24 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 2.9 t -132.12 107.75 8.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -63.2 166.38 25.01 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t -158.16 147.09 19.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 110.862 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.6 p -109.82 125.36 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.86 138.07 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.91 129.58 19.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.899 0.38 . . . . 0.0 110.902 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -105.17 116.61 32.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.9 mm -103.57 141.2 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -127.56 165.11 20.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 9.2 t30 71.79 28.12 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.409 HD11 ' C ' ' A' ' 406' ' ' PHE . 36.4 mt -74.59 126.51 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.7 m120 -73.66 121.94 21.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -39.27 -38.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.4 t -61.66 -42.71 99.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 368' ' ' ASN . 90.3 m -50.13 121.72 5.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.3 p -99.66 154.12 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.25 -55.37 15.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -43.35 -44.53 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 85.3 m -64.66 -54.35 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.543 HD13 ' CD1' ' A' ' 380' ' ' PHE . 11.7 tp -53.2 -43.72 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -59.45 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -54.55 -57.76 16.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 88.1 t -41.17 -49.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.543 ' CD1' HD13 ' A' ' 376' ' ' LEU . 9.9 m-85 -78.46 -25.51 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.1 t -63.2 -12.94 32.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.3 -24.12 64.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 78.4 t -81.39 -59.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.12 -172.65 30.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -68.99 117.03 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.739 0.304 . . . . 0.0 111.055 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.58 133.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.17 -52.13 7.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.4 m -162.48 117.66 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 17.6 t -120.13 132.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.836 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -144.44 162.65 35.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 392' ' ' SER . 87.8 mt -123.82 138.77 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 406' ' ' PHE . 4.9 p -58.35 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -115.93 140.73 48.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -136.25 170.01 16.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.404 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 3.8 mtmp? -86.63 108.81 18.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.25 178.67 8.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -46.03 -35.8 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.412 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -76.02 -31.83 59.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 96.25 35.3 5.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.449 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 401' ' ' LEU . 18.9 t -118.85 145.24 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.378 . . . . 0.0 111.13 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.452 ' N ' HG13 ' A' ' 400' ' ' VAL . 2.3 mm? -73.0 96.4 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 63.0 mt -110.95 137.67 48.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.4 p -57.67 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 80.0 mtp -116.44 14.49 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.53 74.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.607 ' CZ ' ' CB ' ' A' ' 392' ' ' SER . 16.8 p90 -148.97 174.33 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.64 39.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.545 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -126.55 117.47 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 63.0 t -111.8 136.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -123.33 146.7 47.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.02 153.81 33.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -59.39 -42.03 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -113.32 159.52 34.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 110.875 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -16.34 18.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.346 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.66 -48.82 12.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.52 -35.94 14.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.82 65.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -58.56 -27.93 65.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -78.89 -63.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -55.67 -15.86 3.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 25.2 tp -57.81 -62.16 2.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -95.78 -27.63 15.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . 0.439 ' CD ' ' O ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -58.48 -45.14 89.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.529 ' CD1' ' CD2' ' A' ' 380' ' ' PHE . 94.4 mt -83.98 -17.08 41.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 15.8 tp60 -64.85 134.7 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.03 45.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -55.25 131.79 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.3 m -73.44 96.23 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.7 t -111.31 113.2 43.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.58 31.3 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 65.33 6.28 26.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -126.4 126.46 43.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -73.03 126.8 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.488 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 6.7 mt -90.75 159.34 16.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -110.56 103.18 11.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.51 131.83 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -136.47 164.94 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 30.9 mm -88.21 97.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.1 t -83.73 87.75 7.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.21 -48.18 71.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -65.9 128.79 37.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -125.96 150.69 47.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 45.8 m -109.63 133.45 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 147.71 47.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 0.0 110.903 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 97.81 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -83.85 102.01 12.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 55.1 p -48.72 -47.99 40.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.01 157.38 9.77 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.543 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 159.18 54.44 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.716 2.277 . . . . 0.0 112.387 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 58.6 p -153.01 125.59 8.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 35.5 m -42.32 102.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.856 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.484 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.5 t -40.05 -56.4 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 1.7 t -79.68 161.11 26.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 179.93 66.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.2 m -147.98 157.28 43.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.854 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 81.8 p -112.32 139.11 48.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.14 144.01 5.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.8 mt -149.94 112.95 4.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.36 113.61 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 364' ' ' ILE . 1.9 mm -98.8 145.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -131.87 161.59 32.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.6 t30 71.19 30.26 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 76.5 mt -74.77 112.93 11.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -57.85 117.06 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 368' ' ' ASN . 5.6 m-85 -34.26 -54.59 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 m -46.7 -45.17 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 368' ' ' ASN . 85.9 m -48.3 138.48 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 14.6 t -123.22 163.31 20.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -56.57 -15.13 3.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -68.47 -60.33 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 379' ' ' VAL . 51.6 m -61.58 -38.05 86.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.561 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 7.4 tp -62.9 -57.5 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -53.1 -31.87 44.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -80.75 -23.96 59.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 375' ' ' THR . 94.5 t -80.62 -45.25 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.561 ' CD1' ' CD1' ' A' ' 376' ' ' LEU . 8.2 m-85 -76.0 -24.44 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.3 p -61.71 -24.28 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.877 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -58.56 -39.82 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 420' ' ' ALA . 12.0 t -66.96 -48.29 79.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.416 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -179.02 -168.57 38.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.01 130.58 43.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 28.0 mt -92.9 137.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -86.05 -50.19 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -160.06 126.27 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 50.9 t -123.84 98.98 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 87.5 m -117.84 125.32 50.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 392' ' ' SER . 29.0 mt -101.44 155.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 406' ' ' PHE . 50.6 p -69.86 92.93 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -121.29 141.02 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -138.08 167.55 21.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.446 ' HE3' ' N ' ' A' ' 395' ' ' LYS . 0.1 OUTLIER -82.44 102.89 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 399' ' ' GLY . 3.7 p30 -76.28 178.35 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -39.35 -52.62 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.72 73.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 95.03 30.98 7.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.459 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 13.8 t -109.18 151.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.459 ' N ' HG12 ' A' ' 400' ' ' VAL . 0.8 OUTLIER -76.28 112.72 13.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.1 mt -136.54 136.34 39.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.7 m -57.86 164.12 2.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 6.1 mtm -112.29 15.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 98.09 0.72 58.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 392' ' ' SER . 53.5 p90 -156.57 172.33 18.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -167.97 -177.02 38.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -132.38 133.54 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 410' ' ' GLU . 54.5 t -125.55 141.68 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.158 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.404 ' N ' HG13 ' A' ' 409' ' ' VAL . 7.9 tt0 -124.42 142.77 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 23.8 m-85 -113.87 156.51 23.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -61.42 -41.41 97.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -126.93 142.69 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.583 0.706 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.27 -41.58 27.83 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.93 -55.99 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . 0.416 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 42.5 mm-40 -45.45 -36.69 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -69.2 -45.93 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -60.71 -25.28 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -80.73 -63.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' A' ' 383' ' ' VAL . . . -55.52 -18.32 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 17.4 tp -55.84 -66.43 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -93.81 -41.68 9.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -42.27 -46.26 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 57.9 mt -82.24 -29.49 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.3 tp60 -50.17 142.08 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.7 -18.3 30.88 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -56.62 128.04 34.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.463 ' HA ' ' CE ' ' A' ' 433' ' ' LYS . 1.4 m -71.29 99.27 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.15 124.55 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.49 28.52 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.05 -1.53 47.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -124.65 151.53 44.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.463 ' CE ' ' HA ' ' A' ' 428' ' ' THR . 6.0 mmpt? -88.86 133.4 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.496 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 13.4 mt -94.21 154.71 17.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.915 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.79 106.31 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.7 t -97.65 126.76 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -133.95 163.63 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.815 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 10.7 mm -86.36 99.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p -46.26 169.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -135.13 166.33 23.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -109.08 122.03 46.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -52.11 125.99 17.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.403 ' CG2' ' N ' ' A' ' 444' ' ' LYS . 34.9 m -130.14 155.14 46.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.403 ' N ' ' CG2' ' A' ' 443' ' ' THR . 0.0 OUTLIER -127.4 143.39 47.12 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.879 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 446' ' ' ALA . 54.0 Cg_endo -69.75 -46.65 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.677 2.251 . . . . 0.0 112.345 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 445' ' ' PRO . . . -34.0 132.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 97.5 p -169.57 110.99 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -143.36 -149.77 5.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 128.15 15.61 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 16.1 m -153.13 160.63 42.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 91.6 p -117.41 132.95 56.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 13.5 p -96.59 102.34 14.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 110.836 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 68.8 m -128.07 132.9 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.82 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 150.68 76.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.513 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.3 t -164.93 155.85 14.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.848 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.1 p -107.57 131.77 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.871 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.9 142.78 5.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.85 124.41 13.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.4 OUTLIER -90.71 127.75 36.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.3 mm -116.29 142.32 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -131.56 161.18 33.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 72.35 35.91 1.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 406' ' ' PHE . 50.9 mt -85.35 109.55 18.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -52.57 130.96 33.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.839 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -52.33 -16.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.8 t -82.23 -37.26 26.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 97.0 m -55.21 131.99 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 23.2 p -110.66 156.27 21.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -50.48 -43.71 55.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -43.18 -63.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 378' ' ' GLY . 19.5 m -55.95 -65.8 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.557 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 11.8 tp -37.12 -44.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -62.87 -44.13 96.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -61.48 -52.91 48.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.09 -34.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.159 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.557 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 13.5 m-85 -87.19 -11.84 48.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 t -78.07 -14.16 59.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.51 -38.07 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.431 HG13 ' NE2' ' A' ' 416' ' ' GLN . 60.2 t -64.42 -55.93 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -169.04 -163.2 22.68 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.77 126.17 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 19.7 mt -88.84 136.94 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -86.09 -53.21 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 14.2 t -165.67 130.56 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 45.1 t -123.09 122.63 38.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.3 m -130.9 127.42 38.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 392' ' ' SER . 57.9 mt -95.8 140.68 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.692 ' CB ' ' CE2' ' A' ' 406' ' ' PHE . 2.8 p -60.01 91.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . 0.404 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 48.4 mttm -119.8 140.67 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.884 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -139.76 160.79 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -70.72 107.93 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 399' ' ' GLY . 8.6 p30 -88.61 179.25 6.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -38.92 -47.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.63 68.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 91.86 29.83 11.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.454 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 401' ' ' LEU . 57.0 t -110.78 142.6 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.462 ' N ' HG12 ' A' ' 400' ' ' VAL . 2.2 mm? -72.29 96.63 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.404 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 28.9 mt -119.22 149.35 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 p -57.87 160.7 4.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.1 mtm -116.81 10.89 14.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.52 56.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.692 ' CE2' ' CB ' ' A' ' 392' ' ' SER . 9.4 p90 -152.78 176.09 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -166.73 -172.99 34.64 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -137.8 121.65 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 84.7 t -110.65 132.87 57.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -115.91 153.14 32.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -131.89 152.16 51.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -67.15 -25.3 66.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -117.97 151.58 49.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.407 ' O ' ' NE2' ' A' ' 418' ' ' GLN . 58.7 Cg_endo -71.96 -27.72 17.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 416' ' ' GLN . 14.4 tp10 -75.95 -57.19 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 415' ' ' GLU . 30.9 mm100 -34.83 -43.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -56.0 -51.01 69.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mp0 -63.73 -28.49 69.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -65.49 -59.15 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.89 75.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 15.8 tp -38.64 -55.18 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.84 -43.07 6.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -47.49 -43.76 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.25 -24.15 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -56.99 147.22 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.47 11.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -61.06 118.86 7.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 20.7 m -69.23 116.38 9.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.37 117.68 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 61.28 31.2 19.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.12 -4.47 47.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -122.63 131.44 53.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -74.7 143.83 44.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.0 mt -105.57 161.51 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.52 120.26 39.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.406 ' C ' ' HG2' ' A' ' 437' ' ' ARG . 11.7 t -109.41 134.72 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.406 ' HG2' ' C ' ' A' ' 436' ' ' VAL . 5.5 mmm-85 -140.93 159.6 41.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 22.4 mm -76.93 97.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 4.3 p -43.31 132.54 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -137.07 132.66 34.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -108.38 163.79 12.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -114.53 42.08 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.9 t -149.68 145.09 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.162 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.67 139.29 26.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 87.19 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.305 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -173.19 117.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 58.7 m -86.05 85.66 7.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.806 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 137.33 -162.73 25.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 157.04 61.85 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 94.4 p -129.54 120.8 25.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 30.3 m -123.51 154.53 39.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.502 -179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 17.0 m -106.4 104.77 14.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 110.868 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 17.4 t -82.37 100.23 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 75.26 162.02 10.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.491 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.8 m -165.38 162.69 19.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.4 p -114.32 137.34 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.844 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 130.24 141.86 5.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.51 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.11 117.63 7.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -95.78 112.4 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.1 mm -98.97 149.99 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -133.86 158.24 43.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 405' ' ' GLY . 37.4 t30 74.72 36.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 406' ' ' PHE . 45.9 mt -84.21 118.82 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.6 m-20 -56.38 119.87 6.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -41.0 -30.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 53.7 p -73.39 -39.22 65.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 368' ' ' ASN . 55.2 m -46.18 121.11 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 39.4 p -96.23 157.48 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 374' ' ' GLU . 45.1 mt-10 -56.34 -55.9 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.2 tt0 -36.84 -57.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 33.0 m -52.2 -50.5 61.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 380' ' ' PHE . 15.1 tp -55.49 -49.76 71.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -53.08 -36.46 60.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -75.04 -43.65 26.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.455 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.79 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.479 ' CD2' HG12 ' A' ' 409' ' ' VAL . 5.8 m-85 -81.29 -24.48 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.3 t -65.81 -19.98 66.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -63.29 -35.49 80.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.4 -62.7 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -158.07 -150.3 5.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -88.88 122.33 32.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.424 HG21 ' N ' ' A' ' 387' ' ' LYS . 23.1 mt -87.32 142.53 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 386' ' ' ILE . 16.4 tptm -90.26 -49.19 6.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 33.8 t -164.7 118.26 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 7.7 t -113.31 130.34 56.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.5 t -146.05 154.12 41.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 392' ' ' SER . 77.8 mt -115.27 141.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.441 ' N ' HG23 ' A' ' 391' ' ' ILE . 74.6 m -64.87 91.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 53.6 mttt -115.17 147.61 40.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -134.48 156.5 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 395' ' ' LYS . 0.6 OUTLIER -76.9 110.74 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.1 p-10 -82.58 178.48 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 398' ' ' ALA . 0.0 OUTLIER -41.72 -30.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.439 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -87.79 -32.25 19.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.097 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.54 31.02 8.12 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.529 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 401' ' ' LEU . 89.1 t -105.92 143.2 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.105 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 400' ' ' VAL . 0.9 OUTLIER -73.12 112.16 8.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.413 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 32.2 mt -134.5 136.1 42.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.1 m -57.84 159.19 5.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.507 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 47.0 mtm -116.9 21.13 13.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 90.05 4.96 71.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.453 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 404' ' ' MET . 5.7 p90 -155.08 154.31 32.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.388 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.6 168.37 30.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.28 122.23 45.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.479 HG12 ' CD2' ' A' ' 380' ' ' PHE . 86.5 t -115.27 125.21 72.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.55 155.38 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -126.54 165.75 18.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.906 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -71.93 -34.5 69.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.21 161.75 41.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.18 -16.31 19.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.22 -41.54 14.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -51.04 -44.5 61.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.47 88.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -57.13 -35.95 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -67.47 -61.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -52.24 -34.65 46.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.095 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 420' ' ' ALA . 63.7 tp -34.86 -61.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.25 -44.83 5.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -39.87 -35.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 84.0 mt -93.3 -33.4 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.4 tp60 -47.03 139.88 5.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.2 56.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -59.69 129.88 44.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 18.2 m -69.83 114.12 7.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.169 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.1 116.73 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 54.59 31.16 14.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 73.05 -2.79 32.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -123.45 133.13 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -77.95 145.28 36.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.487 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 9.8 mt -106.12 163.28 12.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.46 108.57 17.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.485 ' O ' ' CZ ' ' A' ' 437' ' ' ARG . 42.0 t -92.47 124.74 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.485 ' CZ ' ' O ' ' A' ' 436' ' ' VAL . 11.3 mmp_? -127.17 165.96 18.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 5.2 mm -90.63 97.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.4 p -39.62 -39.25 0.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 64.55 37.82 7.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 442' ' ' ALA . 17.0 tpp180 -95.56 148.24 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 441' ' ' ARG . . . -119.91 124.46 46.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 13.5 t -130.93 154.27 48.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.451 ' CG ' ' HD2' ' A' ' 445' ' ' PRO . 17.9 ttpt -88.15 139.53 30.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.649 0.738 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 444' ' ' LYS . 53.3 Cg_endo -69.79 97.53 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.635 2.224 . . . . 0.0 112.335 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -99.96 165.92 11.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.1 m -92.86 -44.72 8.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 98.4 -146.71 18.29 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.465 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -0.25 6.61 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.706 2.271 . . . . 0.0 112.337 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 15.5 m -102.24 129.27 48.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 1.2 t -150.04 175.65 11.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 75.7 m -114.55 118.83 34.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 48.0 t -174.69 144.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 127.91 109.48 1.52 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.532 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m -160.48 163.77 32.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.879 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.1 p -105.57 159.4 15.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 103.26 139.43 10.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.502 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 409' ' ' VAL . 9.6 mt -141.86 131.3 23.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.64 125.85 40.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.2 mm -116.3 142.06 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.077 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 13.1 tptm -128.89 162.5 27.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 405' ' ' GLY . 35.2 t-20 65.08 45.56 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 43.6 mt -89.52 107.36 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -50.49 124.51 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -47.1 -28.5 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 t -69.22 -35.55 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 13.1 m -56.67 130.44 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.088 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 43.8 p -108.16 156.52 19.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -49.75 -49.42 48.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -43.35 -68.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 91.3 m -44.98 -64.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 18.5 tp -39.77 -51.76 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -54.39 -43.43 71.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -62.13 -48.85 80.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 66.6 t -58.23 -40.77 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -82.51 -20.91 35.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 24.3 t -70.27 -14.01 62.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.809 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -71.49 -37.71 71.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.88 -39.82 85.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.41 44.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.15 123.08 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.08 133.13 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -52.56 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.4 p -157.77 120.87 3.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 36.1 t -119.16 120.43 37.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -143.92 145.44 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 59.0 mt -106.1 148.66 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.4 m -72.65 101.22 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -124.51 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -126.65 165.34 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -77.11 103.42 7.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.445 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 5.6 p30 -79.06 178.14 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -41.08 -46.93 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 96.28 26.66 10.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 401' ' ' LEU . 65.1 t -108.0 142.45 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.136 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.468 ' N ' HG12 ' A' ' 400' ' ' VAL . 2.0 mm? -71.6 102.09 2.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.12 147.66 43.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.5 t -57.99 155.79 10.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.582 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 52.6 mtm -116.06 19.47 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 87.86 1.4 82.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -156.27 153.28 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.12 167.81 30.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.04 128.07 55.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 362' ' ' LEU . 82.3 t -120.49 122.3 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -110.75 144.74 39.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -114.23 169.0 9.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -73.29 -36.9 66.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -131.92 143.88 50.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.37 -39.16 21.56 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 418' ' ' GLN . 25.1 mm-40 -56.95 -63.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.2 mm100 -36.51 -45.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.08 -44.99 90.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 415' ' ' GLU . 16.1 mm-40 -59.14 -30.85 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -75.5 -66.7 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -47.2 -33.0 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 12.7 tp -40.7 -66.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -94.37 -36.56 11.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -48.63 -46.36 39.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 82.3 mt -82.07 -35.57 28.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 9.6 tp60 -42.65 152.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.39 -25.54 4.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -59.57 118.78 6.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 80.8 m -70.88 122.61 20.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.04 119.91 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 60.89 26.73 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.826 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 88.63 -15.89 55.71 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.474 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -116.86 145.45 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -85.11 146.19 27.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.445 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 10.0 mt -100.14 161.58 13.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -115.04 105.2 12.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -97.18 134.94 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -141.79 160.63 39.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.49 95.99 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 33.4 t -81.32 90.74 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -89.33 130.9 35.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.865 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -88.69 156.8 18.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -120.68 -54.34 2.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 8.9 t -104.26 155.44 18.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -106.78 95.48 12.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.535 0.683 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.68 151.59 69.55 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.671 2.247 . . . . 0.0 112.381 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 447' ' ' SER . . . -93.01 139.33 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 446' ' ' ALA . 5.5 m -36.88 111.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 75.16 146.05 1.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -37.16 9.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.718 2.279 . . . . 0.0 112.294 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 3.6 t -148.43 174.01 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 68.3 m -66.17 111.57 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 -179.967 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 4.8 m -143.81 137.02 27.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 110.87 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 47.0 m -84.09 160.77 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.836 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 130.94 113.0 1.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 18.0 m -112.16 108.52 17.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.876 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 9.1 p -108.54 128.41 54.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 150.93 143.37 3.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 mt -145.89 127.58 15.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -102.8 122.93 45.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.464 ' CD1' HG13 ' A' ' 436' ' ' VAL . 3.5 mm -108.66 144.82 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -135.16 159.64 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.7 t30 73.93 27.33 1.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.98 117.79 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.5 m120 -56.73 120.27 7.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -42.04 -35.34 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.5 m -64.9 -40.12 94.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 368' ' ' ASN . 84.8 m -55.31 146.24 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.163 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.8 p -123.19 168.61 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.6 mp0 -57.98 -54.38 47.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.3 mp0 -36.78 -70.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 16.1 m -43.77 -51.43 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.517 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 12.8 tp -54.44 -42.75 70.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 381' ' ' SER . 13.3 mtpt -61.07 -45.11 96.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.0 57.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.517 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.19 -52.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.117 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.517 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 10.8 m-85 -72.23 -20.27 61.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.6 t -69.26 -12.38 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -67.66 -39.56 84.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.413 ' CG2' ' HB1' ' A' ' 420' ' ' ALA . 46.2 t -64.64 -35.18 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.417 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . 169.17 -166.85 40.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.17 125.46 27.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 50.0 mt -85.83 130.5 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -74.36 -52.27 12.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.2 t -160.36 122.97 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 4.5 t -119.39 121.16 38.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 46.5 m -145.76 133.28 20.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 392' ' ' SER . 80.0 mt -99.52 154.89 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 391' ' ' ILE . 38.0 m -73.03 100.15 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . 0.44 ' HG2' ' N ' ' A' ' 403' ' ' SER . 4.1 mtmp? -124.75 134.66 52.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.11 171.58 8.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -81.38 102.38 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.504 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.7 p30 -76.07 177.23 7.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -40.06 -54.36 2.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.19 -28.06 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.43 30.75 8.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.504 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 17.9 t -110.48 144.39 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.435 ' N ' HG11 ' A' ' 400' ' ' VAL . 2.1 mm? -71.68 97.56 1.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.411 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.0 mt -114.85 142.76 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.44 ' N ' ' HG2' ' A' ' 393' ' ' LYS . 58.3 m -58.0 160.5 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.543 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 28.7 mtm -116.86 22.71 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 83.66 1.43 90.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 404' ' ' MET . 4.8 p90 -152.8 154.67 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.917 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.55 -170.24 17.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.479 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -140.26 121.58 14.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 87.5 t -108.7 141.9 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -127.89 145.59 50.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.98 166.3 12.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -68.03 -36.61 80.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -123.28 162.17 41.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.582 0.706 . . . . 0.0 110.889 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.87 -18.86 16.59 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.647 2.231 . . . . 0.0 112.322 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.91 -55.82 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . 0.417 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 42.3 mt-30 -50.33 -31.44 14.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.55 -48.12 65.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -60.78 -29.71 69.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -70.86 -63.93 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.413 ' HB1' ' CG2' ' A' ' 383' ' ' VAL . . . -49.09 -36.62 19.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 420' ' ' ALA . 7.8 tp -37.58 -69.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 -34.46 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -51.8 -34.76 41.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 85.1 mt -96.41 -29.57 13.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -48.33 144.93 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.4 12.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.462 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -55.26 115.9 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 42.0 m -71.11 114.24 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 73.6 t -121.42 125.78 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.82 27.14 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.811 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.51 -3.96 61.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -122.79 142.8 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -88.01 141.65 28.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.24 157.31 17.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.46 119.76 39.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.464 HG13 ' CD1' ' A' ' 364' ' ' ILE . 42.5 t -110.39 138.3 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -133.43 163.71 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.39 95.34 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 32.8 t -78.98 111.65 15.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.83 149.71 50.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.73 147.26 30.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -99.57 -52.64 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 37.0 p -145.74 175.08 10.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.161 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -109.31 95.43 18.5 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.543 0.687 . . . . 0.0 110.879 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 178.04 4.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.672 2.248 . . . . 0.0 112.369 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -150.88 138.45 19.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 57.7 m -67.1 111.42 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.0 70.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 450' ' ' SER . 53.3 Cg_endo -69.8 127.99 15.35 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.666 2.244 . . . . 0.0 112.362 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 449' ' ' PRO . 86.4 p 34.41 41.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.82 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 3.0 m -95.7 162.49 13.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.526 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.1 t -110.8 41.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.364 . . . . 0.0 110.848 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.7 t -74.1 88.84 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 124.7 90.37 0.86 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.537 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m -146.04 158.77 43.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 110.886 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 7.2 p -121.46 158.04 29.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.55 12.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.7 mt -142.05 126.32 17.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -90.81 128.7 36.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 4.1 mm -117.63 144.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -133.14 160.31 37.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 22.6 t30 72.61 40.5 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 25.1 mt -85.61 148.94 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.464 HD22 ' CD2' ' A' ' 432' ' ' HIS . 3.0 m-20 -88.99 124.79 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -46.01 -39.8 9.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -63.28 -32.51 73.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 99.3 m -59.9 131.11 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.0 p -114.19 143.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -40.58 -43.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -38.78 -57.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 76.8 m -62.96 -60.22 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.547 HD12 ' CE1' ' A' ' 380' ' ' PHE . 11.0 tp -39.13 -44.85 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -52.28 -56.17 16.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -59.87 -25.55 61.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 382' ' ' LYS . 57.5 t -73.21 -34.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 409' ' ' VAL . 9.1 m-85 -94.14 -16.36 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 48.7 p -73.6 -17.08 61.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 379' ' ' VAL . 0.2 OUTLIER -75.43 -18.52 59.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 420' ' ' ALA . 53.8 t -95.3 -41.17 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.423 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -167.44 -178.64 39.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.509 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.57 120.08 22.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.775 0.321 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 387' ' ' LYS . 36.8 mt -81.8 143.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.454 ' N ' HG22 ' A' ' 386' ' ' ILE . 13.1 tptp -105.21 -38.87 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.4 t -160.52 118.09 2.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 21.5 t -121.52 116.89 25.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.1 m -142.7 151.15 41.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 392' ' ' SER . 63.4 mt -107.99 148.86 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 391' ' ' ILE . 10.5 m -64.71 85.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -110.71 137.49 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -122.1 156.55 33.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.934 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -73.8 101.5 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.537 ' ND2' ' CD1' ' A' ' 402' ' ' LEU . 21.7 p30 -77.76 179.24 6.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.914 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -40.33 -54.11 2.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.27 69.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.63 31.34 8.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.541 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 401' ' ' LEU . 58.0 t -113.98 143.3 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.089 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.463 ' N ' HG11 ' A' ' 400' ' ' VAL . 2.3 mm? -73.11 96.65 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.537 ' CD1' ' ND2' ' A' ' 396' ' ' ASN . 97.1 mt -105.99 139.29 40.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.1 p -57.9 156.12 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 9.4 mtm -116.42 21.94 13.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.2 89.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 7.8 p90 -149.14 150.4 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -139.51 -172.7 12.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -139.44 116.44 10.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 380' ' ' PHE . 91.5 t -104.5 124.74 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -107.06 137.1 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.55 162.81 14.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -78.1 -22.92 48.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm -133.44 158.78 74.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -30.28 14.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.625 2.217 . . . . 0.0 112.347 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.6 -39.14 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . 0.423 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 2.8 mm-40 -51.42 -49.38 61.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.41 75.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -64.88 -29.72 70.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -78.56 -54.63 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.461 ' N ' HG12 ' A' ' 383' ' ' VAL . . . -61.94 -24.9 67.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 14.2 tp -44.8 -56.24 4.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.21 -44.58 5.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -43.28 -46.71 6.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.463 ' CD2' ' HE2' ' A' ' 382' ' ' LYS . 30.6 mt -80.94 -43.53 19.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 4.2 tp60 -47.25 121.03 3.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.75 -20.11 37.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -60.23 130.06 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.7 m -70.49 96.32 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.115 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.11 112.95 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 62.1 26.02 15.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 70.0 6.58 57.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . 0.464 ' CD2' HD22 ' A' ' 368' ' ' ASN . 21.8 m-70 -121.38 120.59 35.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 110.836 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -71.72 107.39 4.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.411 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 11.2 mt -67.74 161.56 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -119.6 99.26 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.15 134.72 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.068 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -143.46 145.99 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.39 98.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.0 p -43.24 135.61 3.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -79.6 -61.18 2.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.89 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.98 149.75 21.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -110.77 85.27 2.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.4 t -146.44 135.16 22.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.104 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -81.94 147.08 57.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.52 0.676 . . . . 0.0 110.936 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 446' ' ' ALA . 54.3 Cg_endo -69.77 2.87 3.15 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.684 2.256 . . . . 0.0 112.357 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 445' ' ' PRO . . . -34.95 141.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 6.2 t -96.01 153.43 17.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.05 -158.07 7.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 124.29 10.91 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 2.242 . . . . 0.0 112.323 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 38.1 t -108.43 121.59 45.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 59.5 m -92.62 101.33 13.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.88 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.486 -179.961 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 19.2 m -59.62 121.58 11.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.873 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 34.3 m -126.74 90.67 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 71.42 168.06 8.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m -155.22 138.58 15.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.809 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.96 150.68 21.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.845 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.22 143.69 7.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.2 mt -146.55 132.49 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.359 . . . . 0.0 110.921 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.77 126.48 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 3.7 mm -112.15 144.78 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -133.87 162.33 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 68.47 43.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.28 106.5 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.3 m120 -46.92 122.23 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -43.59 -24.46 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 70.2 m -77.05 -38.96 51.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 368' ' ' ASN . 25.5 m -48.8 131.83 18.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 76.5 p -108.48 148.44 30.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 374' ' ' GLU . 2.8 mp0 -45.57 -50.76 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 373' ' ' GLU . 5.8 mm-40 -36.09 -67.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 378' ' ' GLY . 71.1 m -48.71 -67.79 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.154 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.545 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 7.2 tp -35.82 -46.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -64.84 -44.53 89.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -60.43 -21.38 57.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.98 -48.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 10.0 m-85 -70.23 -29.33 66.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 53.5 p -58.74 -19.59 41.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.892 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -64.26 -36.58 84.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.94 -47.66 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.45 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -175.82 -154.43 11.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.523 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 412' ' ' LYS . . . -82.77 125.83 31.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.759 0.314 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 45.2 mt -93.02 130.13 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.123 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -77.5 -49.03 15.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.1 t -169.73 117.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 51.2 t -108.94 128.6 55.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.3 t -140.06 163.15 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 392' ' ' SER . 73.8 mt -126.35 137.23 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 391' ' ' ILE . 27.8 m -56.04 102.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 35.6 mtmt -125.66 136.9 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -128.37 156.26 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -71.71 104.24 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 399' ' ' GLY . 0.5 OUTLIER -79.33 178.82 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -38.61 -53.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.98 74.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.77 22.21 14.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 401' ' ' LEU . 45.8 t -101.34 143.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.376 . . . . 0.0 111.105 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 401' ' ' LEU . 2.4 mm? -73.67 96.03 2.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.412 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.6 mt -109.41 143.82 38.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.4 p -57.91 161.56 3.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 35.9 mtp -117.03 16.7 15.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.02 86.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.51 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -153.02 155.07 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -148.76 -176.01 21.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -127.29 123.26 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 77.8 t -105.62 106.1 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.117 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -85.36 152.72 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -132.7 152.22 51.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 385' ' ' ALA . 4.6 mtmp? -65.22 -32.62 74.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -135.14 141.73 39.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.91 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 415' ' ' GLU . 74.2 Cg_exo -47.64 -58.66 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.689 2.259 . . . . 0.0 112.378 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 414' ' ' PRO . 32.1 mt-10 -37.59 -57.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . 0.45 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 26.8 mm-40 -43.52 -46.09 6.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.4 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -56.6 -27.26 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -77.81 -63.98 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -52.73 -19.44 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 45.5 tp -51.28 -64.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -92.67 -47.64 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . 0.467 ' N ' ' HD3' ' A' ' 422' ' ' LYS . 2.7 tm0? -38.27 -34.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.411 HD13 ' CD1' ' A' ' 380' ' ' PHE . 94.3 mt -96.84 -31.8 12.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -49.63 135.04 19.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.86 -24.94 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.457 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -56.18 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 99.7 m -70.44 106.95 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.155 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.51 118.89 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 62.27 31.06 17.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.29 51.41 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -122.03 129.54 52.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.41 145.92 50.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 7.6 mt -103.57 158.81 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -108.98 119.93 41.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.419 ' C ' ' HG2' ' A' ' 437' ' ' ARG . 14.5 t -109.99 133.87 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 436' ' ' VAL . 8.3 mmm180 -142.0 149.29 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.8 mm -70.14 96.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.8 t -86.5 47.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.93 -47.62 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -92.88 106.65 18.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -80.77 163.78 23.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.139 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 23.6 p -56.61 -56.01 26.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.178 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -90.74 138.99 26.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.528 0.68 . . . . 0.0 110.923 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 146.83 61.34 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -120.91 86.33 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.087 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 15.6 m -129.54 177.43 7.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.48 74.08 0.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 144.61 54.47 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.7 2.267 . . . . 0.0 112.319 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 68.2 m -56.86 164.56 1.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 17.9 t -96.36 88.33 4.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.1 t -41.85 127.44 3.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 110.887 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 6.6 m -157.99 163.67 37.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -75.47 94.17 0.93 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.5 m -103.82 82.89 2.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 64.8 p -95.96 128.01 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 408' ' ' PHE . . . 140.63 141.92 4.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 409' ' ' VAL . 8.4 mt -140.21 127.64 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.98 135.63 33.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 1.8 mm -126.05 142.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 363' ' ' PHE . 7.4 tptp -133.52 159.12 41.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 70.13 45.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 37.4 mt -93.53 108.27 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -51.02 124.31 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -46.48 -28.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -36.94 70.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.83 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 60.2 m -54.95 127.91 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.5 p -99.19 178.44 4.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.89 -47.49 21.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -42.34 -61.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 26.5 m -49.22 -62.36 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.155 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 380' ' ' PHE . 23.0 tp -45.11 -48.56 12.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.427 ' CD ' ' HB3' ' A' ' 389' ' ' CYS . 14.7 mmmt -49.34 -50.07 41.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.41 -34.63 89.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.494 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.49 -44.81 98.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' A' ' 409' ' ' VAL . 5.9 m-85 -80.59 -35.31 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -29.02 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -55.62 -41.61 73.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.497 ' O ' ' NE2' ' A' ' 416' ' ' GLN . 57.5 t -61.79 -39.83 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 169.23 -160.42 33.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.447 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.49 131.72 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 55.1 mt -98.01 134.84 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -81.26 -49.21 11.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.3 t -165.66 116.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.427 ' HB3' ' CD ' ' A' ' 377' ' ' LYS . 4.8 t -111.77 123.11 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -138.08 151.66 48.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 392' ' ' SER . 66.7 mt -118.9 139.33 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.141 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 391' ' ' ILE . 58.0 m -58.43 94.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -121.69 148.25 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -139.1 171.17 14.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -83.55 103.17 12.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 400' ' ' VAL . 9.0 p30 -79.94 177.8 8.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 398' ' ' ALA . 13.2 ptmt -43.77 -35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 397' ' ' LYS . . . -78.8 -32.92 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 97.25 18.93 27.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.496 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 401' ' ' LEU . 59.4 t -102.43 143.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.142 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 400' ' ' VAL . 2.2 mm? -72.88 96.9 2.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.438 HD13 ' ND2' ' A' ' 396' ' ' ASN . 73.7 mt -111.12 148.4 32.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 25.4 m -57.95 159.79 5.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' MET . . . . . 0.47 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 46.6 mtp -116.98 13.82 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 93.8 -4.87 72.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.491 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 1.7 p90 -153.61 158.8 41.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.18 -178.3 24.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . 0.412 ' CZ ' ' HA3' ' A' ' 361' ' ' GLY . 37.8 t80 -131.96 109.75 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.37 . . . . 0.0 110.898 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 380' ' ' PHE . 71.3 t -100.35 124.97 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -110.73 142.35 42.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.6 m-85 -114.83 154.12 29.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -61.83 -34.42 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -122.0 156.97 59.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.578 0.704 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.2 -8.48 19.87 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.341 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.11 -49.51 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 383' ' ' VAL . 30.7 mm100 -52.25 -39.94 61.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.541 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -66.01 -40.02 90.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -63.05 -32.48 73.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -72.7 -66.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 421' ' ' LEU . . . -44.99 -36.61 3.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 420' ' ' ALA . 12.6 tp -34.66 -64.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -96.76 -41.51 8.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -39.56 -41.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 91.1 mt -92.21 -28.54 16.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.2 tp60 -48.78 138.32 11.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.82 -26.04 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -60.11 118.26 6.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 28.7 m -69.88 132.08 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.1 t -135.29 123.01 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 59.13 29.82 19.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 82.97 -13.56 43.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -116.93 145.19 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -88.59 144.02 26.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.49 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 8.3 mt -97.2 149.83 21.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -108.19 112.78 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.78 139.58 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -147.45 149.46 32.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 19.0 mm -68.68 95.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 440' ' ' GLU . 3.9 t -79.19 46.85 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 439' ' ' SER . 29.3 tt0 -36.08 -62.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -65.11 105.49 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -127.54 175.15 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 62.0 p -80.87 105.82 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.138 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -107.2 95.44 13.18 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.555 0.693 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 151.42 69.29 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.259 . . . . 0.0 112.344 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -136.24 112.07 9.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.059 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 39.6 m -117.09 140.87 48.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.852 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 99.9 -166.06 20.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.478 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 0.18 6.02 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.668 2.245 . . . . 0.0 112.368 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 4.3 m 60.68 53.95 3.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 32.0 t -74.3 156.93 36.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.895 0.378 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.7 p -103.14 150.0 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.53 7.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.4 mt -148.88 123.85 10.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -93.65 130.54 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.22 142.76 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -128.71 165.85 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 60.93 47.85 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.56 HD23 HD22 ' A' ' 434' ' ' LEU . 38.4 mt -90.83 113.53 25.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -52.22 121.49 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -44.86 -32.11 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.2 t -68.2 -41.33 81.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 85.8 m -46.28 146.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 38.3 p -121.17 174.71 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.04 -38.06 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -54.01 -59.79 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 59.2 m -54.16 -46.08 72.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.436 HD12 ' CD1' ' A' ' 380' ' ' PHE . 22.2 tp -54.0 -46.01 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' SER . 24.4 mtpp -60.56 -41.12 93.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.65 -51.86 54.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.469 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.514 HG12 HD22 ' A' ' 424' ' ' LEU . 68.5 t -59.8 -39.34 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.463 ' CD2' HG11 ' A' ' 409' ' ' VAL . 11.0 m-85 -82.16 -21.21 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 377' ' ' LYS . 2.0 t -68.92 -14.84 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -66.85 -41.27 87.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 420' ' ' ALA . 3.9 t -67.49 -48.91 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.155 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.09 38.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.96 123.09 23.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.138 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 410' ' ' GLU . 19.1 mt -81.17 130.35 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -76.29 -51.21 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 27.1 t -159.26 134.01 8.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 15.2 p -123.1 126.82 47.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 16.2 m -143.5 122.36 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 34.1 mt -101.01 142.75 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 73.8 m -60.78 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -121.86 135.35 54.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.63 167.41 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.67 106.83 15.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.5 p30 -84.98 179.27 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -39.35 -48.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.89 74.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.51 22.4 26.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.32 143.0 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -72.24 99.71 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.55 140.64 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 31.6 m -58.05 162.91 3.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 21.4 mtm -117.04 16.26 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.23 3.79 63.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.483 ' C ' HD12 ' A' ' 367' ' ' LEU . 8.6 p90 -158.29 157.06 31.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 0.0 110.88 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -153.9 -172.96 22.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -137.39 119.26 15.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 380' ' ' PHE . 36.5 t -107.47 138.48 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 386' ' ' ILE . 44.0 tt0 -118.56 150.66 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.5 m-85 -122.6 163.08 20.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -70.68 -30.87 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -139.63 143.7 36.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.64 -42.03 23.95 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 418' ' ' GLN . 7.4 tt0 -51.71 -66.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -37.82 -48.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.548 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -63.23 -40.13 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 415' ' ' GLU . 45.7 mm-40 -60.86 -33.98 73.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -79.03 -60.14 2.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.683 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.32 -24.51 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.613 HD22 HD11 ' A' ' 438' ' ' ILE . 14.0 tp -50.08 -66.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 422' ' ' LYS . 0.6 OUTLIER -90.99 -35.18 14.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -49.64 -43.14 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.557 HD12 ' HB1' ' A' ' 420' ' ' ALA . 95.0 mt -85.81 -18.28 33.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 8.0 tp60 -62.22 142.38 57.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 88.29 -18.68 39.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -57.83 121.86 11.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.6 m -71.15 96.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.61 123.05 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 59.08 28.81 18.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.64 -4.19 52.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.444 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -124.05 149.33 46.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -91.01 140.14 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.56 HD22 HD23 ' A' ' 367' ' ' LEU . 14.0 mt -97.89 154.61 17.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -104.45 103.38 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.24 132.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -139.98 152.17 46.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.613 HD11 HD22 ' A' ' 421' ' ' LEU . 8.7 mm -71.37 96.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.88 0.372 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.0 p -112.95 136.98 52.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.72 137.99 3.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.3 119.02 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.372 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.574 ' C ' HD13 ' A' ' 364' ' ' ILE . 3.7 t80 -99.19 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.664 ' N ' HD13 ' A' ' 364' ' ' ILE . 1.2 mm -98.72 142.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -129.66 163.23 26.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 72.49 32.53 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.559 HD23 HD22 ' A' ' 434' ' ' LEU . 32.5 mt -81.5 131.79 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -71.7 125.82 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -45.88 -31.22 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 85.3 p -68.54 -38.25 80.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 45.9 m -57.79 137.37 56.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 69.0 p -114.87 176.35 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -65.59 -46.81 77.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.89 -55.0 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 56.9 m -59.93 -51.8 68.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 380' ' ' PHE . 8.9 tp -51.16 -42.54 60.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -57.62 -47.66 81.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.25 -43.88 97.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.06 -45.86 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 0.0 111.141 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' A' ' 376' ' ' LEU . 10.1 m-85 -80.22 -26.41 39.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.0 t -61.95 -16.36 50.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -67.22 -20.97 65.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.457 HG21 ' CB ' ' A' ' 420' ' ' ALA . 73.8 t -84.51 -48.66 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -171.95 -166.77 31.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.93 26.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.2 mt -92.55 139.16 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.168 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -53.86 3.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.0 t -151.36 126.97 10.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 409' ' ' VAL . 49.7 t -127.36 118.72 24.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 167.05 20.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 74.6 mt -126.65 143.7 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.1 m -72.69 103.76 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.87 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -114.34 137.95 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 395' ' ' LYS . 4.7 ttpt -127.2 149.43 49.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.939 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.48 ' N ' ' HG3' ' A' ' 394' ' ' LYS . 49.8 mttm -69.49 105.24 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 399' ' ' GLY . 2.0 p30 -81.69 179.09 7.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -41.39 -41.53 2.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -71.22 -32.52 68.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.58 15.65 49.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.67 143.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.27 99.64 3.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.85 156.33 36.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 21.3 m -57.78 158.72 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.481 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 23.1 mtm -117.06 15.79 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.84 69.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 404' ' ' MET . 5.5 p90 -155.5 155.36 33.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.361 . . . . 0.0 110.895 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.42 25.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.449 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -121.66 121.82 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.727 HG22 ' SG ' ' A' ' 389' ' ' CYS . 76.9 t -116.45 130.47 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -112.55 147.7 36.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.44 153.35 34.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -62.71 -33.42 75.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -125.28 159.8 58.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.566 0.698 . . . . 0.0 110.9 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -18.61 21.23 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -78.21 -49.71 13.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -48.86 -37.43 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.66 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -58.18 -29.51 65.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -78.03 -59.58 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.635 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -56.14 -17.98 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 438' ' ' ILE . 13.7 tp -52.79 -59.15 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 425' ' ' GLN . 12.9 tptp -99.72 -45.14 5.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -39.94 -39.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.635 HD12 ' HB1' ' A' ' 420' ' ' ALA . 95.8 mt -88.11 -26.42 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 10.3 tp60 -57.6 134.63 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.32 31.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -55.03 125.21 19.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.9 m -69.66 97.37 1.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.44 113.91 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.78 29.38 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.859 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.85 39.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -125.42 125.4 43.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -73.89 124.94 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.559 HD22 HD23 ' A' ' 367' ' ' LEU . 7.4 mt -89.39 164.11 15.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -116.43 103.23 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.28 126.02 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -130.93 162.9 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 421' ' ' LEU . 20.0 mm -86.92 98.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.843 0.354 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 80.7 p -85.48 125.73 33.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.439 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 145.44 139.08 3.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.519 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.4 mt -141.43 122.17 14.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.453 ' CB ' ' HB2' ' A' ' 439' ' ' SER . 0.5 OUTLIER -90.66 124.75 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.1 mm -113.35 146.59 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.89 167.02 20.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 12.2 t30 68.86 32.61 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.622 HD12 ' C ' ' A' ' 406' ' ' PHE . 46.4 mt -82.64 113.87 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.49 123.73 17.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -46.06 -21.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -78.37 -39.66 38.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 98.0 m -49.94 131.9 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.134 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 22.0 p -105.77 161.13 14.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.427 ' OE2' HD12 ' A' ' 391' ' ' ILE . 2.0 mp0 -61.85 -54.52 40.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 373' ' ' GLU . 36.5 mt-10 -36.65 -49.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 86.3 m -64.56 -50.88 65.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 380' ' ' PHE . 13.6 tp -54.66 -35.13 63.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 381' ' ' SER . 12.5 mmmt -61.25 -50.2 74.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.48 -42.92 95.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.52 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.85 -56.29 11.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.488 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.4 m-85 -72.13 -39.96 68.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.842 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 14.4 t -48.52 -22.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -55.75 -46.82 77.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.878 HG21 ' HB2' ' A' ' 420' ' ' ALA . 24.6 t -55.51 -61.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -161.13 -152.05 6.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -83.74 127.24 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.327 . . . . 0.0 111.098 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.7 mt -96.34 130.61 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -78.07 -51.32 10.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.924 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 45.7 t -157.31 131.71 8.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.508 ' SG ' HG22 ' A' ' 409' ' ' VAL . 21.4 t -127.0 110.83 13.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -130.48 138.4 50.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.562 HG21 ' OG ' ' A' ' 403' ' ' SER . 40.3 mt -99.49 149.04 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 40.7 m -70.28 102.14 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -123.94 147.15 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -69.66 102.89 1.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 399' ' ' GLY . 9.2 p30 -81.28 177.02 9.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -38.52 -49.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.39 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.92 30.51 8.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.432 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 35.9 t -113.36 143.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.112 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.75 100.29 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 29.4 mt -126.33 152.4 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.562 ' OG ' HG21 ' A' ' 391' ' ' ILE . 37.6 m -57.93 161.1 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 42.5 mtm -117.09 17.09 14.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.846 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.35 0.77 64.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.622 ' C ' HD12 ' A' ' 367' ' ' LEU . 4.7 p90 -153.69 155.27 35.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.868 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -143.02 -178.86 19.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' PHE . . . . . 0.573 ' CZ ' ' HG3' ' A' ' 410' ' ' GLU . 20.0 t80 -133.28 122.39 23.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.508 HG22 ' SG ' ' A' ' 389' ' ' CYS . 73.9 t -120.42 119.59 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.573 ' HG3' ' CZ ' ' A' ' 408' ' ' PHE . 15.2 mt-10 -109.55 141.65 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.0 161.13 15.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -62.58 -34.45 77.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -120.11 157.08 53.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 -10.01 21.28 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.47 -53.68 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -45.98 -38.05 7.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.16 90.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -62.13 -29.6 70.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -72.69 -64.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.878 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.45 -34.01 23.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 420' ' ' ALA . 12.8 tp -37.88 -63.35 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -93.41 -41.02 10.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -47.39 -42.33 21.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.851 HD12 ' HB1' ' A' ' 420' ' ' ALA . 90.3 mt -86.51 -23.13 26.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -56.85 146.98 24.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.78 -16.25 32.59 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -62.42 117.53 6.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 29.1 m -69.89 112.33 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.3 117.6 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 62.31 26.7 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 81.47 -9.33 55.6 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.517 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -116.61 142.67 46.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.428 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 24.0 mttt -88.12 138.04 31.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.63 156.26 16.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -109.48 109.33 20.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.06 136.04 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -141.69 161.26 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.99 96.5 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' SER . . . . . 0.453 ' HB2' ' CB ' ' A' ' 363' ' ' PHE . 5.4 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.838 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.6 p -104.05 144.6 31.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.78 147.59 7.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 417' ' ' ALA . 5.3 mt -146.57 120.44 9.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.52 132.39 34.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.4 mm -118.95 144.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -131.96 160.18 36.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 51.3 t30 69.5 33.8 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 406' ' ' PHE . 57.7 mt -78.46 107.11 10.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 371' ' ' THR . 2.5 m120 -50.12 118.16 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -40.32 -31.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 p -65.7 -43.01 90.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 368' ' ' ASN . 82.4 m -49.49 147.35 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.089 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 53.0 p -127.46 165.25 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.4 -36.04 79.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -50.34 -59.71 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 55.9 m -61.97 -44.95 95.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.559 HD12 ' CD1' ' A' ' 380' ' ' PHE . 21.0 tp -57.22 -33.19 67.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 381' ' ' SER . 4.0 mtpm? -73.09 -28.16 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -82.14 -50.7 4.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.441 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.24 -37.88 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.814 0.34 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.762 ' HA ' HD11 ' A' ' 424' ' ' LEU . 16.6 m-85 -86.27 -22.74 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.9 t -69.51 -9.61 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.86 -28.14 44.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 420' ' ' ALA . 94.3 t -75.71 -38.17 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 178.51 -167.17 37.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ALA . . . . . 0.475 ' HB3' ' HG3' ' A' ' 412' ' ' LYS . . . -78.77 121.24 24.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.081 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.44 ' O ' ' NZ ' ' A' ' 412' ' ' LYS . 20.3 mt -83.52 131.37 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -79.49 -53.3 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 t -157.26 135.07 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.5 p -117.89 128.75 55.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.7 m -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 392' ' ' SER . 79.9 mt -100.69 153.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 391' ' ' ILE . 65.6 m -75.35 94.72 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 33.7 mttm -119.44 154.72 33.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -146.03 162.5 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.04 101.53 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 399' ' ' GLY . 6.6 p30 -77.14 178.62 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.58 -28.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -84.89 -32.98 22.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.069 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.77 18.86 33.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.453 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.25 143.66 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.89 0.376 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.89 102.13 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.414 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 24.3 mt -122.5 149.01 44.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -60.65 159.33 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.519 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 49.4 mtm -116.97 16.68 15.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 92.68 3.32 66.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.525 ' C ' HD12 ' A' ' 367' ' ' LEU . 1.9 p90 -158.29 159.65 36.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -156.92 -175.8 28.26 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -131.13 121.39 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.07 120.77 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -103.89 154.03 20.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.73 174.66 7.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 385' ' ' ALA . 23.3 mmtm -77.02 -37.14 55.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -137.38 151.46 71.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 415' ' ' GLU . 72.1 Cg_exo -46.72 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.25 . . . . 0.0 112.334 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 414' ' ' PRO . 17.7 tt0 -38.07 -48.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -48.54 -54.01 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.433 ' HA ' HD11 ' A' ' 362' ' ' LEU . . . -59.55 -40.4 87.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -59.74 -29.69 68.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -80.41 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.438 ' HA ' HG21 ' A' ' 383' ' ' VAL . . . -53.56 -18.2 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 438' ' ' ILE . 13.4 tp -53.76 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -92.04 -34.35 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 423' ' ' GLN . 0.5 OUTLIER -47.35 -40.77 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.762 HD11 ' HA ' ' A' ' 380' ' ' PHE . 50.2 mt -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' HG23 ' A' ' 436' ' ' VAL . 6.1 tp60 -56.12 147.82 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.14 -12.97 34.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -64.72 115.8 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 75.6 m -70.74 101.95 2.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 434' ' ' LEU . 49.0 t -103.37 121.39 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 62.05 34.0 16.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.35 -6.98 49.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -122.86 138.25 54.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 7.2 mtpm? -79.34 146.19 33.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 429' ' ' VAL . 7.3 mt -105.76 159.13 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.464 ' OE1' ' CG ' ' A' ' 437' ' ' ARG . 3.4 tm-20 -110.49 127.76 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.496 HG23 ' NE2' ' A' ' 425' ' ' GLN . 21.6 t -113.11 135.86 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.464 ' CG ' ' OE1' ' A' ' 435' ' ' GLU . 14.3 mmt180 -140.54 152.49 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 421' ' ' LEU . 12.9 mm -76.12 98.49 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 12.0 p -111.55 153.65 25.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.08 135.83 5.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 417' ' ' ALA . 10.2 mt -137.27 136.43 38.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.536 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.5 OUTLIER -103.34 124.56 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.536 HD13 ' C ' ' A' ' 363' ' ' PHE . 2.1 mm -111.33 142.17 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -132.35 161.7 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 72.73 37.03 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 406' ' ' PHE . 25.5 mt -86.28 126.95 34.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 371' ' ' THR . 5.4 m-20 -69.5 122.23 18.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -39.23 -40.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.9 m -62.44 -39.95 95.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 368' ' ' ASN . 53.4 m -50.88 126.49 16.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 82.6 p -106.82 157.42 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 374' ' ' GLU . 33.9 mt-10 -54.06 -50.04 67.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 373' ' ' GLU . 16.4 tt0 -34.89 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 83.4 m -55.91 -53.16 60.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.52 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 21.6 tp -49.98 -43.48 50.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -50.79 -54.9 19.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.3 -50.98 61.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 92.8 t -47.41 -55.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.182 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.583 ' HA ' HD11 ' A' ' 424' ' ' LEU . 6.7 m-85 -71.46 -34.65 70.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.0 t -53.76 -23.07 10.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -61.14 -35.89 78.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 420' ' ' ALA . 89.6 t -68.83 -42.79 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 176.58 -166.01 36.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.78 118.48 16.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 0.0 111.128 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 410' ' ' GLU . 25.8 mt -82.24 131.38 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.45 -42.84 28.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 m -169.54 126.42 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 2.3 t -119.61 117.25 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 98.9 m -139.77 136.45 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.114 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 392' ' ' SER . 80.5 mt -100.81 152.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 391' ' ' ILE . 10.9 m -70.97 101.7 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -126.41 152.03 46.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -144.0 158.65 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 395' ' ' LYS . 2.3 mppt? -74.12 101.9 4.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.646 ' OD1' ' HB3' ' A' ' 398' ' ' ALA . 4.8 p30 -74.68 179.27 4.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -20.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.646 ' HB3' ' OD1' ' A' ' 396' ' ' ASN . . . -91.52 -30.47 16.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 94.59 20.15 30.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.476 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 56.8 t -106.12 143.35 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 0.0 111.135 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -72.38 98.56 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 97.2 mt -111.46 141.81 44.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 14.2 t -58.07 159.96 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 16.0 mmm -115.71 24.82 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 78.62 -3.89 62.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.443 ' HA ' HD12 ' A' ' 367' ' ' LEU . 1.2 p90 -150.3 147.05 27.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -136.51 177.9 19.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.475 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -130.48 118.72 21.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.842 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 380' ' ' PHE . 77.4 t -106.06 146.13 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 386' ' ' ILE . 21.4 tt0 -129.92 146.38 51.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -120.57 164.5 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -66.42 -48.57 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.32 156.65 35.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.513 0.673 . . . . 0.0 110.917 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.39 -8.29 21.59 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.347 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.35 -46.65 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -49.2 -33.87 13.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 362' ' ' LEU . . . -67.86 -43.85 78.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.94 -31.45 72.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -70.42 -63.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.638 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -49.93 -36.98 29.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 420' ' ' ALA . 16.2 tp -34.84 -64.49 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -96.39 -39.77 9.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -45.09 -45.81 11.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.638 HD12 ' HB1' ' A' ' 420' ' ' ALA . 75.3 mt -83.76 -26.24 29.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.8 tp60 -52.15 152.02 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.3 -21.53 7.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.46 118.96 7.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 41.7 m -72.46 114.14 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.677 HG21 HD11 ' A' ' 434' ' ' LEU . 99.6 t -114.22 118.64 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 58.54 25.64 13.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 86.09 -8.62 72.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -118.43 138.94 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -82.34 144.02 30.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.677 HD11 HG21 ' A' ' 429' ' ' VAL . 6.4 mt -101.86 158.69 15.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.74 102.57 10.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.5 t -94.06 125.91 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -130.85 164.21 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 15.3 mm -82.32 96.05 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 83.2 p -107.39 134.89 49.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.476 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 137.93 139.27 3.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.48 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.58 125.17 14.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.456 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.6 OUTLIER -93.64 118.63 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.5 mm -105.78 148.97 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -136.5 167.49 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 64.83 43.41 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 35.3 mt -94.39 100.66 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -40.74 118.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.419 ' C ' ' O ' ' A' ' 368' ' ' ASN . 6.4 m-85 -36.85 -45.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 65.3 m -58.21 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.4 m -48.59 143.86 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 54.2 p -124.39 157.03 36.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.1 mm-40 -48.07 -47.63 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 373' ' ' GLU . 3.0 tm-20 -34.64 -65.98 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 37.8 m -51.67 -60.38 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.566 HD12 ' CD1' ' A' ' 380' ' ' PHE . 12.5 tp -44.71 -37.41 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 381' ' ' SER . 7.9 mtpm? -71.53 -39.94 70.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.23 -19.99 70.82 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.75 -47.65 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.566 ' CD1' HD12 ' A' ' 376' ' ' LEU . 12.3 m-85 -74.94 -25.44 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 15.1 t -64.94 -16.42 63.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -67.82 -37.55 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 420' ' ' ALA . 92.6 t -66.41 -42.35 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -179.2 -158.65 21.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.527 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ALA . . . . . 0.403 ' HB3' ' HD2' ' A' ' 412' ' ' LYS . . . -85.14 124.11 31.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 410' ' ' GLU . 26.5 mt -82.53 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -54.15 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 98.3 p -149.26 123.16 9.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.447 ' C ' ' OE2' ' A' ' 373' ' ' GLU . 6.2 p -127.39 112.93 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -144.43 138.67 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.151 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 406' ' ' PHE . 76.2 mt -97.73 143.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.9 m -65.6 108.13 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -124.44 134.75 52.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.82 156.98 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 4.7 ptpt -78.9 106.37 10.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 399' ' ' GLY . 50.6 p30 -67.85 177.86 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 397' ' ' LYS . 0.4 OUTLIER -43.5 -35.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.6 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.95 38.0 3.98 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 84.0 t -119.95 143.64 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.27 107.75 6.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.3 mt -128.91 139.11 52.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.1 m -57.85 164.0 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 36.2 mtm -117.27 23.69 11.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.857 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.55 5.5 89.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 12.3 p90 -152.6 154.11 34.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.905 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.08 -162.03 9.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.472 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' PHE . . . . . 0.476 ' CE1' ' CA ' ' A' ' 361' ' ' GLY . 29.6 t80 -137.77 126.53 23.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.877 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 70.0 t -119.57 120.4 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 386' ' ' ILE . 16.7 tt0 -113.07 151.31 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.51 158.91 26.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.403 ' HD2' ' HB3' ' A' ' 385' ' ' ALA . 58.7 mttt -63.12 -36.16 82.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -117.37 160.19 38.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 0.0 110.931 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.66 -20.07 15.93 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.12 -49.35 14.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -46.39 -43.1 15.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.01 -51.52 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.11 -29.32 57.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -77.67 -67.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.603 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.45 -20.21 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 438' ' ' ILE . 12.8 tp -51.52 -70.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -92.29 -31.68 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.924 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLN . . . . . 0.445 ' NE2' HG22 ' A' ' 383' ' ' VAL . 14.2 tt0 -50.52 -39.47 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.592 HD12 ' HB1' ' A' ' 420' ' ' ALA . 85.3 mt -90.18 -36.97 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 12.7 tp60 -40.63 149.13 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.68 -19.26 9.51 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -59.95 133.84 56.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 30.2 m -72.88 123.56 23.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 434' ' ' LEU . 97.0 t -132.35 118.62 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.09 26.98 10.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 84.56 -17.62 29.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -113.24 139.06 49.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -78.06 135.94 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.618 ' CD1' HG21 ' A' ' 429' ' ' VAL . 9.2 mt -92.81 161.71 14.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.52 113.39 21.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.939 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.63 130.66 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -131.57 163.91 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 421' ' ' LEU . 20.1 mm -85.51 96.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.7 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.918 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 57.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 5.8 p -102.9 140.08 37.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.6 142.4 4.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 12.1 mt -146.95 117.19 7.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -91.3 115.46 28.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 436' ' ' VAL . 3.2 mm -106.05 143.73 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' LYS . . . . . 0.483 ' CG ' ' HB3' ' A' ' 435' ' ' GLU . 12.4 ptmt -138.84 178.25 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 47.9 t-20 65.62 27.84 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 434' ' ' LEU . 34.1 mt -76.86 149.79 36.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -88.95 125.78 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -47.13 -20.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.5 m -80.13 -37.86 32.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 43.2 m -61.52 129.95 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 58.8 p -109.99 159.67 17.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -45.51 -42.91 11.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -41.62 -69.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 376' ' ' LEU . 42.3 m -47.18 -67.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.173 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.517 HD11 ' CE1' ' A' ' 380' ' ' PHE . 10.3 tp -35.53 -53.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -55.91 -52.15 65.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.36 -14.08 39.59 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 71.4 t -90.18 -53.52 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.142 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.701 ' HA ' HD11 ' A' ' 424' ' ' LEU . 7.4 m-85 -66.8 -37.68 85.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 11.4 p -52.19 -16.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -63.89 -39.51 94.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 420' ' ' ALA . 37.1 t -68.62 -54.85 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -163.71 -170.33 28.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.7 120.78 18.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.3 mt -79.31 138.36 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.98 -55.1 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 8.7 t -142.19 121.73 13.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.99 116.35 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -148.41 137.17 21.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 33.8 mt -101.39 143.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.2 m -58.3 107.62 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 32.0 mttp -127.15 153.36 46.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -149.76 163.66 37.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -73.26 101.81 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.3 p30 -79.51 178.71 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -41.65 -45.44 3.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.57 -32.64 71.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.88 33.84 6.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.467 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.527 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 84.9 t -119.58 143.69 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.367 . . . . 0.0 111.106 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.01 98.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.41 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 62.8 mt -118.44 153.6 33.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 50.4 m -57.88 159.7 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 49.7 mtp -117.1 13.05 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 96.41 -3.33 63.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.525 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 6.8 p90 -153.21 157.42 40.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.383 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.04 -179.86 22.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -130.33 124.25 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 380' ' ' PHE . 86.1 t -112.41 132.87 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.72 143.06 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.4 153.83 32.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -59.65 -34.15 72.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -122.82 160.72 47.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.58 0.705 . . . . 0.0 110.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.99 -18.98 16.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.311 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -77.15 -52.28 9.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' GLN . . . . . 0.438 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 21.1 mm-40 -47.39 -31.78 4.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.73 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.07 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -61.92 -30.61 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -71.15 -60.24 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -58.21 -33.82 69.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 438' ' ' ILE . 13.5 tp -36.63 -55.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 425' ' ' GLN . 11.7 pttm -100.93 -50.44 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 -38.59 -39.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.709 HD12 ' HB1' ' A' ' 420' ' ' ALA . 55.9 mt -88.59 -30.87 18.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 422' ' ' LYS . 7.9 tp60 -56.79 126.18 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.427 ' O ' ' NZ ' ' A' ' 433' ' ' LYS . . . 109.02 -17.81 31.79 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -60.93 114.48 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 110.853 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 34.1 m -70.95 98.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.44 122.64 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 58.26 27.97 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.12 77.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -123.67 128.66 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 37.0 mttm -80.42 119.53 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 367' ' ' LEU . 10.9 mt -78.87 161.95 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.483 ' HB3' ' CG ' ' A' ' 365' ' ' LYS . 5.7 tt0 -121.51 109.16 14.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.921 HG22 HD12 ' A' ' 364' ' ' ILE . 61.5 t -98.16 135.44 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.15 160.03 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.904 HD11 HD22 ' A' ' 421' ' ' LEU . 29.9 mm -79.48 95.48 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.058 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.897 0.38 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p -107.34 129.12 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.17 143.89 4.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.432 HD22 ' CG1' ' A' ' 436' ' ' VAL . 12.4 mt -144.48 123.3 12.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 363' ' ' PHE . 0.7 OUTLIER -94.78 112.39 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.63 HD13 ' N ' ' A' ' 364' ' ' ILE . 1.4 mm -97.81 144.15 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 366' ' ' ASN . 0.3 OUTLIER -133.52 154.96 50.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 365' ' ' LYS . 32.6 t-20 74.72 44.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.32 123.51 36.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.93 125.63 25.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -45.89 -25.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.1 t -76.58 -38.3 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 62.9 m -54.57 125.47 19.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.175 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 62.5 p -107.49 152.84 23.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 47.1 mt-10 -47.36 -50.92 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 55.4 mt-10 -34.85 -58.35 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 88.7 m -58.2 -62.47 1.8 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 380' ' ' PHE . 24.5 tp -40.19 -48.29 2.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 381' ' ' SER . 45.0 mtpt -54.85 -43.16 72.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -66.99 -26.73 73.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.502 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.85 -41.33 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 111.142 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.489 ' HA ' HD11 ' A' ' 424' ' ' LEU . 5.9 m-85 -83.21 -22.48 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 12.5 t -67.73 -15.77 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -68.79 -33.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.655 HG21 ' HB2' ' A' ' 420' ' ' ALA . 18.6 t -72.61 -44.21 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -176.23 -170.67 39.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -77.23 128.65 34.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 111.084 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 410' ' ' GLU . 35.0 mt -90.63 135.77 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -89.07 -50.65 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 25.9 t -147.83 121.43 9.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.8 117.12 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 8.4 m -143.3 141.62 31.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 392' ' ' SER . 88.0 mt -106.68 154.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.462 ' N ' HG22 ' A' ' 391' ' ' ILE . 56.2 m -71.7 87.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -109.74 131.0 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.2 157.72 43.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 3.1 ptpp? -75.71 102.08 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.502 ' OD1' HD12 ' A' ' 402' ' ' LEU . 0.4 OUTLIER -62.15 175.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 397' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.32 -37.92 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.441 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -71.89 -32.89 67.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.75 38.02 3.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.45 143.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.85 0.357 . . . . 0.0 111.156 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.16 101.01 3.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.502 HD12 ' OD1' ' A' ' 396' ' ' ASN . 86.9 mt -127.08 148.76 50.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.94 163.05 2.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 38.2 mtp -117.09 14.3 14.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.25 70.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.414 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 2.5 p90 -156.05 158.27 37.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.951 0.405 . . . . 0.0 110.846 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.11 -176.85 22.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.79 115.03 16.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.84 130.4 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.162 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 386' ' ' ILE . 16.6 tt0 -111.42 149.53 31.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.08 153.02 43.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -64.37 -38.46 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -116.22 154.22 48.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.24 -14.72 28.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -82.75 -50.96 8.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.87 -41.61 16.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.0 82.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -57.73 -30.38 65.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -72.87 -68.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -48.44 -25.16 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.703 HD22 HD11 ' A' ' 438' ' ' ILE . 41.5 tp -46.65 -66.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -98.92 -40.8 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -41.64 -34.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 380' ' ' PHE . 70.0 mt -94.6 -37.96 11.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 5.7 tp60 -38.61 142.28 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 90.14 -23.53 20.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -56.3 130.0 42.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.7 m -74.16 110.09 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.59 HG12 ' OD1' ' A' ' 430' ' ' ASP . 61.3 t -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ASP . . . . . 0.59 ' OD1' HG12 ' A' ' 429' ' ' VAL . 4.3 m-20 59.3 28.06 17.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.65 1.12 60.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.507 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -126.38 142.24 51.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -83.75 136.66 34.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.48 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 18.7 mt -96.36 157.46 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -111.1 102.04 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.465 HG12 HD12 ' A' ' 421' ' ' LEU . 52.4 t -94.32 121.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -128.26 161.52 29.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.703 HD11 HD22 ' A' ' 421' ' ' LEU . 20.5 mm -78.09 95.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' SER . . . . . 0.414 ' HB2' ' N ' ' A' ' 363' ' ' PHE . 16.9 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 84.2 p -108.48 148.36 30.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 117.26 144.11 7.71 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.444 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.3 mt -147.54 141.58 25.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.521 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.4 OUTLIER -109.23 134.4 51.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.521 HD13 ' C ' ' A' ' 363' ' ' PHE . 2.4 mm -119.01 147.69 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -134.85 159.84 40.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 405' ' ' GLY . 46.5 t-20 70.33 34.46 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.494 HD12 ' C ' ' A' ' 406' ' ' PHE . 53.4 mt -80.73 103.16 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.7 m120 -48.66 119.31 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 368' ' ' ASN . 8.2 m-85 -38.17 -42.73 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 52.3 p -58.19 -42.62 86.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 368' ' ' ASN . 35.5 m -44.53 141.61 1.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.173 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 49.2 p -121.1 143.65 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 39.2 mt-10 -43.32 -52.98 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 21.8 mp0 -34.59 -61.13 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 89.5 m -55.73 -47.01 77.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.0 tp -54.44 -54.84 35.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -55.87 -36.35 67.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.93 61.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.5 -41.52 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.685 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.5 m-85 -77.67 -12.96 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 6.9 t -77.31 -21.41 53.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -61.56 -27.58 68.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.703 HG21 ' HB2' ' A' ' 420' ' ' ALA . 42.2 t -73.85 -48.95 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -172.05 -154.63 10.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -90.1 114.69 26.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.453 HG21 ' HB2' ' A' ' 389' ' ' CYS . 36.0 mt -74.81 138.06 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -93.53 -53.81 3.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.1 t -147.77 112.19 5.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 409' ' ' VAL . 36.1 t -119.13 113.06 20.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -144.59 136.85 26.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 392' ' ' SER . 51.2 mt -93.67 156.62 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.119 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 391' ' ' ILE . 71.8 m -77.47 109.51 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -126.01 172.33 10.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -152.53 154.27 35.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 101.76 6.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 399' ' ' GLY . 48.4 p30 -72.49 176.82 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -47.83 -23.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -89.36 -26.95 20.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 87.76 35.51 9.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 93.5 t -116.83 143.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.159 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' LEU . . . . . 0.413 ' CD2' ' N ' ' A' ' 401' ' ' LEU . 0.5 OUTLIER -73.23 122.43 21.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 70.4 mt -141.01 140.24 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -58.44 156.61 10.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.2 mtm -114.95 20.7 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 88.66 0.92 81.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.494 ' C ' HD12 ' A' ' 367' ' ' LEU . 14.2 p90 -156.45 155.0 31.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.01 -179.9 22.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -130.4 118.31 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.566 HG22 ' SG ' ' A' ' 389' ' ' CYS . 95.5 t -107.48 144.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -124.66 156.42 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' TYR . . . . . 0.401 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 30.1 m-85 -131.81 156.9 45.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -65.44 -35.48 81.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -128.3 143.49 48.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 417' ' ' ALA . 72.4 Cg_exo -46.87 -52.35 7.79 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.695 2.263 . . . . 0.0 112.359 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 416' ' ' GLN . 34.1 mt-10 -44.56 -62.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mm100 -35.85 -42.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 414' ' ' PRO . . . -59.33 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.29 -27.11 68.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -69.14 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.82 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -51.91 -35.52 45.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 420' ' ' ALA . 24.0 tp -36.14 -61.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -100.49 -32.15 10.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -58.26 -16.86 15.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.82 HD12 ' HB1' ' A' ' 420' ' ' ALA . 79.1 mt -115.77 -23.72 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -54.64 147.15 15.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 78.96 -10.82 31.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.501 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -58.88 132.93 55.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.1 m -72.52 109.82 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.193 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.55 HG11 HD11 ' A' ' 434' ' ' LEU . 77.4 t -126.92 113.47 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 61.39 28.79 18.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.48 39.22 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -115.66 143.16 45.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.358 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -84.87 121.04 27.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.55 HD11 HG11 ' A' ' 429' ' ' VAL . 8.8 mt -84.07 155.36 22.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.57 127.88 56.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.444 ' CG1' HD22 ' A' ' 362' ' ' LEU . 28.1 t -112.78 139.3 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 -139.96 166.35 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.1 mm -86.61 95.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.901 0.382 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 6.4 p -109.65 126.47 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.66 135.34 2.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.2 mt -138.57 137.26 36.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -111.49 112.96 25.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.517 HD12 HG22 ' A' ' 436' ' ' VAL . 2.9 mm -97.42 143.71 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -131.8 160.31 35.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 5.5 t30 71.18 40.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -87.28 121.37 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 371' ' ' THR . 12.9 m120 -58.81 122.34 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -43.7 -24.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 -37.88 46.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.3 m -51.31 131.73 28.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 41.4 p -113.89 154.33 27.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 374' ' ' GLU . 85.3 mt-10 -45.85 -54.42 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 373' ' ' GLU . 54.4 mm-40 -35.05 -66.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 378' ' ' GLY . 32.7 m -51.73 -64.03 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 375' ' ' THR . 15.3 tp -36.66 -52.59 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 4.4 mtpm? -55.78 -42.19 75.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -68.82 -25.26 75.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.524 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 94.8 t -78.83 -45.29 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.573 ' CD2' ' CD1' ' A' ' 424' ' ' LEU . 12.6 m-85 -79.26 -46.02 18.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.478 ' N ' HD11 ' A' ' 386' ' ' ILE . 47.7 t -42.81 -28.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -48.15 -47.73 34.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 420' ' ' ALA . 97.2 t -57.79 -57.56 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.59 -167.42 24.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.466 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.9 121.26 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 410' ' ' GLU . 46.2 mt -85.25 139.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -82.9 -52.88 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -155.82 122.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.534 ' SG ' HG22 ' A' ' 409' ' ' VAL . 15.4 t -119.99 124.04 44.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -146.42 166.68 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.48 HG21 ' OG ' ' A' ' 403' ' ' SER . 73.5 mt -127.35 142.22 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.2 t -68.14 115.04 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -128.51 149.92 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -149.5 151.8 34.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 2.4 ptpt -69.58 102.57 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 399' ' ' GLY . 52.5 p30 -64.41 179.12 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -42.88 -40.17 2.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.31 -32.16 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.6 31.94 5.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.47 143.51 29.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.14 116.74 15.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.421 HD12 ' ND2' ' A' ' 396' ' ' ASN . 39.6 mt -137.32 156.53 48.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.48 ' OG ' HG21 ' A' ' 391' ' ' ILE . 1.3 t -57.9 158.53 6.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 16.8 mtm -117.07 19.28 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.89 88.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 404' ' ' MET . 16.8 p90 -158.33 158.93 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.3 -172.6 20.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -125.32 123.69 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.534 HG22 ' SG ' ' A' ' 389' ' ' CYS . 89.9 t -118.53 119.28 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 386' ' ' ILE . 14.9 tt0 -106.54 153.68 21.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' TYR . . . . . 0.517 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 14.5 m-85 -122.53 153.14 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -59.54 -40.55 87.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -125.43 143.72 45.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.31 -41.61 28.13 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.743 2.295 . . . . 0.0 112.342 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 418' ' ' GLN . 1.2 tp10 -57.83 -62.63 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -37.91 -38.14 0.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -71.98 -41.19 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.086 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 415' ' ' GLU . 34.8 mm-40 -66.53 -22.19 66.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -83.28 -63.2 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -49.26 -40.39 34.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 438' ' ' ILE . 8.4 tp -35.42 -62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -92.77 -51.41 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -38.62 -36.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.859 HD12 ' HB1' ' A' ' 420' ' ' ALA . 90.4 mt -92.25 -35.27 13.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -43.6 150.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.01 -8.48 15.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -66.44 118.42 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 10.4 m -69.23 116.82 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 79.9 t -125.12 122.74 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.157 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 58.82 31.76 21.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.97 -8.12 24.67 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -119.58 133.01 55.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -76.57 151.53 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 5.4 mt -116.54 159.9 21.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -116.11 129.38 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 364' ' ' ILE . 36.0 t -116.95 142.35 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -137.11 159.47 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.752 HD11 HD22 ' A' ' 421' ' ' LEU . 24.9 mm -83.89 95.69 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.899 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.892 0.377 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.08 155.08 17.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.84 148.77 9.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.544 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.697 HD22 ' CG1' ' A' ' 436' ' ' VAL . 4.5 mt -147.24 131.88 17.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 365' ' ' LYS . 0.3 OUTLIER -98.38 131.0 45.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.0 mm -117.1 142.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 12.2 tptp -132.29 162.36 31.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.3 t30 64.93 31.52 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.585 HD23 HD22 ' A' ' 434' ' ' LEU . 33.7 mt -72.23 128.84 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -70.9 128.92 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -54.52 -15.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 69.4 m -81.8 -29.03 32.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 81.8 m -65.98 138.93 58.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.6 p -120.13 162.22 19.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.18 -36.51 75.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -50.48 -60.46 2.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 42.9 m -62.29 -55.66 26.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.554 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.6 tp -43.16 -38.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -69.38 -43.73 72.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.79 -20.45 72.34 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.478 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.16 -40.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.554 ' CD1' HD12 ' A' ' 376' ' ' LEU . 11.6 m-85 -82.6 -14.66 54.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 75.8 p -74.87 -15.28 60.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -65.03 -27.52 68.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 420' ' ' ALA . 59.5 t -79.39 -64.18 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -153.33 -162.44 11.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -84.28 118.46 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.755 0.312 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.92 132.34 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -84.07 -55.04 4.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.7 p -154.46 116.62 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 28.5 p -108.54 120.36 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 95.2 m -137.79 127.54 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.77 140.79 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 70.1 m -57.55 99.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.85 157.82 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -153.96 156.34 37.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -74.67 104.58 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 398' ' ' ALA . 5.4 p30 -78.5 178.12 8.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -45.08 -33.62 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.454 ' HB3' ' OD1' ' A' ' 396' ' ' ASN . . . -78.73 -29.26 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 88.57 36.91 7.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.491 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 67.5 t -121.9 143.41 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.113 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -69.12 107.5 3.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 56.0 mt -126.88 143.92 51.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.0 p -59.3 162.39 4.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.537 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 37.6 mtp -117.08 13.78 14.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.12 1.48 64.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.557 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 404' ' ' MET . 1.7 p90 -158.31 158.82 35.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.03 -175.03 22.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -140.7 113.6 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 63.4 t -103.49 121.0 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.18 145.31 28.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -120.82 151.38 39.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -64.64 -14.04 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -141.47 159.07 61.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.635 0.731 . . . . 0.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.67 -44.93 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.4 -49.41 72.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -47.24 -47.9 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -54.37 -60.01 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -48.88 -31.13 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -75.55 -56.76 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 424' ' ' LEU . . . -57.88 -15.03 7.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.574 ' HB2' HD21 ' A' ' 362' ' ' LEU . 14.2 tp -63.61 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.95 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.7 -34.63 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -55.18 -14.69 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 420' ' ' ALA . 46.7 mt -117.82 -37.22 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.7 tp60 -42.13 145.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.9 -10.75 59.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -67.79 122.48 18.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.0 m -69.24 116.33 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.147 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.5 123.21 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.26 26.66 15.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.29 40.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.541 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -121.61 137.34 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -77.73 143.25 38.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.585 HD22 HD23 ' A' ' 367' ' ' LEU . 8.0 mt -102.73 159.18 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -113.81 105.99 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.697 ' CG1' HD22 ' A' ' 362' ' ' LEU . 22.5 t -97.92 133.95 38.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -139.33 166.08 25.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 3.2 mm -87.11 101.53 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.877 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.914 0.388 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.6 p -109.82 125.36 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.86 138.07 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.91 129.58 19.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.899 0.38 . . . . 0.0 110.902 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -105.17 116.61 32.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.9 mm -103.57 141.2 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -127.56 165.11 20.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 9.2 t30 71.79 28.12 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.671 HD12 ' CA ' ' A' ' 406' ' ' PHE . 36.4 mt -74.59 126.51 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.7 m120 -73.66 121.94 21.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -39.27 -38.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.4 t -61.66 -42.71 99.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 368' ' ' ASN . 90.3 m -50.13 121.72 5.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.3 p -99.66 154.12 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.25 -55.37 15.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -43.35 -44.53 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 85.3 m -64.66 -54.35 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.499 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 11.7 tp -53.2 -43.72 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -59.45 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -54.55 -57.76 16.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 88.1 t -41.17 -49.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.556 ' HA ' HD11 ' A' ' 424' ' ' LEU . 9.9 m-85 -78.46 -25.51 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.1 t -63.2 -12.94 32.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.3 -24.12 64.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 420' ' ' ALA . 78.4 t -81.39 -59.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.12 -172.65 30.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -68.99 117.03 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.739 0.304 . . . . 0.0 111.055 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.58 133.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.17 -52.13 7.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.4 m -162.48 117.66 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 409' ' ' VAL . 17.6 t -120.13 132.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -144.44 162.65 35.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 406' ' ' PHE . 87.8 mt -123.82 138.77 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 406' ' ' PHE . 4.9 p -58.35 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -115.93 140.73 48.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -136.25 170.01 16.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -86.63 108.81 18.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 0.3 OUTLIER -80.25 178.67 8.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 397' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -46.03 -35.8 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -76.02 -31.83 59.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 96.25 35.3 5.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.449 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.444 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 18.9 t -118.85 145.24 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.378 . . . . 0.0 111.13 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.0 96.4 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.425 HD12 ' OD1' ' A' ' 396' ' ' ASN . 63.0 mt -110.95 137.67 48.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.4 p -57.67 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 80.0 mtp -116.44 14.49 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.53 74.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.671 ' CA ' HD12 ' A' ' 367' ' ' LEU . 16.8 p90 -148.97 174.33 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.64 39.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.545 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -126.55 117.47 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.887 HG22 ' SG ' ' A' ' 389' ' ' CYS . 63.0 t -111.8 136.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -123.33 146.7 47.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.02 153.81 33.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -59.39 -42.03 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -113.32 159.52 34.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 110.875 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -16.34 18.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.346 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.66 -48.82 12.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.52 -35.94 14.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.82 65.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -58.56 -27.93 65.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -78.89 -63.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -55.67 -15.86 3.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.805 HD22 HD11 ' A' ' 438' ' ' ILE . 25.2 tp -57.81 -62.16 2.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -95.78 -27.63 15.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLN . . . . . 0.439 ' O ' ' CD ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -58.48 -45.14 89.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.556 HD11 ' HA ' ' A' ' 380' ' ' PHE . 94.4 mt -83.98 -17.08 41.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 15.8 tp60 -64.85 134.7 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.03 45.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -55.25 131.79 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.3 m -73.44 96.23 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.7 t -111.31 113.2 43.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.58 31.3 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 65.33 6.28 26.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -126.4 126.46 43.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -73.03 126.8 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.488 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 6.7 mt -90.75 159.34 16.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -110.56 103.18 11.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.443 HG12 HD12 ' A' ' 421' ' ' LEU . 60.7 t -92.51 131.83 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -136.47 164.94 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.805 HD11 HD22 ' A' ' 421' ' ' LEU . 30.9 mm -88.21 97.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 81.8 p -112.32 139.11 48.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.14 144.01 5.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.8 mt -149.94 112.95 4.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.36 113.61 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 364' ' ' ILE . 1.9 mm -98.8 145.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -131.87 161.59 32.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.6 t30 71.19 30.26 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 406' ' ' PHE . 76.5 mt -74.77 112.93 11.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -57.85 117.06 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 368' ' ' ASN . 5.6 m-85 -34.26 -54.59 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 m -46.7 -45.17 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 368' ' ' ASN . 85.9 m -48.3 138.48 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 374' ' ' GLU . 14.6 t -123.22 163.31 20.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -56.57 -15.13 3.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.609 ' H ' HG23 ' A' ' 372' ' ' THR . 21.1 tt0 -68.47 -60.33 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.963 ' O ' HG23 ' A' ' 379' ' ' VAL . 51.6 m -61.58 -38.05 86.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 391' ' ' ILE . 7.4 tp -62.9 -57.5 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -53.1 -31.87 44.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -80.75 -23.96 59.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 375' ' ' THR . 94.5 t -80.62 -45.25 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.701 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.2 m-85 -76.0 -24.44 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.3 p -61.71 -24.28 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.877 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -58.56 -39.82 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.692 HG21 ' HB2' ' A' ' 420' ' ' ALA . 12.0 t -66.96 -48.29 79.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.426 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -179.02 -168.57 38.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.01 130.58 43.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 28.0 mt -92.9 137.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -86.05 -50.19 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -160.06 126.27 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 409' ' ' VAL . 50.9 t -123.84 98.98 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 87.5 m -117.84 125.32 50.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.565 HD11 HD23 ' A' ' 376' ' ' LEU . 29.0 mt -101.44 155.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 406' ' ' PHE . 50.6 p -69.86 92.93 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -121.29 141.02 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -138.08 167.55 21.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.434 ' N ' ' HE3' ' A' ' 395' ' ' LYS . 0.1 OUTLIER -82.44 102.89 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 3.7 p30 -76.28 178.35 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -39.35 -52.62 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.72 73.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 95.03 30.98 7.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.531 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 13.8 t -109.18 151.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 401' ' ' LEU . 0.8 OUTLIER -76.28 112.72 13.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.1 mt -136.54 136.34 39.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.7 m -57.86 164.12 2.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 6.1 mtm -112.29 15.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 98.09 0.72 58.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.673 ' C ' HD12 ' A' ' 367' ' ' LEU . 53.5 p90 -156.57 172.33 18.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -167.97 -177.02 38.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -132.38 133.54 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.627 HG22 ' SG ' ' A' ' 389' ' ' CYS . 54.5 t -125.55 141.68 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.158 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -124.42 142.77 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 23.8 m-85 -113.87 156.51 23.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -61.42 -41.41 97.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -126.93 142.69 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.583 0.706 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.27 -41.58 27.83 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.93 -55.99 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' GLN . . . . . 0.426 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 42.5 mm-40 -45.45 -36.69 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -69.2 -45.93 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -60.71 -25.28 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -80.73 -63.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.692 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -55.52 -18.32 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.83 HD22 HD11 ' A' ' 438' ' ' ILE . 17.4 tp -55.84 -66.43 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -93.81 -41.68 9.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -42.27 -46.26 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 380' ' ' PHE . 57.9 mt -82.24 -29.49 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.3 tp60 -50.17 142.08 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.7 -18.3 30.88 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -56.62 128.04 34.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.478 ' HA ' ' CE ' ' A' ' 433' ' ' LYS . 1.4 m -71.29 99.27 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.15 124.55 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.49 28.52 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.05 -1.53 47.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -124.65 151.53 44.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.478 ' CE ' ' HA ' ' A' ' 428' ' ' THR . 6.0 mmpt? -88.86 133.4 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.496 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 13.4 mt -94.21 154.71 17.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.915 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.79 106.31 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.7 t -97.65 126.76 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -133.95 163.63 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.815 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.83 HD11 HD22 ' A' ' 421' ' ' LEU . 10.7 mm -86.36 99.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.909 0.385 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.1 p -107.57 131.77 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.871 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.9 142.78 5.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.85 124.41 13.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.4 OUTLIER -90.71 127.75 36.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.3 mm -116.29 142.32 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -131.56 161.18 33.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 72.35 35.91 1.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 406' ' ' PHE . 50.9 mt -85.35 109.55 18.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -52.57 130.96 33.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.839 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -52.33 -16.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.8 t -82.23 -37.26 26.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 97.0 m -55.21 131.99 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 23.2 p -110.66 156.27 21.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -50.48 -43.71 55.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -43.18 -63.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 378' ' ' GLY . 19.5 m -55.95 -65.8 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.591 HD12 ' CD1' ' A' ' 380' ' ' PHE . 11.8 tp -37.12 -44.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -62.87 -44.13 96.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -61.48 -52.91 48.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.09 -34.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.159 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.591 ' CD1' HD12 ' A' ' 376' ' ' LEU . 13.5 m-85 -87.19 -11.84 48.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 t -78.07 -14.16 59.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.51 -38.07 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 420' ' ' ALA . 60.2 t -64.42 -55.93 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -169.04 -163.2 22.68 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.77 126.17 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 19.7 mt -88.84 136.94 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -86.09 -53.21 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 14.2 t -165.67 130.56 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 45.1 t -123.09 122.63 38.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.3 m -130.9 127.42 38.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 406' ' ' PHE . 57.9 mt -95.8 140.68 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.692 ' CB ' ' CE2' ' A' ' 406' ' ' PHE . 2.8 p -60.01 91.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -119.8 140.67 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -139.76 160.79 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -70.72 107.93 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 399' ' ' GLY . 8.6 p30 -88.61 179.25 6.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -38.92 -47.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.63 68.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 91.86 29.83 11.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.454 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.78 142.6 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.29 96.63 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 28.9 mt -119.22 149.35 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 p -57.87 160.7 4.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.1 mtm -116.81 10.89 14.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.52 56.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.692 ' CE2' ' CB ' ' A' ' 392' ' ' SER . 9.4 p90 -152.78 176.09 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -166.73 -172.99 34.64 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -137.8 121.65 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 84.7 t -110.65 132.87 57.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -115.91 153.14 32.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -131.89 152.16 51.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -67.15 -25.3 66.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -117.97 151.58 49.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.537 ' O ' ' NE2' ' A' ' 418' ' ' GLN . 58.7 Cg_endo -71.96 -27.72 17.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 416' ' ' GLN . 14.4 tp10 -75.95 -57.19 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' GLN . . . . . 0.503 ' OE1' HG12 ' A' ' 383' ' ' VAL . 96.6 mm-40 -34.83 -43.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -56.0 -51.01 69.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 414' ' ' PRO . 1.4 mp0 -63.73 -28.49 69.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -65.49 -59.15 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.935 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -62.32 -33.89 75.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 438' ' ' ILE . 15.8 tp -38.64 -55.18 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.84 -43.07 6.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -47.49 -43.76 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.935 HD12 ' HB1' ' A' ' 420' ' ' ALA . 86.3 mt -84.25 -24.15 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -56.99 147.22 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.47 11.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -61.06 118.86 7.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 20.7 m -69.23 116.38 9.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.37 117.68 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 61.28 31.2 19.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.12 -4.47 47.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -122.63 131.44 53.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -74.7 143.83 44.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.0 mt -105.57 161.51 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.52 120.26 39.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.41 134.72 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -140.93 159.6 41.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 421' ' ' LEU . 22.4 mm -76.93 97.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.4 p -114.32 137.34 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.844 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 130.24 141.86 5.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.51 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.11 117.63 7.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -95.78 112.4 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 364' ' ' ILE . 2.1 mm -98.97 149.99 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -133.86 158.24 43.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 405' ' ' GLY . 37.4 t30 74.72 36.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 406' ' ' PHE . 45.9 mt -84.21 118.82 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.6 m-20 -56.38 119.87 6.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -41.0 -30.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 53.7 p -73.39 -39.22 65.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 368' ' ' ASN . 55.2 m -46.18 121.11 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 39.4 p -96.23 157.48 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 374' ' ' GLU . 45.1 mt-10 -56.34 -55.9 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.2 tt0 -36.84 -57.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 379' ' ' VAL . 33.0 m -52.2 -50.5 61.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.511 HD11 ' CE1' ' A' ' 380' ' ' PHE . 15.1 tp -55.49 -49.76 71.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -53.08 -36.46 60.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -75.04 -43.65 26.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.455 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 375' ' ' THR . 99.1 t -60.79 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.126 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.62 ' HA ' HD11 ' A' ' 424' ' ' LEU . 5.8 m-85 -81.29 -24.48 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.3 t -65.81 -19.98 66.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -63.29 -35.49 80.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 420' ' ' ALA . 60.3 t -66.4 -62.7 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -158.07 -150.3 5.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -88.88 122.33 32.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 410' ' ' GLU . 23.1 mt -87.32 142.53 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -90.26 -49.19 6.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 33.8 t -164.7 118.26 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.885 ' SG ' HG22 ' A' ' 409' ' ' VAL . 7.7 t -113.31 130.34 56.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.5 t -146.05 154.12 41.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.8 mt -115.27 141.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 74.6 m -64.87 91.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' LYS . . . . . 0.409 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 53.6 mttt -115.17 147.61 40.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -134.48 156.5 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 395' ' ' LYS . 0.6 OUTLIER -76.9 110.74 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.1 p-10 -82.58 178.48 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 398' ' ' ALA . 0.0 OUTLIER -41.72 -30.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -87.79 -32.25 19.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.097 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.54 31.02 8.12 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.529 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.92 143.2 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.105 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.12 112.16 8.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.409 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 32.2 mt -134.5 136.1 42.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.1 m -57.84 159.19 5.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.507 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 47.0 mtm -116.9 21.13 13.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 90.05 4.96 71.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.453 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.521 ' C ' HD12 ' A' ' 367' ' ' LEU . 5.7 p90 -155.08 154.31 32.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.388 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.6 168.37 30.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.28 122.23 45.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.885 HG22 ' SG ' ' A' ' 389' ' ' CYS . 86.5 t -115.27 125.21 72.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 386' ' ' ILE . 28.6 tt0 -111.55 155.38 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -126.54 165.75 18.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.906 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -71.93 -34.5 69.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.21 161.75 41.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.18 -16.31 19.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.22 -41.54 14.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -51.04 -44.5 61.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.47 88.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -57.13 -35.95 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -67.47 -61.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -52.24 -34.65 46.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.095 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.452 HD22 HD11 ' A' ' 438' ' ' ILE . 63.7 tp -34.86 -61.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.25 -44.83 5.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -39.87 -35.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 380' ' ' PHE . 84.0 mt -93.3 -33.4 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.4 tp60 -47.03 139.88 5.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.2 56.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -59.69 129.88 44.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 18.2 m -69.83 114.12 7.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.169 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.1 116.73 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 54.59 31.16 14.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 73.05 -2.79 32.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -123.45 133.13 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -77.95 145.28 36.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.487 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 9.8 mt -106.12 163.28 12.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.46 108.57 17.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.485 ' O ' ' CZ ' ' A' ' 437' ' ' ARG . 42.0 t -92.47 124.74 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.485 ' CZ ' ' O ' ' A' ' 436' ' ' VAL . 11.3 mmp_? -127.17 165.96 18.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.452 HD11 HD22 ' A' ' 421' ' ' LEU . 5.2 mm -90.63 97.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.867 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.879 0.371 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.1 p -105.57 159.4 15.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 103.26 139.43 10.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.502 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 409' ' ' VAL . 9.6 mt -141.86 131.3 23.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.64 125.85 40.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.2 mm -116.3 142.06 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.077 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' LYS . . . . . 0.428 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 13.1 tptm -128.89 162.5 27.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 405' ' ' GLY . 35.2 t-20 65.08 45.56 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 406' ' ' PHE . 43.6 mt -89.52 107.36 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -50.49 124.51 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -47.1 -28.5 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 t -69.22 -35.55 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 13.1 m -56.67 130.44 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.088 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 43.8 p -108.16 156.52 19.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -49.75 -49.42 48.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -43.35 -68.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 91.3 m -44.98 -64.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 18.5 tp -39.77 -51.76 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -54.39 -43.43 71.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -62.13 -48.85 80.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 66.6 t -58.23 -40.77 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.47 ' HA ' HD11 ' A' ' 424' ' ' LEU . 15.2 m-85 -82.51 -20.91 35.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 24.3 t -70.27 -14.01 62.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.809 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -71.49 -37.71 71.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 420' ' ' ALA . 94.9 t -65.88 -39.82 85.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.106 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.41 44.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.15 123.08 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.08 133.13 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -52.56 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.4 p -157.77 120.87 3.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 36.1 t -119.16 120.43 37.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -143.92 145.44 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.595 HG21 ' OG ' ' A' ' 403' ' ' SER . 59.0 mt -106.1 148.66 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.4 m -72.65 101.22 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -124.51 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -126.65 165.34 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -77.11 103.42 7.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.509 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 5.6 p30 -79.06 178.14 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -41.08 -46.93 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 96.28 26.66 10.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.509 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 65.1 t -108.0 142.45 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.136 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.6 102.09 2.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.12 147.66 43.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 391' ' ' ILE . 1.5 t -57.99 155.79 10.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.582 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 52.6 mtm -116.06 19.47 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 87.86 1.4 82.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -156.27 153.28 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.12 167.81 30.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.04 128.07 55.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 362' ' ' LEU . 82.3 t -120.49 122.3 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -110.75 144.74 39.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -114.23 169.0 9.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -73.29 -36.9 66.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -131.92 143.88 50.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.37 -39.16 21.56 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 418' ' ' GLN . 25.1 mm-40 -56.95 -63.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.2 mm100 -36.51 -45.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.08 -44.99 90.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 415' ' ' GLU . 16.1 mm-40 -59.14 -30.85 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -75.5 -66.7 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.607 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -47.2 -33.0 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.102 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 12.7 tp -40.7 -66.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -94.37 -36.56 11.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -48.63 -46.36 39.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.607 HD12 ' HB1' ' A' ' 420' ' ' ALA . 82.3 mt -82.07 -35.57 28.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 9.6 tp60 -42.65 152.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.39 -25.54 4.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -59.57 118.78 6.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 80.8 m -70.88 122.61 20.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.589 HG21 HD11 ' A' ' 434' ' ' LEU . 61.8 t -122.04 119.91 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 60.89 26.73 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.826 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 88.63 -15.89 55.71 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.474 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -116.86 145.45 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -85.11 146.19 27.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.589 HD11 HG21 ' A' ' 429' ' ' VAL . 10.0 mt -100.14 161.58 13.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -115.04 105.2 12.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -97.18 134.94 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -141.79 160.63 39.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.49 95.99 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.895 0.379 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 9.1 p -108.54 128.41 54.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 150.93 143.37 3.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 mt -145.89 127.58 15.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.459 ' C ' HD13 ' A' ' 364' ' ' ILE . 2.5 t80 -102.8 122.93 45.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.75 HD12 HG22 ' A' ' 436' ' ' VAL . 3.5 mm -108.66 144.82 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -135.16 159.64 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.7 t30 73.93 27.33 1.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.98 117.79 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.5 m120 -56.73 120.27 7.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -42.04 -35.34 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.5 m -64.9 -40.12 94.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 368' ' ' ASN . 84.8 m -55.31 146.24 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.163 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.8 p -123.19 168.61 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.6 mp0 -57.98 -54.38 47.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.3 mp0 -36.78 -70.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 379' ' ' VAL . 16.1 m -43.77 -51.43 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.546 HD12 ' CD1' ' A' ' 380' ' ' PHE . 12.8 tp -54.44 -42.75 70.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 381' ' ' SER . 13.3 mtpt -61.07 -45.11 96.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.0 57.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.517 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 375' ' ' THR . 58.2 t -55.19 -52.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.117 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.546 ' CD1' HD12 ' A' ' 376' ' ' LEU . 10.8 m-85 -72.23 -20.27 61.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.6 t -69.26 -12.38 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -67.66 -39.56 84.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 420' ' ' ALA . 46.2 t -64.64 -35.18 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 169.17 -166.85 40.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.17 125.46 27.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 410' ' ' GLU . 50.0 mt -85.83 130.5 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -74.36 -52.27 12.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.2 t -160.36 122.97 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.707 ' SG ' HG22 ' A' ' 409' ' ' VAL . 4.5 t -119.39 121.16 38.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 46.5 m -145.76 133.28 20.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 392' ' ' SER . 80.0 mt -99.52 154.89 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.453 ' N ' HG22 ' A' ' 391' ' ' ILE . 38.0 m -73.03 100.15 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 403' ' ' SER . 4.1 mtmp? -124.75 134.66 52.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.11 171.58 8.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -81.38 102.38 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.7 p30 -76.07 177.23 7.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -40.06 -54.36 2.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.19 -28.06 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.43 30.75 8.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.576 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 17.9 t -110.48 144.39 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -71.68 97.56 1.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.0 mt -114.85 142.76 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.453 ' N ' ' HG2' ' A' ' 393' ' ' LYS . 58.3 m -58.0 160.5 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.543 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 28.7 mtm -116.86 22.71 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 83.66 1.43 90.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 404' ' ' MET . 4.8 p90 -152.8 154.67 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.917 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.55 -170.24 17.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.479 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -140.26 121.58 14.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.707 HG22 ' SG ' ' A' ' 389' ' ' CYS . 87.5 t -108.7 141.9 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 386' ' ' ILE . 23.7 tt0 -127.89 145.59 50.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.98 166.3 12.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -68.03 -36.61 80.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -123.28 162.17 41.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.582 0.706 . . . . 0.0 110.889 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.87 -18.86 16.59 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.647 2.231 . . . . 0.0 112.322 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.91 -55.82 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -50.33 -31.44 14.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.55 -48.12 65.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -60.78 -29.71 69.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -70.86 -63.93 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -49.09 -36.62 19.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 438' ' ' ILE . 7.8 tp -37.58 -69.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 -34.46 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -51.8 -34.76 41.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.731 HD12 ' HB1' ' A' ' 420' ' ' ALA . 85.1 mt -96.41 -29.57 13.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -48.33 144.93 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.4 12.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.462 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -55.26 115.9 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 42.0 m -71.11 114.24 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 73.6 t -121.42 125.78 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.82 27.14 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.811 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.51 -3.96 61.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -122.79 142.8 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -88.01 141.65 28.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.24 157.31 17.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.46 119.76 39.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.75 HG22 HD12 ' A' ' 364' ' ' ILE . 42.5 t -110.39 138.3 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -133.43 163.71 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.755 HD11 HD22 ' A' ' 421' ' ' LEU . 26.8 mm -83.39 95.34 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.862 0.363 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 7.2 p -121.46 158.04 29.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.55 12.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.478 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.7 mt -142.05 126.32 17.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -90.81 128.7 36.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.603 HD12 HG22 ' A' ' 436' ' ' VAL . 4.1 mm -117.63 144.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -133.14 160.31 37.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 22.6 t30 72.61 40.5 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.44 HD23 HD22 ' A' ' 434' ' ' LEU . 25.1 mt -85.61 148.94 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -88.99 124.79 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -46.01 -39.8 9.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -63.28 -32.51 73.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 99.3 m -59.9 131.11 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.0 p -114.19 143.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -40.58 -43.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -38.78 -57.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 76.8 m -62.96 -60.22 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.511 HD11 ' CE1' ' A' ' 380' ' ' PHE . 11.0 tp -39.13 -44.85 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -52.28 -56.17 16.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -59.87 -25.55 61.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 382' ' ' LYS . 57.5 t -73.21 -34.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.987 ' CD2' HG11 ' A' ' 409' ' ' VAL . 9.1 m-85 -94.14 -16.36 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 48.7 p -73.6 -17.08 61.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 379' ' ' VAL . 0.2 OUTLIER -75.43 -18.52 59.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 420' ' ' ALA . 53.8 t -95.3 -41.17 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.442 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -167.44 -178.64 39.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.509 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.57 120.08 22.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.775 0.321 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 36.8 mt -81.8 143.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -105.21 -38.87 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.4 t -160.52 118.09 2.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 409' ' ' VAL . 21.5 t -121.52 116.89 25.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.1 m -142.7 151.15 41.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 406' ' ' PHE . 63.4 mt -107.99 148.86 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.415 ' HB2' ' CD1' ' A' ' 406' ' ' PHE . 10.5 m -64.71 85.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -110.71 137.49 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -122.1 156.55 33.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.934 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -73.8 101.5 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.669 ' ND2' HD12 ' A' ' 402' ' ' LEU . 21.7 p30 -77.76 179.24 6.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.914 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -40.33 -54.11 2.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.27 69.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.63 31.34 8.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.541 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.98 143.3 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.089 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.11 96.65 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.669 HD12 ' ND2' ' A' ' 396' ' ' ASN . 97.1 mt -105.99 139.29 40.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.1 p -57.9 156.12 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 9.4 mtm -116.42 21.94 13.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.2 89.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 7.8 p90 -149.14 150.4 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -139.51 -172.7 12.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -139.44 116.44 10.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.987 HG11 ' CD2' ' A' ' 380' ' ' PHE . 91.5 t -104.5 124.74 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -107.06 137.1 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.55 162.81 14.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -78.1 -22.92 48.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm -133.44 158.78 74.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -30.28 14.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.625 2.217 . . . . 0.0 112.347 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.6 -39.14 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' GLN . . . . . 0.442 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 2.8 mm-40 -51.42 -49.38 61.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.41 75.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -64.88 -29.72 70.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -78.56 -54.63 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -61.94 -24.9 67.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.53 HD22 HD11 ' A' ' 438' ' ' ILE . 14.2 tp -44.8 -56.24 4.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.21 -44.58 5.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -43.28 -46.71 6.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.47 ' CD2' ' HE2' ' A' ' 382' ' ' LYS . 30.6 mt -80.94 -43.53 19.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 4.2 tp60 -47.25 121.03 3.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.75 -20.11 37.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -60.23 130.06 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.7 m -70.49 96.32 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.115 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.11 112.95 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 62.1 26.02 15.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 70.0 6.58 57.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -121.38 120.59 35.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 110.836 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -71.72 107.39 4.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.44 HD22 HD23 ' A' ' 367' ' ' LEU . 11.2 mt -67.74 161.56 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -119.6 99.26 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.603 HG22 HD12 ' A' ' 364' ' ' ILE . 60.4 t -88.15 134.72 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -143.46 145.99 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.53 HD11 HD22 ' A' ' 421' ' ' LEU . 7.1 mm -70.39 98.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.922 0.391 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.96 150.68 21.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.845 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.22 143.69 7.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.445 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.2 mt -146.55 132.49 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.359 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.443 ' C ' HD13 ' A' ' 364' ' ' ILE . 1.2 t80 -95.77 126.48 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 3.7 mm -112.15 144.78 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -133.87 162.33 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.42 ' O ' HD23 ' A' ' 434' ' ' LEU . 19.3 t-20 68.47 43.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.28 106.5 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.3 m120 -46.92 122.23 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -43.59 -24.46 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 70.2 m -77.05 -38.96 51.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 368' ' ' ASN . 25.5 m -48.8 131.83 18.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 76.5 p -108.48 148.44 30.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 374' ' ' GLU . 2.8 mp0 -45.57 -50.76 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 373' ' ' GLU . 5.8 mm-40 -36.09 -67.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 378' ' ' GLY . 71.1 m -48.71 -67.79 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.154 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.545 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 7.2 tp -35.82 -46.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -64.84 -44.53 89.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -60.43 -21.38 57.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.98 -48.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 10.0 m-85 -70.23 -29.33 66.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 53.5 p -58.74 -19.59 41.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.892 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -64.26 -36.58 84.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 420' ' ' ALA . 76.0 t -64.94 -47.66 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.468 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -175.82 -154.43 11.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.523 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ALA . . . . . 0.622 ' HB1' ' HE3' ' A' ' 412' ' ' LYS . . . -82.77 125.83 31.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.759 0.314 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 45.2 mt -93.02 130.13 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.123 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -77.5 -49.03 15.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.1 t -169.73 117.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 409' ' ' VAL . 51.2 t -108.94 128.6 55.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.3 t -140.06 163.15 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.35 137.23 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 m -56.04 102.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 35.6 mtmt -125.66 136.9 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -128.37 156.26 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -71.71 104.24 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 399' ' ' GLY . 0.5 OUTLIER -79.33 178.82 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -38.61 -53.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.98 74.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.77 22.21 14.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.4 ' O ' ' OD1' ' A' ' 396' ' ' ASN . 45.8 t -101.34 143.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.376 . . . . 0.0 111.105 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.67 96.03 2.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.6 mt -109.41 143.82 38.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.4 p -57.91 161.56 3.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 35.9 mtp -117.03 16.7 15.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.02 86.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.51 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -153.02 155.07 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -148.76 -176.01 21.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -127.29 123.26 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' A' ' 380' ' ' PHE . 77.8 t -105.62 106.1 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -85.36 152.72 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -132.7 152.22 51.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.622 ' HE3' ' HB1' ' A' ' 385' ' ' ALA . 4.6 mtmp? -65.22 -32.62 74.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -135.14 141.73 39.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.91 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 415' ' ' GLU . 74.2 Cg_exo -47.64 -58.66 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.689 2.259 . . . . 0.0 112.378 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 414' ' ' PRO . 32.1 mt-10 -37.59 -57.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' GLN . . . . . 0.468 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 26.8 mm-40 -43.52 -46.09 6.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.441 ' O ' HD11 ' A' ' 362' ' ' LEU . . . -61.62 -49.4 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.144 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -56.6 -27.26 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -77.81 -63.98 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -52.73 -19.44 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.829 HD22 HD11 ' A' ' 438' ' ' ILE . 45.5 tp -51.28 -64.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -92.67 -47.64 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLN . . . . . 0.479 ' N ' ' HD3' ' A' ' 422' ' ' LYS . 2.7 tm0? -38.27 -34.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 420' ' ' ALA . 94.3 mt -96.84 -31.8 12.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.463 ' NE2' HG23 ' A' ' 436' ' ' VAL . 6.5 tp60 -49.63 135.04 19.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.86 -24.94 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.457 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -56.18 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 99.7 m -70.44 106.95 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.155 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.759 HG21 HD11 ' A' ' 434' ' ' LEU . 94.1 t -106.51 118.89 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 62.27 31.06 17.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.29 51.41 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -122.03 129.54 52.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.41 145.92 50.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 429' ' ' VAL . 7.6 mt -103.57 158.81 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -108.98 119.93 41.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.463 HG23 ' NE2' ' A' ' 425' ' ' GLN . 14.5 t -109.99 133.87 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.405 ' HG2' ' C ' ' A' ' 436' ' ' VAL . 8.3 mmm180 -142.0 149.29 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.829 HD11 HD22 ' A' ' 421' ' ' LEU . 25.8 mm -70.14 96.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.871 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 64.8 p -95.96 128.01 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 408' ' ' PHE . . . 140.63 141.92 4.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 409' ' ' VAL . 8.4 mt -140.21 127.64 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.98 135.63 33.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 1.8 mm -126.05 142.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' LYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 363' ' ' PHE . 7.4 tptp -133.52 159.12 41.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 70.13 45.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.569 HD23 HD22 ' A' ' 434' ' ' LEU . 37.4 mt -93.53 108.27 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -51.02 124.31 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -46.48 -28.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -36.94 70.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.83 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 60.2 m -54.95 127.91 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.5 p -99.19 178.44 4.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.89 -47.49 21.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -42.34 -61.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 26.5 m -49.22 -62.36 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.155 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 23.0 tp -45.11 -48.56 12.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 389' ' ' CYS . 14.7 mmmt -49.34 -50.07 41.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.41 -34.63 89.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.494 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.49 -44.81 98.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.694 ' CD2' HG11 ' A' ' 409' ' ' VAL . 5.9 m-85 -80.59 -35.31 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -29.02 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -55.62 -41.61 73.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 420' ' ' ALA . 57.5 t -61.79 -39.83 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 169.23 -160.42 33.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.447 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.49 131.72 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 55.1 mt -98.01 134.84 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -81.26 -49.21 11.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.3 t -165.66 116.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.425 ' HB3' ' CD ' ' A' ' 377' ' ' LYS . 4.8 t -111.77 123.11 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -138.08 151.66 48.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.9 139.33 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.141 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 58.0 m -58.43 94.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -121.69 148.25 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -139.1 171.17 14.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -83.55 103.17 12.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.727 ' ND2' HD12 ' A' ' 402' ' ' LEU . 9.0 p30 -79.94 177.8 8.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 398' ' ' ALA . 13.2 ptmt -43.77 -35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 397' ' ' LYS . . . -78.8 -32.92 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 97.25 18.93 27.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.496 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.453 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 59.4 t -102.43 143.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.142 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.88 96.9 2.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.727 HD12 ' ND2' ' A' ' 396' ' ' ASN . 73.7 mt -111.12 148.4 32.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 25.4 m -57.95 159.79 5.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' MET . . . . . 0.47 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 46.6 mtp -116.98 13.82 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 93.8 -4.87 72.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.491 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 1.7 p90 -153.61 158.8 41.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.18 -178.3 24.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' PHE . . . . . 0.432 ' CZ ' ' HA3' ' A' ' 361' ' ' GLY . 37.8 t80 -131.96 109.75 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.37 . . . . 0.0 110.898 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.694 HG11 ' CD2' ' A' ' 380' ' ' PHE . 71.3 t -100.35 124.97 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -110.73 142.35 42.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.6 m-85 -114.83 154.12 29.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -61.83 -34.42 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -122.0 156.97 59.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.578 0.704 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.2 -8.48 19.87 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.341 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.11 -49.51 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -52.25 -39.94 61.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -66.01 -40.02 90.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -63.05 -32.48 73.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -72.7 -66.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.964 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -44.99 -36.61 3.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 438' ' ' ILE . 12.6 tp -34.66 -64.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -96.76 -41.51 8.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 383' ' ' VAL . 8.2 tt0 -39.56 -41.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 380' ' ' PHE . 91.1 mt -92.21 -28.54 16.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.2 tp60 -48.78 138.32 11.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.82 -26.04 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -60.11 118.26 6.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 28.7 m -69.88 132.08 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.1 t -135.29 123.01 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 59.13 29.82 19.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 82.97 -13.56 43.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -116.93 145.19 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -88.59 144.02 26.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.569 HD22 HD23 ' A' ' 367' ' ' LEU . 8.3 mt -97.2 149.83 21.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -108.19 112.78 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.78 139.58 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -147.45 149.46 32.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ILE . . . . . 0.731 HD11 HD22 ' A' ' 421' ' ' LEU . 19.0 mm -68.68 95.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.913 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 77.5 p -165.22 112.24 0.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 110.846 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 61.5 m -113.85 126.17 54.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 127.25 97.68 0.98 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m -149.74 151.48 33.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.378 . . . . 0.0 110.814 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.7 p -103.14 150.0 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.53 7.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.4 mt -148.88 123.85 10.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -93.65 130.54 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.22 142.76 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -128.71 165.85 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 60.93 47.85 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.56 HD23 HD22 ' A' ' 434' ' ' LEU . 38.4 mt -90.83 113.53 25.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -52.22 121.49 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -44.86 -32.11 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.2 t -68.2 -41.33 81.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 85.8 m -46.28 146.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 38.3 p -121.17 174.71 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.04 -38.06 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -54.01 -59.79 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 59.2 m -54.16 -46.08 72.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.436 HD12 ' CD1' ' A' ' 380' ' ' PHE . 22.2 tp -54.0 -46.01 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' SER . 24.4 mtpp -60.56 -41.12 93.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.65 -51.86 54.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.469 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.514 HG12 HD22 ' A' ' 424' ' ' LEU . 68.5 t -59.8 -39.34 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.463 ' CD2' HG11 ' A' ' 409' ' ' VAL . 11.0 m-85 -82.16 -21.21 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 377' ' ' LYS . 2.0 t -68.92 -14.84 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -66.85 -41.27 87.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 420' ' ' ALA . 3.9 t -67.49 -48.91 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.155 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.09 38.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.96 123.09 23.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.138 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 410' ' ' GLU . 19.1 mt -81.17 130.35 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -76.29 -51.21 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 27.1 t -159.26 134.01 8.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 15.2 p -123.1 126.82 47.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 16.2 m -143.5 122.36 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 34.1 mt -101.01 142.75 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 73.8 m -60.78 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -121.86 135.35 54.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.63 167.41 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.67 106.83 15.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.5 p30 -84.98 179.27 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -39.35 -48.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.89 74.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.51 22.4 26.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.32 143.0 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -72.24 99.71 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.55 140.64 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 31.6 m -58.05 162.91 3.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 21.4 mtm -117.04 16.26 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.23 3.79 63.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.483 ' C ' HD12 ' A' ' 367' ' ' LEU . 8.6 p90 -158.29 157.06 31.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 0.0 110.88 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -153.9 -172.96 22.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -137.39 119.26 15.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 380' ' ' PHE . 36.5 t -107.47 138.48 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 386' ' ' ILE . 44.0 tt0 -118.56 150.66 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.5 m-85 -122.6 163.08 20.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -70.68 -30.87 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -139.63 143.7 36.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.64 -42.03 23.95 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 418' ' ' GLN . 7.4 tt0 -51.71 -66.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -37.82 -48.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.548 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -63.23 -40.13 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 415' ' ' GLU . 45.7 mm-40 -60.86 -33.98 73.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -79.03 -60.14 2.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.683 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.32 -24.51 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.613 HD22 HD11 ' A' ' 438' ' ' ILE . 14.0 tp -50.08 -66.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 422' ' ' LYS . 0.6 OUTLIER -90.99 -35.18 14.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -49.64 -43.14 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.557 HD12 ' HB1' ' A' ' 420' ' ' ALA . 95.0 mt -85.81 -18.28 33.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 8.0 tp60 -62.22 142.38 57.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 88.29 -18.68 39.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -57.83 121.86 11.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.6 m -71.15 96.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.61 123.05 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 59.08 28.81 18.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.64 -4.19 52.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.444 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -124.05 149.33 46.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -91.01 140.14 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.56 HD22 HD23 ' A' ' 367' ' ' LEU . 14.0 mt -97.89 154.61 17.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -104.45 103.38 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.24 132.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -139.98 152.17 46.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.613 HD11 HD22 ' A' ' 421' ' ' LEU . 8.7 mm -71.37 96.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p -41.23 154.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 71.04 30.28 2.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -89.85 132.03 35.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -46.07 -53.23 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 58.1 p -60.43 125.52 24.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -87.91 144.58 35.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 130.59 19.6 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.667 2.245 . . . . 0.0 112.356 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -97.19 95.92 8.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.124 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 67.0 m -89.25 110.25 21.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -82.18 167.73 47.73 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.446 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 179.34 3.78 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.671 2.248 . . . . 0.0 112.332 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 7.8 t -128.53 -53.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 17.4 m -80.13 166.74 21.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 58.2 m -47.07 -57.72 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.368 . . . . 0.0 110.847 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 3.2 m -44.68 -55.36 5.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.83 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.63 109.62 2.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.475 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 15.9 m -152.12 169.33 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.372 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.0 p -112.95 136.98 52.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.72 137.99 3.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.3 119.02 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.372 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.574 ' C ' HD13 ' A' ' 364' ' ' ILE . 3.7 t80 -99.19 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.664 ' N ' HD13 ' A' ' 364' ' ' ILE . 1.2 mm -98.72 142.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -129.66 163.23 26.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 72.49 32.53 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.559 HD23 HD22 ' A' ' 434' ' ' LEU . 32.5 mt -81.5 131.79 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -71.7 125.82 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -45.88 -31.22 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 85.3 p -68.54 -38.25 80.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 45.9 m -57.79 137.37 56.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 69.0 p -114.87 176.35 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -65.59 -46.81 77.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.89 -55.0 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 56.9 m -59.93 -51.8 68.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 380' ' ' PHE . 8.9 tp -51.16 -42.54 60.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -57.62 -47.66 81.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.25 -43.88 97.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.06 -45.86 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 0.0 111.141 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' A' ' 376' ' ' LEU . 10.1 m-85 -80.22 -26.41 39.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.0 t -61.95 -16.36 50.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -67.22 -20.97 65.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.457 HG21 ' CB ' ' A' ' 420' ' ' ALA . 73.8 t -84.51 -48.66 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -171.95 -166.77 31.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.93 26.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.2 mt -92.55 139.16 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.168 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -53.86 3.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.0 t -151.36 126.97 10.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 409' ' ' VAL . 49.7 t -127.36 118.72 24.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 167.05 20.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 74.6 mt -126.65 143.7 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.1 m -72.69 103.76 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.87 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -114.34 137.95 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 395' ' ' LYS . 4.7 ttpt -127.2 149.43 49.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.939 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.48 ' N ' ' HG3' ' A' ' 394' ' ' LYS . 49.8 mttm -69.49 105.24 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 399' ' ' GLY . 2.0 p30 -81.69 179.09 7.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -41.39 -41.53 2.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -71.22 -32.52 68.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.58 15.65 49.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.67 143.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.27 99.64 3.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.85 156.33 36.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 21.3 m -57.78 158.72 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.481 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 23.1 mtm -117.06 15.79 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.84 69.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 404' ' ' MET . 5.5 p90 -155.5 155.36 33.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.361 . . . . 0.0 110.895 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.42 25.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.449 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -121.66 121.82 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.727 HG22 ' SG ' ' A' ' 389' ' ' CYS . 76.9 t -116.45 130.47 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -112.55 147.7 36.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.44 153.35 34.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -62.71 -33.42 75.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -125.28 159.8 58.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.566 0.698 . . . . 0.0 110.9 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -18.61 21.23 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -78.21 -49.71 13.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -48.86 -37.43 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.66 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -58.18 -29.51 65.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -78.03 -59.58 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.635 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -56.14 -17.98 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 438' ' ' ILE . 13.7 tp -52.79 -59.15 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 425' ' ' GLN . 12.9 tptp -99.72 -45.14 5.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -39.94 -39.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.635 HD12 ' HB1' ' A' ' 420' ' ' ALA . 95.8 mt -88.11 -26.42 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 10.3 tp60 -57.6 134.63 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.32 31.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -55.03 125.21 19.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.9 m -69.66 97.37 1.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.44 113.91 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.78 29.38 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.859 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.85 39.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -125.42 125.4 43.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -73.89 124.94 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.559 HD22 HD23 ' A' ' 367' ' ' LEU . 7.4 mt -89.39 164.11 15.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -116.43 103.23 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.28 126.02 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -130.93 162.9 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 421' ' ' LEU . 20.0 mm -86.92 98.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 48.1 t -81.34 127.88 33.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -98.65 154.33 18.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -75.52 114.53 14.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -59.83 170.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.1 m -68.99 99.98 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -75.81 149.77 83.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.564 0.697 . . . . 0.0 110.888 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 137.77 36.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.256 . . . . 0.0 112.331 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . 37.48 52.91 1.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.13 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 34.3 m -147.05 113.85 6.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -118.05 162.13 13.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.532 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 0.69 5.28 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.674 2.249 . . . . 0.0 112.344 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 4.6 t -127.8 151.1 49.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 4.8 t -94.57 116.56 28.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.539 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 5.7 m -38.74 -50.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.828 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.2 m -80.07 165.68 22.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 179.71 156.83 18.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.5 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t -117.76 86.39 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 80.7 p -85.48 125.73 33.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.439 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 145.44 139.08 3.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.519 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.4 mt -141.43 122.17 14.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.453 ' CB ' ' HB2' ' A' ' 439' ' ' SER . 0.5 OUTLIER -90.66 124.75 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.1 mm -113.35 146.59 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.89 167.02 20.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 12.2 t30 68.86 32.61 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.622 HD12 ' C ' ' A' ' 406' ' ' PHE . 46.4 mt -82.64 113.87 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.49 123.73 17.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -46.06 -21.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -78.37 -39.66 38.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 98.0 m -49.94 131.9 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.134 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 22.0 p -105.77 161.13 14.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.427 ' OE2' HD12 ' A' ' 391' ' ' ILE . 2.0 mp0 -61.85 -54.52 40.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 373' ' ' GLU . 36.5 mt-10 -36.65 -49.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 86.3 m -64.56 -50.88 65.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 380' ' ' PHE . 13.6 tp -54.66 -35.13 63.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 381' ' ' SER . 12.5 mmmt -61.25 -50.2 74.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.48 -42.92 95.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.52 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.85 -56.29 11.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.488 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.4 m-85 -72.13 -39.96 68.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.842 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 14.4 t -48.52 -22.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -55.75 -46.82 77.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.878 HG21 ' HB2' ' A' ' 420' ' ' ALA . 24.6 t -55.51 -61.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -161.13 -152.05 6.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -83.74 127.24 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.327 . . . . 0.0 111.098 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.7 mt -96.34 130.61 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -78.07 -51.32 10.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.924 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 45.7 t -157.31 131.71 8.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.508 ' SG ' HG22 ' A' ' 409' ' ' VAL . 21.4 t -127.0 110.83 13.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -130.48 138.4 50.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.562 HG21 ' OG ' ' A' ' 403' ' ' SER . 40.3 mt -99.49 149.04 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 40.7 m -70.28 102.14 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -123.94 147.15 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -69.66 102.89 1.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 399' ' ' GLY . 9.2 p30 -81.28 177.02 9.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -38.52 -49.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.39 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.92 30.51 8.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.432 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 35.9 t -113.36 143.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.112 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.75 100.29 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 29.4 mt -126.33 152.4 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.562 ' OG ' HG21 ' A' ' 391' ' ' ILE . 37.6 m -57.93 161.1 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 42.5 mtm -117.09 17.09 14.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.846 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.35 0.77 64.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.622 ' C ' HD12 ' A' ' 367' ' ' LEU . 4.7 p90 -153.69 155.27 35.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.868 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -143.02 -178.86 19.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' PHE . . . . . 0.573 ' CZ ' ' HG3' ' A' ' 410' ' ' GLU . 20.0 t80 -133.28 122.39 23.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.508 HG22 ' SG ' ' A' ' 389' ' ' CYS . 73.9 t -120.42 119.59 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.573 ' HG3' ' CZ ' ' A' ' 408' ' ' PHE . 15.2 mt-10 -109.55 141.65 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.0 161.13 15.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -62.58 -34.45 77.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -120.11 157.08 53.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 -10.01 21.28 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.47 -53.68 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -45.98 -38.05 7.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.16 90.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -62.13 -29.6 70.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -72.69 -64.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.878 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.45 -34.01 23.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 420' ' ' ALA . 12.8 tp -37.88 -63.35 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -93.41 -41.02 10.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -47.39 -42.33 21.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.851 HD12 ' HB1' ' A' ' 420' ' ' ALA . 90.3 mt -86.51 -23.13 26.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -56.85 146.98 24.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.78 -16.25 32.59 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -62.42 117.53 6.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 29.1 m -69.89 112.33 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.3 117.6 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 62.31 26.7 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 81.47 -9.33 55.6 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.517 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -116.61 142.67 46.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.428 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 24.0 mttt -88.12 138.04 31.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.63 156.26 16.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -109.48 109.33 20.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.06 136.04 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -141.69 161.26 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.99 96.5 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.453 ' HB2' ' CB ' ' A' ' 363' ' ' PHE . 5.4 t -91.2 158.65 16.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.838 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -140.49 160.74 39.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -69.28 151.76 45.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -106.86 -43.88 4.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.091 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 10.8 t -126.99 147.48 50.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -77.24 146.73 75.08 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.538 0.685 . . . . 0.0 110.861 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -46.46 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.65 2.233 . . . . 0.0 112.367 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -88.65 89.98 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.13 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 20.3 m -79.94 132.25 36.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 155.67 -170.35 33.56 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 129.61 17.93 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.658 2.239 . . . . 0.0 112.362 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 2.0 t -51.16 155.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 72.4 p -142.19 169.56 17.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.543 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 9.2 m -64.82 -59.22 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.88 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 1.1 t 54.23 37.68 27.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -89.93 112.44 4.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.44 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 66.1 m -144.46 118.46 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.851 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.6 p -104.05 144.6 31.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.78 147.59 7.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 417' ' ' ALA . 5.3 mt -146.57 120.44 9.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.52 132.39 34.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.4 mm -118.95 144.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -131.96 160.18 36.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 51.3 t30 69.5 33.8 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 406' ' ' PHE . 57.7 mt -78.46 107.11 10.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 371' ' ' THR . 2.5 m120 -50.12 118.16 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -40.32 -31.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 p -65.7 -43.01 90.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 368' ' ' ASN . 82.4 m -49.49 147.35 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.089 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 53.0 p -127.46 165.25 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.4 -36.04 79.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -50.34 -59.71 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 55.9 m -61.97 -44.95 95.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.559 HD12 ' CD1' ' A' ' 380' ' ' PHE . 21.0 tp -57.22 -33.19 67.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 381' ' ' SER . 4.0 mtpm? -73.09 -28.16 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -82.14 -50.7 4.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.441 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.24 -37.88 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.814 0.34 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.762 ' HA ' HD11 ' A' ' 424' ' ' LEU . 16.6 m-85 -86.27 -22.74 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.9 t -69.51 -9.61 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.86 -28.14 44.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 420' ' ' ALA . 94.3 t -75.71 -38.17 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 178.51 -167.17 37.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.475 ' HB3' ' HG3' ' A' ' 412' ' ' LYS . . . -78.77 121.24 24.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.081 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.44 ' O ' ' NZ ' ' A' ' 412' ' ' LYS . 20.3 mt -83.52 131.37 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -79.49 -53.3 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 t -157.26 135.07 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.5 p -117.89 128.75 55.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.7 m -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 392' ' ' SER . 79.9 mt -100.69 153.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 391' ' ' ILE . 65.6 m -75.35 94.72 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 33.7 mttm -119.44 154.72 33.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -146.03 162.5 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.04 101.53 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 399' ' ' GLY . 6.6 p30 -77.14 178.62 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.58 -28.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -84.89 -32.98 22.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.069 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.77 18.86 33.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.453 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.25 143.66 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.89 0.376 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.89 102.13 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.414 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 24.3 mt -122.5 149.01 44.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -60.65 159.33 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.519 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 49.4 mtm -116.97 16.68 15.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 92.68 3.32 66.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.525 ' C ' HD12 ' A' ' 367' ' ' LEU . 1.9 p90 -158.29 159.65 36.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -156.92 -175.8 28.26 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -131.13 121.39 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.07 120.77 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -103.89 154.03 20.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.73 174.66 7.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 385' ' ' ALA . 23.3 mmtm -77.02 -37.14 55.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -137.38 151.46 71.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 415' ' ' GLU . 72.1 Cg_exo -46.72 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.25 . . . . 0.0 112.334 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 414' ' ' PRO . 17.7 tt0 -38.07 -48.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -48.54 -54.01 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.433 ' HA ' HD11 ' A' ' 362' ' ' LEU . . . -59.55 -40.4 87.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -59.74 -29.69 68.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -80.41 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.438 ' HA ' HG21 ' A' ' 383' ' ' VAL . . . -53.56 -18.2 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 438' ' ' ILE . 13.4 tp -53.76 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -92.04 -34.35 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 423' ' ' GLN . 0.5 OUTLIER -47.35 -40.77 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.762 HD11 ' HA ' ' A' ' 380' ' ' PHE . 50.2 mt -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' HG23 ' A' ' 436' ' ' VAL . 6.1 tp60 -56.12 147.82 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.14 -12.97 34.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -64.72 115.8 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 75.6 m -70.74 101.95 2.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 434' ' ' LEU . 49.0 t -103.37 121.39 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 62.05 34.0 16.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.35 -6.98 49.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -122.86 138.25 54.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 7.2 mtpm? -79.34 146.19 33.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 429' ' ' VAL . 7.3 mt -105.76 159.13 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.464 ' OE1' ' CG ' ' A' ' 437' ' ' ARG . 3.4 tm-20 -110.49 127.76 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.496 HG23 ' NE2' ' A' ' 425' ' ' GLN . 21.6 t -113.11 135.86 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.464 ' CG ' ' OE1' ' A' ' 435' ' ' GLU . 14.3 mmt180 -140.54 152.49 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 421' ' ' LEU . 12.9 mm -76.12 98.49 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p -50.08 142.31 9.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.72 121.78 45.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -69.21 159.19 33.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -97.98 149.81 22.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.97 137.71 18.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -90.71 138.71 26.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.551 0.691 . . . . 0.0 110.914 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 447' ' ' SER . 54.4 Cg_endo -69.79 -39.77 6.05 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 0.0 112.36 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -54.29 83.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 445' ' ' PRO . 38.3 t -125.75 91.58 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -80.7 146.24 26.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.499 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 450' ' ' SER . 53.4 Cg_endo -69.81 123.72 10.36 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.681 2.254 . . . . 0.0 112.301 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 449' ' ' PRO . 60.1 p 34.39 46.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 63.5 p -77.1 -48.56 17.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.493 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 13.9 m -76.71 119.35 20.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 58.2 m -59.21 155.16 14.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -142.73 89.1 0.17 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.4 m -160.72 147.81 15.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 12.0 p -111.55 153.65 25.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.08 135.83 5.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 417' ' ' ALA . 10.2 mt -137.27 136.43 38.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.536 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.5 OUTLIER -103.34 124.56 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.536 HD13 ' C ' ' A' ' 363' ' ' PHE . 2.1 mm -111.33 142.17 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -132.35 161.7 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 72.73 37.03 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 406' ' ' PHE . 25.5 mt -86.28 126.95 34.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 371' ' ' THR . 5.4 m-20 -69.5 122.23 18.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -39.23 -40.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.9 m -62.44 -39.95 95.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 368' ' ' ASN . 53.4 m -50.88 126.49 16.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 82.6 p -106.82 157.42 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 374' ' ' GLU . 33.9 mt-10 -54.06 -50.04 67.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 373' ' ' GLU . 16.4 tt0 -34.89 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 83.4 m -55.91 -53.16 60.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.52 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 21.6 tp -49.98 -43.48 50.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -50.79 -54.9 19.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.3 -50.98 61.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 92.8 t -47.41 -55.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.182 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.583 ' HA ' HD11 ' A' ' 424' ' ' LEU . 6.7 m-85 -71.46 -34.65 70.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.0 t -53.76 -23.07 10.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -61.14 -35.89 78.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 420' ' ' ALA . 89.6 t -68.83 -42.79 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 176.58 -166.01 36.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.78 118.48 16.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 0.0 111.128 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 410' ' ' GLU . 25.8 mt -82.24 131.38 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.45 -42.84 28.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 m -169.54 126.42 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 2.3 t -119.61 117.25 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 98.9 m -139.77 136.45 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.114 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 392' ' ' SER . 80.5 mt -100.81 152.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 391' ' ' ILE . 10.9 m -70.97 101.7 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -126.41 152.03 46.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -144.0 158.65 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 395' ' ' LYS . 2.3 mppt? -74.12 101.9 4.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.646 ' OD1' ' HB3' ' A' ' 398' ' ' ALA . 4.8 p30 -74.68 179.27 4.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -20.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.646 ' HB3' ' OD1' ' A' ' 396' ' ' ASN . . . -91.52 -30.47 16.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 94.59 20.15 30.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.476 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 56.8 t -106.12 143.35 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 0.0 111.135 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -72.38 98.56 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 97.2 mt -111.46 141.81 44.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 14.2 t -58.07 159.96 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 16.0 mmm -115.71 24.82 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 78.62 -3.89 62.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.443 ' HA ' HD12 ' A' ' 367' ' ' LEU . 1.2 p90 -150.3 147.05 27.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -136.51 177.9 19.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.475 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -130.48 118.72 21.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.842 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 380' ' ' PHE . 77.4 t -106.06 146.13 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 386' ' ' ILE . 21.4 tt0 -129.92 146.38 51.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -120.57 164.5 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -66.42 -48.57 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.32 156.65 35.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.513 0.673 . . . . 0.0 110.917 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.39 -8.29 21.59 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.347 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.35 -46.65 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -49.2 -33.87 13.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 362' ' ' LEU . . . -67.86 -43.85 78.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.94 -31.45 72.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -70.42 -63.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.638 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -49.93 -36.98 29.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 420' ' ' ALA . 16.2 tp -34.84 -64.49 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -96.39 -39.77 9.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -45.09 -45.81 11.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.638 HD12 ' HB1' ' A' ' 420' ' ' ALA . 75.3 mt -83.76 -26.24 29.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.8 tp60 -52.15 152.02 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.3 -21.53 7.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.46 118.96 7.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 41.7 m -72.46 114.14 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.677 HG21 HD11 ' A' ' 434' ' ' LEU . 99.6 t -114.22 118.64 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 58.54 25.64 13.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 86.09 -8.62 72.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -118.43 138.94 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -82.34 144.02 30.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.677 HD11 HG21 ' A' ' 429' ' ' VAL . 6.4 mt -101.86 158.69 15.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.74 102.57 10.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.5 t -94.06 125.91 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -130.85 164.21 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 15.3 mm -82.32 96.05 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 8.1 t -88.01 90.45 8.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.73 173.38 6.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -100.98 130.93 47.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -82.39 -60.01 2.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 81.8 p -114.22 154.86 27.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -108.19 148.61 37.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 0.96 4.92 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.716 2.277 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -46.83 141.55 3.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.8 m -46.7 170.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -97.01 -158.1 31.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 0.98 4.82 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.746 2.298 . . . . 0.0 112.349 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 69.5 p -128.36 170.67 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 2.7 m -96.87 109.88 22.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.471 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 2.1 m -59.02 101.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.866 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 19.6 m -57.72 146.59 30.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 174.78 131.37 1.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.0 m -132.42 109.55 9.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 83.2 p -107.39 134.89 49.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.476 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 137.93 139.27 3.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.48 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.58 125.17 14.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.456 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.6 OUTLIER -93.64 118.63 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.5 mm -105.78 148.97 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -136.5 167.49 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 64.83 43.41 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 35.3 mt -94.39 100.66 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -40.74 118.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.419 ' C ' ' O ' ' A' ' 368' ' ' ASN . 6.4 m-85 -36.85 -45.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 65.3 m -58.21 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.4 m -48.59 143.86 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 54.2 p -124.39 157.03 36.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.1 mm-40 -48.07 -47.63 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 373' ' ' GLU . 3.0 tm-20 -34.64 -65.98 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 37.8 m -51.67 -60.38 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.566 HD12 ' CD1' ' A' ' 380' ' ' PHE . 12.5 tp -44.71 -37.41 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 381' ' ' SER . 7.9 mtpm? -71.53 -39.94 70.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.23 -19.99 70.82 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.75 -47.65 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.566 ' CD1' HD12 ' A' ' 376' ' ' LEU . 12.3 m-85 -74.94 -25.44 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 15.1 t -64.94 -16.42 63.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -67.82 -37.55 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 420' ' ' ALA . 92.6 t -66.41 -42.35 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -179.2 -158.65 21.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.527 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.403 ' HB3' ' HD2' ' A' ' 412' ' ' LYS . . . -85.14 124.11 31.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 410' ' ' GLU . 26.5 mt -82.53 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -54.15 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 98.3 p -149.26 123.16 9.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.447 ' C ' ' OE2' ' A' ' 373' ' ' GLU . 6.2 p -127.39 112.93 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -144.43 138.67 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.151 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 406' ' ' PHE . 76.2 mt -97.73 143.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.9 m -65.6 108.13 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -124.44 134.75 52.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.82 156.98 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 4.7 ptpt -78.9 106.37 10.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 399' ' ' GLY . 50.6 p30 -67.85 177.86 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 397' ' ' LYS . 0.4 OUTLIER -43.5 -35.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.6 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.95 38.0 3.98 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 84.0 t -119.95 143.64 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.27 107.75 6.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.3 mt -128.91 139.11 52.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.1 m -57.85 164.0 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 36.2 mtm -117.27 23.69 11.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.857 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.55 5.5 89.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 12.3 p90 -152.6 154.11 34.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.905 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.08 -162.03 9.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.472 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' PHE . . . . . 0.476 ' CE1' ' CA ' ' A' ' 361' ' ' GLY . 29.6 t80 -137.77 126.53 23.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.877 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 70.0 t -119.57 120.4 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 386' ' ' ILE . 16.7 tt0 -113.07 151.31 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.51 158.91 26.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.403 ' HD2' ' HB3' ' A' ' 385' ' ' ALA . 58.7 mttt -63.12 -36.16 82.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -117.37 160.19 38.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 0.0 110.931 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.66 -20.07 15.93 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.12 -49.35 14.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -46.39 -43.1 15.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.01 -51.52 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.11 -29.32 57.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -77.67 -67.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.603 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.45 -20.21 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 438' ' ' ILE . 12.8 tp -51.52 -70.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -92.29 -31.68 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.924 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLN . . . . . 0.445 ' NE2' HG22 ' A' ' 383' ' ' VAL . 14.2 tt0 -50.52 -39.47 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.592 HD12 ' HB1' ' A' ' 420' ' ' ALA . 85.3 mt -90.18 -36.97 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 12.7 tp60 -40.63 149.13 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.68 -19.26 9.51 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -59.95 133.84 56.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 30.2 m -72.88 123.56 23.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 434' ' ' LEU . 97.0 t -132.35 118.62 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.09 26.98 10.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 84.56 -17.62 29.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -113.24 139.06 49.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -78.06 135.94 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.618 ' CD1' HG21 ' A' ' 429' ' ' VAL . 9.2 mt -92.81 161.71 14.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.52 113.39 21.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.939 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.63 130.66 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -131.57 163.91 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 421' ' ' LEU . 20.1 mm -85.51 96.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.7 t -82.13 94.25 7.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.42 ' CD ' ' O ' ' A' ' 440' ' ' GLU . 2.5 pp20? -98.8 37.59 1.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 3.4 tpp85 -104.05 124.31 48.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -92.19 119.55 31.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.14 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 23.9 m -82.16 -63.8 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -103.44 144.35 28.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.58 0.705 . . . . 0.0 110.919 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 111.89 2.94 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.23 . . . . 0.0 112.325 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -39.41 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 32.2 t -174.98 115.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 174.01 148.01 6.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 113.34 3.35 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.65 2.233 . . . . 0.0 112.33 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 34.8 p -48.18 100.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 80.8 p -133.8 119.22 18.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 4.1 m -65.77 107.9 1.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.371 . . . . 0.0 110.86 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 44.5 m -76.41 140.18 41.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.797 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -139.98 87.79 0.2 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 57.4 m -136.73 117.02 13.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 5.8 p -102.9 140.08 37.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.6 142.4 4.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 12.1 mt -146.95 117.19 7.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -91.3 115.46 28.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 436' ' ' VAL . 3.2 mm -106.05 143.73 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' LYS . . . . . 0.483 ' CG ' ' HB3' ' A' ' 435' ' ' GLU . 12.4 ptmt -138.84 178.25 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 47.9 t-20 65.62 27.84 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 434' ' ' LEU . 34.1 mt -76.86 149.79 36.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -88.95 125.78 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -47.13 -20.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.5 m -80.13 -37.86 32.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 43.2 m -61.52 129.95 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 58.8 p -109.99 159.67 17.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -45.51 -42.91 11.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -41.62 -69.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 376' ' ' LEU . 42.3 m -47.18 -67.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.173 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.517 HD11 ' CE1' ' A' ' 380' ' ' PHE . 10.3 tp -35.53 -53.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -55.91 -52.15 65.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.36 -14.08 39.59 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 71.4 t -90.18 -53.52 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.142 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.701 ' HA ' HD11 ' A' ' 424' ' ' LEU . 7.4 m-85 -66.8 -37.68 85.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 11.4 p -52.19 -16.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -63.89 -39.51 94.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 420' ' ' ALA . 37.1 t -68.62 -54.85 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -163.71 -170.33 28.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.7 120.78 18.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.3 mt -79.31 138.36 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.98 -55.1 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 8.7 t -142.19 121.73 13.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.99 116.35 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -148.41 137.17 21.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 33.8 mt -101.39 143.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.2 m -58.3 107.62 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 32.0 mttp -127.15 153.36 46.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -149.76 163.66 37.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -73.26 101.81 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.3 p30 -79.51 178.71 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -41.65 -45.44 3.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.57 -32.64 71.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.88 33.84 6.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.467 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.527 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 84.9 t -119.58 143.69 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.367 . . . . 0.0 111.106 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.01 98.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.41 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 62.8 mt -118.44 153.6 33.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 50.4 m -57.88 159.7 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 49.7 mtp -117.1 13.05 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 96.41 -3.33 63.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.525 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 6.8 p90 -153.21 157.42 40.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.383 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.04 -179.86 22.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -130.33 124.25 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 380' ' ' PHE . 86.1 t -112.41 132.87 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.72 143.06 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.4 153.83 32.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -59.65 -34.15 72.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -122.82 160.72 47.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.58 0.705 . . . . 0.0 110.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.99 -18.98 16.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.311 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -77.15 -52.28 9.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' GLN . . . . . 0.438 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 21.1 mm-40 -47.39 -31.78 4.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.73 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.07 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -61.92 -30.61 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -71.15 -60.24 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -58.21 -33.82 69.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 438' ' ' ILE . 13.5 tp -36.63 -55.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 425' ' ' GLN . 11.7 pttm -100.93 -50.44 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 -38.59 -39.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.709 HD12 ' HB1' ' A' ' 420' ' ' ALA . 55.9 mt -88.59 -30.87 18.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 422' ' ' LYS . 7.9 tp60 -56.79 126.18 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.427 ' O ' ' NZ ' ' A' ' 433' ' ' LYS . . . 109.02 -17.81 31.79 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -60.93 114.48 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 110.853 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 34.1 m -70.95 98.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.44 122.64 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 58.26 27.97 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.12 77.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -123.67 128.66 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 37.0 mttm -80.42 119.53 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 367' ' ' LEU . 10.9 mt -78.87 161.95 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.483 ' HB3' ' CG ' ' A' ' 365' ' ' LYS . 5.7 tt0 -121.51 109.16 14.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.921 HG22 HD12 ' A' ' 364' ' ' ILE . 61.5 t -98.16 135.44 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.15 160.03 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.904 HD11 HD22 ' A' ' 421' ' ' LEU . 29.9 mm -79.48 95.48 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.058 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 6.0 t -92.65 127.97 38.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -118.35 149.82 40.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -109.67 138.93 45.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -84.73 -46.74 11.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 64.5 p -79.43 163.08 25.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.89 147.1 59.92 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.614 0.721 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 143.78 52.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.387 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -86.04 -57.51 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 59.7 m -43.99 128.13 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 160.77 -76.15 0.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.51 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -4.71 14.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.628 2.219 . . . . 0.0 112.376 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 37.4 m -43.75 115.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 44.1 p -102.4 167.02 10.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.856 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.435 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 4.7 t -88.25 -63.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 110.839 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 21.1 t -75.17 -52.84 9.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -178.62 156.69 19.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.3 t -117.67 109.15 16.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.38 . . . . 0.0 110.806 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p -107.34 129.12 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.17 143.89 4.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.432 HD22 ' CG1' ' A' ' 436' ' ' VAL . 12.4 mt -144.48 123.3 12.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 363' ' ' PHE . 0.7 OUTLIER -94.78 112.39 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.63 HD13 ' N ' ' A' ' 364' ' ' ILE . 1.4 mm -97.81 144.15 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 366' ' ' ASN . 0.3 OUTLIER -133.52 154.96 50.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 365' ' ' LYS . 32.6 t-20 74.72 44.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.32 123.51 36.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.93 125.63 25.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -45.89 -25.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.1 t -76.58 -38.3 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 62.9 m -54.57 125.47 19.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.175 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 62.5 p -107.49 152.84 23.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 47.1 mt-10 -47.36 -50.92 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 55.4 mt-10 -34.85 -58.35 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 88.7 m -58.2 -62.47 1.8 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 380' ' ' PHE . 24.5 tp -40.19 -48.29 2.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 381' ' ' SER . 45.0 mtpt -54.85 -43.16 72.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -66.99 -26.73 73.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.502 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.85 -41.33 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 111.142 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.489 ' HA ' HD11 ' A' ' 424' ' ' LEU . 5.9 m-85 -83.21 -22.48 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 12.5 t -67.73 -15.77 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -68.79 -33.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.655 HG21 ' HB2' ' A' ' 420' ' ' ALA . 18.6 t -72.61 -44.21 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -176.23 -170.67 39.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -77.23 128.65 34.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 111.084 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 410' ' ' GLU . 35.0 mt -90.63 135.77 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -89.07 -50.65 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 25.9 t -147.83 121.43 9.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.8 117.12 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 8.4 m -143.3 141.62 31.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 392' ' ' SER . 88.0 mt -106.68 154.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.462 ' N ' HG22 ' A' ' 391' ' ' ILE . 56.2 m -71.7 87.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -109.74 131.0 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.2 157.72 43.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 3.1 ptpp? -75.71 102.08 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.502 ' OD1' HD12 ' A' ' 402' ' ' LEU . 0.4 OUTLIER -62.15 175.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.32 -37.92 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.441 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -71.89 -32.89 67.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.75 38.02 3.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.45 143.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.85 0.357 . . . . 0.0 111.156 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.16 101.01 3.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.502 HD12 ' OD1' ' A' ' 396' ' ' ASN . 86.9 mt -127.08 148.76 50.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.94 163.05 2.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 38.2 mtp -117.09 14.3 14.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.25 70.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.414 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 2.5 p90 -156.05 158.27 37.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.951 0.405 . . . . 0.0 110.846 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.11 -176.85 22.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.79 115.03 16.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.84 130.4 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.162 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 386' ' ' ILE . 16.6 tt0 -111.42 149.53 31.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.08 153.02 43.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -64.37 -38.46 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -116.22 154.22 48.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.24 -14.72 28.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -82.75 -50.96 8.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.87 -41.61 16.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.0 82.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -57.73 -30.38 65.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -72.87 -68.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -48.44 -25.16 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.703 HD22 HD11 ' A' ' 438' ' ' ILE . 41.5 tp -46.65 -66.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -98.92 -40.8 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -41.64 -34.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 380' ' ' PHE . 70.0 mt -94.6 -37.96 11.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 5.7 tp60 -38.61 142.28 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 90.14 -23.53 20.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -56.3 130.0 42.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.7 m -74.16 110.09 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.59 HG12 ' OD1' ' A' ' 430' ' ' ASP . 61.3 t -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ASP . . . . . 0.59 ' OD1' HG12 ' A' ' 429' ' ' VAL . 4.3 m-20 59.3 28.06 17.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.65 1.12 60.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.507 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -126.38 142.24 51.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -83.75 136.66 34.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.48 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 18.7 mt -96.36 157.46 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -111.1 102.04 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.465 HG12 HD12 ' A' ' 421' ' ' LEU . 52.4 t -94.32 121.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -128.26 161.52 29.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.703 HD11 HD22 ' A' ' 421' ' ' LEU . 20.5 mm -78.09 95.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.414 ' HB2' ' N ' ' A' ' 363' ' ' PHE . 16.9 t -82.96 87.43 6.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -62.89 -38.51 91.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -90.73 131.73 36.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -91.23 159.17 16.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.114 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 8.4 t -46.38 131.37 10.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.143 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -117.21 142.29 29.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.541 ' O ' ' HB3' ' A' ' 446' ' ' ALA . 54.5 Cg_endo -69.74 -3.0 11.12 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 445' ' ' PRO . . . 73.78 38.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.6 m -65.24 -42.93 92.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.95 83.16 1.03 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 85.83 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 88.4 p -115.24 131.75 56.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 77.9 p -144.37 141.12 29.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.827 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.504 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 51.4 m -74.75 138.91 43.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 39.1 t -74.25 -65.59 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -167.93 110.01 0.37 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.3 m -136.57 160.77 37.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 84.2 p -108.48 148.36 30.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 117.26 144.11 7.71 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.444 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.3 mt -147.54 141.58 25.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.521 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.4 OUTLIER -109.23 134.4 51.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.521 HD13 ' C ' ' A' ' 363' ' ' PHE . 2.4 mm -119.01 147.69 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -134.85 159.84 40.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 405' ' ' GLY . 46.5 t-20 70.33 34.46 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.494 HD12 ' C ' ' A' ' 406' ' ' PHE . 53.4 mt -80.73 103.16 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.7 m120 -48.66 119.31 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 368' ' ' ASN . 8.2 m-85 -38.17 -42.73 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 52.3 p -58.19 -42.62 86.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 368' ' ' ASN . 35.5 m -44.53 141.61 1.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.173 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 49.2 p -121.1 143.65 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 39.2 mt-10 -43.32 -52.98 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 21.8 mp0 -34.59 -61.13 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 89.5 m -55.73 -47.01 77.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.0 tp -54.44 -54.84 35.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -55.87 -36.35 67.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.93 61.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.5 -41.52 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.685 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.5 m-85 -77.67 -12.96 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 6.9 t -77.31 -21.41 53.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -61.56 -27.58 68.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.703 HG21 ' HB2' ' A' ' 420' ' ' ALA . 42.2 t -73.85 -48.95 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -172.05 -154.63 10.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -90.1 114.69 26.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.453 HG21 ' HB2' ' A' ' 389' ' ' CYS . 36.0 mt -74.81 138.06 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -93.53 -53.81 3.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.1 t -147.77 112.19 5.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 409' ' ' VAL . 36.1 t -119.13 113.06 20.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -144.59 136.85 26.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 392' ' ' SER . 51.2 mt -93.67 156.62 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.119 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 391' ' ' ILE . 71.8 m -77.47 109.51 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -126.01 172.33 10.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -152.53 154.27 35.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 101.76 6.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 399' ' ' GLY . 48.4 p30 -72.49 176.82 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -47.83 -23.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -89.36 -26.95 20.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 87.76 35.51 9.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 93.5 t -116.83 143.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.159 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.413 ' CD2' ' N ' ' A' ' 401' ' ' LEU . 0.5 OUTLIER -73.23 122.43 21.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 70.4 mt -141.01 140.24 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -58.44 156.61 10.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.2 mtm -114.95 20.7 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 88.66 0.92 81.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.494 ' C ' HD12 ' A' ' 367' ' ' LEU . 14.2 p90 -156.45 155.0 31.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.01 -179.9 22.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -130.4 118.31 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.566 HG22 ' SG ' ' A' ' 389' ' ' CYS . 95.5 t -107.48 144.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -124.66 156.42 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' TYR . . . . . 0.401 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 30.1 m-85 -131.81 156.9 45.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -65.44 -35.48 81.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -128.3 143.49 48.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 417' ' ' ALA . 72.4 Cg_exo -46.87 -52.35 7.79 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.695 2.263 . . . . 0.0 112.359 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 416' ' ' GLN . 34.1 mt-10 -44.56 -62.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mm100 -35.85 -42.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 414' ' ' PRO . . . -59.33 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.29 -27.11 68.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -69.14 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.82 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -51.91 -35.52 45.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 420' ' ' ALA . 24.0 tp -36.14 -61.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -100.49 -32.15 10.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -58.26 -16.86 15.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.82 HD12 ' HB1' ' A' ' 420' ' ' ALA . 79.1 mt -115.77 -23.72 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -54.64 147.15 15.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 78.96 -10.82 31.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.501 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -58.88 132.93 55.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.1 m -72.52 109.82 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.193 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.55 HG11 HD11 ' A' ' 434' ' ' LEU . 77.4 t -126.92 113.47 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 61.39 28.79 18.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.48 39.22 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -115.66 143.16 45.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.358 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -84.87 121.04 27.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.55 HD11 HG11 ' A' ' 429' ' ' VAL . 8.8 mt -84.07 155.36 22.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.57 127.88 56.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.444 ' CG1' HD22 ' A' ' 362' ' ' LEU . 28.1 t -112.78 139.3 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 -139.96 166.35 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.1 mm -86.61 95.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.9 t -86.55 108.11 18.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -105.34 173.85 6.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -78.71 134.55 37.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.03 78.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.095 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 10.1 t -129.2 139.27 51.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 143.76 88.67 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.892 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 95.6 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -122.31 154.69 37.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.8 m -42.99 164.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -122.25 83.46 0.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.436 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 101.56 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.732 2.288 . . . . 0.0 112.314 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 8.0 t -165.42 170.84 14.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 12.7 m -109.93 141.1 43.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 356' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 355' ' ' GLY . 2.5 t 36.86 37.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.341 . . . . 0.0 110.802 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 36.1 m -115.81 95.01 4.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -158.5 133.98 3.65 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.7 t -148.82 145.54 27.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.848 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 6.4 p -109.65 126.47 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.66 135.34 2.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.2 mt -138.57 137.26 36.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -111.49 112.96 25.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.517 HD12 HG22 ' A' ' 436' ' ' VAL . 2.9 mm -97.42 143.71 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -131.8 160.31 35.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 5.5 t30 71.18 40.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -87.28 121.37 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 371' ' ' THR . 12.9 m120 -58.81 122.34 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -43.7 -24.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 -37.88 46.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.3 m -51.31 131.73 28.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 41.4 p -113.89 154.33 27.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 374' ' ' GLU . 85.3 mt-10 -45.85 -54.42 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 373' ' ' GLU . 54.4 mm-40 -35.05 -66.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 378' ' ' GLY . 32.7 m -51.73 -64.03 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 375' ' ' THR . 15.3 tp -36.66 -52.59 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 4.4 mtpm? -55.78 -42.19 75.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -68.82 -25.26 75.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.524 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 94.8 t -78.83 -45.29 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.573 ' CD2' ' CD1' ' A' ' 424' ' ' LEU . 12.6 m-85 -79.26 -46.02 18.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.478 ' N ' HD11 ' A' ' 386' ' ' ILE . 47.7 t -42.81 -28.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -48.15 -47.73 34.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 420' ' ' ALA . 97.2 t -57.79 -57.56 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.59 -167.42 24.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.466 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.9 121.26 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 410' ' ' GLU . 46.2 mt -85.25 139.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -82.9 -52.88 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -155.82 122.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.534 ' SG ' HG22 ' A' ' 409' ' ' VAL . 15.4 t -119.99 124.04 44.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -146.42 166.68 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.48 HG21 ' OG ' ' A' ' 403' ' ' SER . 73.5 mt -127.35 142.22 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.2 t -68.14 115.04 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -128.51 149.92 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -149.5 151.8 34.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 2.4 ptpt -69.58 102.57 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 399' ' ' GLY . 52.5 p30 -64.41 179.12 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -42.88 -40.17 2.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.31 -32.16 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.6 31.94 5.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.47 143.51 29.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.14 116.74 15.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.421 HD12 ' ND2' ' A' ' 396' ' ' ASN . 39.6 mt -137.32 156.53 48.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.48 ' OG ' HG21 ' A' ' 391' ' ' ILE . 1.3 t -57.9 158.53 6.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 16.8 mtm -117.07 19.28 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.89 88.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 404' ' ' MET . 16.8 p90 -158.33 158.93 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.3 -172.6 20.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -125.32 123.69 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.534 HG22 ' SG ' ' A' ' 389' ' ' CYS . 89.9 t -118.53 119.28 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 386' ' ' ILE . 14.9 tt0 -106.54 153.68 21.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' TYR . . . . . 0.517 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 14.5 m-85 -122.53 153.14 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -59.54 -40.55 87.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -125.43 143.72 45.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.31 -41.61 28.13 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.743 2.295 . . . . 0.0 112.342 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 418' ' ' GLN . 1.2 tp10 -57.83 -62.63 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -37.91 -38.14 0.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -71.98 -41.19 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.086 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 415' ' ' GLU . 34.8 mm-40 -66.53 -22.19 66.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -83.28 -63.2 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -49.26 -40.39 34.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 438' ' ' ILE . 8.4 tp -35.42 -62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -92.77 -51.41 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -38.62 -36.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.859 HD12 ' HB1' ' A' ' 420' ' ' ALA . 90.4 mt -92.25 -35.27 13.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -43.6 150.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.01 -8.48 15.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -66.44 118.42 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 10.4 m -69.23 116.82 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 79.9 t -125.12 122.74 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.157 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 58.82 31.76 21.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.97 -8.12 24.67 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -119.58 133.01 55.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -76.57 151.53 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 5.4 mt -116.54 159.9 21.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -116.11 129.38 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 364' ' ' ILE . 36.0 t -116.95 142.35 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -137.11 159.47 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.752 HD11 HD22 ' A' ' 421' ' ' LEU . 24.9 mm -83.89 95.69 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 23.3 t -79.61 97.83 6.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -72.64 -47.08 50.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -76.69 131.81 39.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -128.61 113.0 14.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.6 p -45.53 164.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -75.78 145.02 77.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.562 0.696 . . . . 0.0 110.919 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -32.8 17.97 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.668 2.246 . . . . 0.0 112.361 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -62.37 116.11 4.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.2 m -73.56 103.2 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 94.16 85.89 1.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.46 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 2.8 3.2 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.335 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 15.8 m 59.07 45.42 14.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.3 t -73.59 135.75 43.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.531 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 7.9 t -63.07 151.57 39.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 110.886 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 3.6 m -118.33 -43.27 2.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.906 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 97.07 115.41 3.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 6.2 m -170.44 154.85 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.86 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.08 155.08 17.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.84 148.77 9.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.544 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.697 HD22 ' CG1' ' A' ' 436' ' ' VAL . 4.5 mt -147.24 131.88 17.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 365' ' ' LYS . 0.3 OUTLIER -98.38 131.0 45.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.0 mm -117.1 142.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 12.2 tptp -132.29 162.36 31.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.3 t30 64.93 31.52 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.585 HD23 HD22 ' A' ' 434' ' ' LEU . 33.7 mt -72.23 128.84 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -70.9 128.92 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -54.52 -15.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 69.4 m -81.8 -29.03 32.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 81.8 m -65.98 138.93 58.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.6 p -120.13 162.22 19.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.18 -36.51 75.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -50.48 -60.46 2.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 42.9 m -62.29 -55.66 26.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.554 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.6 tp -43.16 -38.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -69.38 -43.73 72.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.79 -20.45 72.34 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.478 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.16 -40.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.554 ' CD1' HD12 ' A' ' 376' ' ' LEU . 11.6 m-85 -82.6 -14.66 54.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 75.8 p -74.87 -15.28 60.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -65.03 -27.52 68.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 420' ' ' ALA . 59.5 t -79.39 -64.18 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -153.33 -162.44 11.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -84.28 118.46 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.755 0.312 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.92 132.34 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -84.07 -55.04 4.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.7 p -154.46 116.62 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 28.5 p -108.54 120.36 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 95.2 m -137.79 127.54 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.77 140.79 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 70.1 m -57.55 99.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.85 157.82 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -153.96 156.34 37.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -74.67 104.58 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 398' ' ' ALA . 5.4 p30 -78.5 178.12 8.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -45.08 -33.62 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.454 ' HB3' ' OD1' ' A' ' 396' ' ' ASN . . . -78.73 -29.26 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 88.57 36.91 7.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.491 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 67.5 t -121.9 143.41 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.113 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -69.12 107.5 3.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 56.0 mt -126.88 143.92 51.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.0 p -59.3 162.39 4.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.537 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 37.6 mtp -117.08 13.78 14.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.12 1.48 64.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.557 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 404' ' ' MET . 1.7 p90 -158.31 158.82 35.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.03 -175.03 22.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -140.7 113.6 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 63.4 t -103.49 121.0 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.18 145.31 28.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -120.82 151.38 39.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -64.64 -14.04 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -141.47 159.07 61.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.635 0.731 . . . . 0.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.67 -44.93 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.4 -49.41 72.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -47.24 -47.9 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -54.37 -60.01 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -48.88 -31.13 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -75.55 -56.76 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 424' ' ' LEU . . . -57.88 -15.03 7.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.574 ' HB2' HD21 ' A' ' 362' ' ' LEU . 14.2 tp -63.61 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.95 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.7 -34.63 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -55.18 -14.69 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 420' ' ' ALA . 46.7 mt -117.82 -37.22 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.7 tp60 -42.13 145.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.9 -10.75 59.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -67.79 122.48 18.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.0 m -69.24 116.33 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.147 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.5 123.21 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.26 26.66 15.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.29 40.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.541 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -121.61 137.34 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -77.73 143.25 38.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.585 HD22 HD23 ' A' ' 367' ' ' LEU . 8.0 mt -102.73 159.18 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -113.81 105.99 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.697 ' CG1' HD22 ' A' ' 362' ' ' LEU . 22.5 t -97.92 133.95 38.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -139.33 166.08 25.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 3.2 mm -87.11 101.53 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 30.9 t -84.68 131.44 34.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -132.29 118.98 20.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.925 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 441' ' ' ARG . 0.0 OUTLIER -100.41 136.38 40.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -42.39 161.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 72.8 p 47.61 41.93 14.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.111 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 148.56 87.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.567 0.699 . . . . 0.0 110.905 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 137.8 36.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.719 2.28 . . . . 0.0 112.331 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -142.58 156.83 45.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.6 p -96.9 163.23 13.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 161.99 169.23 25.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.518 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -0.24 6.64 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.728 2.286 . . . . 0.0 112.312 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 9.9 t -48.49 167.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.831 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 16.5 t -155.3 144.36 20.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 95.8 p -40.47 125.24 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 2.9 t -132.12 107.75 8.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -63.2 166.38 25.01 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t -158.16 147.09 19.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 110.862 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.6 p -109.82 125.36 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.86 138.07 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.91 129.58 19.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.899 0.38 . . . . 0.0 110.902 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -105.17 116.61 32.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.9 mm -103.57 141.2 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -127.56 165.11 20.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 9.2 t30 71.79 28.12 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.671 HD12 ' CA ' ' A' ' 406' ' ' PHE . 36.4 mt -74.59 126.51 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.7 m120 -73.66 121.94 21.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -39.27 -38.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.4 t -61.66 -42.71 99.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 368' ' ' ASN . 90.3 m -50.13 121.72 5.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.3 p -99.66 154.12 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.25 -55.37 15.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -43.35 -44.53 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 85.3 m -64.66 -54.35 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.499 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 11.7 tp -53.2 -43.72 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -59.45 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -54.55 -57.76 16.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 88.1 t -41.17 -49.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.556 ' HA ' HD11 ' A' ' 424' ' ' LEU . 9.9 m-85 -78.46 -25.51 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.1 t -63.2 -12.94 32.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.3 -24.12 64.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 420' ' ' ALA . 78.4 t -81.39 -59.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.12 -172.65 30.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -68.99 117.03 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.739 0.304 . . . . 0.0 111.055 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.58 133.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.17 -52.13 7.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.4 m -162.48 117.66 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 409' ' ' VAL . 17.6 t -120.13 132.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -144.44 162.65 35.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 406' ' ' PHE . 87.8 mt -123.82 138.77 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 406' ' ' PHE . 4.9 p -58.35 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -115.93 140.73 48.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -136.25 170.01 16.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -86.63 108.81 18.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 0.3 OUTLIER -80.25 178.67 8.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -46.03 -35.8 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -76.02 -31.83 59.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 96.25 35.3 5.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.449 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.444 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 18.9 t -118.85 145.24 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.378 . . . . 0.0 111.13 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.0 96.4 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.425 HD12 ' OD1' ' A' ' 396' ' ' ASN . 63.0 mt -110.95 137.67 48.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.4 p -57.67 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 80.0 mtp -116.44 14.49 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.53 74.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.671 ' CA ' HD12 ' A' ' 367' ' ' LEU . 16.8 p90 -148.97 174.33 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.64 39.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.545 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -126.55 117.47 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.887 HG22 ' SG ' ' A' ' 389' ' ' CYS . 63.0 t -111.8 136.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -123.33 146.7 47.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.02 153.81 33.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -59.39 -42.03 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -113.32 159.52 34.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 110.875 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -16.34 18.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.346 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.66 -48.82 12.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.52 -35.94 14.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.82 65.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -58.56 -27.93 65.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -78.89 -63.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -55.67 -15.86 3.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.805 HD22 HD11 ' A' ' 438' ' ' ILE . 25.2 tp -57.81 -62.16 2.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -95.78 -27.63 15.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLN . . . . . 0.439 ' O ' ' CD ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -58.48 -45.14 89.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.556 HD11 ' HA ' ' A' ' 380' ' ' PHE . 94.4 mt -83.98 -17.08 41.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 15.8 tp60 -64.85 134.7 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.03 45.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -55.25 131.79 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.3 m -73.44 96.23 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.7 t -111.31 113.2 43.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.58 31.3 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 65.33 6.28 26.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -126.4 126.46 43.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -73.03 126.8 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.488 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 6.7 mt -90.75 159.34 16.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -110.56 103.18 11.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.443 HG12 HD12 ' A' ' 421' ' ' LEU . 60.7 t -92.51 131.83 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -136.47 164.94 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.805 HD11 HD22 ' A' ' 421' ' ' LEU . 30.9 mm -88.21 97.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.1 t -83.73 87.75 7.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.21 -48.18 71.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -65.9 128.79 37.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -125.96 150.69 47.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 45.8 m -109.63 133.45 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 147.71 47.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 0.0 110.903 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 97.81 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -83.85 102.01 12.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 55.1 p -48.72 -47.99 40.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.01 157.38 9.77 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.543 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 159.18 54.44 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.716 2.277 . . . . 0.0 112.387 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 58.6 p -153.01 125.59 8.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 35.5 m -42.32 102.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.856 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.484 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.5 t -40.05 -56.4 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 1.7 t -79.68 161.11 26.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 179.93 66.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.2 m -147.98 157.28 43.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.854 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 81.8 p -112.32 139.11 48.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.14 144.01 5.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.8 mt -149.94 112.95 4.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.36 113.61 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 364' ' ' ILE . 1.9 mm -98.8 145.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -131.87 161.59 32.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.6 t30 71.19 30.26 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 406' ' ' PHE . 76.5 mt -74.77 112.93 11.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -57.85 117.06 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 368' ' ' ASN . 5.6 m-85 -34.26 -54.59 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 m -46.7 -45.17 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 368' ' ' ASN . 85.9 m -48.3 138.48 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 374' ' ' GLU . 14.6 t -123.22 163.31 20.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -56.57 -15.13 3.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.609 ' H ' HG23 ' A' ' 372' ' ' THR . 21.1 tt0 -68.47 -60.33 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.963 ' O ' HG23 ' A' ' 379' ' ' VAL . 51.6 m -61.58 -38.05 86.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 391' ' ' ILE . 7.4 tp -62.9 -57.5 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -53.1 -31.87 44.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -80.75 -23.96 59.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 375' ' ' THR . 94.5 t -80.62 -45.25 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.701 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.2 m-85 -76.0 -24.44 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.3 p -61.71 -24.28 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.877 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -58.56 -39.82 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.692 HG21 ' HB2' ' A' ' 420' ' ' ALA . 12.0 t -66.96 -48.29 79.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.426 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -179.02 -168.57 38.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.01 130.58 43.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 28.0 mt -92.9 137.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -86.05 -50.19 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -160.06 126.27 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 409' ' ' VAL . 50.9 t -123.84 98.98 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 87.5 m -117.84 125.32 50.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.565 HD11 HD23 ' A' ' 376' ' ' LEU . 29.0 mt -101.44 155.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 406' ' ' PHE . 50.6 p -69.86 92.93 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -121.29 141.02 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -138.08 167.55 21.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.434 ' N ' ' HE3' ' A' ' 395' ' ' LYS . 0.1 OUTLIER -82.44 102.89 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 3.7 p30 -76.28 178.35 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -39.35 -52.62 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.72 73.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 95.03 30.98 7.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.531 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 13.8 t -109.18 151.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 401' ' ' LEU . 0.8 OUTLIER -76.28 112.72 13.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.1 mt -136.54 136.34 39.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.7 m -57.86 164.12 2.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 6.1 mtm -112.29 15.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 98.09 0.72 58.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.673 ' C ' HD12 ' A' ' 367' ' ' LEU . 53.5 p90 -156.57 172.33 18.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -167.97 -177.02 38.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -132.38 133.54 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.627 HG22 ' SG ' ' A' ' 389' ' ' CYS . 54.5 t -125.55 141.68 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.158 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -124.42 142.77 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 23.8 m-85 -113.87 156.51 23.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -61.42 -41.41 97.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -126.93 142.69 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.583 0.706 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.27 -41.58 27.83 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.93 -55.99 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' GLN . . . . . 0.426 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 42.5 mm-40 -45.45 -36.69 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -69.2 -45.93 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -60.71 -25.28 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -80.73 -63.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.692 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -55.52 -18.32 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.83 HD22 HD11 ' A' ' 438' ' ' ILE . 17.4 tp -55.84 -66.43 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -93.81 -41.68 9.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -42.27 -46.26 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 380' ' ' PHE . 57.9 mt -82.24 -29.49 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.3 tp60 -50.17 142.08 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.7 -18.3 30.88 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -56.62 128.04 34.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.478 ' HA ' ' CE ' ' A' ' 433' ' ' LYS . 1.4 m -71.29 99.27 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.15 124.55 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.49 28.52 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.05 -1.53 47.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -124.65 151.53 44.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.478 ' CE ' ' HA ' ' A' ' 428' ' ' THR . 6.0 mmpt? -88.86 133.4 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.496 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 13.4 mt -94.21 154.71 17.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.915 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.79 106.31 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.7 t -97.65 126.76 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -133.95 163.63 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.815 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.83 HD11 HD22 ' A' ' 421' ' ' LEU . 10.7 mm -86.36 99.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p -46.26 169.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -135.13 166.33 23.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -109.08 122.03 46.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -52.11 125.99 17.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 444' ' ' LYS . 34.9 m -130.14 155.14 46.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.427 ' N ' HG22 ' A' ' 443' ' ' THR . 0.0 OUTLIER -127.4 143.39 47.12 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.879 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 446' ' ' ALA . 54.0 Cg_endo -69.75 -46.65 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.677 2.251 . . . . 0.0 112.345 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 445' ' ' PRO . . . -34.0 132.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 97.5 p -169.57 110.99 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -143.36 -149.77 5.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 128.15 15.61 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 16.1 m -153.13 160.63 42.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 91.6 p -117.41 132.95 56.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 13.5 p -96.59 102.34 14.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 110.836 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 68.8 m -128.07 132.9 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.82 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 150.68 76.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.513 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.3 t -164.93 155.85 14.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.848 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.1 p -107.57 131.77 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.871 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.9 142.78 5.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.85 124.41 13.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.4 OUTLIER -90.71 127.75 36.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.3 mm -116.29 142.32 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -131.56 161.18 33.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 72.35 35.91 1.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 406' ' ' PHE . 50.9 mt -85.35 109.55 18.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -52.57 130.96 33.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.839 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -52.33 -16.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.8 t -82.23 -37.26 26.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 97.0 m -55.21 131.99 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 23.2 p -110.66 156.27 21.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -50.48 -43.71 55.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -43.18 -63.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 378' ' ' GLY . 19.5 m -55.95 -65.8 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.591 HD12 ' CD1' ' A' ' 380' ' ' PHE . 11.8 tp -37.12 -44.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -62.87 -44.13 96.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -61.48 -52.91 48.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.09 -34.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.159 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.591 ' CD1' HD12 ' A' ' 376' ' ' LEU . 13.5 m-85 -87.19 -11.84 48.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 t -78.07 -14.16 59.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.51 -38.07 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 420' ' ' ALA . 60.2 t -64.42 -55.93 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -169.04 -163.2 22.68 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.77 126.17 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 19.7 mt -88.84 136.94 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -86.09 -53.21 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 14.2 t -165.67 130.56 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 45.1 t -123.09 122.63 38.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.3 m -130.9 127.42 38.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 406' ' ' PHE . 57.9 mt -95.8 140.68 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.692 ' CB ' ' CE2' ' A' ' 406' ' ' PHE . 2.8 p -60.01 91.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -119.8 140.67 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -139.76 160.79 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -70.72 107.93 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 399' ' ' GLY . 8.6 p30 -88.61 179.25 6.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -38.92 -47.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.63 68.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 91.86 29.83 11.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.454 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.78 142.6 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.29 96.63 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 28.9 mt -119.22 149.35 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 p -57.87 160.7 4.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.1 mtm -116.81 10.89 14.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.52 56.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.692 ' CE2' ' CB ' ' A' ' 392' ' ' SER . 9.4 p90 -152.78 176.09 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -166.73 -172.99 34.64 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -137.8 121.65 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 84.7 t -110.65 132.87 57.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -115.91 153.14 32.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -131.89 152.16 51.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -67.15 -25.3 66.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -117.97 151.58 49.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.537 ' O ' ' NE2' ' A' ' 418' ' ' GLN . 58.7 Cg_endo -71.96 -27.72 17.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 416' ' ' GLN . 14.4 tp10 -75.95 -57.19 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' GLN . . . . . 0.503 ' OE1' HG12 ' A' ' 383' ' ' VAL . 96.6 mm-40 -34.83 -43.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -56.0 -51.01 69.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 414' ' ' PRO . 1.4 mp0 -63.73 -28.49 69.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -65.49 -59.15 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.935 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -62.32 -33.89 75.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 438' ' ' ILE . 15.8 tp -38.64 -55.18 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.84 -43.07 6.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -47.49 -43.76 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.935 HD12 ' HB1' ' A' ' 420' ' ' ALA . 86.3 mt -84.25 -24.15 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -56.99 147.22 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.47 11.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -61.06 118.86 7.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 20.7 m -69.23 116.38 9.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.37 117.68 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 61.28 31.2 19.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.12 -4.47 47.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -122.63 131.44 53.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -74.7 143.83 44.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.0 mt -105.57 161.51 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.52 120.26 39.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.41 134.72 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -140.93 159.6 41.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 421' ' ' LEU . 22.4 mm -76.93 97.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 4.3 p -43.31 132.54 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -137.07 132.66 34.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -108.38 163.79 12.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -114.53 42.08 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.9 t -149.68 145.09 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.162 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.67 139.29 26.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 87.19 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.305 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -173.19 117.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 58.7 m -86.05 85.66 7.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.806 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 137.33 -162.73 25.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 157.04 61.85 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 94.4 p -129.54 120.8 25.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 30.3 m -123.51 154.53 39.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.502 -179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 17.0 m -106.4 104.77 14.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 110.868 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 17.4 t -82.37 100.23 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 75.26 162.02 10.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.491 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.8 m -165.38 162.69 19.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.4 p -114.32 137.34 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.844 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 130.24 141.86 5.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.51 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.11 117.63 7.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -95.78 112.4 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 364' ' ' ILE . 2.1 mm -98.97 149.99 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -133.86 158.24 43.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 405' ' ' GLY . 37.4 t30 74.72 36.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 406' ' ' PHE . 45.9 mt -84.21 118.82 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.6 m-20 -56.38 119.87 6.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -41.0 -30.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 53.7 p -73.39 -39.22 65.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 368' ' ' ASN . 55.2 m -46.18 121.11 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 39.4 p -96.23 157.48 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 374' ' ' GLU . 45.1 mt-10 -56.34 -55.9 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.2 tt0 -36.84 -57.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 379' ' ' VAL . 33.0 m -52.2 -50.5 61.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.511 HD11 ' CE1' ' A' ' 380' ' ' PHE . 15.1 tp -55.49 -49.76 71.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -53.08 -36.46 60.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -75.04 -43.65 26.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.455 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 375' ' ' THR . 99.1 t -60.79 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.126 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.62 ' HA ' HD11 ' A' ' 424' ' ' LEU . 5.8 m-85 -81.29 -24.48 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.3 t -65.81 -19.98 66.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -63.29 -35.49 80.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 420' ' ' ALA . 60.3 t -66.4 -62.7 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -158.07 -150.3 5.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -88.88 122.33 32.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 410' ' ' GLU . 23.1 mt -87.32 142.53 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -90.26 -49.19 6.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 33.8 t -164.7 118.26 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.885 ' SG ' HG22 ' A' ' 409' ' ' VAL . 7.7 t -113.31 130.34 56.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.5 t -146.05 154.12 41.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.8 mt -115.27 141.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 74.6 m -64.87 91.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' LYS . . . . . 0.409 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 53.6 mttt -115.17 147.61 40.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -134.48 156.5 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 395' ' ' LYS . 0.6 OUTLIER -76.9 110.74 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.1 p-10 -82.58 178.48 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 398' ' ' ALA . 0.0 OUTLIER -41.72 -30.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -87.79 -32.25 19.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.097 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.54 31.02 8.12 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.529 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.92 143.2 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.105 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.12 112.16 8.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.409 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 32.2 mt -134.5 136.1 42.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.1 m -57.84 159.19 5.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.507 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 47.0 mtm -116.9 21.13 13.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 90.05 4.96 71.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.453 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.521 ' C ' HD12 ' A' ' 367' ' ' LEU . 5.7 p90 -155.08 154.31 32.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.388 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.6 168.37 30.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.28 122.23 45.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.885 HG22 ' SG ' ' A' ' 389' ' ' CYS . 86.5 t -115.27 125.21 72.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 386' ' ' ILE . 28.6 tt0 -111.55 155.38 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -126.54 165.75 18.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.906 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -71.93 -34.5 69.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.21 161.75 41.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.18 -16.31 19.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.22 -41.54 14.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -51.04 -44.5 61.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.47 88.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -57.13 -35.95 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -67.47 -61.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -52.24 -34.65 46.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.095 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.452 HD22 HD11 ' A' ' 438' ' ' ILE . 63.7 tp -34.86 -61.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.25 -44.83 5.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -39.87 -35.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 380' ' ' PHE . 84.0 mt -93.3 -33.4 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.4 tp60 -47.03 139.88 5.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.2 56.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -59.69 129.88 44.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 18.2 m -69.83 114.12 7.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.169 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.1 116.73 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 54.59 31.16 14.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 73.05 -2.79 32.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -123.45 133.13 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -77.95 145.28 36.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.487 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 9.8 mt -106.12 163.28 12.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.46 108.57 17.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.485 ' O ' ' CZ ' ' A' ' 437' ' ' ARG . 42.0 t -92.47 124.74 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.485 ' CZ ' ' O ' ' A' ' 436' ' ' VAL . 11.3 mmp_? -127.17 165.96 18.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.452 HD11 HD22 ' A' ' 421' ' ' LEU . 5.2 mm -90.63 97.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.4 p -39.62 -39.25 0.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 64.55 37.82 7.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -95.56 148.24 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -119.91 124.46 46.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 13.5 t -130.93 154.27 48.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.457 ' CG ' ' HD2' ' A' ' 445' ' ' PRO . 17.9 ttpt -88.15 139.53 30.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.649 0.738 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 444' ' ' LYS . 53.3 Cg_endo -69.79 97.53 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.635 2.224 . . . . 0.0 112.335 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -99.96 165.92 11.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.1 m -92.86 -44.72 8.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 449' ' ' PRO . . . 98.4 -146.71 18.29 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.465 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' ' 448' ' ' GLY . 54.3 Cg_endo -69.71 -0.25 6.61 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.706 2.271 . . . . 0.0 112.337 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 15.5 m -102.24 129.27 48.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 1.2 t -150.04 175.65 11.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 75.7 m -114.55 118.83 34.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 48.0 t -174.69 144.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 127.91 109.48 1.52 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.532 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m -160.48 163.77 32.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.879 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.1 p -105.57 159.4 15.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 103.26 139.43 10.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.502 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 409' ' ' VAL . 9.6 mt -141.86 131.3 23.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.64 125.85 40.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.2 mm -116.3 142.06 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.077 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' LYS . . . . . 0.428 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 13.1 tptm -128.89 162.5 27.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 405' ' ' GLY . 35.2 t-20 65.08 45.56 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 406' ' ' PHE . 43.6 mt -89.52 107.36 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -50.49 124.51 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -47.1 -28.5 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 t -69.22 -35.55 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 13.1 m -56.67 130.44 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.088 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 43.8 p -108.16 156.52 19.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -49.75 -49.42 48.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -43.35 -68.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 91.3 m -44.98 -64.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 18.5 tp -39.77 -51.76 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -54.39 -43.43 71.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -62.13 -48.85 80.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 66.6 t -58.23 -40.77 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.47 ' HA ' HD11 ' A' ' 424' ' ' LEU . 15.2 m-85 -82.51 -20.91 35.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 24.3 t -70.27 -14.01 62.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.809 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -71.49 -37.71 71.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 420' ' ' ALA . 94.9 t -65.88 -39.82 85.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.106 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.41 44.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.15 123.08 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.08 133.13 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -52.56 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.4 p -157.77 120.87 3.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 36.1 t -119.16 120.43 37.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -143.92 145.44 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.595 HG21 ' OG ' ' A' ' 403' ' ' SER . 59.0 mt -106.1 148.66 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.4 m -72.65 101.22 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -124.51 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -126.65 165.34 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -77.11 103.42 7.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.509 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 5.6 p30 -79.06 178.14 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -41.08 -46.93 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 96.28 26.66 10.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.509 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 65.1 t -108.0 142.45 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.136 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.6 102.09 2.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.12 147.66 43.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 391' ' ' ILE . 1.5 t -57.99 155.79 10.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.582 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 52.6 mtm -116.06 19.47 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 87.86 1.4 82.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -156.27 153.28 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.12 167.81 30.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.04 128.07 55.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 362' ' ' LEU . 82.3 t -120.49 122.3 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -110.75 144.74 39.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -114.23 169.0 9.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -73.29 -36.9 66.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -131.92 143.88 50.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.37 -39.16 21.56 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 418' ' ' GLN . 25.1 mm-40 -56.95 -63.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.2 mm100 -36.51 -45.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.08 -44.99 90.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 415' ' ' GLU . 16.1 mm-40 -59.14 -30.85 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -75.5 -66.7 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.607 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -47.2 -33.0 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.102 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 12.7 tp -40.7 -66.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -94.37 -36.56 11.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -48.63 -46.36 39.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.607 HD12 ' HB1' ' A' ' 420' ' ' ALA . 82.3 mt -82.07 -35.57 28.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 9.6 tp60 -42.65 152.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.39 -25.54 4.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -59.57 118.78 6.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 80.8 m -70.88 122.61 20.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.589 HG21 HD11 ' A' ' 434' ' ' LEU . 61.8 t -122.04 119.91 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 60.89 26.73 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.826 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 88.63 -15.89 55.71 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.474 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -116.86 145.45 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -85.11 146.19 27.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.589 HD11 HG21 ' A' ' 429' ' ' VAL . 10.0 mt -100.14 161.58 13.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -115.04 105.2 12.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -97.18 134.94 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -141.79 160.63 39.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.49 95.99 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 33.4 t -81.32 90.74 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -89.33 130.9 35.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.865 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -88.69 156.8 18.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -120.68 -54.34 2.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 8.9 t -104.26 155.44 18.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 445' ' ' PRO . 16.3 mttm -106.78 95.48 12.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.535 0.683 . . . . 0.0 110.869 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 444' ' ' LYS . 54.8 Cg_endo -69.68 151.59 69.55 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.671 2.247 . . . . 0.0 112.381 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 447' ' ' SER . . . -93.01 139.33 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 446' ' ' ALA . 5.5 m -36.88 111.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 75.16 146.05 1.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -37.16 9.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.718 2.279 . . . . 0.0 112.294 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 3.6 t -148.43 174.01 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 68.3 m -66.17 111.57 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 -179.967 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 4.8 m -143.81 137.02 27.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 110.87 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 47.0 m -84.09 160.77 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.836 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 130.94 113.0 1.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 18.0 m -112.16 108.52 17.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.876 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 9.1 p -108.54 128.41 54.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 150.93 143.37 3.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 mt -145.89 127.58 15.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.459 ' C ' HD13 ' A' ' 364' ' ' ILE . 2.5 t80 -102.8 122.93 45.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.75 HD12 HG22 ' A' ' 436' ' ' VAL . 3.5 mm -108.66 144.82 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -135.16 159.64 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.7 t30 73.93 27.33 1.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.98 117.79 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.5 m120 -56.73 120.27 7.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -42.04 -35.34 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.5 m -64.9 -40.12 94.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 368' ' ' ASN . 84.8 m -55.31 146.24 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.163 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.8 p -123.19 168.61 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.6 mp0 -57.98 -54.38 47.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.3 mp0 -36.78 -70.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 379' ' ' VAL . 16.1 m -43.77 -51.43 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.546 HD12 ' CD1' ' A' ' 380' ' ' PHE . 12.8 tp -54.44 -42.75 70.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 381' ' ' SER . 13.3 mtpt -61.07 -45.11 96.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.0 57.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.517 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 375' ' ' THR . 58.2 t -55.19 -52.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.117 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.546 ' CD1' HD12 ' A' ' 376' ' ' LEU . 10.8 m-85 -72.23 -20.27 61.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.6 t -69.26 -12.38 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -67.66 -39.56 84.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 420' ' ' ALA . 46.2 t -64.64 -35.18 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 169.17 -166.85 40.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.17 125.46 27.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 410' ' ' GLU . 50.0 mt -85.83 130.5 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -74.36 -52.27 12.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.2 t -160.36 122.97 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.707 ' SG ' HG22 ' A' ' 409' ' ' VAL . 4.5 t -119.39 121.16 38.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 46.5 m -145.76 133.28 20.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 392' ' ' SER . 80.0 mt -99.52 154.89 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.453 ' N ' HG22 ' A' ' 391' ' ' ILE . 38.0 m -73.03 100.15 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 403' ' ' SER . 4.1 mtmp? -124.75 134.66 52.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.11 171.58 8.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -81.38 102.38 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.7 p30 -76.07 177.23 7.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -40.06 -54.36 2.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.19 -28.06 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.43 30.75 8.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.576 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 17.9 t -110.48 144.39 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -71.68 97.56 1.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.0 mt -114.85 142.76 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.453 ' N ' ' HG2' ' A' ' 393' ' ' LYS . 58.3 m -58.0 160.5 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.543 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 28.7 mtm -116.86 22.71 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 83.66 1.43 90.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 404' ' ' MET . 4.8 p90 -152.8 154.67 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.917 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.55 -170.24 17.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.479 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -140.26 121.58 14.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.707 HG22 ' SG ' ' A' ' 389' ' ' CYS . 87.5 t -108.7 141.9 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 386' ' ' ILE . 23.7 tt0 -127.89 145.59 50.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.98 166.3 12.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -68.03 -36.61 80.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -123.28 162.17 41.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.582 0.706 . . . . 0.0 110.889 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.87 -18.86 16.59 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.647 2.231 . . . . 0.0 112.322 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.91 -55.82 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -50.33 -31.44 14.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.55 -48.12 65.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -60.78 -29.71 69.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -70.86 -63.93 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -49.09 -36.62 19.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 438' ' ' ILE . 7.8 tp -37.58 -69.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 -34.46 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -51.8 -34.76 41.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.731 HD12 ' HB1' ' A' ' 420' ' ' ALA . 85.1 mt -96.41 -29.57 13.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -48.33 144.93 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.4 12.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.462 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -55.26 115.9 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 42.0 m -71.11 114.24 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 73.6 t -121.42 125.78 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.82 27.14 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.811 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.51 -3.96 61.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -122.79 142.8 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -88.01 141.65 28.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.24 157.31 17.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.46 119.76 39.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.75 HG22 HD12 ' A' ' 364' ' ' ILE . 42.5 t -110.39 138.3 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -133.43 163.71 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.755 HD11 HD22 ' A' ' 421' ' ' LEU . 26.8 mm -83.39 95.34 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 32.8 t -78.98 111.65 15.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.83 149.71 50.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.73 147.26 30.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -99.57 -52.64 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 37.0 p -145.74 175.08 10.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.161 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 445' ' ' PRO . 23.5 mmtp -109.31 95.43 18.5 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.543 0.687 . . . . 0.0 110.879 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 444' ' ' LYS . 54.0 Cg_endo -69.77 178.04 4.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.672 2.248 . . . . 0.0 112.369 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -150.88 138.45 19.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 57.7 m -67.1 111.42 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.0 70.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 450' ' ' SER . 53.3 Cg_endo -69.8 127.99 15.35 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.666 2.244 . . . . 0.0 112.362 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 449' ' ' PRO . 86.4 p 34.41 41.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.82 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 3.0 m -95.7 162.49 13.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.526 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.1 t -110.8 41.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.364 . . . . 0.0 110.848 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.7 t -74.1 88.84 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 124.7 90.37 0.86 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.537 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m -146.04 158.77 43.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 110.886 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 7.2 p -121.46 158.04 29.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.55 12.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.478 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.7 mt -142.05 126.32 17.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -90.81 128.7 36.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.603 HD12 HG22 ' A' ' 436' ' ' VAL . 4.1 mm -117.63 144.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -133.14 160.31 37.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 22.6 t30 72.61 40.5 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.44 HD23 HD22 ' A' ' 434' ' ' LEU . 25.1 mt -85.61 148.94 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -88.99 124.79 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -46.01 -39.8 9.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -63.28 -32.51 73.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 99.3 m -59.9 131.11 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.0 p -114.19 143.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -40.58 -43.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -38.78 -57.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 76.8 m -62.96 -60.22 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.511 HD11 ' CE1' ' A' ' 380' ' ' PHE . 11.0 tp -39.13 -44.85 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -52.28 -56.17 16.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -59.87 -25.55 61.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 382' ' ' LYS . 57.5 t -73.21 -34.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.987 ' CD2' HG11 ' A' ' 409' ' ' VAL . 9.1 m-85 -94.14 -16.36 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 48.7 p -73.6 -17.08 61.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 379' ' ' VAL . 0.2 OUTLIER -75.43 -18.52 59.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 420' ' ' ALA . 53.8 t -95.3 -41.17 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.442 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -167.44 -178.64 39.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.509 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.57 120.08 22.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.775 0.321 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 36.8 mt -81.8 143.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -105.21 -38.87 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.4 t -160.52 118.09 2.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 409' ' ' VAL . 21.5 t -121.52 116.89 25.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.1 m -142.7 151.15 41.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 406' ' ' PHE . 63.4 mt -107.99 148.86 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.415 ' HB2' ' CD1' ' A' ' 406' ' ' PHE . 10.5 m -64.71 85.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -110.71 137.49 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -122.1 156.55 33.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.934 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -73.8 101.5 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.669 ' ND2' HD12 ' A' ' 402' ' ' LEU . 21.7 p30 -77.76 179.24 6.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.914 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -40.33 -54.11 2.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.27 69.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.63 31.34 8.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.541 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.98 143.3 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.089 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.11 96.65 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.669 HD12 ' ND2' ' A' ' 396' ' ' ASN . 97.1 mt -105.99 139.29 40.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.1 p -57.9 156.12 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 9.4 mtm -116.42 21.94 13.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.2 89.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 7.8 p90 -149.14 150.4 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -139.51 -172.7 12.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -139.44 116.44 10.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.987 HG11 ' CD2' ' A' ' 380' ' ' PHE . 91.5 t -104.5 124.74 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -107.06 137.1 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.55 162.81 14.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -78.1 -22.92 48.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm -133.44 158.78 74.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -30.28 14.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.625 2.217 . . . . 0.0 112.347 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.6 -39.14 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' GLN . . . . . 0.442 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 2.8 mm-40 -51.42 -49.38 61.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.41 75.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -64.88 -29.72 70.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -78.56 -54.63 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -61.94 -24.9 67.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.53 HD22 HD11 ' A' ' 438' ' ' ILE . 14.2 tp -44.8 -56.24 4.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.21 -44.58 5.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -43.28 -46.71 6.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.47 ' CD2' ' HE2' ' A' ' 382' ' ' LYS . 30.6 mt -80.94 -43.53 19.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 4.2 tp60 -47.25 121.03 3.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.75 -20.11 37.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -60.23 130.06 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.7 m -70.49 96.32 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.115 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.11 112.95 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 62.1 26.02 15.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 70.0 6.58 57.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -121.38 120.59 35.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 110.836 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -71.72 107.39 4.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.44 HD22 HD23 ' A' ' 367' ' ' LEU . 11.2 mt -67.74 161.56 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -119.6 99.26 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.603 HG22 HD12 ' A' ' 364' ' ' ILE . 60.4 t -88.15 134.72 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -143.46 145.99 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.53 HD11 HD22 ' A' ' 421' ' ' LEU . 7.1 mm -70.39 98.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.0 p -43.24 135.61 3.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -79.6 -61.18 2.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.89 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.98 149.75 21.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -110.77 85.27 2.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.4 t -146.44 135.16 22.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.104 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -81.94 147.08 57.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.52 0.676 . . . . 0.0 110.936 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 446' ' ' ALA . 54.3 Cg_endo -69.77 2.87 3.15 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.684 2.256 . . . . 0.0 112.357 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 445' ' ' PRO . . . -34.95 141.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 6.2 t -96.01 153.43 17.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.05 -158.07 7.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 124.29 10.91 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 2.242 . . . . 0.0 112.323 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 38.1 t -108.43 121.59 45.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 59.5 m -92.62 101.33 13.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.88 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.486 -179.961 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 19.2 m -59.62 121.58 11.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.873 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 34.3 m -126.74 90.67 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 71.42 168.06 8.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m -155.22 138.58 15.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.809 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.96 150.68 21.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.845 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.22 143.69 7.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.445 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.2 mt -146.55 132.49 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.359 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.443 ' C ' HD13 ' A' ' 364' ' ' ILE . 1.2 t80 -95.77 126.48 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 3.7 mm -112.15 144.78 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -133.87 162.33 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.42 ' O ' HD23 ' A' ' 434' ' ' LEU . 19.3 t-20 68.47 43.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.28 106.5 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.3 m120 -46.92 122.23 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -43.59 -24.46 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 70.2 m -77.05 -38.96 51.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 368' ' ' ASN . 25.5 m -48.8 131.83 18.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 76.5 p -108.48 148.44 30.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 374' ' ' GLU . 2.8 mp0 -45.57 -50.76 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 373' ' ' GLU . 5.8 mm-40 -36.09 -67.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 378' ' ' GLY . 71.1 m -48.71 -67.79 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.154 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.545 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 7.2 tp -35.82 -46.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -64.84 -44.53 89.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -60.43 -21.38 57.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.98 -48.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 10.0 m-85 -70.23 -29.33 66.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 53.5 p -58.74 -19.59 41.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.892 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -64.26 -36.58 84.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 420' ' ' ALA . 76.0 t -64.94 -47.66 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.468 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -175.82 -154.43 11.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.523 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.622 ' HB1' ' HE3' ' A' ' 412' ' ' LYS . . . -82.77 125.83 31.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.759 0.314 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 45.2 mt -93.02 130.13 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.123 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -77.5 -49.03 15.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.1 t -169.73 117.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 409' ' ' VAL . 51.2 t -108.94 128.6 55.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.3 t -140.06 163.15 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.35 137.23 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 m -56.04 102.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 35.6 mtmt -125.66 136.9 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -128.37 156.26 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -71.71 104.24 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 399' ' ' GLY . 0.5 OUTLIER -79.33 178.82 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -38.61 -53.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.98 74.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.77 22.21 14.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.4 ' O ' ' OD1' ' A' ' 396' ' ' ASN . 45.8 t -101.34 143.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.376 . . . . 0.0 111.105 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.67 96.03 2.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.6 mt -109.41 143.82 38.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.4 p -57.91 161.56 3.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 35.9 mtp -117.03 16.7 15.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.02 86.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.51 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -153.02 155.07 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -148.76 -176.01 21.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -127.29 123.26 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' A' ' 380' ' ' PHE . 77.8 t -105.62 106.1 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -85.36 152.72 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -132.7 152.22 51.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.622 ' HE3' ' HB1' ' A' ' 385' ' ' ALA . 4.6 mtmp? -65.22 -32.62 74.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -135.14 141.73 39.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.91 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 415' ' ' GLU . 74.2 Cg_exo -47.64 -58.66 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.689 2.259 . . . . 0.0 112.378 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 414' ' ' PRO . 32.1 mt-10 -37.59 -57.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' GLN . . . . . 0.468 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 26.8 mm-40 -43.52 -46.09 6.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.441 ' O ' HD11 ' A' ' 362' ' ' LEU . . . -61.62 -49.4 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.144 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -56.6 -27.26 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -77.81 -63.98 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -52.73 -19.44 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.829 HD22 HD11 ' A' ' 438' ' ' ILE . 45.5 tp -51.28 -64.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -92.67 -47.64 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLN . . . . . 0.479 ' N ' ' HD3' ' A' ' 422' ' ' LYS . 2.7 tm0? -38.27 -34.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 420' ' ' ALA . 94.3 mt -96.84 -31.8 12.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.463 ' NE2' HG23 ' A' ' 436' ' ' VAL . 6.5 tp60 -49.63 135.04 19.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.86 -24.94 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.457 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -56.18 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 99.7 m -70.44 106.95 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.155 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.759 HG21 HD11 ' A' ' 434' ' ' LEU . 94.1 t -106.51 118.89 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 62.27 31.06 17.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.29 51.41 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -122.03 129.54 52.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.41 145.92 50.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 429' ' ' VAL . 7.6 mt -103.57 158.81 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -108.98 119.93 41.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.463 HG23 ' NE2' ' A' ' 425' ' ' GLN . 14.5 t -109.99 133.87 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.405 ' HG2' ' C ' ' A' ' 436' ' ' VAL . 8.3 mmm180 -142.0 149.29 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.829 HD11 HD22 ' A' ' 421' ' ' LEU . 25.8 mm -70.14 96.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.8 t -86.5 47.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.93 -47.62 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -92.88 106.65 18.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -80.77 163.78 23.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.139 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 23.6 p -56.61 -56.01 26.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.178 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -90.74 138.99 26.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.528 0.68 . . . . 0.0 110.923 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 146.83 61.34 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -120.91 86.33 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.087 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 15.6 m -129.54 177.43 7.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.48 74.08 0.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 144.61 54.47 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.7 2.267 . . . . 0.0 112.319 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 68.2 m -56.86 164.56 1.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 17.9 t -96.36 88.33 4.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.1 t -41.85 127.44 3.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 110.887 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 6.6 m -157.99 163.67 37.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -75.47 94.17 0.93 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.5 m -103.82 82.89 2.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 64.8 p -95.96 128.01 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 408' ' ' PHE . . . 140.63 141.92 4.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 409' ' ' VAL . 8.4 mt -140.21 127.64 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.98 135.63 33.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 1.8 mm -126.05 142.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' LYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 363' ' ' PHE . 7.4 tptp -133.52 159.12 41.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 70.13 45.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.569 HD23 HD22 ' A' ' 434' ' ' LEU . 37.4 mt -93.53 108.27 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -51.02 124.31 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -46.48 -28.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -36.94 70.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.83 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 60.2 m -54.95 127.91 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.5 p -99.19 178.44 4.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.89 -47.49 21.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -42.34 -61.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 26.5 m -49.22 -62.36 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.155 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 23.0 tp -45.11 -48.56 12.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 389' ' ' CYS . 14.7 mmmt -49.34 -50.07 41.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.41 -34.63 89.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.494 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.49 -44.81 98.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.694 ' CD2' HG11 ' A' ' 409' ' ' VAL . 5.9 m-85 -80.59 -35.31 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -29.02 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -55.62 -41.61 73.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 420' ' ' ALA . 57.5 t -61.79 -39.83 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 169.23 -160.42 33.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.447 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.49 131.72 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 55.1 mt -98.01 134.84 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -81.26 -49.21 11.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.3 t -165.66 116.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.425 ' HB3' ' CD ' ' A' ' 377' ' ' LYS . 4.8 t -111.77 123.11 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -138.08 151.66 48.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.9 139.33 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.141 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 58.0 m -58.43 94.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -121.69 148.25 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -139.1 171.17 14.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -83.55 103.17 12.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.727 ' ND2' HD12 ' A' ' 402' ' ' LEU . 9.0 p30 -79.94 177.8 8.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 398' ' ' ALA . 13.2 ptmt -43.77 -35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 397' ' ' LYS . . . -78.8 -32.92 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 97.25 18.93 27.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.496 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.453 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 59.4 t -102.43 143.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.142 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.88 96.9 2.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.727 HD12 ' ND2' ' A' ' 396' ' ' ASN . 73.7 mt -111.12 148.4 32.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 25.4 m -57.95 159.79 5.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' MET . . . . . 0.47 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 46.6 mtp -116.98 13.82 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 93.8 -4.87 72.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.491 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 1.7 p90 -153.61 158.8 41.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.18 -178.3 24.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' PHE . . . . . 0.432 ' CZ ' ' HA3' ' A' ' 361' ' ' GLY . 37.8 t80 -131.96 109.75 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.37 . . . . 0.0 110.898 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.694 HG11 ' CD2' ' A' ' 380' ' ' PHE . 71.3 t -100.35 124.97 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -110.73 142.35 42.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.6 m-85 -114.83 154.12 29.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -61.83 -34.42 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -122.0 156.97 59.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.578 0.704 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.2 -8.48 19.87 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.341 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.11 -49.51 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -52.25 -39.94 61.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -66.01 -40.02 90.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -63.05 -32.48 73.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -72.7 -66.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.964 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -44.99 -36.61 3.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 438' ' ' ILE . 12.6 tp -34.66 -64.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -96.76 -41.51 8.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 383' ' ' VAL . 8.2 tt0 -39.56 -41.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 380' ' ' PHE . 91.1 mt -92.21 -28.54 16.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.2 tp60 -48.78 138.32 11.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.82 -26.04 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -60.11 118.26 6.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 28.7 m -69.88 132.08 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.1 t -135.29 123.01 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 59.13 29.82 19.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 82.97 -13.56 43.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -116.93 145.19 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -88.59 144.02 26.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.569 HD22 HD23 ' A' ' 367' ' ' LEU . 8.3 mt -97.2 149.83 21.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -108.19 112.78 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.78 139.58 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -147.45 149.46 32.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ILE . . . . . 0.731 HD11 HD22 ' A' ' 421' ' ' LEU . 19.0 mm -68.68 95.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 440' ' ' GLU . 3.9 t -79.19 46.85 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 439' ' ' SER . 29.3 tt0 -36.08 -62.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -65.11 105.49 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -127.54 175.15 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 62.0 p -80.87 105.82 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.138 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 445' ' ' PRO . 5.1 mmpt? -107.2 95.44 13.18 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.555 0.693 . . . . 0.0 110.855 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 444' ' ' LYS . 54.2 Cg_endo -69.72 151.42 69.29 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.259 . . . . 0.0 112.344 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -136.24 112.07 9.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.059 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 39.6 m -117.09 140.87 48.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.852 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 99.9 -166.06 20.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.478 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 0.18 6.02 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.668 2.245 . . . . 0.0 112.368 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 4.3 m 60.68 53.95 3.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 32.0 t -74.3 156.93 36.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.895 0.378 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.7 p -103.14 150.0 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.53 7.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.4 mt -148.88 123.85 10.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -93.65 130.54 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.22 142.76 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -128.71 165.85 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 60.93 47.85 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.56 HD23 HD22 ' A' ' 434' ' ' LEU . 38.4 mt -90.83 113.53 25.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -52.22 121.49 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -44.86 -32.11 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.2 t -68.2 -41.33 81.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 85.8 m -46.28 146.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 38.3 p -121.17 174.71 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.04 -38.06 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -54.01 -59.79 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 59.2 m -54.16 -46.08 72.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.436 HD12 ' CD1' ' A' ' 380' ' ' PHE . 22.2 tp -54.0 -46.01 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' SER . 24.4 mtpp -60.56 -41.12 93.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.65 -51.86 54.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.469 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.514 HG12 HD22 ' A' ' 424' ' ' LEU . 68.5 t -59.8 -39.34 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.463 ' CD2' HG11 ' A' ' 409' ' ' VAL . 11.0 m-85 -82.16 -21.21 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 377' ' ' LYS . 2.0 t -68.92 -14.84 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -66.85 -41.27 87.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 420' ' ' ALA . 3.9 t -67.49 -48.91 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.155 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.09 38.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.96 123.09 23.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.138 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 410' ' ' GLU . 19.1 mt -81.17 130.35 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -76.29 -51.21 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 27.1 t -159.26 134.01 8.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 15.2 p -123.1 126.82 47.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 16.2 m -143.5 122.36 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 34.1 mt -101.01 142.75 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 73.8 m -60.78 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -121.86 135.35 54.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.63 167.41 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.67 106.83 15.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.5 p30 -84.98 179.27 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -39.35 -48.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.89 74.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.51 22.4 26.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.32 143.0 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -72.24 99.71 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.55 140.64 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 31.6 m -58.05 162.91 3.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 21.4 mtm -117.04 16.26 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.23 3.79 63.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.483 ' C ' HD12 ' A' ' 367' ' ' LEU . 8.6 p90 -158.29 157.06 31.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 0.0 110.88 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -153.9 -172.96 22.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -137.39 119.26 15.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 380' ' ' PHE . 36.5 t -107.47 138.48 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 386' ' ' ILE . 44.0 tt0 -118.56 150.66 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.5 m-85 -122.6 163.08 20.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -70.68 -30.87 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -139.63 143.7 36.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.64 -42.03 23.95 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 418' ' ' GLN . 7.4 tt0 -51.71 -66.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -37.82 -48.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.548 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -63.23 -40.13 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 415' ' ' GLU . 45.7 mm-40 -60.86 -33.98 73.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -79.03 -60.14 2.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.683 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.32 -24.51 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.613 HD22 HD11 ' A' ' 438' ' ' ILE . 14.0 tp -50.08 -66.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 422' ' ' LYS . 0.6 OUTLIER -90.99 -35.18 14.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -49.64 -43.14 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.557 HD12 ' HB1' ' A' ' 420' ' ' ALA . 95.0 mt -85.81 -18.28 33.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 8.0 tp60 -62.22 142.38 57.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 88.29 -18.68 39.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -57.83 121.86 11.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.6 m -71.15 96.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.61 123.05 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 59.08 28.81 18.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.64 -4.19 52.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.444 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -124.05 149.33 46.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -91.01 140.14 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.56 HD22 HD23 ' A' ' 367' ' ' LEU . 14.0 mt -97.89 154.61 17.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -104.45 103.38 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.24 132.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -139.98 152.17 46.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.613 HD11 HD22 ' A' ' 421' ' ' LEU . 8.7 mm -71.37 96.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.88 0.372 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.0 p -112.95 136.98 52.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.72 137.99 3.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.3 119.02 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.372 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.574 ' C ' HD13 ' A' ' 364' ' ' ILE . 3.7 t80 -99.19 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.664 ' N ' HD13 ' A' ' 364' ' ' ILE . 1.2 mm -98.72 142.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -129.66 163.23 26.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 6.3 t30 72.49 32.53 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.559 HD23 HD22 ' A' ' 434' ' ' LEU . 32.5 mt -81.5 131.79 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.466 HD21 ' CD2' ' A' ' 432' ' ' HIS . 5.0 m120 -71.7 125.82 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -45.88 -31.22 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 85.3 p -68.54 -38.25 80.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 45.9 m -57.79 137.37 56.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 69.0 p -114.87 176.35 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -65.59 -46.81 77.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.89 -55.0 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 56.9 m -59.93 -51.8 68.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 380' ' ' PHE . 8.9 tp -51.16 -42.54 60.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -57.62 -47.66 81.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.25 -43.88 97.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.06 -45.86 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 0.0 111.141 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' A' ' 376' ' ' LEU . 10.1 m-85 -80.22 -26.41 39.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.0 t -61.95 -16.36 50.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -67.22 -20.97 65.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.457 HG21 ' CB ' ' A' ' 420' ' ' ALA . 73.8 t -84.51 -48.66 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -171.95 -166.77 31.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.93 26.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.2 mt -92.55 139.16 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.168 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -53.86 3.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.0 t -151.36 126.97 10.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 409' ' ' VAL . 49.7 t -127.36 118.72 24.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 167.05 20.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 74.6 mt -126.65 143.7 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.1 m -72.69 103.76 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.87 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -114.34 137.95 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 395' ' ' LYS . 4.7 ttpt -127.2 149.43 49.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.939 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.48 ' N ' ' HG3' ' A' ' 394' ' ' LYS . 49.8 mttm -69.49 105.24 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 399' ' ' GLY . 2.0 p30 -81.69 179.09 7.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -41.39 -41.53 2.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -71.22 -32.52 68.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.58 15.65 49.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.67 143.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.27 99.64 3.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.85 156.33 36.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 21.3 m -57.78 158.72 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.481 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 23.1 mtm -117.06 15.79 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.84 69.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 404' ' ' MET . 5.5 p90 -155.5 155.36 33.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.361 . . . . 0.0 110.895 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.42 25.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.449 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -121.66 121.82 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.727 HG22 ' SG ' ' A' ' 389' ' ' CYS . 76.9 t -116.45 130.47 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -112.55 147.7 36.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.44 153.35 34.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -62.71 -33.42 75.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -125.28 159.8 58.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.566 0.698 . . . . 0.0 110.9 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -18.61 21.23 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -78.21 -49.71 13.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -48.86 -37.43 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.66 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -58.18 -29.51 65.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -78.03 -59.58 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.635 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -56.14 -17.98 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 438' ' ' ILE . 13.7 tp -52.79 -59.15 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 425' ' ' GLN . 12.9 tptp -99.72 -45.14 5.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -39.94 -39.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.635 HD12 ' HB1' ' A' ' 420' ' ' ALA . 95.8 mt -88.11 -26.42 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 10.3 tp60 -57.6 134.63 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.32 31.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -55.03 125.21 19.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.9 m -69.66 97.37 1.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.44 113.91 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.78 29.38 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.859 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.85 39.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . 0.466 ' CD2' HD21 ' A' ' 368' ' ' ASN . 25.5 m-70 -125.42 125.4 43.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -73.89 124.94 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.559 HD22 HD23 ' A' ' 367' ' ' LEU . 7.4 mt -89.39 164.11 15.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -116.43 103.23 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.28 126.02 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -130.93 162.9 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 421' ' ' LEU . 20.0 mm -86.92 98.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.843 0.354 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 80.7 p -85.48 125.73 33.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.439 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 145.44 139.08 3.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.519 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.4 mt -141.43 122.17 14.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.453 ' CB ' ' HB2' ' A' ' 439' ' ' SER . 0.5 OUTLIER -90.66 124.75 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.1 mm -113.35 146.59 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.89 167.02 20.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 12.2 t30 68.86 32.61 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.622 HD12 ' C ' ' A' ' 406' ' ' PHE . 46.4 mt -82.64 113.87 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.49 123.73 17.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -46.06 -21.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -78.37 -39.66 38.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 98.0 m -49.94 131.9 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.134 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 22.0 p -105.77 161.13 14.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.427 ' OE2' HD12 ' A' ' 391' ' ' ILE . 2.0 mp0 -61.85 -54.52 40.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 373' ' ' GLU . 36.5 mt-10 -36.65 -49.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 86.3 m -64.56 -50.88 65.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 380' ' ' PHE . 13.6 tp -54.66 -35.13 63.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 381' ' ' SER . 12.5 mmmt -61.25 -50.2 74.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.48 -42.92 95.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.52 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.85 -56.29 11.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.488 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.4 m-85 -72.13 -39.96 68.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.842 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 14.4 t -48.52 -22.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -55.75 -46.82 77.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.878 HG21 ' HB2' ' A' ' 420' ' ' ALA . 24.6 t -55.51 -61.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -161.13 -152.05 6.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -83.74 127.24 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.327 . . . . 0.0 111.098 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.7 mt -96.34 130.61 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.433 ' NZ ' ' HA ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -78.07 -51.32 10.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.924 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 45.7 t -157.31 131.71 8.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.508 ' SG ' HG22 ' A' ' 409' ' ' VAL . 21.4 t -127.0 110.83 13.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -130.48 138.4 50.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.562 HG21 ' OG ' ' A' ' 403' ' ' SER . 40.3 mt -99.49 149.04 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 40.7 m -70.28 102.14 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -123.94 147.15 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -69.66 102.89 1.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 399' ' ' GLY . 9.2 p30 -81.28 177.02 9.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -38.52 -49.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.39 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.92 30.51 8.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.432 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 35.9 t -113.36 143.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.112 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.75 100.29 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 29.4 mt -126.33 152.4 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.562 ' OG ' HG21 ' A' ' 391' ' ' ILE . 37.6 m -57.93 161.1 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 42.5 mtm -117.09 17.09 14.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.846 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.35 0.77 64.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.622 ' C ' HD12 ' A' ' 367' ' ' LEU . 4.7 p90 -153.69 155.27 35.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.868 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -143.02 -178.86 19.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . 0.573 ' CZ ' ' HG3' ' A' ' 410' ' ' GLU . 20.0 t80 -133.28 122.39 23.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.508 HG22 ' SG ' ' A' ' 389' ' ' CYS . 73.9 t -120.42 119.59 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.573 ' HG3' ' CZ ' ' A' ' 408' ' ' PHE . 15.2 mt-10 -109.55 141.65 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.0 161.13 15.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -62.58 -34.45 77.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -120.11 157.08 53.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 -10.01 21.28 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.47 -53.68 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -45.98 -38.05 7.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.16 90.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -62.13 -29.6 70.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -72.69 -64.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.878 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.45 -34.01 23.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 420' ' ' ALA . 12.8 tp -37.88 -63.35 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -93.41 -41.02 10.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -47.39 -42.33 21.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.851 HD12 ' HB1' ' A' ' 420' ' ' ALA . 90.3 mt -86.51 -23.13 26.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -56.85 146.98 24.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.78 -16.25 32.59 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -62.42 117.53 6.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 29.1 m -69.89 112.33 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.3 117.6 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 62.31 26.7 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 81.47 -9.33 55.6 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.517 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -116.61 142.67 46.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.428 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 24.0 mttt -88.12 138.04 31.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.63 156.26 16.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -109.48 109.33 20.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.06 136.04 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -141.69 161.26 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.99 96.5 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . 0.453 ' HB2' ' CB ' ' A' ' 363' ' ' PHE . 5.4 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.838 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.6 p -104.05 144.6 31.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.78 147.59 7.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 417' ' ' ALA . 5.3 mt -146.57 120.44 9.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.52 132.39 34.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.4 mm -118.95 144.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -131.96 160.18 36.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 51.3 t30 69.5 33.8 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 406' ' ' PHE . 57.7 mt -78.46 107.11 10.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 371' ' ' THR . 2.5 m120 -50.12 118.16 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -40.32 -31.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 p -65.7 -43.01 90.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 368' ' ' ASN . 82.4 m -49.49 147.35 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.089 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 53.0 p -127.46 165.25 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.4 -36.04 79.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -50.34 -59.71 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 55.9 m -61.97 -44.95 95.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.559 HD12 ' CD1' ' A' ' 380' ' ' PHE . 21.0 tp -57.22 -33.19 67.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 381' ' ' SER . 4.0 mtpm? -73.09 -28.16 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -82.14 -50.7 4.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.441 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.24 -37.88 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.814 0.34 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.762 ' HA ' HD11 ' A' ' 424' ' ' LEU . 16.6 m-85 -86.27 -22.74 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.9 t -69.51 -9.61 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.86 -28.14 44.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 420' ' ' ALA . 94.3 t -75.71 -38.17 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 178.51 -167.17 37.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . 0.475 ' HB3' ' HG3' ' A' ' 412' ' ' LYS . . . -78.77 121.24 24.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.081 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.44 ' O ' ' NZ ' ' A' ' 412' ' ' LYS . 20.3 mt -83.52 131.37 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -79.49 -53.3 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 t -157.26 135.07 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.5 p -117.89 128.75 55.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.7 m -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 392' ' ' SER . 79.9 mt -100.69 153.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 391' ' ' ILE . 65.6 m -75.35 94.72 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 33.7 mttm -119.44 154.72 33.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -146.03 162.5 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.04 101.53 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 399' ' ' GLY . 6.6 p30 -77.14 178.62 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.58 -28.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -84.89 -32.98 22.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.069 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.77 18.86 33.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.453 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.25 143.66 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.89 0.376 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.89 102.13 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.414 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 24.3 mt -122.5 149.01 44.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -60.65 159.33 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.519 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 49.4 mtm -116.97 16.68 15.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 92.68 3.32 66.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.525 ' C ' HD12 ' A' ' 367' ' ' LEU . 1.9 p90 -158.29 159.65 36.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -156.92 -175.8 28.26 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -131.13 121.39 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.07 120.77 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -103.89 154.03 20.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.73 174.66 7.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 385' ' ' ALA . 23.3 mmtm -77.02 -37.14 55.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -137.38 151.46 71.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 415' ' ' GLU . 72.1 Cg_exo -46.72 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.25 . . . . 0.0 112.334 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 414' ' ' PRO . 17.7 tt0 -38.07 -48.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -48.54 -54.01 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.433 ' HA ' HD11 ' A' ' 362' ' ' LEU . . . -59.55 -40.4 87.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -59.74 -29.69 68.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -80.41 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.438 ' HA ' HG21 ' A' ' 383' ' ' VAL . . . -53.56 -18.2 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 438' ' ' ILE . 13.4 tp -53.76 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -92.04 -34.35 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . 0.428 ' CD ' ' O ' ' A' ' 423' ' ' GLN . 0.5 OUTLIER -47.35 -40.77 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.762 HD11 ' HA ' ' A' ' 380' ' ' PHE . 50.2 mt -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' HG23 ' A' ' 436' ' ' VAL . 6.1 tp60 -56.12 147.82 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.14 -12.97 34.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -64.72 115.8 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 75.6 m -70.74 101.95 2.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 434' ' ' LEU . 49.0 t -103.37 121.39 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 62.05 34.0 16.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.35 -6.98 49.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -122.86 138.25 54.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 7.2 mtpm? -79.34 146.19 33.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 429' ' ' VAL . 7.3 mt -105.76 159.13 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.464 ' OE1' ' CG ' ' A' ' 437' ' ' ARG . 3.4 tm-20 -110.49 127.76 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.496 HG23 ' NE2' ' A' ' 425' ' ' GLN . 21.6 t -113.11 135.86 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.464 ' CG ' ' OE1' ' A' ' 435' ' ' GLU . 14.3 mmt180 -140.54 152.49 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 421' ' ' LEU . 12.9 mm -76.12 98.49 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 12.0 p -111.55 153.65 25.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.08 135.83 5.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 417' ' ' ALA . 10.2 mt -137.27 136.43 38.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.536 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.5 OUTLIER -103.34 124.56 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.536 HD13 ' C ' ' A' ' 363' ' ' PHE . 2.1 mm -111.33 142.17 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -132.35 161.7 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 72.73 37.03 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 406' ' ' PHE . 25.5 mt -86.28 126.95 34.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 371' ' ' THR . 5.4 m-20 -69.5 122.23 18.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -39.23 -40.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.9 m -62.44 -39.95 95.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 368' ' ' ASN . 53.4 m -50.88 126.49 16.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 82.6 p -106.82 157.42 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 374' ' ' GLU . 33.9 mt-10 -54.06 -50.04 67.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 373' ' ' GLU . 16.4 tt0 -34.89 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 83.4 m -55.91 -53.16 60.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.52 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 21.6 tp -49.98 -43.48 50.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -50.79 -54.9 19.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.3 -50.98 61.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 92.8 t -47.41 -55.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.182 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.583 ' HA ' HD11 ' A' ' 424' ' ' LEU . 6.7 m-85 -71.46 -34.65 70.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.0 t -53.76 -23.07 10.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -61.14 -35.89 78.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 420' ' ' ALA . 89.6 t -68.83 -42.79 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 176.58 -166.01 36.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.78 118.48 16.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 0.0 111.128 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 410' ' ' GLU . 25.8 mt -82.24 131.38 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.45 -42.84 28.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 m -169.54 126.42 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 2.3 t -119.61 117.25 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 98.9 m -139.77 136.45 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.114 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 392' ' ' SER . 80.5 mt -100.81 152.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 391' ' ' ILE . 10.9 m -70.97 101.7 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -126.41 152.03 46.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -144.0 158.65 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 395' ' ' LYS . 2.3 mppt? -74.12 101.9 4.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.646 ' OD1' ' HB3' ' A' ' 398' ' ' ALA . 4.8 p30 -74.68 179.27 4.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -20.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.646 ' HB3' ' OD1' ' A' ' 396' ' ' ASN . . . -91.52 -30.47 16.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 94.59 20.15 30.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.476 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 56.8 t -106.12 143.35 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 0.0 111.135 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -72.38 98.56 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 97.2 mt -111.46 141.81 44.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 14.2 t -58.07 159.96 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 16.0 mmm -115.71 24.82 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 78.62 -3.89 62.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.443 ' HA ' HD12 ' A' ' 367' ' ' LEU . 1.2 p90 -150.3 147.05 27.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -136.51 177.9 19.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.475 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -130.48 118.72 21.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.842 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 380' ' ' PHE . 77.4 t -106.06 146.13 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 386' ' ' ILE . 21.4 tt0 -129.92 146.38 51.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -120.57 164.5 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -66.42 -48.57 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.32 156.65 35.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.513 0.673 . . . . 0.0 110.917 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.39 -8.29 21.59 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.347 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.35 -46.65 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -49.2 -33.87 13.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 362' ' ' LEU . . . -67.86 -43.85 78.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.94 -31.45 72.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -70.42 -63.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.638 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -49.93 -36.98 29.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 420' ' ' ALA . 16.2 tp -34.84 -64.49 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -96.39 -39.77 9.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -45.09 -45.81 11.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.638 HD12 ' HB1' ' A' ' 420' ' ' ALA . 75.3 mt -83.76 -26.24 29.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.8 tp60 -52.15 152.02 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.3 -21.53 7.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.46 118.96 7.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 41.7 m -72.46 114.14 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.677 HG21 HD11 ' A' ' 434' ' ' LEU . 99.6 t -114.22 118.64 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 58.54 25.64 13.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 86.09 -8.62 72.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -118.43 138.94 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -82.34 144.02 30.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.677 HD11 HG21 ' A' ' 429' ' ' VAL . 6.4 mt -101.86 158.69 15.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.74 102.57 10.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.5 t -94.06 125.91 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -130.85 164.21 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 15.3 mm -82.32 96.05 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 83.2 p -107.39 134.89 49.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.476 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 137.93 139.27 3.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.48 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.58 125.17 14.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.456 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.6 OUTLIER -93.64 118.63 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.5 mm -105.78 148.97 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -136.5 167.49 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 64.83 43.41 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 35.3 mt -94.39 100.66 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -40.74 118.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.419 ' C ' ' O ' ' A' ' 368' ' ' ASN . 6.4 m-85 -36.85 -45.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 65.3 m -58.21 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.4 m -48.59 143.86 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 54.2 p -124.39 157.03 36.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.1 mm-40 -48.07 -47.63 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 373' ' ' GLU . 3.0 tm-20 -34.64 -65.98 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 37.8 m -51.67 -60.38 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.566 HD12 ' CD1' ' A' ' 380' ' ' PHE . 12.5 tp -44.71 -37.41 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 381' ' ' SER . 7.9 mtpm? -71.53 -39.94 70.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.23 -19.99 70.82 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.75 -47.65 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.566 ' CD1' HD12 ' A' ' 376' ' ' LEU . 12.3 m-85 -74.94 -25.44 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 15.1 t -64.94 -16.42 63.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -67.82 -37.55 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 420' ' ' ALA . 92.6 t -66.41 -42.35 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -179.2 -158.65 21.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.527 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . 0.403 ' HB3' ' HD2' ' A' ' 412' ' ' LYS . . . -85.14 124.11 31.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 410' ' ' GLU . 26.5 mt -82.53 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -54.15 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 98.3 p -149.26 123.16 9.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.447 ' C ' ' OE2' ' A' ' 373' ' ' GLU . 6.2 p -127.39 112.93 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -144.43 138.67 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.151 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 406' ' ' PHE . 76.2 mt -97.73 143.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.9 m -65.6 108.13 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -124.44 134.75 52.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.82 156.98 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 4.7 ptpt -78.9 106.37 10.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 399' ' ' GLY . 50.6 p30 -67.85 177.86 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 397' ' ' LYS . 0.4 OUTLIER -43.5 -35.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.6 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.95 38.0 3.98 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 84.0 t -119.95 143.64 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.27 107.75 6.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.3 mt -128.91 139.11 52.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.1 m -57.85 164.0 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 36.2 mtm -117.27 23.69 11.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.857 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.55 5.5 89.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 12.3 p90 -152.6 154.11 34.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.905 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.08 -162.03 9.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.472 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . 0.476 ' CE1' ' CA ' ' A' ' 361' ' ' GLY . 29.6 t80 -137.77 126.53 23.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.877 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 70.0 t -119.57 120.4 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 386' ' ' ILE . 16.7 tt0 -113.07 151.31 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.51 158.91 26.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.403 ' HD2' ' HB3' ' A' ' 385' ' ' ALA . 58.7 mttt -63.12 -36.16 82.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -117.37 160.19 38.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 0.0 110.931 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.66 -20.07 15.93 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.12 -49.35 14.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -46.39 -43.1 15.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.01 -51.52 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.11 -29.32 57.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -77.67 -67.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.603 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.45 -20.21 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 438' ' ' ILE . 12.8 tp -51.52 -70.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -92.29 -31.68 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.924 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . 0.445 ' NE2' HG22 ' A' ' 383' ' ' VAL . 14.2 tt0 -50.52 -39.47 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.592 HD12 ' HB1' ' A' ' 420' ' ' ALA . 85.3 mt -90.18 -36.97 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 12.7 tp60 -40.63 149.13 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.68 -19.26 9.51 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -59.95 133.84 56.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 30.2 m -72.88 123.56 23.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 434' ' ' LEU . 97.0 t -132.35 118.62 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.09 26.98 10.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 84.56 -17.62 29.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -113.24 139.06 49.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -78.06 135.94 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.618 ' CD1' HG21 ' A' ' 429' ' ' VAL . 9.2 mt -92.81 161.71 14.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.52 113.39 21.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.939 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.63 130.66 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -131.57 163.91 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 421' ' ' LEU . 20.1 mm -85.51 96.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.7 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 57.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 5.8 p -102.9 140.08 37.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.6 142.4 4.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 12.1 mt -146.95 117.19 7.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -91.3 115.46 28.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 436' ' ' VAL . 3.2 mm -106.05 143.73 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . 0.483 ' CG ' ' HB3' ' A' ' 435' ' ' GLU . 12.4 ptmt -138.84 178.25 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 47.9 t-20 65.62 27.84 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 434' ' ' LEU . 34.1 mt -76.86 149.79 36.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -88.95 125.78 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -47.13 -20.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.5 m -80.13 -37.86 32.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 43.2 m -61.52 129.95 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 58.8 p -109.99 159.67 17.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -45.51 -42.91 11.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -41.62 -69.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 376' ' ' LEU . 42.3 m -47.18 -67.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.173 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.517 HD11 ' CE1' ' A' ' 380' ' ' PHE . 10.3 tp -35.53 -53.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -55.91 -52.15 65.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.36 -14.08 39.59 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 71.4 t -90.18 -53.52 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.142 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.701 ' HA ' HD11 ' A' ' 424' ' ' LEU . 7.4 m-85 -66.8 -37.68 85.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 11.4 p -52.19 -16.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -63.89 -39.51 94.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 420' ' ' ALA . 37.1 t -68.62 -54.85 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -163.71 -170.33 28.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.7 120.78 18.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.3 mt -79.31 138.36 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.98 -55.1 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 8.7 t -142.19 121.73 13.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.99 116.35 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -148.41 137.17 21.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 33.8 mt -101.39 143.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.2 m -58.3 107.62 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 32.0 mttp -127.15 153.36 46.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -149.76 163.66 37.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -73.26 101.81 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.3 p30 -79.51 178.71 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -41.65 -45.44 3.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.57 -32.64 71.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.88 33.84 6.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.467 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.527 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 84.9 t -119.58 143.69 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.367 . . . . 0.0 111.106 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.01 98.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.41 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 62.8 mt -118.44 153.6 33.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 50.4 m -57.88 159.7 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 49.7 mtp -117.1 13.05 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 96.41 -3.33 63.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.525 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 6.8 p90 -153.21 157.42 40.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.383 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.04 -179.86 22.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -130.33 124.25 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 380' ' ' PHE . 86.1 t -112.41 132.87 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.72 143.06 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.4 153.83 32.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -59.65 -34.15 72.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -122.82 160.72 47.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.58 0.705 . . . . 0.0 110.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.99 -18.98 16.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.311 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -77.15 -52.28 9.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . 0.438 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 21.1 mm-40 -47.39 -31.78 4.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.73 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.07 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -61.92 -30.61 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -71.15 -60.24 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -58.21 -33.82 69.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 438' ' ' ILE . 13.5 tp -36.63 -55.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 425' ' ' GLN . 11.7 pttm -100.93 -50.44 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 -38.59 -39.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.709 HD12 ' HB1' ' A' ' 420' ' ' ALA . 55.9 mt -88.59 -30.87 18.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 422' ' ' LYS . 7.9 tp60 -56.79 126.18 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.427 ' O ' ' NZ ' ' A' ' 433' ' ' LYS . . . 109.02 -17.81 31.79 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . 0.429 ' CD2' ' CG2' ' A' ' 429' ' ' VAL . 16.4 t60 -60.93 114.48 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 34.1 m -70.95 98.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.429 ' CG2' ' CD2' ' A' ' 427' ' ' HIS . 84.9 t -104.44 122.64 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 58.26 27.97 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.12 77.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -123.67 128.66 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 37.0 mttm -80.42 119.53 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 367' ' ' LEU . 10.9 mt -78.87 161.95 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.483 ' HB3' ' CG ' ' A' ' 365' ' ' LYS . 5.7 tt0 -121.51 109.16 14.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.921 HG22 HD12 ' A' ' 364' ' ' ILE . 61.5 t -98.16 135.44 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.15 160.03 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.904 HD11 HD22 ' A' ' 421' ' ' LEU . 29.9 mm -79.48 95.48 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.058 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.897 0.38 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p -107.34 129.12 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.17 143.89 4.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.432 HD22 ' CG1' ' A' ' 436' ' ' VAL . 12.4 mt -144.48 123.3 12.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 363' ' ' PHE . 0.7 OUTLIER -94.78 112.39 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.63 ' N ' HD13 ' A' ' 364' ' ' ILE . 1.4 mm -97.81 144.15 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 366' ' ' ASN . 0.3 OUTLIER -133.52 154.96 50.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 365' ' ' LYS . 32.6 t-20 74.72 44.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.32 123.51 36.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.93 125.63 25.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -45.89 -25.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.1 t -76.58 -38.3 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 62.9 m -54.57 125.47 19.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.175 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 62.5 p -107.49 152.84 23.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 47.1 mt-10 -47.36 -50.92 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 55.4 mt-10 -34.85 -58.35 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 88.7 m -58.2 -62.47 1.8 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 380' ' ' PHE . 24.5 tp -40.19 -48.29 2.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 381' ' ' SER . 45.0 mtpt -54.85 -43.16 72.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -66.99 -26.73 73.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.502 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.85 -41.33 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 111.142 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.489 ' HA ' HD11 ' A' ' 424' ' ' LEU . 5.9 m-85 -83.21 -22.48 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 12.5 t -67.73 -15.77 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -68.79 -33.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.655 HG21 ' HB2' ' A' ' 420' ' ' ALA . 18.6 t -72.61 -44.21 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -176.23 -170.67 39.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -77.23 128.65 34.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 111.084 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 410' ' ' GLU . 35.0 mt -90.63 135.77 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -89.07 -50.65 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 25.9 t -147.83 121.43 9.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.8 117.12 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 8.4 m -143.3 141.62 31.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 392' ' ' SER . 88.0 mt -106.68 154.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.462 ' N ' HG22 ' A' ' 391' ' ' ILE . 56.2 m -71.7 87.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -109.74 131.0 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.2 157.72 43.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 3.1 ptpp? -75.71 102.08 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.502 ' OD1' HD12 ' A' ' 402' ' ' LEU . 0.4 OUTLIER -62.15 175.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.32 -37.92 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.441 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -71.89 -32.89 67.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.75 38.02 3.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.45 143.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.85 0.357 . . . . 0.0 111.156 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.16 101.01 3.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.502 HD12 ' OD1' ' A' ' 396' ' ' ASN . 86.9 mt -127.08 148.76 50.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.94 163.05 2.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 38.2 mtp -117.09 14.3 14.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.25 70.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.414 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 2.5 p90 -156.05 158.27 37.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.951 0.405 . . . . 0.0 110.846 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.11 -176.85 22.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.79 115.03 16.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.84 130.4 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.162 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 386' ' ' ILE . 16.6 tt0 -111.42 149.53 31.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.08 153.02 43.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -64.37 -38.46 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -116.22 154.22 48.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.24 -14.72 28.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -82.75 -50.96 8.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.87 -41.61 16.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.0 82.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -57.73 -30.38 65.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -72.87 -68.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -48.44 -25.16 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.703 HD22 HD11 ' A' ' 438' ' ' ILE . 41.5 tp -46.65 -66.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -98.92 -40.8 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -41.64 -34.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 380' ' ' PHE . 70.0 mt -94.6 -37.96 11.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 5.7 tp60 -38.61 142.28 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 90.14 -23.53 20.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -56.3 130.0 42.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.7 m -74.16 110.09 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.59 HG12 ' OD1' ' A' ' 430' ' ' ASP . 61.3 t -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . 0.59 ' OD1' HG12 ' A' ' 429' ' ' VAL . 4.3 m-20 59.3 28.06 17.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.65 1.12 60.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.507 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -126.38 142.24 51.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -83.75 136.66 34.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.48 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 18.7 mt -96.36 157.46 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -111.1 102.04 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.465 HG12 HD12 ' A' ' 421' ' ' LEU . 52.4 t -94.32 121.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -128.26 161.52 29.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.703 HD11 HD22 ' A' ' 421' ' ' LEU . 20.5 mm -78.09 95.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . 0.414 ' HB2' ' N ' ' A' ' 363' ' ' PHE . 16.9 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 84.2 p -108.48 148.36 30.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 117.26 144.11 7.71 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.444 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.3 mt -147.54 141.58 25.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.521 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.4 OUTLIER -109.23 134.4 51.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.521 HD13 ' C ' ' A' ' 363' ' ' PHE . 2.4 mm -119.01 147.69 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -134.85 159.84 40.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 405' ' ' GLY . 46.5 t-20 70.33 34.46 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.494 HD12 ' C ' ' A' ' 406' ' ' PHE . 53.4 mt -80.73 103.16 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.7 m120 -48.66 119.31 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 368' ' ' ASN . 8.2 m-85 -38.17 -42.73 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 52.3 p -58.19 -42.62 86.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 368' ' ' ASN . 35.5 m -44.53 141.61 1.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.173 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 49.2 p -121.1 143.65 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 39.2 mt-10 -43.32 -52.98 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 21.8 mp0 -34.59 -61.13 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 89.5 m -55.73 -47.01 77.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.0 tp -54.44 -54.84 35.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -55.87 -36.35 67.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.93 61.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.5 -41.52 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.685 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.5 m-85 -77.67 -12.96 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 6.9 t -77.31 -21.41 53.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -61.56 -27.58 68.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.703 HG21 ' HB2' ' A' ' 420' ' ' ALA . 42.2 t -73.85 -48.95 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -172.05 -154.63 10.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -90.1 114.69 26.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.453 HG21 ' HB2' ' A' ' 389' ' ' CYS . 36.0 mt -74.81 138.06 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -93.53 -53.81 3.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.1 t -147.77 112.19 5.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 409' ' ' VAL . 36.1 t -119.13 113.06 20.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -144.59 136.85 26.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 392' ' ' SER . 51.2 mt -93.67 156.62 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.119 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 391' ' ' ILE . 71.8 m -77.47 109.51 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -126.01 172.33 10.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -152.53 154.27 35.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 101.76 6.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 399' ' ' GLY . 48.4 p30 -72.49 176.82 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -47.83 -23.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -89.36 -26.95 20.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 87.76 35.51 9.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 93.5 t -116.83 143.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.159 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . 0.413 ' CD2' ' N ' ' A' ' 401' ' ' LEU . 0.5 OUTLIER -73.23 122.43 21.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 70.4 mt -141.01 140.24 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -58.44 156.61 10.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.2 mtm -114.95 20.7 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 88.66 0.92 81.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.494 ' C ' HD12 ' A' ' 367' ' ' LEU . 14.2 p90 -156.45 155.0 31.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.01 -179.9 22.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -130.4 118.31 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.566 HG22 ' SG ' ' A' ' 389' ' ' CYS . 95.5 t -107.48 144.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -124.66 156.42 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . 0.401 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 30.1 m-85 -131.81 156.9 45.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -65.44 -35.48 81.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -128.3 143.49 48.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 417' ' ' ALA . 72.4 Cg_exo -46.87 -52.35 7.79 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.695 2.263 . . . . 0.0 112.359 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 416' ' ' GLN . 34.1 mt-10 -44.56 -62.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mm100 -35.85 -42.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 414' ' ' PRO . . . -59.33 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.29 -27.11 68.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -69.14 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.82 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -51.91 -35.52 45.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 420' ' ' ALA . 24.0 tp -36.14 -61.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -100.49 -32.15 10.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -58.26 -16.86 15.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.82 HD12 ' HB1' ' A' ' 420' ' ' ALA . 79.1 mt -115.77 -23.72 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -54.64 147.15 15.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 78.96 -10.82 31.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.501 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -58.88 132.93 55.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.1 m -72.52 109.82 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.193 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.55 HG11 HD11 ' A' ' 434' ' ' LEU . 77.4 t -126.92 113.47 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 61.39 28.79 18.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.48 39.22 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -115.66 143.16 45.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.358 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -84.87 121.04 27.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.55 HD11 HG11 ' A' ' 429' ' ' VAL . 8.8 mt -84.07 155.36 22.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.57 127.88 56.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.444 ' CG1' HD22 ' A' ' 362' ' ' LEU . 28.1 t -112.78 139.3 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 -139.96 166.35 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.1 mm -86.61 95.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.901 0.382 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 6.4 p -109.65 126.47 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.66 135.34 2.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.2 mt -138.57 137.26 36.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -111.49 112.96 25.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.517 HD12 HG22 ' A' ' 436' ' ' VAL . 2.9 mm -97.42 143.71 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -131.8 160.31 35.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 5.5 t30 71.18 40.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -87.28 121.37 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 371' ' ' THR . 12.9 m120 -58.81 122.34 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -43.7 -24.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 -37.88 46.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.3 m -51.31 131.73 28.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 41.4 p -113.89 154.33 27.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 374' ' ' GLU . 85.3 mt-10 -45.85 -54.42 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 373' ' ' GLU . 54.4 mm-40 -35.05 -66.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 378' ' ' GLY . 32.7 m -51.73 -64.03 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 375' ' ' THR . 15.3 tp -36.66 -52.59 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 377' ' ' LYS . 4.4 mtpm? -55.78 -42.19 75.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -68.82 -25.26 75.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.524 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 94.8 t -78.83 -45.29 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.573 ' CD2' ' CD1' ' A' ' 424' ' ' LEU . 12.6 m-85 -79.26 -46.02 18.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.478 ' N ' HD11 ' A' ' 386' ' ' ILE . 47.7 t -42.81 -28.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -48.15 -47.73 34.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 420' ' ' ALA . 97.2 t -57.79 -57.56 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.59 -167.42 24.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.466 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.9 121.26 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 410' ' ' GLU . 46.2 mt -85.25 139.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -82.9 -52.88 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -155.82 122.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.534 ' SG ' HG22 ' A' ' 409' ' ' VAL . 15.4 t -119.99 124.04 44.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -146.42 166.68 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.48 HG21 ' OG ' ' A' ' 403' ' ' SER . 73.5 mt -127.35 142.22 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.2 t -68.14 115.04 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -128.51 149.92 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -149.5 151.8 34.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 2.4 ptpt -69.58 102.57 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 399' ' ' GLY . 52.5 p30 -64.41 179.12 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -42.88 -40.17 2.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.31 -32.16 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.6 31.94 5.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.47 143.51 29.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.14 116.74 15.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.421 HD12 ' ND2' ' A' ' 396' ' ' ASN . 39.6 mt -137.32 156.53 48.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.48 ' OG ' HG21 ' A' ' 391' ' ' ILE . 1.3 t -57.9 158.53 6.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 16.8 mtm -117.07 19.28 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.89 88.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 404' ' ' MET . 16.8 p90 -158.33 158.93 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.3 -172.6 20.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -125.32 123.69 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.534 HG22 ' SG ' ' A' ' 389' ' ' CYS . 89.9 t -118.53 119.28 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 386' ' ' ILE . 14.9 tt0 -106.54 153.68 21.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . 0.517 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 14.5 m-85 -122.53 153.14 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -59.54 -40.55 87.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -125.43 143.72 45.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.31 -41.61 28.13 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.743 2.295 . . . . 0.0 112.342 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 418' ' ' GLN . 1.2 tp10 -57.83 -62.63 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -37.91 -38.14 0.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -71.98 -41.19 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.086 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 415' ' ' GLU . 34.8 mm-40 -66.53 -22.19 66.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -83.28 -63.2 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -49.26 -40.39 34.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 438' ' ' ILE . 8.4 tp -35.42 -62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -92.77 -51.41 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -38.62 -36.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.859 HD12 ' HB1' ' A' ' 420' ' ' ALA . 90.4 mt -92.25 -35.27 13.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -43.6 150.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.01 -8.48 15.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -66.44 118.42 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 10.4 m -69.23 116.82 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 79.9 t -125.12 122.74 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.157 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 58.82 31.76 21.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.97 -8.12 24.67 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . 0.411 ' CD2' HD21 ' A' ' 368' ' ' ASN . 87.5 m-70 -119.58 133.01 55.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -76.57 151.53 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 5.4 mt -116.54 159.9 21.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -116.11 129.38 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 364' ' ' ILE . 36.0 t -116.95 142.35 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -137.11 159.47 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.752 HD11 HD22 ' A' ' 421' ' ' LEU . 24.9 mm -83.89 95.69 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.899 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.892 0.377 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.08 155.08 17.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.84 148.77 9.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.544 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.697 HD22 ' CG1' ' A' ' 436' ' ' VAL . 4.5 mt -147.24 131.88 17.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 365' ' ' LYS . 0.3 OUTLIER -98.38 131.0 45.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.0 mm -117.1 142.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 12.2 tptp -132.29 162.36 31.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.3 t30 64.93 31.52 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.585 HD23 HD22 ' A' ' 434' ' ' LEU . 33.7 mt -72.23 128.84 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.483 HD21 ' CD2' ' A' ' 432' ' ' HIS . 16.3 m120 -70.9 128.92 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -54.52 -15.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 69.4 m -81.8 -29.03 32.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 81.8 m -65.98 138.93 58.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.6 p -120.13 162.22 19.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.18 -36.51 75.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -50.48 -60.46 2.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 42.9 m -62.29 -55.66 26.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.554 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.6 tp -43.16 -38.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -69.38 -43.73 72.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.79 -20.45 72.34 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.478 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.16 -40.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.554 ' CD1' HD12 ' A' ' 376' ' ' LEU . 11.6 m-85 -82.6 -14.66 54.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 75.8 p -74.87 -15.28 60.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -65.03 -27.52 68.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 420' ' ' ALA . 59.5 t -79.39 -64.18 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -153.33 -162.44 11.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -84.28 118.46 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.755 0.312 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.92 132.34 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -84.07 -55.04 4.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.7 p -154.46 116.62 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 28.5 p -108.54 120.36 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 95.2 m -137.79 127.54 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.77 140.79 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 70.1 m -57.55 99.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.85 157.82 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -153.96 156.34 37.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -74.67 104.58 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 398' ' ' ALA . 5.4 p30 -78.5 178.12 8.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -45.08 -33.62 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.454 ' HB3' ' OD1' ' A' ' 396' ' ' ASN . . . -78.73 -29.26 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 88.57 36.91 7.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.491 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 67.5 t -121.9 143.41 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.113 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -69.12 107.5 3.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 56.0 mt -126.88 143.92 51.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.0 p -59.3 162.39 4.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.537 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 37.6 mtp -117.08 13.78 14.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.12 1.48 64.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.557 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 404' ' ' MET . 1.7 p90 -158.31 158.82 35.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.03 -175.03 22.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -140.7 113.6 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 63.4 t -103.49 121.0 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.18 145.31 28.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -120.82 151.38 39.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -64.64 -14.04 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -141.47 159.07 61.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.635 0.731 . . . . 0.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.67 -44.93 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.4 -49.41 72.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -47.24 -47.9 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -54.37 -60.01 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -48.88 -31.13 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -75.55 -56.76 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 424' ' ' LEU . . . -57.88 -15.03 7.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.574 ' HB2' HD21 ' A' ' 362' ' ' LEU . 14.2 tp -63.61 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.95 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.7 -34.63 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -55.18 -14.69 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 420' ' ' ALA . 46.7 mt -117.82 -37.22 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.7 tp60 -42.13 145.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.9 -10.75 59.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -67.79 122.48 18.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.0 m -69.24 116.33 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.147 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.5 123.21 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.26 26.66 15.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.29 40.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.541 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . 0.483 ' CD2' HD21 ' A' ' 368' ' ' ASN . 89.9 m-70 -121.61 137.34 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -77.73 143.25 38.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.585 HD22 HD23 ' A' ' 367' ' ' LEU . 8.0 mt -102.73 159.18 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -113.81 105.99 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.697 ' CG1' HD22 ' A' ' 362' ' ' LEU . 22.5 t -97.92 133.95 38.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -139.33 166.08 25.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 3.2 mm -87.11 101.53 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.914 0.388 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.6 p -109.82 125.36 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.86 138.07 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.91 129.58 19.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.899 0.38 . . . . 0.0 110.902 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -105.17 116.61 32.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.9 mm -103.57 141.2 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -127.56 165.11 20.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 9.2 t30 71.79 28.12 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.671 HD12 ' CA ' ' A' ' 406' ' ' PHE . 36.4 mt -74.59 126.51 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.7 m120 -73.66 121.94 21.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -39.27 -38.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.4 t -61.66 -42.71 99.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 368' ' ' ASN . 90.3 m -50.13 121.72 5.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.3 p -99.66 154.12 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.25 -55.37 15.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -43.35 -44.53 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 85.3 m -64.66 -54.35 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.499 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 11.7 tp -53.2 -43.72 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -59.45 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -54.55 -57.76 16.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 88.1 t -41.17 -49.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.556 ' HA ' HD11 ' A' ' 424' ' ' LEU . 9.9 m-85 -78.46 -25.51 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.1 t -63.2 -12.94 32.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.3 -24.12 64.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 420' ' ' ALA . 78.4 t -81.39 -59.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.12 -172.65 30.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -68.99 117.03 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.739 0.304 . . . . 0.0 111.055 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.58 133.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.17 -52.13 7.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.4 m -162.48 117.66 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 409' ' ' VAL . 17.6 t -120.13 132.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -144.44 162.65 35.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 406' ' ' PHE . 87.8 mt -123.82 138.77 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 406' ' ' PHE . 4.9 p -58.35 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -115.93 140.73 48.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -136.25 170.01 16.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -86.63 108.81 18.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 0.3 OUTLIER -80.25 178.67 8.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -46.03 -35.8 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -76.02 -31.83 59.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 96.25 35.3 5.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.449 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.444 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 18.9 t -118.85 145.24 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.378 . . . . 0.0 111.13 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.0 96.4 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.425 HD12 ' OD1' ' A' ' 396' ' ' ASN . 63.0 mt -110.95 137.67 48.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.4 p -57.67 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 80.0 mtp -116.44 14.49 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.53 74.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.671 ' CA ' HD12 ' A' ' 367' ' ' LEU . 16.8 p90 -148.97 174.33 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.64 39.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.545 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -126.55 117.47 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.887 HG22 ' SG ' ' A' ' 389' ' ' CYS . 63.0 t -111.8 136.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -123.33 146.7 47.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.02 153.81 33.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -59.39 -42.03 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -113.32 159.52 34.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 110.875 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -16.34 18.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.346 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.66 -48.82 12.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.52 -35.94 14.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.82 65.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -58.56 -27.93 65.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -78.89 -63.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -55.67 -15.86 3.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.805 HD22 HD11 ' A' ' 438' ' ' ILE . 25.2 tp -57.81 -62.16 2.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -95.78 -27.63 15.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . 0.439 ' CD ' ' O ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -58.48 -45.14 89.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.556 HD11 ' HA ' ' A' ' 380' ' ' PHE . 94.4 mt -83.98 -17.08 41.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 15.8 tp60 -64.85 134.7 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.03 45.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -55.25 131.79 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.3 m -73.44 96.23 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.7 t -111.31 113.2 43.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.58 31.3 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 65.33 6.28 26.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -126.4 126.46 43.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -73.03 126.8 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.488 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 6.7 mt -90.75 159.34 16.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -110.56 103.18 11.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.443 HG12 HD12 ' A' ' 421' ' ' LEU . 60.7 t -92.51 131.83 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -136.47 164.94 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.805 HD11 HD22 ' A' ' 421' ' ' LEU . 30.9 mm -88.21 97.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 81.8 p -112.32 139.11 48.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.14 144.01 5.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.8 mt -149.94 112.95 4.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.36 113.61 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 364' ' ' ILE . 1.9 mm -98.8 145.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -131.87 161.59 32.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.6 t30 71.19 30.26 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 406' ' ' PHE . 76.5 mt -74.77 112.93 11.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -57.85 117.06 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 368' ' ' ASN . 5.6 m-85 -34.26 -54.59 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 m -46.7 -45.17 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 368' ' ' ASN . 85.9 m -48.3 138.48 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 374' ' ' GLU . 14.6 t -123.22 163.31 20.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -56.57 -15.13 3.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.609 ' H ' HG23 ' A' ' 372' ' ' THR . 21.1 tt0 -68.47 -60.33 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.963 ' O ' HG23 ' A' ' 379' ' ' VAL . 51.6 m -61.58 -38.05 86.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 391' ' ' ILE . 7.4 tp -62.9 -57.5 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -53.1 -31.87 44.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -80.75 -23.96 59.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 375' ' ' THR . 94.5 t -80.62 -45.25 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.701 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.2 m-85 -76.0 -24.44 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.3 p -61.71 -24.28 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.877 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -58.56 -39.82 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.692 HG21 ' HB2' ' A' ' 420' ' ' ALA . 12.0 t -66.96 -48.29 79.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.426 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -179.02 -168.57 38.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.01 130.58 43.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 28.0 mt -92.9 137.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -86.05 -50.19 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -160.06 126.27 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 409' ' ' VAL . 50.9 t -123.84 98.98 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 87.5 m -117.84 125.32 50.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.565 HD11 HD23 ' A' ' 376' ' ' LEU . 29.0 mt -101.44 155.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 406' ' ' PHE . 50.6 p -69.86 92.93 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -121.29 141.02 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -138.08 167.55 21.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.434 ' HE3' ' N ' ' A' ' 395' ' ' LYS . 0.1 OUTLIER -82.44 102.89 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 3.7 p30 -76.28 178.35 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -39.35 -52.62 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.72 73.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 95.03 30.98 7.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.531 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 13.8 t -109.18 151.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 401' ' ' LEU . 0.8 OUTLIER -76.28 112.72 13.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.1 mt -136.54 136.34 39.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.7 m -57.86 164.12 2.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 6.1 mtm -112.29 15.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 98.09 0.72 58.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.673 ' C ' HD12 ' A' ' 367' ' ' LEU . 53.5 p90 -156.57 172.33 18.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -167.97 -177.02 38.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -132.38 133.54 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.627 HG22 ' SG ' ' A' ' 389' ' ' CYS . 54.5 t -125.55 141.68 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.158 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -124.42 142.77 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 23.8 m-85 -113.87 156.51 23.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -61.42 -41.41 97.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -126.93 142.69 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.583 0.706 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.27 -41.58 27.83 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.93 -55.99 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . 0.426 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 42.5 mm-40 -45.45 -36.69 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -69.2 -45.93 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -60.71 -25.28 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -80.73 -63.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.692 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -55.52 -18.32 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.83 HD22 HD11 ' A' ' 438' ' ' ILE . 17.4 tp -55.84 -66.43 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -93.81 -41.68 9.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -42.27 -46.26 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 380' ' ' PHE . 57.9 mt -82.24 -29.49 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.3 tp60 -50.17 142.08 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.7 -18.3 30.88 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -56.62 128.04 34.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.478 ' HA ' ' CE ' ' A' ' 433' ' ' LYS . 1.4 m -71.29 99.27 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.15 124.55 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.49 28.52 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.05 -1.53 47.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -124.65 151.53 44.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.478 ' CE ' ' HA ' ' A' ' 428' ' ' THR . 6.0 mmpt? -88.86 133.4 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.496 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 13.4 mt -94.21 154.71 17.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.915 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.79 106.31 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.7 t -97.65 126.76 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -133.95 163.63 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.815 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.83 HD11 HD22 ' A' ' 421' ' ' LEU . 10.7 mm -86.36 99.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.909 0.385 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.1 p -107.57 131.77 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.871 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.9 142.78 5.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.85 124.41 13.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.4 OUTLIER -90.71 127.75 36.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.3 mm -116.29 142.32 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -131.56 161.18 33.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 72.35 35.91 1.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 406' ' ' PHE . 50.9 mt -85.35 109.55 18.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -52.57 130.96 33.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.839 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -52.33 -16.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.8 t -82.23 -37.26 26.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 97.0 m -55.21 131.99 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 23.2 p -110.66 156.27 21.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -50.48 -43.71 55.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -43.18 -63.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 378' ' ' GLY . 19.5 m -55.95 -65.8 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.591 HD12 ' CD1' ' A' ' 380' ' ' PHE . 11.8 tp -37.12 -44.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -62.87 -44.13 96.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -61.48 -52.91 48.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.09 -34.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.159 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.591 ' CD1' HD12 ' A' ' 376' ' ' LEU . 13.5 m-85 -87.19 -11.84 48.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 t -78.07 -14.16 59.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.51 -38.07 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 420' ' ' ALA . 60.2 t -64.42 -55.93 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -169.04 -163.2 22.68 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.77 126.17 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 19.7 mt -88.84 136.94 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -86.09 -53.21 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 14.2 t -165.67 130.56 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 45.1 t -123.09 122.63 38.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.3 m -130.9 127.42 38.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 406' ' ' PHE . 57.9 mt -95.8 140.68 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.692 ' CB ' ' CE2' ' A' ' 406' ' ' PHE . 2.8 p -60.01 91.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -119.8 140.67 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -139.76 160.79 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -70.72 107.93 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 399' ' ' GLY . 8.6 p30 -88.61 179.25 6.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -38.92 -47.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.63 68.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 91.86 29.83 11.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.454 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.78 142.6 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.29 96.63 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 28.9 mt -119.22 149.35 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 p -57.87 160.7 4.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.1 mtm -116.81 10.89 14.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.52 56.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.692 ' CE2' ' CB ' ' A' ' 392' ' ' SER . 9.4 p90 -152.78 176.09 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -166.73 -172.99 34.64 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -137.8 121.65 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 84.7 t -110.65 132.87 57.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -115.91 153.14 32.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -131.89 152.16 51.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -67.15 -25.3 66.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -117.97 151.58 49.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.407 ' O ' ' NE2' ' A' ' 418' ' ' GLN . 58.7 Cg_endo -71.96 -27.72 17.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 416' ' ' GLN . 14.4 tp10 -75.95 -57.19 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . 0.653 ' NE2' HG12 ' A' ' 383' ' ' VAL . 30.9 mm100 -34.83 -43.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -56.0 -51.01 69.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mp0 -63.73 -28.49 69.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -65.49 -59.15 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.935 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -62.32 -33.89 75.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 438' ' ' ILE . 15.8 tp -38.64 -55.18 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.84 -43.07 6.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -47.49 -43.76 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.935 HD12 ' HB1' ' A' ' 420' ' ' ALA . 86.3 mt -84.25 -24.15 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -56.99 147.22 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.47 11.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -61.06 118.86 7.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 20.7 m -69.23 116.38 9.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.37 117.68 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 61.28 31.2 19.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.12 -4.47 47.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -122.63 131.44 53.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -74.7 143.83 44.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.0 mt -105.57 161.51 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.52 120.26 39.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.41 134.72 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -140.93 159.6 41.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 421' ' ' LEU . 22.4 mm -76.93 97.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.4 p -114.32 137.34 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.844 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 130.24 141.86 5.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.51 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.11 117.63 7.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -95.78 112.4 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.419 ' N ' HD13 ' A' ' 364' ' ' ILE . 2.1 mm -98.97 149.99 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -133.86 158.24 43.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 405' ' ' GLY . 37.4 t30 74.72 36.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 406' ' ' PHE . 45.9 mt -84.21 118.82 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.6 m-20 -56.38 119.87 6.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -41.0 -30.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 53.7 p -73.39 -39.22 65.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 368' ' ' ASN . 55.2 m -46.18 121.11 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 39.4 p -96.23 157.48 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 374' ' ' GLU . 45.1 mt-10 -56.34 -55.9 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.2 tt0 -36.84 -57.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 379' ' ' VAL . 33.0 m -52.2 -50.5 61.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.511 HD11 ' CE1' ' A' ' 380' ' ' PHE . 15.1 tp -55.49 -49.76 71.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -53.08 -36.46 60.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -75.04 -43.65 26.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.455 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 375' ' ' THR . 99.1 t -60.79 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.126 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.62 ' HA ' HD11 ' A' ' 424' ' ' LEU . 5.8 m-85 -81.29 -24.48 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.3 t -65.81 -19.98 66.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -63.29 -35.49 80.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 420' ' ' ALA . 60.3 t -66.4 -62.7 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -158.07 -150.3 5.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -88.88 122.33 32.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 410' ' ' GLU . 23.1 mt -87.32 142.53 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -90.26 -49.19 6.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 33.8 t -164.7 118.26 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.885 ' SG ' HG22 ' A' ' 409' ' ' VAL . 7.7 t -113.31 130.34 56.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.5 t -146.05 154.12 41.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.8 mt -115.27 141.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 74.6 m -64.87 91.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . 0.409 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 53.6 mttt -115.17 147.61 40.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -134.48 156.5 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 395' ' ' LYS . 0.6 OUTLIER -76.9 110.74 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.1 p-10 -82.58 178.48 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 398' ' ' ALA . 0.0 OUTLIER -41.72 -30.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -87.79 -32.25 19.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.097 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.54 31.02 8.12 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.529 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.92 143.2 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.105 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.12 112.16 8.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.409 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 32.2 mt -134.5 136.1 42.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.1 m -57.84 159.19 5.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.507 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 47.0 mtm -116.9 21.13 13.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 90.05 4.96 71.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.453 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.521 ' C ' HD12 ' A' ' 367' ' ' LEU . 5.7 p90 -155.08 154.31 32.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.388 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.6 168.37 30.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.28 122.23 45.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.885 HG22 ' SG ' ' A' ' 389' ' ' CYS . 86.5 t -115.27 125.21 72.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 386' ' ' ILE . 28.6 tt0 -111.55 155.38 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -126.54 165.75 18.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.906 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -71.93 -34.5 69.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.21 161.75 41.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.18 -16.31 19.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.22 -41.54 14.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -51.04 -44.5 61.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.47 88.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -57.13 -35.95 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -67.47 -61.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -52.24 -34.65 46.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.095 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.452 HD22 HD11 ' A' ' 438' ' ' ILE . 63.7 tp -34.86 -61.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.25 -44.83 5.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -39.87 -35.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 380' ' ' PHE . 84.0 mt -93.3 -33.4 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.4 tp60 -47.03 139.88 5.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.2 56.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -59.69 129.88 44.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 18.2 m -69.83 114.12 7.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.169 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.1 116.73 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 54.59 31.16 14.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 73.05 -2.79 32.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -123.45 133.13 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -77.95 145.28 36.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.487 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 9.8 mt -106.12 163.28 12.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.46 108.57 17.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.485 ' O ' ' CZ ' ' A' ' 437' ' ' ARG . 42.0 t -92.47 124.74 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.485 ' CZ ' ' O ' ' A' ' 436' ' ' VAL . 11.3 mmp_? -127.17 165.96 18.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.452 HD11 HD22 ' A' ' 421' ' ' LEU . 5.2 mm -90.63 97.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.867 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.879 0.371 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.1 p -105.57 159.4 15.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 103.26 139.43 10.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.502 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 409' ' ' VAL . 9.6 mt -141.86 131.3 23.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.64 125.85 40.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.2 mm -116.3 142.06 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.077 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . 0.428 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 13.1 tptm -128.89 162.5 27.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 405' ' ' GLY . 35.2 t-20 65.08 45.56 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 406' ' ' PHE . 43.6 mt -89.52 107.36 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -50.49 124.51 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -47.1 -28.5 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 t -69.22 -35.55 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 13.1 m -56.67 130.44 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.088 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 43.8 p -108.16 156.52 19.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -49.75 -49.42 48.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -43.35 -68.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 91.3 m -44.98 -64.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 18.5 tp -39.77 -51.76 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -54.39 -43.43 71.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -62.13 -48.85 80.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 66.6 t -58.23 -40.77 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.47 ' HA ' HD11 ' A' ' 424' ' ' LEU . 15.2 m-85 -82.51 -20.91 35.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 24.3 t -70.27 -14.01 62.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.809 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -71.49 -37.71 71.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 420' ' ' ALA . 94.9 t -65.88 -39.82 85.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.106 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.41 44.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.15 123.08 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.08 133.13 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -52.56 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.4 p -157.77 120.87 3.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 36.1 t -119.16 120.43 37.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -143.92 145.44 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.595 HG21 ' OG ' ' A' ' 403' ' ' SER . 59.0 mt -106.1 148.66 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.4 m -72.65 101.22 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -124.51 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -126.65 165.34 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -77.11 103.42 7.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.509 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 5.6 p30 -79.06 178.14 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -41.08 -46.93 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 96.28 26.66 10.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.509 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 65.1 t -108.0 142.45 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.136 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.6 102.09 2.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.12 147.66 43.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 391' ' ' ILE . 1.5 t -57.99 155.79 10.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.582 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 52.6 mtm -116.06 19.47 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 87.86 1.4 82.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -156.27 153.28 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.12 167.81 30.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.04 128.07 55.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 362' ' ' LEU . 82.3 t -120.49 122.3 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -110.75 144.74 39.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -114.23 169.0 9.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -73.29 -36.9 66.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -131.92 143.88 50.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.37 -39.16 21.56 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 418' ' ' GLN . 25.1 mm-40 -56.95 -63.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.2 mm100 -36.51 -45.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.08 -44.99 90.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 415' ' ' GLU . 16.1 mm-40 -59.14 -30.85 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -75.5 -66.7 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.607 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -47.2 -33.0 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.102 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 12.7 tp -40.7 -66.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -94.37 -36.56 11.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -48.63 -46.36 39.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.607 HD12 ' HB1' ' A' ' 420' ' ' ALA . 82.3 mt -82.07 -35.57 28.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 9.6 tp60 -42.65 152.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.39 -25.54 4.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -59.57 118.78 6.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 80.8 m -70.88 122.61 20.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.589 HG21 HD11 ' A' ' 434' ' ' LEU . 61.8 t -122.04 119.91 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 60.89 26.73 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.826 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 88.63 -15.89 55.71 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.474 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -116.86 145.45 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -85.11 146.19 27.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.589 HD11 HG21 ' A' ' 429' ' ' VAL . 10.0 mt -100.14 161.58 13.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -115.04 105.2 12.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -97.18 134.94 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -141.79 160.63 39.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.49 95.99 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.895 0.379 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 9.1 p -108.54 128.41 54.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 150.93 143.37 3.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 mt -145.89 127.58 15.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.459 ' C ' HD13 ' A' ' 364' ' ' ILE . 2.5 t80 -102.8 122.93 45.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.75 HD12 HG22 ' A' ' 436' ' ' VAL . 3.5 mm -108.66 144.82 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -135.16 159.64 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.7 t30 73.93 27.33 1.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.98 117.79 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.5 m120 -56.73 120.27 7.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -42.04 -35.34 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.5 m -64.9 -40.12 94.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 368' ' ' ASN . 84.8 m -55.31 146.24 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.163 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.8 p -123.19 168.61 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.6 mp0 -57.98 -54.38 47.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.3 mp0 -36.78 -70.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 379' ' ' VAL . 16.1 m -43.77 -51.43 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.546 HD12 ' CD1' ' A' ' 380' ' ' PHE . 12.8 tp -54.44 -42.75 70.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 381' ' ' SER . 13.3 mtpt -61.07 -45.11 96.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.0 57.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.517 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 375' ' ' THR . 58.2 t -55.19 -52.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.117 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.546 ' CD1' HD12 ' A' ' 376' ' ' LEU . 10.8 m-85 -72.23 -20.27 61.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.6 t -69.26 -12.38 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -67.66 -39.56 84.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 420' ' ' ALA . 46.2 t -64.64 -35.18 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.433 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . 169.17 -166.85 40.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.17 125.46 27.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 410' ' ' GLU . 50.0 mt -85.83 130.5 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -74.36 -52.27 12.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.2 t -160.36 122.97 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.707 ' SG ' HG22 ' A' ' 409' ' ' VAL . 4.5 t -119.39 121.16 38.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 46.5 m -145.76 133.28 20.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 392' ' ' SER . 80.0 mt -99.52 154.89 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.453 ' N ' HG22 ' A' ' 391' ' ' ILE . 38.0 m -73.03 100.15 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 403' ' ' SER . 4.1 mtmp? -124.75 134.66 52.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.11 171.58 8.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -81.38 102.38 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.7 p30 -76.07 177.23 7.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -40.06 -54.36 2.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.19 -28.06 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.43 30.75 8.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.576 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 17.9 t -110.48 144.39 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -71.68 97.56 1.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.0 mt -114.85 142.76 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.453 ' N ' ' HG2' ' A' ' 393' ' ' LYS . 58.3 m -58.0 160.5 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.543 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 28.7 mtm -116.86 22.71 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 83.66 1.43 90.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 404' ' ' MET . 4.8 p90 -152.8 154.67 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.917 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.55 -170.24 17.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.479 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -140.26 121.58 14.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.707 HG22 ' SG ' ' A' ' 389' ' ' CYS . 87.5 t -108.7 141.9 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 386' ' ' ILE . 23.7 tt0 -127.89 145.59 50.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.98 166.3 12.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -68.03 -36.61 80.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -123.28 162.17 41.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.582 0.706 . . . . 0.0 110.889 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.87 -18.86 16.59 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.647 2.231 . . . . 0.0 112.322 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.91 -55.82 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . 0.433 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 42.3 mt-30 -50.33 -31.44 14.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.55 -48.12 65.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -60.78 -29.71 69.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -70.86 -63.93 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -49.09 -36.62 19.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 438' ' ' ILE . 7.8 tp -37.58 -69.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 -34.46 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -51.8 -34.76 41.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.731 HD12 ' HB1' ' A' ' 420' ' ' ALA . 85.1 mt -96.41 -29.57 13.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -48.33 144.93 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.4 12.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.462 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -55.26 115.9 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 42.0 m -71.11 114.24 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 73.6 t -121.42 125.78 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.82 27.14 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.811 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.51 -3.96 61.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -122.79 142.8 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -88.01 141.65 28.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.24 157.31 17.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.46 119.76 39.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.75 HG22 HD12 ' A' ' 364' ' ' ILE . 42.5 t -110.39 138.3 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -133.43 163.71 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.755 HD11 HD22 ' A' ' 421' ' ' LEU . 26.8 mm -83.39 95.34 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.862 0.363 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 7.2 p -121.46 158.04 29.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.55 12.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.478 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.7 mt -142.05 126.32 17.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -90.81 128.7 36.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.603 HD12 HG22 ' A' ' 436' ' ' VAL . 4.1 mm -117.63 144.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -133.14 160.31 37.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 22.6 t30 72.61 40.5 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.44 HD23 HD22 ' A' ' 434' ' ' LEU . 25.1 mt -85.61 148.94 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.498 HD21 ' CD2' ' A' ' 432' ' ' HIS . 3.0 m-20 -88.99 124.79 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -46.01 -39.8 9.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -63.28 -32.51 73.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 99.3 m -59.9 131.11 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.0 p -114.19 143.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -40.58 -43.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -38.78 -57.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 76.8 m -62.96 -60.22 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.511 HD11 ' CE1' ' A' ' 380' ' ' PHE . 11.0 tp -39.13 -44.85 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -52.28 -56.17 16.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -59.87 -25.55 61.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 382' ' ' LYS . 57.5 t -73.21 -34.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.987 ' CD2' HG11 ' A' ' 409' ' ' VAL . 9.1 m-85 -94.14 -16.36 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 48.7 p -73.6 -17.08 61.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 379' ' ' VAL . 0.2 OUTLIER -75.43 -18.52 59.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 420' ' ' ALA . 53.8 t -95.3 -41.17 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.442 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -167.44 -178.64 39.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.509 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.57 120.08 22.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.775 0.321 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 36.8 mt -81.8 143.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -105.21 -38.87 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.4 t -160.52 118.09 2.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 409' ' ' VAL . 21.5 t -121.52 116.89 25.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.1 m -142.7 151.15 41.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 406' ' ' PHE . 63.4 mt -107.99 148.86 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.415 ' HB2' ' CD1' ' A' ' 406' ' ' PHE . 10.5 m -64.71 85.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -110.71 137.49 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -122.1 156.55 33.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.934 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -73.8 101.5 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.669 ' ND2' HD12 ' A' ' 402' ' ' LEU . 21.7 p30 -77.76 179.24 6.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.914 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -40.33 -54.11 2.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.27 69.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.63 31.34 8.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.541 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.98 143.3 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.089 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.11 96.65 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.669 HD12 ' ND2' ' A' ' 396' ' ' ASN . 97.1 mt -105.99 139.29 40.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.1 p -57.9 156.12 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 9.4 mtm -116.42 21.94 13.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.2 89.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 7.8 p90 -149.14 150.4 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -139.51 -172.7 12.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -139.44 116.44 10.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.987 HG11 ' CD2' ' A' ' 380' ' ' PHE . 91.5 t -104.5 124.74 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -107.06 137.1 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.55 162.81 14.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -78.1 -22.92 48.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm -133.44 158.78 74.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -30.28 14.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.625 2.217 . . . . 0.0 112.347 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.6 -39.14 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . 0.442 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 2.8 mm-40 -51.42 -49.38 61.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.41 75.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -64.88 -29.72 70.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -78.56 -54.63 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -61.94 -24.9 67.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.53 HD22 HD11 ' A' ' 438' ' ' ILE . 14.2 tp -44.8 -56.24 4.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.21 -44.58 5.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -43.28 -46.71 6.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.47 ' CD2' ' HE2' ' A' ' 382' ' ' LYS . 30.6 mt -80.94 -43.53 19.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 4.2 tp60 -47.25 121.03 3.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.75 -20.11 37.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -60.23 130.06 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.7 m -70.49 96.32 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.115 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.11 112.95 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 62.1 26.02 15.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 70.0 6.58 57.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . 0.498 ' CD2' HD21 ' A' ' 368' ' ' ASN . 21.8 m-70 -121.38 120.59 35.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 110.836 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -71.72 107.39 4.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.44 HD22 HD23 ' A' ' 367' ' ' LEU . 11.2 mt -67.74 161.56 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -119.6 99.26 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.603 HG22 HD12 ' A' ' 364' ' ' ILE . 60.4 t -88.15 134.72 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -143.46 145.99 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.53 HD11 HD22 ' A' ' 421' ' ' LEU . 7.1 mm -70.39 98.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.922 0.391 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.96 150.68 21.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.845 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.22 143.69 7.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.445 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.2 mt -146.55 132.49 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.359 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.443 ' C ' HD13 ' A' ' 364' ' ' ILE . 1.2 t80 -95.77 126.48 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 3.7 mm -112.15 144.78 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -133.87 162.33 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.42 ' O ' HD23 ' A' ' 434' ' ' LEU . 19.3 t-20 68.47 43.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.28 106.5 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.3 m120 -46.92 122.23 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -43.59 -24.46 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 70.2 m -77.05 -38.96 51.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 368' ' ' ASN . 25.5 m -48.8 131.83 18.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 76.5 p -108.48 148.44 30.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 374' ' ' GLU . 2.8 mp0 -45.57 -50.76 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 373' ' ' GLU . 5.8 mm-40 -36.09 -67.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 378' ' ' GLY . 71.1 m -48.71 -67.79 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.154 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.545 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 7.2 tp -35.82 -46.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -64.84 -44.53 89.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -60.43 -21.38 57.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.98 -48.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 10.0 m-85 -70.23 -29.33 66.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 53.5 p -58.74 -19.59 41.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.892 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -64.26 -36.58 84.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 420' ' ' ALA . 76.0 t -64.94 -47.66 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.468 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -175.82 -154.43 11.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.523 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . 0.622 ' HB1' ' HE3' ' A' ' 412' ' ' LYS . . . -82.77 125.83 31.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.759 0.314 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 45.2 mt -93.02 130.13 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.123 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -77.5 -49.03 15.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.1 t -169.73 117.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 409' ' ' VAL . 51.2 t -108.94 128.6 55.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.3 t -140.06 163.15 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.35 137.23 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 m -56.04 102.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 35.6 mtmt -125.66 136.9 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -128.37 156.26 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -71.71 104.24 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 399' ' ' GLY . 0.5 OUTLIER -79.33 178.82 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -38.61 -53.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.98 74.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.77 22.21 14.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.4 ' O ' ' OD1' ' A' ' 396' ' ' ASN . 45.8 t -101.34 143.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.376 . . . . 0.0 111.105 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.67 96.03 2.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.6 mt -109.41 143.82 38.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.4 p -57.91 161.56 3.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 35.9 mtp -117.03 16.7 15.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.02 86.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.51 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -153.02 155.07 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -148.76 -176.01 21.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -127.29 123.26 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' A' ' 380' ' ' PHE . 77.8 t -105.62 106.1 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -85.36 152.72 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -132.7 152.22 51.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.622 ' HE3' ' HB1' ' A' ' 385' ' ' ALA . 4.6 mtmp? -65.22 -32.62 74.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -135.14 141.73 39.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.91 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 415' ' ' GLU . 74.2 Cg_exo -47.64 -58.66 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.689 2.259 . . . . 0.0 112.378 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 414' ' ' PRO . 32.1 mt-10 -37.59 -57.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . 0.468 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 26.8 mm-40 -43.52 -46.09 6.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.441 ' O ' HD11 ' A' ' 362' ' ' LEU . . . -61.62 -49.4 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.144 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -56.6 -27.26 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -77.81 -63.98 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -52.73 -19.44 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.829 HD22 HD11 ' A' ' 438' ' ' ILE . 45.5 tp -51.28 -64.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -92.67 -47.64 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . 0.479 ' N ' ' HD3' ' A' ' 422' ' ' LYS . 2.7 tm0? -38.27 -34.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 420' ' ' ALA . 94.3 mt -96.84 -31.8 12.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.463 ' NE2' HG23 ' A' ' 436' ' ' VAL . 6.5 tp60 -49.63 135.04 19.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.86 -24.94 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.457 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -56.18 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 99.7 m -70.44 106.95 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.155 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.759 HG21 HD11 ' A' ' 434' ' ' LEU . 94.1 t -106.51 118.89 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 62.27 31.06 17.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.29 51.41 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -122.03 129.54 52.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.41 145.92 50.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 429' ' ' VAL . 7.6 mt -103.57 158.81 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -108.98 119.93 41.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.463 HG23 ' NE2' ' A' ' 425' ' ' GLN . 14.5 t -109.99 133.87 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.405 ' HG2' ' C ' ' A' ' 436' ' ' VAL . 8.3 mmm180 -142.0 149.29 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.829 HD11 HD22 ' A' ' 421' ' ' LEU . 25.8 mm -70.14 96.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.871 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 64.8 p -95.96 128.01 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 408' ' ' PHE . . . 140.63 141.92 4.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 409' ' ' VAL . 8.4 mt -140.21 127.64 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.98 135.63 33.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 1.8 mm -126.05 142.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 363' ' ' PHE . 7.4 tptp -133.52 159.12 41.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 70.13 45.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.569 HD23 HD22 ' A' ' 434' ' ' LEU . 37.4 mt -93.53 108.27 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -51.02 124.31 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -46.48 -28.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -36.94 70.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.83 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 60.2 m -54.95 127.91 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.5 p -99.19 178.44 4.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.89 -47.49 21.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -42.34 -61.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 26.5 m -49.22 -62.36 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.155 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 23.0 tp -45.11 -48.56 12.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 389' ' ' CYS . 14.7 mmmt -49.34 -50.07 41.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.41 -34.63 89.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.494 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.49 -44.81 98.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.694 ' CD2' HG11 ' A' ' 409' ' ' VAL . 5.9 m-85 -80.59 -35.31 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -29.02 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -55.62 -41.61 73.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 420' ' ' ALA . 57.5 t -61.79 -39.83 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 169.23 -160.42 33.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.447 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.49 131.72 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 55.1 mt -98.01 134.84 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -81.26 -49.21 11.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.3 t -165.66 116.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.425 ' HB3' ' CD ' ' A' ' 377' ' ' LYS . 4.8 t -111.77 123.11 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -138.08 151.66 48.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.9 139.33 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.141 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 58.0 m -58.43 94.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -121.69 148.25 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -139.1 171.17 14.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -83.55 103.17 12.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.727 ' ND2' HD12 ' A' ' 402' ' ' LEU . 9.0 p30 -79.94 177.8 8.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 398' ' ' ALA . 13.2 ptmt -43.77 -35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 397' ' ' LYS . . . -78.8 -32.92 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 97.25 18.93 27.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.496 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.453 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 59.4 t -102.43 143.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.142 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.88 96.9 2.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.727 HD12 ' ND2' ' A' ' 396' ' ' ASN . 73.7 mt -111.12 148.4 32.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 25.4 m -57.95 159.79 5.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . 0.47 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 46.6 mtp -116.98 13.82 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 93.8 -4.87 72.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.491 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 1.7 p90 -153.61 158.8 41.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.18 -178.3 24.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . 0.432 ' CZ ' ' HA3' ' A' ' 361' ' ' GLY . 37.8 t80 -131.96 109.75 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.37 . . . . 0.0 110.898 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.694 HG11 ' CD2' ' A' ' 380' ' ' PHE . 71.3 t -100.35 124.97 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -110.73 142.35 42.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.6 m-85 -114.83 154.12 29.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -61.83 -34.42 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -122.0 156.97 59.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.578 0.704 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.2 -8.48 19.87 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.341 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.11 -49.51 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 383' ' ' VAL . 30.7 mm100 -52.25 -39.94 61.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -66.01 -40.02 90.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -63.05 -32.48 73.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -72.7 -66.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.964 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -44.99 -36.61 3.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 438' ' ' ILE . 12.6 tp -34.66 -64.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -96.76 -41.51 8.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 383' ' ' VAL . 8.2 tt0 -39.56 -41.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 380' ' ' PHE . 91.1 mt -92.21 -28.54 16.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.2 tp60 -48.78 138.32 11.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.82 -26.04 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -60.11 118.26 6.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 28.7 m -69.88 132.08 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.1 t -135.29 123.01 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 59.13 29.82 19.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 82.97 -13.56 43.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -116.93 145.19 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -88.59 144.02 26.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.569 HD22 HD23 ' A' ' 367' ' ' LEU . 8.3 mt -97.2 149.83 21.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -108.19 112.78 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.78 139.58 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -147.45 149.46 32.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ILE . . . . . 0.731 HD11 HD22 ' A' ' 421' ' ' LEU . 19.0 mm -68.68 95.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.913 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 77.5 p -165.22 112.24 0.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 110.846 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 61.5 m -113.85 126.17 54.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 127.25 97.68 0.98 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m -149.74 151.48 33.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.378 . . . . 0.0 110.814 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.7 p -103.14 150.0 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.53 7.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.4 mt -148.88 123.85 10.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -93.65 130.54 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.22 142.76 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -128.71 165.85 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 60.93 47.85 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.56 HD23 HD22 ' A' ' 434' ' ' LEU . 38.4 mt -90.83 113.53 25.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -52.22 121.49 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -44.86 -32.11 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.2 t -68.2 -41.33 81.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 85.8 m -46.28 146.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 38.3 p -121.17 174.71 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.04 -38.06 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -54.01 -59.79 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 59.2 m -54.16 -46.08 72.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.436 HD12 ' CD1' ' A' ' 380' ' ' PHE . 22.2 tp -54.0 -46.01 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' SER . 24.4 mtpp -60.56 -41.12 93.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.65 -51.86 54.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.469 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.514 HG12 HD22 ' A' ' 424' ' ' LEU . 68.5 t -59.8 -39.34 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.463 ' CD2' HG11 ' A' ' 409' ' ' VAL . 11.0 m-85 -82.16 -21.21 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 377' ' ' LYS . 2.0 t -68.92 -14.84 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -66.85 -41.27 87.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 420' ' ' ALA . 3.9 t -67.49 -48.91 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.155 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.09 38.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.96 123.09 23.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.138 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 410' ' ' GLU . 19.1 mt -81.17 130.35 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -76.29 -51.21 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 27.1 t -159.26 134.01 8.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 15.2 p -123.1 126.82 47.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 16.2 m -143.5 122.36 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 34.1 mt -101.01 142.75 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 73.8 m -60.78 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -121.86 135.35 54.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.63 167.41 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.67 106.83 15.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.5 p30 -84.98 179.27 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -39.35 -48.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.89 74.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.51 22.4 26.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.32 143.0 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -72.24 99.71 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.55 140.64 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 31.6 m -58.05 162.91 3.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 21.4 mtm -117.04 16.26 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.23 3.79 63.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.483 ' C ' HD12 ' A' ' 367' ' ' LEU . 8.6 p90 -158.29 157.06 31.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 0.0 110.88 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -153.9 -172.96 22.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -137.39 119.26 15.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 380' ' ' PHE . 36.5 t -107.47 138.48 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 386' ' ' ILE . 44.0 tt0 -118.56 150.66 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.5 m-85 -122.6 163.08 20.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -70.68 -30.87 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -139.63 143.7 36.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.64 -42.03 23.95 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 418' ' ' GLN . 7.4 tt0 -51.71 -66.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -37.82 -48.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.548 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -63.23 -40.13 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 415' ' ' GLU . 45.7 mm-40 -60.86 -33.98 73.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -79.03 -60.14 2.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.683 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.32 -24.51 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.613 HD22 HD11 ' A' ' 438' ' ' ILE . 14.0 tp -50.08 -66.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 422' ' ' LYS . 0.6 OUTLIER -90.99 -35.18 14.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -49.64 -43.14 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.557 HD12 ' HB1' ' A' ' 420' ' ' ALA . 95.0 mt -85.81 -18.28 33.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 8.0 tp60 -62.22 142.38 57.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 88.29 -18.68 39.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -57.83 121.86 11.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.6 m -71.15 96.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.61 123.05 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 59.08 28.81 18.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.64 -4.19 52.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.444 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -124.05 149.33 46.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -91.01 140.14 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.56 HD22 HD23 ' A' ' 367' ' ' LEU . 14.0 mt -97.89 154.61 17.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -104.45 103.38 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.24 132.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -139.98 152.17 46.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.613 HD11 HD22 ' A' ' 421' ' ' LEU . 8.7 mm -71.37 96.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p -41.23 154.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 71.04 30.28 2.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -89.85 132.03 35.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -46.07 -53.23 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 58.1 p -60.43 125.52 24.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -87.91 144.58 35.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 130.59 19.6 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.667 2.245 . . . . 0.0 112.356 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -97.19 95.92 8.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.124 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 67.0 m -89.25 110.25 21.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -82.18 167.73 47.73 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.446 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 179.34 3.78 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.671 2.248 . . . . 0.0 112.332 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 7.8 t -128.53 -53.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 17.4 m -80.13 166.74 21.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 58.2 m -47.07 -57.72 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.368 . . . . 0.0 110.847 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 3.2 m -44.68 -55.36 5.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.83 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.63 109.62 2.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.475 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 15.9 m -152.12 169.33 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.372 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.0 p -112.95 136.98 52.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.72 137.99 3.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.3 119.02 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.372 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.574 ' C ' HD13 ' A' ' 364' ' ' ILE . 3.7 t80 -99.19 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.664 ' N ' HD13 ' A' ' 364' ' ' ILE . 1.2 mm -98.72 142.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -129.66 163.23 26.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 6.3 t30 72.49 32.53 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.559 HD23 HD22 ' A' ' 434' ' ' LEU . 32.5 mt -81.5 131.79 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.466 HD21 ' CD2' ' A' ' 432' ' ' HIS . 5.0 m120 -71.7 125.82 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -45.88 -31.22 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 85.3 p -68.54 -38.25 80.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 45.9 m -57.79 137.37 56.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 69.0 p -114.87 176.35 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -65.59 -46.81 77.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.89 -55.0 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 56.9 m -59.93 -51.8 68.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 380' ' ' PHE . 8.9 tp -51.16 -42.54 60.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -57.62 -47.66 81.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.25 -43.88 97.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.06 -45.86 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 0.0 111.141 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' A' ' 376' ' ' LEU . 10.1 m-85 -80.22 -26.41 39.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.0 t -61.95 -16.36 50.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -67.22 -20.97 65.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.457 HG21 ' CB ' ' A' ' 420' ' ' ALA . 73.8 t -84.51 -48.66 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -171.95 -166.77 31.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.93 26.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.2 mt -92.55 139.16 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.168 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -53.86 3.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.0 t -151.36 126.97 10.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 409' ' ' VAL . 49.7 t -127.36 118.72 24.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 167.05 20.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 74.6 mt -126.65 143.7 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.1 m -72.69 103.76 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.87 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -114.34 137.95 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 395' ' ' LYS . 4.7 ttpt -127.2 149.43 49.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.939 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.48 ' N ' ' HG3' ' A' ' 394' ' ' LYS . 49.8 mttm -69.49 105.24 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 399' ' ' GLY . 2.0 p30 -81.69 179.09 7.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -41.39 -41.53 2.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -71.22 -32.52 68.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.58 15.65 49.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.46 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.67 143.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.27 99.64 3.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.85 156.33 36.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 21.3 m -57.78 158.72 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.481 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 23.1 mtm -117.06 15.79 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.05 3.84 69.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 404' ' ' MET . 5.5 p90 -155.5 155.36 33.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.361 . . . . 0.0 110.895 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.42 25.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.449 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -121.66 121.82 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.727 HG22 ' SG ' ' A' ' 389' ' ' CYS . 76.9 t -116.45 130.47 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -112.55 147.7 36.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.44 153.35 34.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -62.71 -33.42 75.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -125.28 159.8 58.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.566 0.698 . . . . 0.0 110.9 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -18.61 21.23 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -78.21 -49.71 13.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -48.86 -37.43 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.66 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -58.18 -29.51 65.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -78.03 -59.58 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.635 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -56.14 -17.98 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 438' ' ' ILE . 13.7 tp -52.79 -59.15 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 425' ' ' GLN . 12.9 tptp -99.72 -45.14 5.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -39.94 -39.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.635 HD12 ' HB1' ' A' ' 420' ' ' ALA . 95.8 mt -88.11 -26.42 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 10.3 tp60 -57.6 134.63 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.32 31.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -55.03 125.21 19.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.9 m -69.66 97.37 1.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.44 113.91 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.78 29.38 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.859 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.85 39.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . 0.466 ' CD2' HD21 ' A' ' 368' ' ' ASN . 25.5 m-70 -125.42 125.4 43.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -73.89 124.94 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.559 HD22 HD23 ' A' ' 367' ' ' LEU . 7.4 mt -89.39 164.11 15.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -116.43 103.23 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.28 126.02 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -130.93 162.9 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 421' ' ' LEU . 20.0 mm -86.92 98.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 48.1 t -81.34 127.88 33.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -98.65 154.33 18.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -75.52 114.53 14.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -59.83 170.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.1 m -68.99 99.98 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -75.81 149.77 83.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.564 0.697 . . . . 0.0 110.888 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 137.77 36.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.256 . . . . 0.0 112.331 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . 37.48 52.91 1.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.13 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 34.3 m -147.05 113.85 6.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -118.05 162.13 13.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.532 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 0.69 5.28 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.674 2.249 . . . . 0.0 112.344 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 4.6 t -127.8 151.1 49.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 4.8 t -94.57 116.56 28.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.539 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 5.7 m -38.74 -50.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.828 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.2 m -80.07 165.68 22.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 179.71 156.83 18.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.5 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t -117.76 86.39 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 80.7 p -85.48 125.73 33.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.439 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 145.44 139.08 3.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.519 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.4 mt -141.43 122.17 14.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.366 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.453 ' CB ' ' HB2' ' A' ' 439' ' ' SER . 0.5 OUTLIER -90.66 124.75 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.1 mm -113.35 146.59 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.89 167.02 20.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 12.2 t30 68.86 32.61 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.622 HD12 ' C ' ' A' ' 406' ' ' PHE . 46.4 mt -82.64 113.87 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.49 123.73 17.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -46.06 -21.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -78.37 -39.66 38.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 98.0 m -49.94 131.9 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.134 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 22.0 p -105.77 161.13 14.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.427 ' OE2' HD12 ' A' ' 391' ' ' ILE . 2.0 mp0 -61.85 -54.52 40.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 373' ' ' GLU . 36.5 mt-10 -36.65 -49.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 86.3 m -64.56 -50.88 65.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 380' ' ' PHE . 13.6 tp -54.66 -35.13 63.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 381' ' ' SER . 12.5 mmmt -61.25 -50.2 74.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.48 -42.92 95.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.52 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.85 -56.29 11.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.488 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.4 m-85 -72.13 -39.96 68.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.842 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 14.4 t -48.52 -22.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -55.75 -46.82 77.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.878 HG21 ' HB2' ' A' ' 420' ' ' ALA . 24.6 t -55.51 -61.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -161.13 -152.05 6.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -83.74 127.24 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.327 . . . . 0.0 111.098 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.7 mt -96.34 130.61 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.433 ' NZ ' ' HA ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -78.07 -51.32 10.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.924 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 45.7 t -157.31 131.71 8.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.508 ' SG ' HG22 ' A' ' 409' ' ' VAL . 21.4 t -127.0 110.83 13.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -130.48 138.4 50.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.562 HG21 ' OG ' ' A' ' 403' ' ' SER . 40.3 mt -99.49 149.04 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 40.7 m -70.28 102.14 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -123.94 147.15 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -69.66 102.89 1.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 399' ' ' GLY . 9.2 p30 -81.28 177.02 9.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -38.52 -49.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.39 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.92 30.51 8.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.432 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 35.9 t -113.36 143.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 111.112 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.75 100.29 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 29.4 mt -126.33 152.4 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.562 ' OG ' HG21 ' A' ' 391' ' ' ILE . 37.6 m -57.93 161.1 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 42.5 mtm -117.09 17.09 14.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.846 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.35 0.77 64.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.622 ' C ' HD12 ' A' ' 367' ' ' LEU . 4.7 p90 -153.69 155.27 35.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.868 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -143.02 -178.86 19.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . 0.573 ' CZ ' ' HG3' ' A' ' 410' ' ' GLU . 20.0 t80 -133.28 122.39 23.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.508 HG22 ' SG ' ' A' ' 389' ' ' CYS . 73.9 t -120.42 119.59 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.573 ' HG3' ' CZ ' ' A' ' 408' ' ' PHE . 15.2 mt-10 -109.55 141.65 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.0 161.13 15.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -62.58 -34.45 77.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -120.11 157.08 53.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 -10.01 21.28 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.47 -53.68 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -45.98 -38.05 7.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.16 90.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -62.13 -29.6 70.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -72.69 -64.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.878 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.45 -34.01 23.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 420' ' ' ALA . 12.8 tp -37.88 -63.35 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -93.41 -41.02 10.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -47.39 -42.33 21.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.851 HD12 ' HB1' ' A' ' 420' ' ' ALA . 90.3 mt -86.51 -23.13 26.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -56.85 146.98 24.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.78 -16.25 32.59 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -62.42 117.53 6.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 29.1 m -69.89 112.33 6.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.3 117.6 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 62.31 26.7 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 81.47 -9.33 55.6 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.517 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -116.61 142.67 46.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.428 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 24.0 mttt -88.12 138.04 31.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.63 156.26 16.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -109.48 109.33 20.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.06 136.04 29.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -141.69 161.26 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.99 96.5 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . 0.453 ' HB2' ' CB ' ' A' ' 363' ' ' PHE . 5.4 t -91.2 158.65 16.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.838 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -140.49 160.74 39.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -69.28 151.76 45.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -106.86 -43.88 4.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.091 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 10.8 t -126.99 147.48 50.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -77.24 146.73 75.08 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.538 0.685 . . . . 0.0 110.861 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -46.46 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.65 2.233 . . . . 0.0 112.367 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -88.65 89.98 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.13 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 20.3 m -79.94 132.25 36.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 155.67 -170.35 33.56 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 129.61 17.93 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.658 2.239 . . . . 0.0 112.362 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 2.0 t -51.16 155.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 72.4 p -142.19 169.56 17.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.543 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 9.2 m -64.82 -59.22 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.88 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 1.1 t 54.23 37.68 27.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -89.93 112.44 4.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.44 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 66.1 m -144.46 118.46 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.851 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 2.6 p -104.05 144.6 31.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.78 147.59 7.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 417' ' ' ALA . 5.3 mt -146.57 120.44 9.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.52 132.39 34.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.4 mm -118.95 144.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -131.96 160.18 36.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 51.3 t30 69.5 33.8 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 406' ' ' PHE . 57.7 mt -78.46 107.11 10.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 371' ' ' THR . 2.5 m120 -50.12 118.16 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -40.32 -31.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 p -65.7 -43.01 90.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 368' ' ' ASN . 82.4 m -49.49 147.35 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.089 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 53.0 p -127.46 165.25 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.4 -36.04 79.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -50.34 -59.71 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 55.9 m -61.97 -44.95 95.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.559 HD12 ' CD1' ' A' ' 380' ' ' PHE . 21.0 tp -57.22 -33.19 67.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 381' ' ' SER . 4.0 mtpm? -73.09 -28.16 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -82.14 -50.7 4.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.441 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.24 -37.88 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.814 0.34 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.762 ' HA ' HD11 ' A' ' 424' ' ' LEU . 16.6 m-85 -86.27 -22.74 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.9 t -69.51 -9.61 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.86 -28.14 44.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 420' ' ' ALA . 94.3 t -75.71 -38.17 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 178.51 -167.17 37.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.475 ' HB3' ' HG3' ' A' ' 412' ' ' LYS . . . -78.77 121.24 24.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.081 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.44 ' O ' ' NZ ' ' A' ' 412' ' ' LYS . 20.3 mt -83.52 131.37 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -79.49 -53.3 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 t -157.26 135.07 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.5 p -117.89 128.75 55.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.7 m -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 392' ' ' SER . 79.9 mt -100.69 153.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 391' ' ' ILE . 65.6 m -75.35 94.72 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 33.7 mttm -119.44 154.72 33.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -146.03 162.5 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.04 101.53 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 399' ' ' GLY . 6.6 p30 -77.14 178.62 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.58 -28.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -84.89 -32.98 22.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.069 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.77 18.86 33.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.453 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.25 143.66 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.89 0.376 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.89 102.13 3.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.414 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 24.3 mt -122.5 149.01 44.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -60.65 159.33 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.519 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 49.4 mtm -116.97 16.68 15.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 92.68 3.32 66.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.525 ' C ' HD12 ' A' ' 367' ' ' LEU . 1.9 p90 -158.29 159.65 36.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -156.92 -175.8 28.26 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -131.13 121.39 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.07 120.77 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -103.89 154.03 20.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.73 174.66 7.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 385' ' ' ALA . 23.3 mmtm -77.02 -37.14 55.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -137.38 151.46 71.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 415' ' ' GLU . 72.1 Cg_exo -46.72 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.25 . . . . 0.0 112.334 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 414' ' ' PRO . 17.7 tt0 -38.07 -48.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -48.54 -54.01 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.433 ' HA ' HD11 ' A' ' 362' ' ' LEU . . . -59.55 -40.4 87.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -59.74 -29.69 68.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -80.41 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.438 ' HA ' HG21 ' A' ' 383' ' ' VAL . . . -53.56 -18.2 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 438' ' ' ILE . 13.4 tp -53.76 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -92.04 -34.35 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . 0.428 ' CD ' ' O ' ' A' ' 423' ' ' GLN . 0.5 OUTLIER -47.35 -40.77 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.762 HD11 ' HA ' ' A' ' 380' ' ' PHE . 50.2 mt -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' HG23 ' A' ' 436' ' ' VAL . 6.1 tp60 -56.12 147.82 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.14 -12.97 34.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -64.72 115.8 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 75.6 m -70.74 101.95 2.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 434' ' ' LEU . 49.0 t -103.37 121.39 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 62.05 34.0 16.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.35 -6.98 49.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -122.86 138.25 54.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 7.2 mtpm? -79.34 146.19 33.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 429' ' ' VAL . 7.3 mt -105.76 159.13 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.464 ' OE1' ' CG ' ' A' ' 437' ' ' ARG . 3.4 tm-20 -110.49 127.76 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.496 HG23 ' NE2' ' A' ' 425' ' ' GLN . 21.6 t -113.11 135.86 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.464 ' CG ' ' OE1' ' A' ' 435' ' ' GLU . 14.3 mmt180 -140.54 152.49 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 421' ' ' LEU . 12.9 mm -76.12 98.49 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p -50.08 142.31 9.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.72 121.78 45.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -69.21 159.19 33.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -97.98 149.81 22.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.97 137.71 18.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.409 ' HD2' ' C ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -90.71 138.71 26.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.551 0.691 . . . . 0.0 110.914 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 447' ' ' SER . 54.4 Cg_endo -69.79 -39.77 6.05 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 0.0 112.36 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -54.29 83.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 445' ' ' PRO . 38.3 t -125.75 91.58 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -80.7 146.24 26.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.499 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 450' ' ' SER . 53.4 Cg_endo -69.81 123.72 10.36 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.681 2.254 . . . . 0.0 112.301 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 449' ' ' PRO . 60.1 p 34.39 46.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 63.5 p -77.1 -48.56 17.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.493 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 13.9 m -76.71 119.35 20.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 58.2 m -59.21 155.16 14.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -142.73 89.1 0.17 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.4 m -160.72 147.81 15.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 12.0 p -111.55 153.65 25.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.08 135.83 5.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 417' ' ' ALA . 10.2 mt -137.27 136.43 38.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.536 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.5 OUTLIER -103.34 124.56 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.536 HD13 ' C ' ' A' ' 363' ' ' PHE . 2.1 mm -111.33 142.17 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -132.35 161.7 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 72.73 37.03 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 406' ' ' PHE . 25.5 mt -86.28 126.95 34.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 371' ' ' THR . 5.4 m-20 -69.5 122.23 18.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -39.23 -40.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.9 m -62.44 -39.95 95.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 368' ' ' ASN . 53.4 m -50.88 126.49 16.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 82.6 p -106.82 157.42 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 374' ' ' GLU . 33.9 mt-10 -54.06 -50.04 67.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 373' ' ' GLU . 16.4 tt0 -34.89 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 83.4 m -55.91 -53.16 60.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.52 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 21.6 tp -49.98 -43.48 50.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -50.79 -54.9 19.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.3 -50.98 61.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 92.8 t -47.41 -55.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.182 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.583 ' HA ' HD11 ' A' ' 424' ' ' LEU . 6.7 m-85 -71.46 -34.65 70.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.0 t -53.76 -23.07 10.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -61.14 -35.89 78.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 420' ' ' ALA . 89.6 t -68.83 -42.79 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 176.58 -166.01 36.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.78 118.48 16.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 0.0 111.128 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 410' ' ' GLU . 25.8 mt -82.24 131.38 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.45 -42.84 28.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.6 m -169.54 126.42 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 2.3 t -119.61 117.25 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 98.9 m -139.77 136.45 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.114 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 392' ' ' SER . 80.5 mt -100.81 152.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 391' ' ' ILE . 10.9 m -70.97 101.7 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -126.41 152.03 46.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -144.0 158.65 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 395' ' ' LYS . 2.3 mppt? -74.12 101.9 4.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.646 ' OD1' ' HB3' ' A' ' 398' ' ' ALA . 4.8 p30 -74.68 179.27 4.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -20.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.646 ' HB3' ' OD1' ' A' ' 396' ' ' ASN . . . -91.52 -30.47 16.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 94.59 20.15 30.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.476 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 56.8 t -106.12 143.35 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 0.0 111.135 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -72.38 98.56 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 97.2 mt -111.46 141.81 44.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 14.2 t -58.07 159.96 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 16.0 mmm -115.71 24.82 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 78.62 -3.89 62.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.443 ' HA ' HD12 ' A' ' 367' ' ' LEU . 1.2 p90 -150.3 147.05 27.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -136.51 177.9 19.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.475 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -130.48 118.72 21.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.842 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 380' ' ' PHE . 77.4 t -106.06 146.13 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 386' ' ' ILE . 21.4 tt0 -129.92 146.38 51.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -120.57 164.5 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -66.42 -48.57 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.32 156.65 35.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.513 0.673 . . . . 0.0 110.917 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.39 -8.29 21.59 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.347 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.35 -46.65 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -49.2 -33.87 13.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 362' ' ' LEU . . . -67.86 -43.85 78.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.94 -31.45 72.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -70.42 -63.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.638 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -49.93 -36.98 29.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 420' ' ' ALA . 16.2 tp -34.84 -64.49 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -96.39 -39.77 9.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -45.09 -45.81 11.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.638 HD12 ' HB1' ' A' ' 420' ' ' ALA . 75.3 mt -83.76 -26.24 29.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.8 tp60 -52.15 152.02 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.3 -21.53 7.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.46 118.96 7.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 41.7 m -72.46 114.14 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.677 HG21 HD11 ' A' ' 434' ' ' LEU . 99.6 t -114.22 118.64 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 58.54 25.64 13.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 86.09 -8.62 72.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -118.43 138.94 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -82.34 144.02 30.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.677 HD11 HG21 ' A' ' 429' ' ' VAL . 6.4 mt -101.86 158.69 15.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.74 102.57 10.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 40.5 t -94.06 125.91 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -130.85 164.21 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 15.3 mm -82.32 96.05 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 8.1 t -88.01 90.45 8.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.73 173.38 6.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -100.98 130.93 47.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -82.39 -60.01 2.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 81.8 p -114.22 154.86 27.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -108.19 148.61 37.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 0.96 4.92 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.716 2.277 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -46.83 141.55 3.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.8 m -46.7 170.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -97.01 -158.1 31.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 0.98 4.82 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.746 2.298 . . . . 0.0 112.349 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 69.5 p -128.36 170.67 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 2.7 m -96.87 109.88 22.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.471 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 2.1 m -59.02 101.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.866 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 19.6 m -57.72 146.59 30.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 174.78 131.37 1.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.0 m -132.42 109.55 9.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 83.2 p -107.39 134.89 49.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.476 ' CA ' ' CE1' ' A' ' 408' ' ' PHE . . . 137.93 139.27 3.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.48 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.58 125.17 14.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.456 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.6 OUTLIER -93.64 118.63 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.5 mm -105.78 148.97 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -136.5 167.49 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 64.83 43.41 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 35.3 mt -94.39 100.66 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -40.74 118.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.419 ' C ' ' O ' ' A' ' 368' ' ' ASN . 6.4 m-85 -36.85 -45.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 65.3 m -58.21 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.4 m -48.59 143.86 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 54.2 p -124.39 157.03 36.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.1 mm-40 -48.07 -47.63 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 373' ' ' GLU . 3.0 tm-20 -34.64 -65.98 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 37.8 m -51.67 -60.38 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.566 HD12 ' CD1' ' A' ' 380' ' ' PHE . 12.5 tp -44.71 -37.41 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 381' ' ' SER . 7.9 mtpm? -71.53 -39.94 70.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.23 -19.99 70.82 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.75 -47.65 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.566 ' CD1' HD12 ' A' ' 376' ' ' LEU . 12.3 m-85 -74.94 -25.44 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 15.1 t -64.94 -16.42 63.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -67.82 -37.55 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 420' ' ' ALA . 92.6 t -66.41 -42.35 90.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -179.2 -158.65 21.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.527 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.403 ' HB3' ' HD2' ' A' ' 412' ' ' LYS . . . -85.14 124.11 31.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 410' ' ' GLU . 26.5 mt -82.53 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -54.15 4.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 98.3 p -149.26 123.16 9.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.447 ' C ' ' OE2' ' A' ' 373' ' ' GLU . 6.2 p -127.39 112.93 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -144.43 138.67 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.151 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 406' ' ' PHE . 76.2 mt -97.73 143.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.9 m -65.6 108.13 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -124.44 134.75 52.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.82 156.98 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 4.7 ptpt -78.9 106.37 10.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 399' ' ' GLY . 50.6 p30 -67.85 177.86 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 397' ' ' LYS . 0.4 OUTLIER -43.5 -35.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.6 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.95 38.0 3.98 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 84.0 t -119.95 143.64 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.27 107.75 6.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.3 mt -128.91 139.11 52.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.1 m -57.85 164.0 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 36.2 mtm -117.27 23.69 11.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.857 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.55 5.5 89.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 12.3 p90 -152.6 154.11 34.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.905 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.08 -162.03 9.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.472 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . 0.476 ' CE1' ' CA ' ' A' ' 361' ' ' GLY . 29.6 t80 -137.77 126.53 23.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.877 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 70.0 t -119.57 120.4 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 386' ' ' ILE . 16.7 tt0 -113.07 151.31 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.51 158.91 26.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.403 ' HD2' ' HB3' ' A' ' 385' ' ' ALA . 58.7 mttt -63.12 -36.16 82.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -117.37 160.19 38.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 0.0 110.931 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.66 -20.07 15.93 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -78.12 -49.35 14.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -46.39 -43.1 15.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.01 -51.52 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.11 -29.32 57.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -77.67 -67.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.603 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -50.45 -20.21 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 438' ' ' ILE . 12.8 tp -51.52 -70.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -92.29 -31.68 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.924 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . 0.445 ' NE2' HG22 ' A' ' 383' ' ' VAL . 14.2 tt0 -50.52 -39.47 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.592 HD12 ' HB1' ' A' ' 420' ' ' ALA . 85.3 mt -90.18 -36.97 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 12.7 tp60 -40.63 149.13 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.68 -19.26 9.51 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -59.95 133.84 56.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 30.2 m -72.88 123.56 23.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 434' ' ' LEU . 97.0 t -132.35 118.62 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.09 26.98 10.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 84.56 -17.62 29.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -113.24 139.06 49.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -78.06 135.94 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.618 ' CD1' HG21 ' A' ' 429' ' ' VAL . 9.2 mt -92.81 161.71 14.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.52 113.39 21.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.939 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.63 130.66 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -131.57 163.91 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 421' ' ' LEU . 20.1 mm -85.51 96.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.7 t -82.13 94.25 7.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.42 ' CD ' ' O ' ' A' ' 440' ' ' GLU . 2.5 pp20? -98.8 37.59 1.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 3.4 tpp85 -104.05 124.31 48.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -92.19 119.55 31.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.14 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 23.9 m -82.16 -63.8 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -103.44 144.35 28.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.58 0.705 . . . . 0.0 110.919 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 111.89 2.94 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.23 . . . . 0.0 112.325 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -39.41 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 32.2 t -174.98 115.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 174.01 148.01 6.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 113.34 3.35 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.65 2.233 . . . . 0.0 112.33 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 34.8 p -48.18 100.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 80.8 p -133.8 119.22 18.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 4.1 m -65.77 107.9 1.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.371 . . . . 0.0 110.86 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 44.5 m -76.41 140.18 41.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.797 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -139.98 87.79 0.2 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 57.4 m -136.73 117.02 13.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 5.8 p -102.9 140.08 37.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.6 142.4 4.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 12.1 mt -146.95 117.19 7.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -91.3 115.46 28.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 436' ' ' VAL . 3.2 mm -106.05 143.73 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . 0.483 ' CG ' ' HB3' ' A' ' 435' ' ' GLU . 12.4 ptmt -138.84 178.25 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 433' ' ' LYS . 47.9 t-20 65.62 27.84 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 434' ' ' LEU . 34.1 mt -76.86 149.79 36.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -88.95 125.78 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -47.13 -20.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.5 m -80.13 -37.86 32.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 43.2 m -61.52 129.95 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 58.8 p -109.99 159.67 17.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -45.51 -42.91 11.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -41.62 -69.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 376' ' ' LEU . 42.3 m -47.18 -67.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.173 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.517 HD11 ' CE1' ' A' ' 380' ' ' PHE . 10.3 tp -35.53 -53.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -55.91 -52.15 65.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -61.36 -14.08 39.59 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 71.4 t -90.18 -53.52 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.142 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.701 ' HA ' HD11 ' A' ' 424' ' ' LEU . 7.4 m-85 -66.8 -37.68 85.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 11.4 p -52.19 -16.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -63.89 -39.51 94.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 420' ' ' ALA . 37.1 t -68.62 -54.85 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -163.71 -170.33 28.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.7 120.78 18.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 41.3 mt -79.31 138.36 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.98 -55.1 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 8.7 t -142.19 121.73 13.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.99 116.35 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -148.41 137.17 21.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 33.8 mt -101.39 143.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.2 m -58.3 107.62 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 32.0 mttp -127.15 153.36 46.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -149.76 163.66 37.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -73.26 101.81 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.3 p30 -79.51 178.71 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -41.65 -45.44 3.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.57 -32.64 71.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.88 33.84 6.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.467 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.527 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 84.9 t -119.58 143.69 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.367 . . . . 0.0 111.106 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.01 98.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.41 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 62.8 mt -118.44 153.6 33.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 50.4 m -57.88 159.7 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 49.7 mtp -117.1 13.05 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 96.41 -3.33 63.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.525 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 6.8 p90 -153.21 157.42 40.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.383 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.04 -179.86 22.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -130.33 124.25 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 380' ' ' PHE . 86.1 t -112.41 132.87 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.72 143.06 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.4 153.83 32.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -59.65 -34.15 72.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -122.82 160.72 47.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.58 0.705 . . . . 0.0 110.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.99 -18.98 16.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.311 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -77.15 -52.28 9.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . 0.438 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 21.1 mm-40 -47.39 -31.78 4.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.98 -45.73 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.07 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -61.92 -30.61 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -71.15 -60.24 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -58.21 -33.82 69.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 438' ' ' ILE . 13.5 tp -36.63 -55.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 425' ' ' GLN . 11.7 pttm -100.93 -50.44 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 -38.59 -39.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.709 HD12 ' HB1' ' A' ' 420' ' ' ALA . 55.9 mt -88.59 -30.87 18.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 422' ' ' LYS . 7.9 tp60 -56.79 126.18 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.427 ' O ' ' NZ ' ' A' ' 433' ' ' LYS . . . 109.02 -17.81 31.79 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . 0.429 ' CD2' ' CG2' ' A' ' 429' ' ' VAL . 16.4 t60 -60.93 114.48 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 34.1 m -70.95 98.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.429 ' CG2' ' CD2' ' A' ' 427' ' ' HIS . 84.9 t -104.44 122.64 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 58.26 27.97 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.12 77.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -123.67 128.66 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 366' ' ' ASN . 37.0 mttm -80.42 119.53 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 367' ' ' LEU . 10.9 mt -78.87 161.95 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.483 ' HB3' ' CG ' ' A' ' 365' ' ' LYS . 5.7 tt0 -121.51 109.16 14.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.921 HG22 HD12 ' A' ' 364' ' ' ILE . 61.5 t -98.16 135.44 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.15 160.03 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.904 HD11 HD22 ' A' ' 421' ' ' LEU . 29.9 mm -79.48 95.48 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.058 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 6.0 t -92.65 127.97 38.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -118.35 149.82 40.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -109.67 138.93 45.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -84.73 -46.74 11.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 64.5 p -79.43 163.08 25.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.89 147.1 59.92 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.614 0.721 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 143.78 52.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.387 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -86.04 -57.51 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 59.7 m -43.99 128.13 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 160.77 -76.15 0.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.51 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -4.71 14.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.628 2.219 . . . . 0.0 112.376 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 37.4 m -43.75 115.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 44.1 p -102.4 167.02 10.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.856 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.435 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 4.7 t -88.25 -63.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 110.839 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 21.1 t -75.17 -52.84 9.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -178.62 156.69 19.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.3 t -117.67 109.15 16.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.38 . . . . 0.0 110.806 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p -107.34 129.12 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.17 143.89 4.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.518 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.432 HD22 ' CG1' ' A' ' 436' ' ' VAL . 12.4 mt -144.48 123.3 12.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 363' ' ' PHE . 0.7 OUTLIER -94.78 112.39 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.63 ' N ' HD13 ' A' ' 364' ' ' ILE . 1.4 mm -97.81 144.15 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 366' ' ' ASN . 0.3 OUTLIER -133.52 154.96 50.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 365' ' ' LYS . 32.6 t-20 74.72 44.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.32 123.51 36.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.93 125.63 25.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -45.89 -25.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.1 t -76.58 -38.3 55.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 62.9 m -54.57 125.47 19.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.175 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 62.5 p -107.49 152.84 23.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 47.1 mt-10 -47.36 -50.92 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 55.4 mt-10 -34.85 -58.35 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 88.7 m -58.2 -62.47 1.8 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 380' ' ' PHE . 24.5 tp -40.19 -48.29 2.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 381' ' ' SER . 45.0 mtpt -54.85 -43.16 72.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -66.99 -26.73 73.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.502 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.85 -41.33 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 111.142 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.489 ' HA ' HD11 ' A' ' 424' ' ' LEU . 5.9 m-85 -83.21 -22.48 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 12.5 t -67.73 -15.77 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -68.79 -33.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.655 HG21 ' HB2' ' A' ' 420' ' ' ALA . 18.6 t -72.61 -44.21 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -176.23 -170.67 39.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -77.23 128.65 34.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 111.084 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 410' ' ' GLU . 35.0 mt -90.63 135.77 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -89.07 -50.65 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 25.9 t -147.83 121.43 9.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.8 117.12 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 8.4 m -143.3 141.62 31.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 392' ' ' SER . 88.0 mt -106.68 154.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.462 ' N ' HG22 ' A' ' 391' ' ' ILE . 56.2 m -71.7 87.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -109.74 131.0 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.2 157.72 43.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 3.1 ptpp? -75.71 102.08 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.502 ' OD1' HD12 ' A' ' 402' ' ' LEU . 0.4 OUTLIER -62.15 175.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -42.32 -37.92 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.441 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -71.89 -32.89 67.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.75 38.02 3.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.45 143.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.85 0.357 . . . . 0.0 111.156 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.16 101.01 3.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.502 HD12 ' OD1' ' A' ' 396' ' ' ASN . 86.9 mt -127.08 148.76 50.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.94 163.05 2.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 38.2 mtp -117.09 14.3 14.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.25 70.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.414 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 2.5 p90 -156.05 158.27 37.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.951 0.405 . . . . 0.0 110.846 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.11 -176.85 22.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.79 115.03 16.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.84 130.4 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.162 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 386' ' ' ILE . 16.6 tt0 -111.42 149.53 31.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.08 153.02 43.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -64.37 -38.46 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -116.22 154.22 48.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.24 -14.72 28.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -82.75 -50.96 8.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.87 -41.61 16.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.0 82.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -57.73 -30.38 65.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -72.87 -68.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -48.44 -25.16 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.703 HD22 HD11 ' A' ' 438' ' ' ILE . 41.5 tp -46.65 -66.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -98.92 -40.8 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -41.64 -34.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 380' ' ' PHE . 70.0 mt -94.6 -37.96 11.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 5.7 tp60 -38.61 142.28 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 90.14 -23.53 20.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -56.3 130.0 42.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 26.7 m -74.16 110.09 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.59 HG12 ' OD1' ' A' ' 430' ' ' ASP . 61.3 t -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . 0.59 ' OD1' HG12 ' A' ' 429' ' ' VAL . 4.3 m-20 59.3 28.06 17.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.65 1.12 60.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.507 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -126.38 142.24 51.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -83.75 136.66 34.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.48 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 18.7 mt -96.36 157.46 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -111.1 102.04 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.465 HG12 HD12 ' A' ' 421' ' ' LEU . 52.4 t -94.32 121.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -128.26 161.52 29.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.703 HD11 HD22 ' A' ' 421' ' ' LEU . 20.5 mm -78.09 95.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . 0.414 ' HB2' ' N ' ' A' ' 363' ' ' PHE . 16.9 t -82.96 87.43 6.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -62.89 -38.51 91.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -90.73 131.73 36.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -91.23 159.17 16.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.114 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 8.4 t -46.38 131.37 10.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.143 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -117.21 142.29 29.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.541 ' O ' ' HB3' ' A' ' 446' ' ' ALA . 54.5 Cg_endo -69.74 -3.0 11.12 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 445' ' ' PRO . . . 73.78 38.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.6 m -65.24 -42.93 92.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 115.95 83.16 1.03 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 85.83 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 88.4 p -115.24 131.75 56.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 77.9 p -144.37 141.12 29.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.827 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.504 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 51.4 m -74.75 138.91 43.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 39.1 t -74.25 -65.59 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -167.93 110.01 0.37 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.3 m -136.57 160.77 37.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 84.2 p -108.48 148.36 30.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 117.26 144.11 7.71 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.444 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.3 mt -147.54 141.58 25.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.521 ' C ' HD13 ' A' ' 364' ' ' ILE . 0.4 OUTLIER -109.23 134.4 51.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.521 HD13 ' C ' ' A' ' 363' ' ' PHE . 2.4 mm -119.01 147.69 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -134.85 159.84 40.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 405' ' ' GLY . 46.5 t-20 70.33 34.46 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.494 HD12 ' C ' ' A' ' 406' ' ' PHE . 53.4 mt -80.73 103.16 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.7 m120 -48.66 119.31 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 368' ' ' ASN . 8.2 m-85 -38.17 -42.73 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 52.3 p -58.19 -42.62 86.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 368' ' ' ASN . 35.5 m -44.53 141.61 1.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.173 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 49.2 p -121.1 143.65 48.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 374' ' ' GLU . 39.2 mt-10 -43.32 -52.98 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 373' ' ' GLU . 21.8 mp0 -34.59 -61.13 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 89.5 m -55.73 -47.01 77.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.0 tp -54.44 -54.84 35.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -55.87 -36.35 67.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.93 61.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.5 -41.52 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.685 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.5 m-85 -77.67 -12.96 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 6.9 t -77.31 -21.41 53.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -61.56 -27.58 68.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.703 HG21 ' HB2' ' A' ' 420' ' ' ALA . 42.2 t -73.85 -48.95 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -172.05 -154.63 10.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -90.1 114.69 26.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.453 HG21 ' HB2' ' A' ' 389' ' ' CYS . 36.0 mt -74.81 138.06 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -93.53 -53.81 3.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 42.1 t -147.77 112.19 5.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 409' ' ' VAL . 36.1 t -119.13 113.06 20.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.5 m -144.59 136.85 26.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 392' ' ' SER . 51.2 mt -93.67 156.62 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.119 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 391' ' ' ILE . 71.8 m -77.47 109.51 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -126.01 172.33 10.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -152.53 154.27 35.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 101.76 6.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 399' ' ' GLY . 48.4 p30 -72.49 176.82 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -47.83 -23.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -89.36 -26.95 20.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 87.76 35.51 9.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 93.5 t -116.83 143.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.159 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.413 ' CD2' ' N ' ' A' ' 401' ' ' LEU . 0.5 OUTLIER -73.23 122.43 21.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 70.4 mt -141.01 140.24 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -58.44 156.61 10.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.2 mtm -114.95 20.7 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 88.66 0.92 81.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.494 ' C ' HD12 ' A' ' 367' ' ' LEU . 14.2 p90 -156.45 155.0 31.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -146.01 -179.9 22.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -130.4 118.31 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.566 HG22 ' SG ' ' A' ' 389' ' ' CYS . 95.5 t -107.48 144.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -124.66 156.42 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . 0.401 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 30.1 m-85 -131.81 156.9 45.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -65.44 -35.48 81.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -128.3 143.49 48.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 417' ' ' ALA . 72.4 Cg_exo -46.87 -52.35 7.79 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.695 2.263 . . . . 0.0 112.359 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 416' ' ' GLN . 34.1 mt-10 -44.56 -62.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mm100 -35.85 -42.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 414' ' ' PRO . . . -59.33 -52.3 66.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.29 -27.11 68.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -69.14 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.82 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -51.91 -35.52 45.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 420' ' ' ALA . 24.0 tp -36.14 -61.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -100.49 -32.15 10.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -58.26 -16.86 15.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.82 HD12 ' HB1' ' A' ' 420' ' ' ALA . 79.1 mt -115.77 -23.72 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -54.64 147.15 15.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 78.96 -10.82 31.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.501 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -58.88 132.93 55.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.1 m -72.52 109.82 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.193 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.55 HG11 HD11 ' A' ' 434' ' ' LEU . 77.4 t -126.92 113.47 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 61.39 28.79 18.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.48 39.22 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -115.66 143.16 45.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.358 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -84.87 121.04 27.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.55 HD11 HG11 ' A' ' 429' ' ' VAL . 8.8 mt -84.07 155.36 22.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.57 127.88 56.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.444 ' CG1' HD22 ' A' ' 362' ' ' LEU . 28.1 t -112.78 139.3 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 -139.96 166.35 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.1 mm -86.61 95.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.9 t -86.55 108.11 18.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -105.34 173.85 6.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -78.71 134.55 37.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.03 78.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.095 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 10.1 t -129.2 139.27 51.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 143.76 88.67 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.892 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 95.6 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -122.31 154.69 37.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.8 m -42.99 164.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -122.25 83.46 0.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.436 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 101.56 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.732 2.288 . . . . 0.0 112.314 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 8.0 t -165.42 170.84 14.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 12.7 m -109.93 141.1 43.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 356' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 355' ' ' GLY . 2.5 t 36.86 37.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.341 . . . . 0.0 110.802 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 36.1 m -115.81 95.01 4.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -158.5 133.98 3.65 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.7 t -148.82 145.54 27.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.848 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 6.4 p -109.65 126.47 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 144.66 135.34 2.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.2 mt -138.57 137.26 36.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -111.49 112.96 25.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.517 HD12 HG22 ' A' ' 436' ' ' VAL . 2.9 mm -97.42 143.71 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -131.8 160.31 35.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 5.5 t30 71.18 40.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -87.28 121.37 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 371' ' ' THR . 12.9 m120 -58.81 122.34 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -43.7 -24.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 -37.88 46.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 368' ' ' ASN . 95.3 m -51.31 131.73 28.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 41.4 p -113.89 154.33 27.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 374' ' ' GLU . 85.3 mt-10 -45.85 -54.42 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 373' ' ' GLU . 54.4 mm-40 -35.05 -66.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 378' ' ' GLY . 32.7 m -51.73 -64.03 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 375' ' ' THR . 15.3 tp -36.66 -52.59 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 377' ' ' LYS . 4.4 mtpm? -55.78 -42.19 75.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -68.82 -25.26 75.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.524 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 94.8 t -78.83 -45.29 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.573 ' CD2' ' CD1' ' A' ' 424' ' ' LEU . 12.6 m-85 -79.26 -46.02 18.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.478 ' N ' HD11 ' A' ' 386' ' ' ILE . 47.7 t -42.81 -28.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -48.15 -47.73 34.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 420' ' ' ALA . 97.2 t -57.79 -57.56 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.59 -167.42 24.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.466 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -72.9 121.26 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 410' ' ' GLU . 46.2 mt -85.25 139.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -82.9 -52.88 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -155.82 122.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.534 ' SG ' HG22 ' A' ' 409' ' ' VAL . 15.4 t -119.99 124.04 44.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.5 t -146.42 166.68 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.48 HG21 ' OG ' ' A' ' 403' ' ' SER . 73.5 mt -127.35 142.22 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.2 t -68.14 115.04 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -128.51 149.92 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -149.5 151.8 34.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 395' ' ' LYS . 2.4 ptpt -69.58 102.57 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 399' ' ' GLY . 52.5 p30 -64.41 179.12 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -42.88 -40.17 2.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.31 -32.16 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 100.6 31.94 5.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.47 143.51 29.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.14 116.74 15.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.421 HD12 ' ND2' ' A' ' 396' ' ' ASN . 39.6 mt -137.32 156.53 48.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.48 ' OG ' HG21 ' A' ' 391' ' ' ILE . 1.3 t -57.9 158.53 6.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 16.8 mtm -117.07 19.28 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.89 88.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 404' ' ' MET . 16.8 p90 -158.33 158.93 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.3 -172.6 20.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -125.32 123.69 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.534 HG22 ' SG ' ' A' ' 389' ' ' CYS . 89.9 t -118.53 119.28 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 386' ' ' ILE . 14.9 tt0 -106.54 153.68 21.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . 0.517 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 14.5 m-85 -122.53 153.14 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -59.54 -40.55 87.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -125.43 143.72 45.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.31 -41.61 28.13 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.743 2.295 . . . . 0.0 112.342 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 418' ' ' GLN . 1.2 tp10 -57.83 -62.63 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -37.91 -38.14 0.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -71.98 -41.19 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.086 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 415' ' ' GLU . 34.8 mm-40 -66.53 -22.19 66.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -83.28 -63.2 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -49.26 -40.39 34.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 438' ' ' ILE . 8.4 tp -35.42 -62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -92.77 -51.41 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -38.62 -36.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.859 HD12 ' HB1' ' A' ' 420' ' ' ALA . 90.4 mt -92.25 -35.27 13.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -43.6 150.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.01 -8.48 15.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -66.44 118.42 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 10.4 m -69.23 116.82 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 79.9 t -125.12 122.74 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.157 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 58.82 31.76 21.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.97 -8.12 24.67 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . 0.411 ' CD2' HD21 ' A' ' 368' ' ' ASN . 87.5 m-70 -119.58 133.01 55.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -76.57 151.53 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 5.4 mt -116.54 159.9 21.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -116.11 129.38 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 364' ' ' ILE . 36.0 t -116.95 142.35 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -137.11 159.47 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.752 HD11 HD22 ' A' ' 421' ' ' LEU . 24.9 mm -83.89 95.69 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 23.3 t -79.61 97.83 6.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -72.64 -47.08 50.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -76.69 131.81 39.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -128.61 113.0 14.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.6 p -45.53 164.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -75.78 145.02 77.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.562 0.696 . . . . 0.0 110.919 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -32.8 17.97 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.668 2.246 . . . . 0.0 112.361 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -62.37 116.11 4.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.2 m -73.56 103.2 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 94.16 85.89 1.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.46 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 2.8 3.2 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.335 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 15.8 m 59.07 45.42 14.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.3 t -73.59 135.75 43.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.531 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 7.9 t -63.07 151.57 39.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 110.886 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 3.6 m -118.33 -43.27 2.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.906 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 97.07 115.41 3.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 6.2 m -170.44 154.85 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.86 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.08 155.08 17.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.84 148.77 9.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.544 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.697 HD22 ' CG1' ' A' ' 436' ' ' VAL . 4.5 mt -147.24 131.88 17.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 365' ' ' LYS . 0.3 OUTLIER -98.38 131.0 45.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 2.0 mm -117.1 142.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 12.2 tptp -132.29 162.36 31.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.3 t30 64.93 31.52 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.585 HD23 HD22 ' A' ' 434' ' ' LEU . 33.7 mt -72.23 128.84 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.483 HD21 ' CD2' ' A' ' 432' ' ' HIS . 16.3 m120 -70.9 128.92 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -54.52 -15.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 69.4 m -81.8 -29.03 32.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 81.8 m -65.98 138.93 58.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.6 p -120.13 162.22 19.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.18 -36.51 75.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -50.48 -60.46 2.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 42.9 m -62.29 -55.66 26.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.554 HD12 ' CD1' ' A' ' 380' ' ' PHE . 16.6 tp -43.16 -38.59 2.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -69.38 -43.73 72.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.79 -20.45 72.34 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.478 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.16 -40.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.554 ' CD1' HD12 ' A' ' 376' ' ' LEU . 11.6 m-85 -82.6 -14.66 54.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 75.8 p -74.87 -15.28 60.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -65.03 -27.52 68.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 420' ' ' ALA . 59.5 t -79.39 -64.18 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -153.33 -162.44 11.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -84.28 118.46 24.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.755 0.312 . . . . 0.0 111.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.92 132.34 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -84.07 -55.04 4.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.7 p -154.46 116.62 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 28.5 p -108.54 120.36 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 95.2 m -137.79 127.54 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.77 140.79 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 70.1 m -57.55 99.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.85 157.82 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -153.96 156.34 37.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -74.67 104.58 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 398' ' ' ALA . 5.4 p30 -78.5 178.12 8.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -45.08 -33.62 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.454 ' HB3' ' OD1' ' A' ' 396' ' ' ASN . . . -78.73 -29.26 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 88.57 36.91 7.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.491 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 67.5 t -121.9 143.41 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.113 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -69.12 107.5 3.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 56.0 mt -126.88 143.92 51.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.0 p -59.3 162.39 4.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.537 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 37.6 mtp -117.08 13.78 14.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.12 1.48 64.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.557 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 404' ' ' MET . 1.7 p90 -158.31 158.82 35.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.845 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.03 -175.03 22.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -140.7 113.6 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 63.4 t -103.49 121.0 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.18 145.31 28.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -120.82 151.38 39.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -64.64 -14.04 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -141.47 159.07 61.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.635 0.731 . . . . 0.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.67 -44.93 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.4 -49.41 72.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -47.24 -47.9 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -54.37 -60.01 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -48.88 -31.13 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -75.55 -56.76 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 424' ' ' LEU . . . -57.88 -15.03 7.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.574 ' HB2' HD21 ' A' ' 362' ' ' LEU . 14.2 tp -63.61 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.95 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.7 -34.63 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -55.18 -14.69 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 420' ' ' ALA . 46.7 mt -117.82 -37.22 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 13.7 tp60 -42.13 145.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.9 -10.75 59.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -67.79 122.48 18.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.0 m -69.24 116.33 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.147 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.5 123.21 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.26 26.66 15.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.29 40.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.541 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . 0.483 ' CD2' HD21 ' A' ' 368' ' ' ASN . 89.9 m-70 -121.61 137.34 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -77.73 143.25 38.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.585 HD22 HD23 ' A' ' 367' ' ' LEU . 8.0 mt -102.73 159.18 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -113.81 105.99 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.697 ' CG1' HD22 ' A' ' 362' ' ' LEU . 22.5 t -97.92 133.95 38.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -139.33 166.08 25.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 3.2 mm -87.11 101.53 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 30.9 t -84.68 131.44 34.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -132.29 118.98 20.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.925 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 441' ' ' ARG . 0.0 OUTLIER -100.41 136.38 40.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -42.39 161.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 72.8 p 47.61 41.93 14.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.111 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 148.56 87.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.567 0.699 . . . . 0.0 110.905 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 137.8 36.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.719 2.28 . . . . 0.0 112.331 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -142.58 156.83 45.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.6 p -96.9 163.23 13.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 161.99 169.23 25.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.518 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -0.24 6.64 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.728 2.286 . . . . 0.0 112.312 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 9.9 t -48.49 167.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.831 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 16.5 t -155.3 144.36 20.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 95.8 p -40.47 125.24 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 2.9 t -132.12 107.75 8.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -63.2 166.38 25.01 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t -158.16 147.09 19.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 110.862 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.6 p -109.82 125.36 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.86 138.07 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.5 mt -143.91 129.58 19.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.899 0.38 . . . . 0.0 110.902 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -105.17 116.61 32.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.9 mm -103.57 141.2 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -127.56 165.11 20.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 9.2 t30 71.79 28.12 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.671 HD12 ' CA ' ' A' ' 406' ' ' PHE . 36.4 mt -74.59 126.51 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.7 m120 -73.66 121.94 21.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -39.27 -38.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.4 t -61.66 -42.71 99.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 368' ' ' ASN . 90.3 m -50.13 121.72 5.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.3 p -99.66 154.12 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.25 -55.37 15.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -43.35 -44.53 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 85.3 m -64.66 -54.35 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.499 ' CD1' ' CD1' ' A' ' 380' ' ' PHE . 11.7 tp -53.2 -43.72 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -59.45 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -54.55 -57.76 16.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 88.1 t -41.17 -49.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.556 ' HA ' HD11 ' A' ' 424' ' ' LEU . 9.9 m-85 -78.46 -25.51 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.1 t -63.2 -12.94 32.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.3 -24.12 64.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 420' ' ' ALA . 78.4 t -81.39 -59.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.12 -172.65 30.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -68.99 117.03 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.739 0.304 . . . . 0.0 111.055 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.58 133.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.17 -52.13 7.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.4 m -162.48 117.66 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 409' ' ' VAL . 17.6 t -120.13 132.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -144.44 162.65 35.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 406' ' ' PHE . 87.8 mt -123.82 138.77 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 406' ' ' PHE . 4.9 p -58.35 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -115.93 140.73 48.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -136.25 170.01 16.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -86.63 108.81 18.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 0.3 OUTLIER -80.25 178.67 8.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -46.03 -35.8 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -76.02 -31.83 59.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 96.25 35.3 5.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.449 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.444 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 18.9 t -118.85 145.24 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.378 . . . . 0.0 111.13 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.0 96.4 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.425 HD12 ' OD1' ' A' ' 396' ' ' ASN . 63.0 mt -110.95 137.67 48.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.4 p -57.67 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 80.0 mtp -116.44 14.49 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.53 74.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.671 ' CA ' HD12 ' A' ' 367' ' ' LEU . 16.8 p90 -148.97 174.33 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.33 175.64 39.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.545 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -126.55 117.47 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.887 HG22 ' SG ' ' A' ' 389' ' ' CYS . 63.0 t -111.8 136.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -123.33 146.7 47.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.02 153.81 33.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -59.39 -42.03 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -113.32 159.52 34.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 110.875 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -16.34 18.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.346 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.66 -48.82 12.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.52 -35.94 14.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.82 65.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -58.56 -27.93 65.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -78.89 -63.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -55.67 -15.86 3.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.805 HD22 HD11 ' A' ' 438' ' ' ILE . 25.2 tp -57.81 -62.16 2.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -95.78 -27.63 15.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . 0.439 ' CD ' ' O ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -58.48 -45.14 89.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.556 HD11 ' HA ' ' A' ' 380' ' ' PHE . 94.4 mt -83.98 -17.08 41.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 15.8 tp60 -64.85 134.7 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.03 45.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -55.25 131.79 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.3 m -73.44 96.23 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.7 t -111.31 113.2 43.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.58 31.3 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 65.33 6.28 26.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -126.4 126.46 43.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -73.03 126.8 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.488 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 6.7 mt -90.75 159.34 16.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -110.56 103.18 11.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.443 HG12 HD12 ' A' ' 421' ' ' LEU . 60.7 t -92.51 131.83 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -136.47 164.94 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.805 HD11 HD22 ' A' ' 421' ' ' LEU . 30.9 mm -88.21 97.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.1 t -83.73 87.75 7.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.21 -48.18 71.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -65.9 128.79 37.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -125.96 150.69 47.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 45.8 m -109.63 133.45 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 147.71 47.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 0.0 110.903 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 97.81 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -83.85 102.01 12.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 55.1 p -48.72 -47.99 40.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.01 157.38 9.77 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.543 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 159.18 54.44 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.716 2.277 . . . . 0.0 112.387 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 58.6 p -153.01 125.59 8.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 35.5 m -42.32 102.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.856 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.484 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.5 t -40.05 -56.4 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 1.7 t -79.68 161.11 26.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 179.93 66.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.2 m -147.98 157.28 43.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.854 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 81.8 p -112.32 139.11 48.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.14 144.01 5.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.8 mt -149.94 112.95 4.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.36 113.61 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 364' ' ' ILE . 1.9 mm -98.8 145.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -131.87 161.59 32.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.6 t30 71.19 30.26 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 406' ' ' PHE . 76.5 mt -74.77 112.93 11.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.7 m120 -57.85 117.06 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 368' ' ' ASN . 5.6 m-85 -34.26 -54.59 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 m -46.7 -45.17 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 368' ' ' ASN . 85.9 m -48.3 138.48 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 374' ' ' GLU . 14.6 t -123.22 163.31 20.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -56.57 -15.13 3.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.609 ' H ' HG23 ' A' ' 372' ' ' THR . 21.1 tt0 -68.47 -60.33 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.963 ' O ' HG23 ' A' ' 379' ' ' VAL . 51.6 m -61.58 -38.05 86.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 391' ' ' ILE . 7.4 tp -62.9 -57.5 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -53.1 -31.87 44.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -80.75 -23.96 59.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 375' ' ' THR . 94.5 t -80.62 -45.25 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.701 ' HA ' HD11 ' A' ' 424' ' ' LEU . 8.2 m-85 -76.0 -24.44 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.3 p -61.71 -24.28 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.877 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -58.56 -39.82 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.692 HG21 ' HB2' ' A' ' 420' ' ' ALA . 12.0 t -66.96 -48.29 79.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.426 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -179.02 -168.57 38.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.01 130.58 43.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 28.0 mt -92.9 137.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -86.05 -50.19 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.5 p -160.06 126.27 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 409' ' ' VAL . 50.9 t -123.84 98.98 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 87.5 m -117.84 125.32 50.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.565 HD11 HD23 ' A' ' 376' ' ' LEU . 29.0 mt -101.44 155.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 406' ' ' PHE . 50.6 p -69.86 92.93 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -121.29 141.02 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -138.08 167.55 21.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.434 ' HE3' ' N ' ' A' ' 395' ' ' LYS . 0.1 OUTLIER -82.44 102.89 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 3.7 p30 -76.28 178.35 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -39.35 -52.62 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.57 -31.72 73.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 95.03 30.98 7.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.531 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 13.8 t -109.18 151.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 401' ' ' LEU . 0.8 OUTLIER -76.28 112.72 13.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 66.1 mt -136.54 136.34 39.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 70.7 m -57.86 164.12 2.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 6.1 mtm -112.29 15.61 20.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 98.09 0.72 58.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.673 ' C ' HD12 ' A' ' 367' ' ' LEU . 53.5 p90 -156.57 172.33 18.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -167.97 -177.02 38.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -132.38 133.54 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.627 HG22 ' SG ' ' A' ' 389' ' ' CYS . 54.5 t -125.55 141.68 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.158 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -124.42 142.77 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 23.8 m-85 -113.87 156.51 23.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -61.42 -41.41 97.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -126.93 142.69 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.583 0.706 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.27 -41.58 27.83 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.93 -55.99 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . 0.426 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 42.5 mm-40 -45.45 -36.69 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -69.2 -45.93 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -60.71 -25.28 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -80.73 -63.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.692 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -55.52 -18.32 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.83 HD22 HD11 ' A' ' 438' ' ' ILE . 17.4 tp -55.84 -66.43 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -93.81 -41.68 9.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -42.27 -46.26 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 380' ' ' PHE . 57.9 mt -82.24 -29.49 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.3 tp60 -50.17 142.08 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.7 -18.3 30.88 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -56.62 128.04 34.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.478 ' HA ' ' CE ' ' A' ' 433' ' ' LYS . 1.4 m -71.29 99.27 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.15 124.55 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.49 28.52 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 74.05 -1.53 47.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -124.65 151.53 44.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.478 ' CE ' ' HA ' ' A' ' 428' ' ' THR . 6.0 mmpt? -88.86 133.4 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.496 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 13.4 mt -94.21 154.71 17.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.915 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.79 106.31 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.7 t -97.65 126.76 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -133.95 163.63 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.815 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.83 HD11 HD22 ' A' ' 421' ' ' LEU . 10.7 mm -86.36 99.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.3 p -46.26 169.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -135.13 166.33 23.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -109.08 122.03 46.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -52.11 125.99 17.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 444' ' ' LYS . 34.9 m -130.14 155.14 46.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.427 ' N ' HG22 ' A' ' 443' ' ' THR . 0.0 OUTLIER -127.4 143.39 47.12 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.879 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 446' ' ' ALA . 54.0 Cg_endo -69.75 -46.65 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.677 2.251 . . . . 0.0 112.345 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 445' ' ' PRO . . . -34.0 132.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 97.5 p -169.57 110.99 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -143.36 -149.77 5.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 128.15 15.61 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 16.1 m -153.13 160.63 42.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 91.6 p -117.41 132.95 56.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 13.5 p -96.59 102.34 14.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 110.836 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 68.8 m -128.07 132.9 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.82 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 150.68 76.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.513 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.3 t -164.93 155.85 14.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.848 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.1 p -107.57 131.77 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.871 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.9 142.78 5.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.85 124.41 13.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.4 OUTLIER -90.71 127.75 36.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.3 mm -116.29 142.32 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -131.56 161.18 33.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 72.35 35.91 1.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 406' ' ' PHE . 50.9 mt -85.35 109.55 18.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -52.57 130.96 33.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.839 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -52.33 -16.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.8 t -82.23 -37.26 26.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 97.0 m -55.21 131.99 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 23.2 p -110.66 156.27 21.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -50.48 -43.71 55.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -43.18 -63.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 378' ' ' GLY . 19.5 m -55.95 -65.8 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.591 HD12 ' CD1' ' A' ' 380' ' ' PHE . 11.8 tp -37.12 -44.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -62.87 -44.13 96.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -61.48 -52.91 48.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.09 -34.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.159 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.591 ' CD1' HD12 ' A' ' 376' ' ' LEU . 13.5 m-85 -87.19 -11.84 48.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 t -78.07 -14.16 59.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.51 -38.07 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 420' ' ' ALA . 60.2 t -64.42 -55.93 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -169.04 -163.2 22.68 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.77 126.17 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 19.7 mt -88.84 136.94 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -86.09 -53.21 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 14.2 t -165.67 130.56 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 45.1 t -123.09 122.63 38.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 91.3 m -130.9 127.42 38.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 406' ' ' PHE . 57.9 mt -95.8 140.68 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.692 ' CB ' ' CE2' ' A' ' 406' ' ' PHE . 2.8 p -60.01 91.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -119.8 140.67 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -139.76 160.79 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -70.72 107.93 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 399' ' ' GLY . 8.6 p30 -88.61 179.25 6.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -38.92 -47.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.44 -31.63 68.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 91.86 29.83 11.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.454 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.78 142.6 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.29 96.63 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 28.9 mt -119.22 149.35 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 p -57.87 160.7 4.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.1 mtm -116.81 10.89 14.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.52 56.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.692 ' CE2' ' CB ' ' A' ' 392' ' ' SER . 9.4 p90 -152.78 176.09 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -166.73 -172.99 34.64 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -137.8 121.65 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 84.7 t -110.65 132.87 57.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.09 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -115.91 153.14 32.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -131.89 152.16 51.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -67.15 -25.3 66.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -117.97 151.58 49.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.407 ' O ' ' NE2' ' A' ' 418' ' ' GLN . 58.7 Cg_endo -71.96 -27.72 17.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.357 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 416' ' ' GLN . 14.4 tp10 -75.95 -57.19 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . 0.653 ' NE2' HG12 ' A' ' 383' ' ' VAL . 30.9 mm100 -34.83 -43.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -56.0 -51.01 69.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 415' ' ' GLU . 3.4 mp0 -63.73 -28.49 69.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -65.49 -59.15 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.935 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -62.32 -33.89 75.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 438' ' ' ILE . 15.8 tp -38.64 -55.18 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.84 -43.07 6.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -47.49 -43.76 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.935 HD12 ' HB1' ' A' ' 420' ' ' ALA . 86.3 mt -84.25 -24.15 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -56.99 147.22 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.47 11.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -61.06 118.86 7.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 20.7 m -69.23 116.38 9.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.37 117.68 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 61.28 31.2 19.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 76.12 -4.47 47.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -122.63 131.44 53.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -74.7 143.83 44.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 9.0 mt -105.57 161.51 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.52 120.26 39.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.41 134.72 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -140.93 159.6 41.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 421' ' ' LEU . 22.4 mm -76.93 97.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 4.3 p -43.31 132.54 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -137.07 132.66 34.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -108.38 163.79 12.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -114.53 42.08 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.9 t -149.68 145.09 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.162 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.67 139.29 26.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 87.19 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.305 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -173.19 117.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 58.7 m -86.05 85.66 7.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.806 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 137.33 -162.73 25.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 157.04 61.85 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 94.4 p -129.54 120.8 25.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 30.3 m -123.51 154.53 39.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.502 -179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 17.0 m -106.4 104.77 14.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 110.868 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 17.4 t -82.37 100.23 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 75.26 162.02 10.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.491 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.8 m -165.38 162.69 19.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.4 p -114.32 137.34 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.844 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 130.24 141.86 5.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.51 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.11 117.63 7.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -95.78 112.4 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.419 ' N ' HD13 ' A' ' 364' ' ' ILE . 2.1 mm -98.97 149.99 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -133.86 158.24 43.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 405' ' ' GLY . 37.4 t30 74.72 36.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 406' ' ' PHE . 45.9 mt -84.21 118.82 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 371' ' ' THR . 4.6 m-20 -56.38 119.87 6.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -41.0 -30.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 53.7 p -73.39 -39.22 65.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 368' ' ' ASN . 55.2 m -46.18 121.11 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 39.4 p -96.23 157.48 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 374' ' ' GLU . 45.1 mt-10 -56.34 -55.9 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.2 tt0 -36.84 -57.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 379' ' ' VAL . 33.0 m -52.2 -50.5 61.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.511 HD11 ' CE1' ' A' ' 380' ' ' PHE . 15.1 tp -55.49 -49.76 71.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -53.08 -36.46 60.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -75.04 -43.65 26.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.455 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 375' ' ' THR . 99.1 t -60.79 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.126 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.62 ' HA ' HD11 ' A' ' 424' ' ' LEU . 5.8 m-85 -81.29 -24.48 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.3 t -65.81 -19.98 66.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -63.29 -35.49 80.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 420' ' ' ALA . 60.3 t -66.4 -62.7 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -158.07 -150.3 5.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -88.88 122.33 32.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 410' ' ' GLU . 23.1 mt -87.32 142.53 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -90.26 -49.19 6.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 33.8 t -164.7 118.26 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.885 ' SG ' HG22 ' A' ' 409' ' ' VAL . 7.7 t -113.31 130.34 56.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.5 t -146.05 154.12 41.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 77.8 mt -115.27 141.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 74.6 m -64.87 91.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . 0.409 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 53.6 mttt -115.17 147.61 40.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -134.48 156.5 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 395' ' ' LYS . 0.6 OUTLIER -76.9 110.74 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 399' ' ' GLY . 5.1 p-10 -82.58 178.48 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 398' ' ' ALA . 0.0 OUTLIER -41.72 -30.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 397' ' ' LYS . . . -87.79 -32.25 19.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.097 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 94.54 31.02 8.12 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.529 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.92 143.2 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.105 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.12 112.16 8.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.409 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 32.2 mt -134.5 136.1 42.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.1 m -57.84 159.19 5.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.507 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 47.0 mtm -116.9 21.13 13.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 90.05 4.96 71.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.453 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.521 ' C ' HD12 ' A' ' 367' ' ' LEU . 5.7 p90 -155.08 154.31 32.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.388 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.6 168.37 30.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.28 122.23 45.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.885 HG22 ' SG ' ' A' ' 389' ' ' CYS . 86.5 t -115.27 125.21 72.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 386' ' ' ILE . 28.6 tt0 -111.55 155.38 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -126.54 165.75 18.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.906 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -71.93 -34.5 69.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.21 161.75 41.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.18 -16.31 19.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.22 -41.54 14.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -51.04 -44.5 61.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.59 -46.47 88.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -57.13 -35.95 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -67.47 -61.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -52.24 -34.65 46.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.095 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.452 HD22 HD11 ' A' ' 438' ' ' ILE . 63.7 tp -34.86 -61.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.25 -44.83 5.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -39.87 -35.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 380' ' ' PHE . 84.0 mt -93.3 -33.4 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.4 tp60 -47.03 139.88 5.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 89.14 -16.2 56.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -59.69 129.88 44.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 18.2 m -69.83 114.12 7.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.169 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.1 116.73 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 54.59 31.16 14.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 73.05 -2.79 32.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -123.45 133.13 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -77.95 145.28 36.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.487 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 9.8 mt -106.12 163.28 12.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.46 108.57 17.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.485 ' O ' ' CZ ' ' A' ' 437' ' ' ARG . 42.0 t -92.47 124.74 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.485 ' CZ ' ' O ' ' A' ' 436' ' ' VAL . 11.3 mmp_? -127.17 165.96 18.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.452 HD11 HD22 ' A' ' 421' ' ' LEU . 5.2 mm -90.63 97.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.4 p -39.62 -39.25 0.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 64.55 37.82 7.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -95.56 148.24 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -119.91 124.46 46.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 13.5 t -130.93 154.27 48.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.457 ' CG ' ' HD2' ' A' ' 445' ' ' PRO . 17.9 ttpt -88.15 139.53 30.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.649 0.738 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 444' ' ' LYS . 53.3 Cg_endo -69.79 97.53 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.635 2.224 . . . . 0.0 112.335 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -99.96 165.92 11.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.1 m -92.86 -44.72 8.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 449' ' ' PRO . . . 98.4 -146.71 18.29 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.465 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' ' 448' ' ' GLY . 54.3 Cg_endo -69.71 -0.25 6.61 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.706 2.271 . . . . 0.0 112.337 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 15.5 m -102.24 129.27 48.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 1.2 t -150.04 175.65 11.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 75.7 m -114.55 118.83 34.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 48.0 t -174.69 144.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 127.91 109.48 1.52 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.532 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m -160.48 163.77 32.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.879 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 78.1 p -105.57 159.4 15.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 103.26 139.43 10.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.502 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 409' ' ' VAL . 9.6 mt -141.86 131.3 23.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.64 125.85 40.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 2.2 mm -116.3 142.06 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.077 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . 0.428 ' CD ' ' HB3' ' A' ' 406' ' ' PHE . 13.1 tptm -128.89 162.5 27.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 405' ' ' GLY . 35.2 t-20 65.08 45.56 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 406' ' ' PHE . 43.6 mt -89.52 107.36 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -50.49 124.51 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -47.1 -28.5 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 29.7 t -69.22 -35.55 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 13.1 m -56.67 130.44 45.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.088 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 43.8 p -108.16 156.52 19.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -49.75 -49.42 48.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -43.35 -68.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 91.3 m -44.98 -64.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 18.5 tp -39.77 -51.76 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -54.39 -43.43 71.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -62.13 -48.85 80.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 66.6 t -58.23 -40.77 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.47 ' HA ' HD11 ' A' ' 424' ' ' LEU . 15.2 m-85 -82.51 -20.91 35.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 24.3 t -70.27 -14.01 62.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.809 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -71.49 -37.71 71.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 420' ' ' ALA . 94.9 t -65.88 -39.82 85.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.106 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.41 44.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -69.15 123.08 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.08 133.13 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -52.56 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.4 p -157.77 120.87 3.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 36.1 t -119.16 120.43 37.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -143.92 145.44 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.595 HG21 ' OG ' ' A' ' 403' ' ' SER . 59.0 mt -106.1 148.66 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.4 m -72.65 101.22 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -124.51 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -126.65 165.34 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -77.11 103.42 7.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.509 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 5.6 p30 -79.06 178.14 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -41.08 -46.93 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 96.28 26.66 10.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.509 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 65.1 t -108.0 142.45 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.136 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.6 102.09 2.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.12 147.66 43.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 391' ' ' ILE . 1.5 t -57.99 155.79 10.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.582 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 52.6 mtm -116.06 19.47 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 366' ' ' ASN . . . 87.86 1.4 82.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -156.27 153.28 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.12 167.81 30.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.04 128.07 55.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 362' ' ' LEU . 82.3 t -120.49 122.3 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -110.75 144.74 39.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -114.23 169.0 9.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -73.29 -36.9 66.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -131.92 143.88 50.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.37 -39.16 21.56 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 418' ' ' GLN . 25.1 mm-40 -56.95 -63.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 415' ' ' GLU . 3.2 mm100 -36.51 -45.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.08 -44.99 90.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 415' ' ' GLU . 16.1 mm-40 -59.14 -30.85 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -75.5 -66.7 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.607 ' HB1' HD12 ' A' ' 424' ' ' LEU . . . -47.2 -33.0 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.102 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 12.7 tp -40.7 -66.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -94.37 -36.56 11.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -48.63 -46.36 39.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.607 HD12 ' HB1' ' A' ' 420' ' ' ALA . 82.3 mt -82.07 -35.57 28.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 9.6 tp60 -42.65 152.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.39 -25.54 4.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -59.57 118.78 6.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 80.8 m -70.88 122.61 20.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.589 HG21 HD11 ' A' ' 434' ' ' LEU . 61.8 t -122.04 119.91 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 60.89 26.73 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.826 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 88.63 -15.89 55.71 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.474 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -116.86 145.45 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -85.11 146.19 27.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.589 HD11 HG21 ' A' ' 429' ' ' VAL . 10.0 mt -100.14 161.58 13.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -115.04 105.2 12.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 22.6 t -97.18 134.94 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -141.79 160.63 39.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.49 95.99 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 33.4 t -81.32 90.74 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -89.33 130.9 35.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.865 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -88.69 156.8 18.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -120.68 -54.34 2.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 8.9 t -104.26 155.44 18.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 445' ' ' PRO . 16.3 mttm -106.78 95.48 12.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.535 0.683 . . . . 0.0 110.869 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 444' ' ' LYS . 54.8 Cg_endo -69.68 151.59 69.55 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.671 2.247 . . . . 0.0 112.381 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 447' ' ' SER . . . -93.01 139.33 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 446' ' ' ALA . 5.5 m -36.88 111.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 75.16 146.05 1.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -37.16 9.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.718 2.279 . . . . 0.0 112.294 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 3.6 t -148.43 174.01 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 68.3 m -66.17 111.57 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 -179.967 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 4.8 m -143.81 137.02 27.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 110.87 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 47.0 m -84.09 160.77 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.836 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 130.94 113.0 1.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 18.0 m -112.16 108.52 17.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.876 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 9.1 p -108.54 128.41 54.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 150.93 143.37 3.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 mt -145.89 127.58 15.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.459 ' C ' HD13 ' A' ' 364' ' ' ILE . 2.5 t80 -102.8 122.93 45.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.75 HD12 HG22 ' A' ' 436' ' ' VAL . 3.5 mm -108.66 144.82 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -135.16 159.64 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.7 t30 73.93 27.33 1.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.98 117.79 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 371' ' ' THR . 3.5 m120 -56.73 120.27 7.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -42.04 -35.34 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.5 m -64.9 -40.12 94.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 368' ' ' ASN . 84.8 m -55.31 146.24 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.163 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 18.8 p -123.19 168.61 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 374' ' ' GLU . 5.6 mp0 -57.98 -54.38 47.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 373' ' ' GLU . 13.3 mp0 -36.78 -70.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 379' ' ' VAL . 16.1 m -43.77 -51.43 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.546 HD12 ' CD1' ' A' ' 380' ' ' PHE . 12.8 tp -54.44 -42.75 70.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 381' ' ' SER . 13.3 mtpt -61.07 -45.11 96.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.0 57.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.517 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 375' ' ' THR . 58.2 t -55.19 -52.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.117 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.546 ' CD1' HD12 ' A' ' 376' ' ' LEU . 10.8 m-85 -72.23 -20.27 61.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 377' ' ' LYS . 1.6 t -69.26 -12.38 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -67.66 -39.56 84.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.734 HG21 ' HB2' ' A' ' 420' ' ' ALA . 46.2 t -64.64 -35.18 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.433 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . 169.17 -166.85 40.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -73.17 125.46 27.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 410' ' ' GLU . 50.0 mt -85.83 130.5 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -74.36 -52.27 12.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.2 t -160.36 122.97 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.707 ' SG ' HG22 ' A' ' 409' ' ' VAL . 4.5 t -119.39 121.16 38.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 46.5 m -145.76 133.28 20.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 392' ' ' SER . 80.0 mt -99.52 154.89 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.453 ' N ' HG22 ' A' ' 391' ' ' ILE . 38.0 m -73.03 100.15 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 403' ' ' SER . 4.1 mtmp? -124.75 134.66 52.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.11 171.58 8.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -81.38 102.38 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 400' ' ' VAL . 4.7 p30 -76.07 177.23 7.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -40.06 -54.36 2.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.19 -28.06 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.43 30.75 8.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.576 ' H ' ' ND2' ' A' ' 396' ' ' ASN . 17.9 t -110.48 144.39 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -71.68 97.56 1.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.0 mt -114.85 142.76 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.453 ' N ' ' HG2' ' A' ' 393' ' ' LYS . 58.3 m -58.0 160.5 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.543 ' O ' ' CE2' ' A' ' 406' ' ' PHE . 28.7 mtm -116.86 22.71 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 83.66 1.43 90.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 404' ' ' MET . 4.8 p90 -152.8 154.67 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.917 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -150.55 -170.24 17.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.479 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -140.26 121.58 14.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.707 HG22 ' SG ' ' A' ' 389' ' ' CYS . 87.5 t -108.7 141.9 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 386' ' ' ILE . 23.7 tt0 -127.89 145.59 50.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.98 166.3 12.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -68.03 -36.61 80.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -123.28 162.17 41.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.582 0.706 . . . . 0.0 110.889 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.87 -18.86 16.59 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.647 2.231 . . . . 0.0 112.322 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.91 -55.82 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . 0.433 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 42.3 mt-30 -50.33 -31.44 14.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -68.55 -48.12 65.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -60.78 -29.71 69.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -70.86 -63.93 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -49.09 -36.62 19.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 438' ' ' ILE . 7.8 tp -37.58 -69.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 -34.46 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -51.8 -34.76 41.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.731 HD12 ' HB1' ' A' ' 420' ' ' ALA . 85.1 mt -96.41 -29.57 13.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -48.33 144.93 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.4 12.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.462 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -55.26 115.9 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 42.0 m -71.11 114.24 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 73.6 t -121.42 125.78 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.82 27.14 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.811 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 78.51 -3.96 61.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -122.79 142.8 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -88.01 141.65 28.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.3 mt -105.24 157.31 17.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.46 119.76 39.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.75 HG22 HD12 ' A' ' 364' ' ' ILE . 42.5 t -110.39 138.3 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -133.43 163.71 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.755 HD11 HD22 ' A' ' 421' ' ' LEU . 26.8 mm -83.39 95.34 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 32.8 t -78.98 111.65 15.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.83 149.71 50.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.73 147.26 30.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -99.57 -52.64 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 37.0 p -145.74 175.08 10.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.161 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 445' ' ' PRO . 23.5 mmtp -109.31 95.43 18.5 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.543 0.687 . . . . 0.0 110.879 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 444' ' ' LYS . 54.0 Cg_endo -69.77 178.04 4.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.672 2.248 . . . . 0.0 112.369 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -150.88 138.45 19.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 57.7 m -67.1 111.42 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.0 70.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 450' ' ' SER . 53.3 Cg_endo -69.8 127.99 15.35 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.666 2.244 . . . . 0.0 112.362 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 449' ' ' PRO . 86.4 p 34.41 41.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.82 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 3.0 m -95.7 162.49 13.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.526 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.1 t -110.8 41.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.364 . . . . 0.0 110.848 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.7 t -74.1 88.84 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 124.7 90.37 0.86 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.537 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.9 m -146.04 158.77 43.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 110.886 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 7.2 p -121.46 158.04 29.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.55 12.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.478 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.7 mt -142.05 126.32 17.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -90.81 128.7 36.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.603 HD12 HG22 ' A' ' 436' ' ' VAL . 4.1 mm -117.63 144.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -133.14 160.31 37.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 22.6 t30 72.61 40.5 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.44 HD23 HD22 ' A' ' 434' ' ' LEU . 25.1 mt -85.61 148.94 25.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.498 HD21 ' CD2' ' A' ' 432' ' ' HIS . 3.0 m-20 -88.99 124.79 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -46.01 -39.8 9.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.1 m -63.28 -32.51 73.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 99.3 m -59.9 131.11 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 40.0 p -114.19 143.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -40.58 -43.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -38.78 -57.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 76.8 m -62.96 -60.22 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.511 HD11 ' CE1' ' A' ' 380' ' ' PHE . 11.0 tp -39.13 -44.85 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -52.28 -56.17 16.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -59.87 -25.55 61.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 382' ' ' LYS . 57.5 t -73.21 -34.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.987 ' CD2' HG11 ' A' ' 409' ' ' VAL . 9.1 m-85 -94.14 -16.36 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 48.7 p -73.6 -17.08 61.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 379' ' ' VAL . 0.2 OUTLIER -75.43 -18.52 59.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 420' ' ' ALA . 53.8 t -95.3 -41.17 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.442 ' HA3' ' CD ' ' A' ' 416' ' ' GLN . . . -167.44 -178.64 39.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.509 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.57 120.08 22.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.775 0.321 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 36.8 mt -81.8 143.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -105.21 -38.87 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.4 t -160.52 118.09 2.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 409' ' ' VAL . 21.5 t -121.52 116.89 25.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.1 m -142.7 151.15 41.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 406' ' ' PHE . 63.4 mt -107.99 148.86 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.415 ' HB2' ' CD1' ' A' ' 406' ' ' PHE . 10.5 m -64.71 85.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -110.71 137.49 48.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -122.1 156.55 33.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.934 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -73.8 101.5 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.669 ' ND2' HD12 ' A' ' 402' ' ' LEU . 21.7 p30 -77.76 179.24 6.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.914 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -40.33 -54.11 2.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.27 69.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 93.63 31.34 8.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.541 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.98 143.3 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.089 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.11 96.65 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.669 HD12 ' ND2' ' A' ' 396' ' ' ASN . 97.1 mt -105.99 139.29 40.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.1 p -57.9 156.12 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 406' ' ' PHE . 9.4 mtm -116.42 21.94 13.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.2 89.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 404' ' ' MET . 7.8 p90 -149.14 150.4 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -139.51 -172.7 12.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -139.44 116.44 10.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.987 HG11 ' CD2' ' A' ' 380' ' ' PHE . 91.5 t -104.5 124.74 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -107.06 137.1 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.55 162.81 14.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -78.1 -22.92 48.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm -133.44 158.78 74.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -30.28 14.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.625 2.217 . . . . 0.0 112.347 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.6 -39.14 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . 0.442 ' CD ' ' HA3' ' A' ' 384' ' ' GLY . 2.8 mm-40 -51.42 -49.38 61.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.41 75.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -64.88 -29.72 70.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -78.56 -54.63 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -61.94 -24.9 67.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.53 HD22 HD11 ' A' ' 438' ' ' ILE . 14.2 tp -44.8 -56.24 4.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.21 -44.58 5.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -43.28 -46.71 6.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.47 ' CD2' ' HE2' ' A' ' 382' ' ' LYS . 30.6 mt -80.94 -43.53 19.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 4.2 tp60 -47.25 121.03 3.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.75 -20.11 37.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -60.23 130.06 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.7 m -70.49 96.32 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.115 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.11 112.95 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 62.1 26.02 15.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 70.0 6.58 57.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . 0.498 ' CD2' HD21 ' A' ' 368' ' ' ASN . 21.8 m-70 -121.38 120.59 35.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 110.836 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -71.72 107.39 4.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.44 HD22 HD23 ' A' ' 367' ' ' LEU . 11.2 mt -67.74 161.56 25.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -119.6 99.26 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.603 HG22 HD12 ' A' ' 364' ' ' ILE . 60.4 t -88.15 134.72 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -143.46 145.99 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.53 HD11 HD22 ' A' ' 421' ' ' LEU . 7.1 mm -70.39 98.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.0 p -43.24 135.61 3.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -79.6 -61.18 2.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.89 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.98 149.75 21.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -110.77 85.27 2.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.4 t -146.44 135.16 22.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.104 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -81.94 147.08 57.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.52 0.676 . . . . 0.0 110.936 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 446' ' ' ALA . 54.3 Cg_endo -69.77 2.87 3.15 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.684 2.256 . . . . 0.0 112.357 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 445' ' ' PRO . . . -34.95 141.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 6.2 t -96.01 153.43 17.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.05 -158.07 7.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 124.29 10.91 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 2.242 . . . . 0.0 112.323 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 38.1 t -108.43 121.59 45.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 59.5 m -92.62 101.33 13.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.88 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.486 -179.961 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 19.2 m -59.62 121.58 11.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.873 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 34.3 m -126.74 90.67 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 71.42 168.06 8.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.7 m -155.22 138.58 15.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.809 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.96 150.68 21.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.845 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 119.22 143.69 7.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.445 HD22 ' CG1' ' A' ' 436' ' ' VAL . 6.2 mt -146.55 132.49 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.359 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.443 ' C ' HD13 ' A' ' 364' ' ' ILE . 1.2 t80 -95.77 126.48 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 3.7 mm -112.15 144.78 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -133.87 162.33 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.42 ' O ' HD23 ' A' ' 434' ' ' LEU . 19.3 t-20 68.47 43.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.28 106.5 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 371' ' ' THR . 7.3 m120 -46.92 122.23 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -43.59 -24.46 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 70.2 m -77.05 -38.96 51.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 368' ' ' ASN . 25.5 m -48.8 131.83 18.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 76.5 p -108.48 148.44 30.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 374' ' ' GLU . 2.8 mp0 -45.57 -50.76 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 373' ' ' GLU . 5.8 mm-40 -36.09 -67.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 378' ' ' GLY . 71.1 m -48.71 -67.79 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.154 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.545 ' CD1' ' CE1' ' A' ' 380' ' ' PHE . 7.2 tp -35.82 -46.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -64.84 -44.53 89.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 375' ' ' THR . . . -60.43 -21.38 57.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.98 -48.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 376' ' ' LEU . 10.0 m-85 -70.23 -29.33 66.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 53.5 p -58.74 -19.59 41.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.892 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -64.26 -36.58 84.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 420' ' ' ALA . 76.0 t -64.94 -47.66 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.468 ' HA3' ' NE2' ' A' ' 416' ' ' GLN . . . -175.82 -154.43 11.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.523 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.622 ' HB1' ' HE3' ' A' ' 412' ' ' LYS . . . -82.77 125.83 31.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.759 0.314 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 45.2 mt -93.02 130.13 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.123 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -77.5 -49.03 15.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.1 t -169.73 117.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 409' ' ' VAL . 51.2 t -108.94 128.6 55.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.3 t -140.06 163.15 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.35 137.23 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 m -56.04 102.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 402' ' ' LEU . 35.6 mtmt -125.66 136.9 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -128.37 156.26 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -71.71 104.24 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 399' ' ' GLY . 0.5 OUTLIER -79.33 178.82 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -38.61 -53.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.98 74.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 98.77 22.21 14.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.4 ' O ' ' OD1' ' A' ' 396' ' ' ASN . 45.8 t -101.34 143.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.376 . . . . 0.0 111.105 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.67 96.03 2.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 393' ' ' LYS . 91.6 mt -109.41 143.82 38.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.4 p -57.91 161.56 3.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.586 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 35.9 mtp -117.03 16.7 15.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.02 86.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.51 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 404' ' ' MET . 4.9 p90 -153.02 155.07 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -148.76 -176.01 21.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -127.29 123.26 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' A' ' 380' ' ' PHE . 77.8 t -105.62 106.1 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -85.36 152.72 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -132.7 152.22 51.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.622 ' HE3' ' HB1' ' A' ' 385' ' ' ALA . 4.6 mtmp? -65.22 -32.62 74.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -135.14 141.73 39.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.91 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 415' ' ' GLU . 74.2 Cg_exo -47.64 -58.66 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.689 2.259 . . . . 0.0 112.378 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 414' ' ' PRO . 32.1 mt-10 -37.59 -57.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . 0.468 ' NE2' ' HA3' ' A' ' 384' ' ' GLY . 26.8 mm-40 -43.52 -46.09 6.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.441 ' O ' HD11 ' A' ' 362' ' ' LEU . . . -61.62 -49.4 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.144 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -56.6 -27.26 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -77.81 -63.98 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -52.73 -19.44 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.829 HD22 HD11 ' A' ' 438' ' ' ILE . 45.5 tp -51.28 -64.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 423' ' ' GLN . 0.0 OUTLIER -92.67 -47.64 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . 0.479 ' N ' ' HD3' ' A' ' 422' ' ' LYS . 2.7 tm0? -38.27 -34.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 420' ' ' ALA . 94.3 mt -96.84 -31.8 12.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.463 ' NE2' HG23 ' A' ' 436' ' ' VAL . 6.5 tp60 -49.63 135.04 19.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.86 -24.94 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.457 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -56.18 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 99.7 m -70.44 106.95 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.155 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.759 HG21 HD11 ' A' ' 434' ' ' LEU . 94.1 t -106.51 118.89 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 62.27 31.06 17.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 79.95 -8.29 51.41 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -122.03 129.54 52.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.41 145.92 50.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 429' ' ' VAL . 7.6 mt -103.57 158.81 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -108.98 119.93 41.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.463 HG23 ' NE2' ' A' ' 425' ' ' GLN . 14.5 t -109.99 133.87 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.405 ' HG2' ' C ' ' A' ' 436' ' ' VAL . 8.3 mmm180 -142.0 149.29 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.829 HD11 HD22 ' A' ' 421' ' ' LEU . 25.8 mm -70.14 96.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 3.8 t -86.5 47.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.93 -47.62 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -92.88 106.65 18.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -80.77 163.78 23.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.139 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 23.6 p -56.61 -56.01 26.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.178 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -90.74 138.99 26.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.528 0.68 . . . . 0.0 110.923 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 146.83 61.34 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -120.91 86.33 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.087 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 15.6 m -129.54 177.43 7.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.48 74.08 0.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 144.61 54.47 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.7 2.267 . . . . 0.0 112.319 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 68.2 m -56.86 164.56 1.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 17.9 t -96.36 88.33 4.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' SER . . . . . . . . . . . . . 1.1 t -41.85 127.44 3.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 110.887 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 6.6 m -157.99 163.67 37.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -75.47 94.17 0.93 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.5 m -103.82 82.89 2.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 64.8 p -95.96 128.01 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 408' ' ' PHE . . . 140.63 141.92 4.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 409' ' ' VAL . 8.4 mt -140.21 127.64 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 363' ' ' PHE . 0.3 OUTLIER -87.98 135.63 33.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 406' ' ' PHE . 1.8 mm -126.05 142.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 363' ' ' PHE . 7.4 tptp -133.52 159.12 41.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 70.13 45.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.569 HD23 HD22 ' A' ' 434' ' ' LEU . 37.4 mt -93.53 108.27 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -51.02 124.31 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -46.48 -28.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -36.94 70.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.83 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' THR . . . . . . . . . . . . . 60.2 m -54.95 127.91 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.5 p -99.19 178.44 4.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.89 -47.49 21.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -42.34 -61.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . . . . . . . . . 26.5 m -49.22 -62.36 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.155 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . . . . . . . . . 23.0 tp -45.11 -48.56 12.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 389' ' ' CYS . 14.7 mmmt -49.34 -50.07 41.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -65.41 -34.63 89.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.494 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.49 -44.81 98.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.694 ' CD2' HG11 ' A' ' 409' ' ' VAL . 5.9 m-85 -80.59 -35.31 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -29.02 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -55.62 -41.61 73.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 420' ' ' ALA . 57.5 t -61.79 -39.83 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 169.23 -160.42 33.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.447 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.49 131.72 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . . . . . . . . . 55.1 mt -98.01 134.84 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -81.26 -49.21 11.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.3 t -165.66 116.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.425 ' HB3' ' CD ' ' A' ' 377' ' ' LYS . 4.8 t -111.77 123.11 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 t -138.08 151.66 48.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.9 139.33 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.141 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 58.0 m -58.43 94.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -121.69 148.25 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -139.1 171.17 14.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -83.55 103.17 12.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.727 ' ND2' HD12 ' A' ' 402' ' ' LEU . 9.0 p30 -79.94 177.8 8.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 398' ' ' ALA . 13.2 ptmt -43.77 -35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 397' ' ' LYS . . . -78.8 -32.92 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 396' ' ' ASN . . . 97.25 18.93 27.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.496 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.453 ' O ' ' ND2' ' A' ' 396' ' ' ASN . 59.4 t -102.43 143.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.142 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.88 96.9 2.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.727 HD12 ' ND2' ' A' ' 396' ' ' ASN . 73.7 mt -111.12 148.4 32.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 25.4 m -57.95 159.79 5.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . 0.47 ' O ' ' CE1' ' A' ' 406' ' ' PHE . 46.6 mtp -116.98 13.82 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 93.8 -4.87 72.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.491 ' CB ' ' O ' ' A' ' 364' ' ' ILE . 1.7 p90 -153.61 158.8 41.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.18 -178.3 24.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . 0.432 ' CZ ' ' HA3' ' A' ' 361' ' ' GLY . 37.8 t80 -131.96 109.75 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.37 . . . . 0.0 110.898 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.694 HG11 ' CD2' ' A' ' 380' ' ' PHE . 71.3 t -100.35 124.97 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -110.73 142.35 42.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 417' ' ' ALA . 18.6 m-85 -114.83 154.12 29.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -61.83 -34.42 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -122.0 156.97 59.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.578 0.704 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.2 -8.48 19.87 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.341 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.11 -49.51 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 383' ' ' VAL . 30.7 mm100 -52.25 -39.94 61.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 411' ' ' TYR . . . -66.01 -40.02 90.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -63.05 -32.48 73.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -72.7 -66.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.964 ' HB2' HG21 ' A' ' 383' ' ' VAL . . . -44.99 -36.61 3.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 438' ' ' ILE . 12.6 tp -34.66 -64.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -96.76 -41.51 8.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 383' ' ' VAL . 8.2 tt0 -39.56 -41.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 380' ' ' PHE . 91.1 mt -92.21 -28.54 16.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 434' ' ' LEU . 6.2 tp60 -48.78 138.32 11.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 97.82 -26.04 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -60.11 118.26 6.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 28.7 m -69.88 132.08 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 95.1 t -135.29 123.01 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 59.13 29.82 19.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 82.97 -13.56 43.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -116.93 145.19 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -88.59 144.02 26.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.569 HD22 HD23 ' A' ' 367' ' ' LEU . 8.3 mt -97.2 149.83 21.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -108.19 112.78 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.78 139.58 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -147.45 149.46 32.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . 0.731 HD11 HD22 ' A' ' 421' ' ' LEU . 19.0 mm -68.68 95.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 440' ' ' GLU . 3.9 t -79.19 46.85 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 439' ' ' SER . 29.3 tt0 -36.08 -62.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -65.11 105.49 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -127.54 175.15 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 62.0 p -80.87 105.82 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.138 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 445' ' ' PRO . 5.1 mmpt? -107.2 95.44 13.18 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.555 0.693 . . . . 0.0 110.855 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 444' ' ' LYS . 54.2 Cg_endo -69.72 151.42 69.29 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.259 . . . . 0.0 112.344 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -136.24 112.07 9.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.059 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 39.6 m -117.09 140.87 48.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.852 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 99.9 -166.06 20.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.478 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 0.18 6.02 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.668 2.245 . . . . 0.0 112.368 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 4.3 m 60.68 53.95 3.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 32.0 t -74.3 156.93 36.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 -179.982 . . . . . . . . 0 0 . 1 stop_ save_